
<html lang="en"     class="pb-page"  data-request-id="9c38847a-8c7d-43ab-961d-25810f39c084"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2014.57.issue-5;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm401840s;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection" /></meta><meta name="dc.Creator" content="Paul M.  Scola" /></meta><meta name="dc.Creator" content="Alan Xiangdong  Wang" /></meta><meta name="dc.Creator" content="Andrew C.  Good" /></meta><meta name="dc.Creator" content="Li-Qiang  Sun" /></meta><meta name="dc.Creator" content="Keith D.  Combrink" /></meta><meta name="dc.Creator" content="Jeffrey A.  Campbell" /></meta><meta name="dc.Creator" content="Jie  Chen" /></meta><meta name="dc.Creator" content="Yong  Tu" /></meta><meta name="dc.Creator" content="Ny  Sin" /></meta><meta name="dc.Creator" content="Brian L.  Venables" /></meta><meta name="dc.Creator" content="Sing-Yuen  Sit" /></meta><meta name="dc.Creator" content="Yan  Chen" /></meta><meta name="dc.Creator" content="Anthony  Cocuzza" /></meta><meta name="dc.Creator" content="Donna M.  Bilder" /></meta><meta name="dc.Creator" content="Stanley  D’Andrea" /></meta><meta name="dc.Creator" content="Barbara  Zheng" /></meta><meta name="dc.Creator" content="Piyasena  Hewawasam" /></meta><meta name="dc.Creator" content="Min  Ding" /></meta><meta name="dc.Creator" content="Jan  Thuring" /></meta><meta name="dc.Creator" content="Jianqing  Li" /></meta><meta name="dc.Creator" content="Dennis  Hernandez" /></meta><meta name="dc.Creator" content="Fei  Yu" /></meta><meta name="dc.Creator" content="Paul  Falk" /></meta><meta name="dc.Creator" content="Guangzhi  Zhai" /></meta><meta name="dc.Creator" content="Amy K.  Sheaffer" /></meta><meta name="dc.Creator" content="Chaoqun  Chen" /></meta><meta name="dc.Creator" content="Min S.  Lee" /></meta><meta name="dc.Creator" content="Diana  Barry" /></meta><meta name="dc.Creator" content="Jay O.  Knipe" /></meta><meta name="dc.Creator" content="Wenying  Li" /></meta><meta name="dc.Creator" content="Yong-Hae  Han" /></meta><meta name="dc.Creator" content="Susan  Jenkins" /></meta><meta name="dc.Creator" content="Christoph  Gesenberg" /></meta><meta name="dc.Creator" content="Qi  Gao" /></meta><meta name="dc.Creator" content="Michael W.  Sinz" /></meta><meta name="dc.Creator" content="Kenneth S.  Santone" /></meta><meta name="dc.Creator" content="Tatyana  Zvyaga" /></meta><meta name="dc.Creator" content="Ramkumar  Rajamani" /></meta><meta name="dc.Creator" content="Herbert E.  Klei" /></meta><meta name="dc.Creator" content="Richard J.  Colonno" /></meta><meta name="dc.Creator" content="Dennis M.  Grasela" /></meta><meta name="dc.Creator" content="Eric  Hughes" /></meta><meta name="dc.Creator" content="Caly  Chien" /></meta><meta name="dc.Creator" content="Stephen  Adams" /></meta><meta name="dc.Creator" content="Paul C.  Levesque" /></meta><meta name="dc.Creator" content="Danshi  Li" /></meta><meta name="dc.Creator" content="Jialong  Zhu" /></meta><meta name="dc.Creator" content="Nicholas A.  Meanwell" /></meta><meta name="dc.Creator" content="Fiona  McPhee" /></meta><meta name="dc.Description" content="The discovery of BMS-605339 (35), a tripeptidic inhibitor of the NS3/4A enzyme, is described. This compound incorporates a cyclopropylacylsulfonamide moiety that was designed to improve the potency..." /></meta><meta name="Description" content="The discovery of BMS-605339 (35), a tripeptidic inhibitor of the NS3/4A enzyme, is described. This compound incorporates a cyclopropylacylsulfonamide moiety that was designed to improve the potency..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 20, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401840s" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401840s" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401840s" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401840s" /></link>
        
    
    

<title>Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401840s" /></meta><meta property="og:title" content="Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0018.jpeg" /></meta><meta property="og:description" content="The discovery of BMS-605339 (35), a tripeptidic inhibitor of the NS3/4A enzyme, is described. This compound incorporates a cyclopropylacylsulfonamide moiety that was designed to improve the potency of carboxylic acid prototypes through the introduction of favorable nonbonding interactions within the S1′ site of the protease. The identification of 35 was enabled through the optimization and balance of critical properties including potency and pharmacokinetics (PK). This was achieved through modulation of the P2* subsite of the inhibitor which identified the isoquinoline ring system as a key template for improving PK properties with further optimization achieved through functionalization. A methoxy moiety at the C6 position of this isoquinoline ring system proved to be optimal with respect to potency and PK, thus providing the clinical compound 35 which demonstrated antiviral activity in HCV-infected patients." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401840s"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401840s">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401840s&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401840s&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401840s&amp;href=/doi/10.1021/jm401840s" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 1708-1729</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401312n" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm500297k" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+M.++Scola">Paul M. Scola</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan+Xiangdong++Wang">Alan Xiangdong Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+C.++Good">Andrew C. Good</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li-Qiang++Sun">Li-Qiang Sun</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Keith+D.++Combrink">Keith D. Combrink</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey+A.++Campbell">Jeffrey A. Campbell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jie++Chen">Jie Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yong++Tu">Yong Tu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ny++Sin">Ny Sin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian+L.++Venables">Brian L. Venables</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sing-Yuen++Sit">Sing-Yuen Sit</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yan++Chen">Yan Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anthony++Cocuzza">Anthony Cocuzza</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donna+M.++Bilder">Donna M. Bilder</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stanley++D%E2%80%99Andrea">Stanley D’Andrea</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barbara++Zheng">Barbara Zheng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Piyasena++Hewawasam">Piyasena Hewawasam</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Min++Ding">Min Ding</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jan++Thuring">Jan Thuring</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jianqing++Li">Jianqing Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>×</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dennis++Hernandez">Dennis Hernandez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fei++Yu">Fei Yu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Falk">Paul Falk</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guangzhi++Zhai">Guangzhi Zhai</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amy+K.++Sheaffer">Amy K. Sheaffer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chaoqun++Chen">Chaoqun Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Min+S.++Lee">Min S. Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Diana++Barry">Diana Barry</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jay+O.++Knipe">Jay O. Knipe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wenying++Li">Wenying Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yong-Hae++Han">Yong-Hae Han</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan++Jenkins">Susan Jenkins</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christoph++Gesenberg">Christoph Gesenberg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qi++Gao">Qi Gao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∞</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+W.++Sinz">Michael W. Sinz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth+S.++Santone">Kenneth S. Santone</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tatyana++Zvyaga">Tatyana Zvyaga</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ramkumar++Rajamani">Ramkumar Rajamani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Herbert+E.++Klei">Herbert E. Klei</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard+J.++Colonno">Richard J. Colonno</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dennis+M.++Grasela">Dennis M. Grasela</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric++Hughes">Eric Hughes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Caly++Chien">Caly Chien</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen++Adams">Stephen Adams</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+C.++Levesque">Paul C. Levesque</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Danshi++Li">Danshi Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jialong++Zhu">Jialong Zhu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas+A.++Meanwell">Nicholas A. Meanwell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fiona++McPhee">Fiona McPhee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Virology Discovery Biology, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Computer-Assisted Drug Design, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Department of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Department of Early Clinical and Translational Research, Discovery Medicine—Virology, Bristol-Myers Squibb Research and Development, Hopewell, New Jersey 08543, United States</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">Department of Lead Discovery and Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div><div class="aff-info" id="aff7"><span class="aff-symbol">∞</span> <span class="aff-text">Department of Pharmaceutical Development, Bristol-Myers Squibb Research and Development, 1 Squibb Drive, New Brunswick, New Jersey 08903, United States</span></div><div class="aff-info" id="aff8"><span class="aff-symbol">×</span> <span class="aff-text">Department of Discovery Chemical Synthesis, Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 203-677-7870. Fax: 203-677-7804. E-mail: <a href="/cdn-cgi/l/email-protection#98c8f9edf4b6cbfbf7f4f9d8faf5ebb6fbf7f5"><span class="__cf_email__" data-cfemail="dd8dbca8b1f38ebeb2b1bc9dbfb0aef3beb2b0">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401840s&amp;href=/doi/10.1021%2Fjm401840s" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 1708–1729</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 20, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 November 2013</li><li><span class="item_label"><b>Published</b> online</span>20 February 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 March 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401840s" title="DOI URL">https://doi.org/10.1021/jm401840s</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1708%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPaul%2BM.%2BScola%252C%2BAlan%2BXiangdong%2BWang%252C%2BAndrew%2BC.%2BGood%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D5%26contentID%3Djm401840s%26title%3DDiscovery%2Band%2BEarly%2BClinical%2BEvaluation%2Bof%2BBMS-605339%252C%2Ba%2BPotent%2Band%2BOrally%2BEfficacious%2BTripeptidic%2BAcylsulfonamide%2BNS3%2BProtease%2BInhibitor%2Bfor%2Bthe%2BTreatment%2Bof%2BHepatitis%2BC%2BVirus%2BInfection%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1729%26publicationDate%3DMarch%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401840s"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2274</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">47</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401840s" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;M. Scola&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;Xiangdong Wang&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;C. Good&quot;},{&quot;first_name&quot;:&quot;Li-Qiang&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Keith&quot;,&quot;last_name&quot;:&quot;D. Combrink&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;A. Campbell&quot;},{&quot;first_name&quot;:&quot;Jie&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Yong&quot;,&quot;last_name&quot;:&quot;Tu&quot;},{&quot;first_name&quot;:&quot;Ny&quot;,&quot;last_name&quot;:&quot;Sin&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;L. Venables&quot;},{&quot;first_name&quot;:&quot;Sing-Yuen&quot;,&quot;last_name&quot;:&quot;Sit&quot;},{&quot;first_name&quot;:&quot;Yan&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;Cocuzza&quot;},{&quot;first_name&quot;:&quot;Donna&quot;,&quot;last_name&quot;:&quot;M. Bilder&quot;},{&quot;first_name&quot;:&quot;Stanley&quot;,&quot;last_name&quot;:&quot;D’Andrea&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;Zheng&quot;},{&quot;first_name&quot;:&quot;Piyasena&quot;,&quot;last_name&quot;:&quot;Hewawasam&quot;},{&quot;first_name&quot;:&quot;Min&quot;,&quot;last_name&quot;:&quot;Ding&quot;},{&quot;first_name&quot;:&quot;Jan&quot;,&quot;last_name&quot;:&quot;Thuring&quot;},{&quot;first_name&quot;:&quot;Jianqing&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;Hernandez&quot;},{&quot;first_name&quot;:&quot;Fei&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Falk&quot;},{&quot;first_name&quot;:&quot;Guangzhi&quot;,&quot;last_name&quot;:&quot;Zhai&quot;},{&quot;first_name&quot;:&quot;Amy&quot;,&quot;last_name&quot;:&quot;K. Sheaffer&quot;},{&quot;first_name&quot;:&quot;Chaoqun&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Min&quot;,&quot;last_name&quot;:&quot;S. Lee&quot;},{&quot;first_name&quot;:&quot;Diana&quot;,&quot;last_name&quot;:&quot;Barry&quot;},{&quot;first_name&quot;:&quot;Jay&quot;,&quot;last_name&quot;:&quot;O. Knipe&quot;},{&quot;first_name&quot;:&quot;Wenying&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Yong-Hae&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;Jenkins&quot;},{&quot;first_name&quot;:&quot;Christoph&quot;,&quot;last_name&quot;:&quot;Gesenberg&quot;},{&quot;first_name&quot;:&quot;Qi&quot;,&quot;last_name&quot;:&quot;Gao&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;W. Sinz&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;S. Santone&quot;},{&quot;first_name&quot;:&quot;Tatyana&quot;,&quot;last_name&quot;:&quot;Zvyaga&quot;},{&quot;first_name&quot;:&quot;Ramkumar&quot;,&quot;last_name&quot;:&quot;Rajamani&quot;},{&quot;first_name&quot;:&quot;Herbert&quot;,&quot;last_name&quot;:&quot;E. Klei&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;J. Colonno&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;M. Grasela&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;Hughes&quot;},{&quot;first_name&quot;:&quot;Caly&quot;,&quot;last_name&quot;:&quot;Chien&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;Adams&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;C. Levesque&quot;},{&quot;first_name&quot;:&quot;Danshi&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Jialong&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;A. Meanwell&quot;},{&quot;first_name&quot;:&quot;Fiona&quot;,&quot;last_name&quot;:&quot;McPhee&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;1708-1729&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401840s&quot;},&quot;abstract&quot;:&quot;The discovery of BMS-605339 (35), a tripeptidic inhibitor of the NS3/4A enzyme, is described. This compound incorporates a cyclopropylacylsulfonamide moiety that was designed to improve the potency of carboxylic acid prototypes through the introduction of favorable nonbonding interactions within the S1′ site of the protease. The identification of 35 was enabled through the optimization and balance of critical properties including potency and pharmacokinetics (PK). This was achieved through modulation of the P2* subsite of the inhibitor which identified the isoquinoline ring system as a key template for improving PK properties with further optimization achieved through functionalization. A methoxy moiety at the C6 position of this isoquinoline ring system proved to be optimal with respect to potency and PK, thus providing the clinical compound 35 which demonstrated antiviral activity in HCV-infected patients.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401840s&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401840s" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401840s&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401840s" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401840s&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401840s" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401840s&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401840s&amp;href=/doi/10.1021/jm401840s" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401840s" /></input><a href="/doi/pdf/10.1021/jm401840s" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401840s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401840s%26sid%3Dliteratum%253Aachs%26pmid%3D24555570%26genre%3Darticle%26aulast%3DScola%26date%3D2014%26atitle%3DDiscovery%2Band%2BEarly%2BClinical%2BEvaluation%2Bof%2BBMS-605339%252C%2Ba%2BPotent%2Band%2BOrally%2BEfficacious%2BTripeptidic%2BAcylsulfonamide%2BNS3%2BProtease%2BInhibitor%2Bfor%2Bthe%2BTreatment%2Bof%2BHepatitis%2BC%2BVirus%2BInfection%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D5%26spage%3D1708%26epage%3D1729%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jmcmar.2014.57.issue-5/production/jmcmar.2014.57.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401840s&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The discovery of BMS-605339 (<b>35</b>), a tripeptidic inhibitor of the NS3/4A enzyme, is described. This compound incorporates a cyclopropylacylsulfonamide moiety that was designed to improve the potency of carboxylic acid prototypes through the introduction of favorable nonbonding interactions within the S1′ site of the protease. The identification of <b>35</b> was enabled through the optimization and balance of critical properties including potency and pharmacokinetics (PK). This was achieved through modulation of the P2* subsite of the inhibitor which identified the isoquinoline ring system as a key template for improving PK properties with further optimization achieved through functionalization. A methoxy moiety at the C6 position of this isoquinoline ring system proved to be optimal with respect to potency and PK, thus providing the clinical compound <b>35</b> which demonstrated antiviral activity in HCV-infected patients.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/57/5"><issue-title>HCV Therapies</issue-title></a> special issue.</p></div><div class="extra-info-sec articleNote withdrawn"><h4><span></span> Accession Codes</h4><p class="last">The PDB code for <b>35</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NWK">4NWK</a>.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86477" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86477" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Hepatitis C virus (HCV) is a global pandemic that afflicts approximately 3% of the world’s population.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1-4)</a> The insidious nature of this disease is underscored by its benign presentation during the acute phase and the paucity of specific symptoms throughout the early stages. In its advanced stages, however, HCV is debilitating, as a significant number of patients suffer from advanced cirrhosis and ultimately hepatocellular carcinoma.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> Hepatitis C virus exists as six major genotypes (GT-1–6), each of which can be found as distinct clusters in regions throughout the world.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> Upon treatment, individuals infected with hepatitis C can potentially be cleared of the virus, but the drug regimen employed and viral response rates are dependent on genotype. Immune modulation was the initial cornerstone of therapy with pegylated (PEG) interferon-α combined with ribavirin administered to accomplish this goal.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Patients infected with GT-2 or GT-3 respond best to treatment with this regimen, with sustained viral responses (SVRs) of 70–80% measured at 24 weeks after treatment. In contrast, the SVR rates for GT-1 patients treated with PEG interferon-α and ribavirin are less than 50%. Hence, in the development of direct acting antivirals, the GT-1 virus has been a primary focus of efforts due to the more acute medical need. As a consequence of those efforts, treatment for individuals infected with HCV GT-1 has evolved to depend on the use of PEG interferon-α and ribavirin<a onclick="showRef(event, 'ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12">(9-12)</a> in conjunction with one of the two recently approved HCV NS3 protease inhibitors, boceprevir or telaprevir.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> Supplementing the former standard of care regimen with either of these small molecule, direct-acting antiviral agents has resulted in an increase in SVR rates.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> However, both of these protease inhibitors require thrice daily (t.i.d.) dosing, a regimen generally associated with compliance issues, particularly against the backdrop of the side effect profile of the combination of PEG interferon-α and ribavirin, which in turn may facilitate the emergence of drug resistant virus. In addition, treatment with boceprevir therapy is further complicated by a 4-week lead-in with PEG interferon-α and ribavirin, while telaprevir has recently been issued a black box warning by the FDA in response to reports of toxic epidermal necrolysis in patients receiving the drug.<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16-18)</a> Hence, a need exists for the identification of effective HCV inhibitors that are amenable to less frequent dosing schedules while also demonstrating improved efficacy and safety profiles that can be combined with mechanistically orthogonal agents.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> In this article, we describe the design concept behind the discovery of acylsulfonamide-based tripeptidic inhibitors of the viral NS3/4A protease and the prosecution of this chemical series that culminated in the advancement of a compound into phase I clinical trials for the treatment of HCV-infected patients.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37302" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37302" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our efforts in this area began with analysis of the hexapeptide <b>1</b>, reported as a potent inhibitor of the NS3/4A protease complex.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> As described, when bound to the active site of the enzyme, this peptide engaged in a series of nonbonding interactions with the enzyme that extended along the nonprime binding groove (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Of particular interest were interactions involving the C-terminus carboxylic acid group of <b>1</b> which engages in a salt bridge interaction with the catalytic histidine while also functioning as an acceptor of a hydrogen bond from the backbone of glycine 139 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Single point mutagenesis studies and structure–activity relationship determinations indicated that these nonbonding interactions between the P1 acid of peptide <b>1</b> and the NS3/4A enzyme complex were essential for enzyme inhibition.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0019.gif" alt="" id="GRAPHIC-d1971e865-autogenerated" /></img><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Details of the binding interactions of peptide inhibitor <b>1</b> bound to the NS3/4A complex.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401840s&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Surface of NS3/4A enzyme illustrating the S1 and S1′ subsites.  Close-up of 1 bound to NS3/4A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401840s&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the evaluation of strategies to further the binding capacity of peptidic inhibitors such as <b>1</b>, the concept of improving potency via interactions within the S1′ subsite of the NS3/4A enzyme was considered.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> As illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, the S1′ site is a shallow pocket along the surface of the peptide that is contiguous with the oxyanion hole. In an effort to enhance the binding interaction of these peptidic inhibitors of the NS3/4A enzyme, a ligand design strategy was pursued in which the essential interactions between the carboxylic acid group of <b>1</b> and the catalytic site were maintained while projecting functionality into the S1′ site. On the basis of modeling considerations, acylsulfonamides were proposed as a structural motif that could maintain the electrostatic interactions of the parent carboxylic acid while offering the potential to extend structural elements into the prime side of the enzyme and engage in favorable nonbonding interactions. The disclosure of tripeptidic carboxylic acids represented by <b>2</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) as potent inhibitors of HCV NS3/4A led to the selection of this chemotype as a suitable vehicle with which to explore the concept.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. HCV Inhibitory Profile of the Tripeptide Carboxylic Acid <b>2</b> and Acylsulfonamide Homologues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0010.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0011.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_p">The tripeptidic methylacylsulfonamide <b>3</b> presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> was the first compound prepared to explore the design concept and proved to be equipotent in a GT-1a enzyme inhibition assay with the carboxylic acid prototype <b>2</b>.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> This result was meaningful, since it indicated that the methylsulfonamide moiety of <b>3</b> bound effectively in the catalytic site of the enzyme and thus served as a functional replacement for the terminal carboxylic acid. Guided by the model, the prime side SAR was further explored by introducing structural features designed to more effectively complement the uniquely defined S1′ subsite. Most immediately, the cyclopropylacylsulfonamide <b>6</b> was evaluated and this compound inhibited HCV NS3/4A activity with an IC<sub>50</sub> of 1 nM. The potency of <b>6</b> represents an approximately 50-fold enhancement in intrinsic activity compared to carboxylic acid <b>2</b> and a 30-fold increase in activity compared to the prototypical acylsulfonamide <b>3</b>. Close analogues of cyclopropylsulfonamide <b>6</b> were significantly less active, with the ethylacylsulfonamide <b>4</b> showing 6-fold reduced intrinsic activity (IC<sub>50</sub> = 6 nM) when compared to <b>6</b>, while the isopropylacylsulfonamide <b>5</b>, which adds just two hydrogen atoms to <b>6</b>, is 19-fold weaker, IC<sub>50</sub> = 19 nM. The rationale for the enhanced potency associated with cyclopropylsulfonamide <b>6</b> compared to carboxylic acid <b>2</b> was evident from a modeled structure of <b>6</b> bound to the NS3/4A enzyme, depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a. In general, the spatial orientation of the acylsulfonamide group of <b>6</b> with respect to the catalytic site and S1′ pocket of the enzyme suggests that productive nonbonding interactions in these regions are responsible for the observed gain in potency. Specifically, the nitrogen of the acylsulfonamide group participates in a salt bridge with the catalytic histidine of NS3 protease, an observation consistent with the relative p<i>K</i><sub>a</sub> of this functionality,<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24-26)</a> while the carbonyl moiety accepts a hydrogen bond from glycine 137 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>b). The presence of charge on the amide nitrogen rather than oxygen is supported by calculations of the electrostatic potential for the acylsulfonamide group as well as crystal structure data reported for acylsulfonamides.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Most interestingly, the electron withdrawing sulfonyl group of <b>6</b> has multiple functions, since it acidifies the amide N–H while presenting hydrogen-bond-accepting capacity to the oxyanion whole via its diastereotopic oxygen atoms, each of which engages a backbone NH, one to Gly137 and the other to Ser139 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>b). Moreover, the bridging sulfonyl moiety positions the terminal cyclopropyl ring in the S1′ pocket where it engages in favorable hydrophobic interactions with the enzyme subsite. This specific aliphatic binding element was critical to activity while also sensitive to small structural modifications, since simple ring-opening to <b>5</b> or expansion to a cyclobutane (<b>7</b>), cyclopentane (<b>8</b>), or cyclohexane (<b>9</b>) resulted in a marked reduction in inhibitory activity although the phenyl analogue <b>10</b>, the unsaturated homologue of <b>9</b>, is 18-fold more potent than <b>9</b> but still markedly less potent than <b>6</b>. These prime side SARs were rationalized using a plot of the van der Waals surface of the protein which highlights the shallow cavity within the S1′ site that is defined by Gln41, Phe43, Val55, and Gly58, with Phe43 forming the base (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>c). An assessment of the optimized geometries of the sulfonamide caps in analogues <b>3</b>–<b>9</b> suggested that the cyclopropyl moiety exhibited a shape most complementary with the S1′ pocket, thus maximizing van der Waals surface contact and explaining the potency of <b>6</b>. Though most of the S1′ site is static, based on modeling efforts, the mobility of Gln41 allows for accommodation of larger groups such as phenyl substitution (<b>10</b>), albeit being a suboptimal fit in the shallow cavity.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0003.jpeg" id="GRAPHIC-d1971e1052-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Model of acylsulfonamide <b>6</b> bound to the NS3/4A protease enzyme. (b) Key interactions between the acylsulfonamide moiety and the NS3 protein. (c) Cyclopropyl moiety bound to the S1′ pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401840s&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The tripeptidic acylsulfonamide <b>6</b> and carboxylic acid <b>2</b> were evaluated in a cell-based HCV replicon assay<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> derived from HCV GT-1b wherein <b>6</b> with EC<sub>50</sub> = 4 nM was 120-fold more potent than <b>2</b>, EC<sub>50</sub> = 550 nM. Importantly, the enhanced cell-based antiviral activity of acylsulfonamide <b>6</b> compared to carboxylic acid <b>2</b> was consistent with the comparative potency of these inhibitors in the biochemical screen. From a drug design perspective, the acylsulfonamide functionality provides enhanced potency both in biochemical and in cell-based assays without resort to the use of either conformational restraint tactics<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (e.g., macrocyclization) or mechanism-based motifs<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and this structural feature has been widely adopted in NS3 protease inhibitor design.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p">The low nanomolar potency of <b>6</b> in the cell-based assay met our target criteria for antiviral activity in cell culture, and efforts turned to optimizing the pharmacokinetics (PK) properties of this series. The PK profile of <b>6</b> was determined in both rat and dog. When dosed orally to rats at 20 mg/kg, <b>6</b> demonstrated an exposure of 0.73 μM·h and an oral bioavailability of 9%. Intravenous adminstration of <b>6</b> at 5 mg/kg resulted in clearance of 55 mL min<sup>–1</sup> kg<sup>–1</sup> and a half-life of 1 h. A similar PK profile was observed for <b>6</b> in the dog (3 mg/kg dose) with exposure of 2.0 μM·h, oral bioavailability of 20%, clearance of 16 mL min<sup>–1</sup> kg<sup>–1</sup>, and a half-life of 0.6 h. Since the overall PK profile of <b>6</b> reflected poor oral exposure, high clearance, and a short half-life, a critical objective in the identification of a first-generation protease inhibitor in the acylsulfonamide series became the optimization of these parameters. Two additional observations with respect to compound <b>6</b> proved to be instrumental in shaping the prosecution of this program. First, the metabolic stability of this compound in rat and dog liver microsomes was high, <i>t</i><sub>1/2</sub> of 162 and 170 min, respectively. This level of microsomal stability is predictive of low oxidative clearance in these species. Second, after oral dosing to rats, the concentration of compound <b>6</b> was greater in the liver than in plasma, and this hepatotropic distribution was maintained at each of the time points measured. For example, at the 4 h time point, the liver concentration of <b>6</b> was 5.8 μM and the plasma level was 0.58 μM, while at 8 h, the liver level was 0.6 μM and the plasma level was 0.004 μM. Collectively, these findings were suggestive that the in vivo clearance for <b>6</b> in both the rat and dog was not exclusively driven by metabolic events and raised the prospect that transporters may be playing a role in compound uptake into the liver of both of these species.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> The elevated and sustained liver levels observed for <b>6</b> were considered a favorable attribute in the context of a potential treatment for HCV, since the replication cycle of this virus is believed to occur predominantly in the liver.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Hence, in the optimization of compound <b>6</b>, the potential relevance of identifying a compound that possessed a hepatotropic distribution profile was recognized. To this end, an in vivo assay was developed in which compounds were dosed intraduodenally to surgically prepared rats and plasma levels were monitored over 4 h, while liver levels were captured at the 4 h time point at the end of the experiment. This route of administration was selected in order to circumvent potential absorption issues associated with the oral dosing of compounds exhibiting low solubility in vehicle. Additionally, the throughput in this abbreviated assay was greater than that for more complete rat PK studies, which facilitated the rapid evaluation of this series of compounds.</div><div class="NLM_p">In optimizing a given chemical series, the reduction of molecular weight is one tactic by which pharmacokinetics properties may be improved, and this approach was examined in the context of compound <b>6</b>.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The model structure of compound <b>6</b> with the NS3/4A enzyme suggsted that each of the H-bond donors and acceptors along the tripeptide backbone of <b>6</b> was complemented by the enzyme and appeared to contribute to binding. Moreover, each of the side chains as well as the P4 moiety interfaced with the enzyme through van der Waals contact and effective desolvation of enclosed pockets. Since we sought to maintain the key H-bond donor–acceptor interactions between ligand and enzyme, attention was focused on strategically reducing the size of the amino acid side chains of <b>6</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Virology and PK Parameters for Acylsulfonamide Derivatives<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0012.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0013.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">The asterisk (∗) denotes that the compound was dosed as a mixture of diastereoisomers epimeric at the C2 position of the P1 cyclopropane ring.</p></div></div><div></div></div><div class="NLM_p">Truncation of the P1 and P3 amino acid side chains of <b>6</b>, as well as P4, was examined with the result that each analogue, compounds <b>11</b>–<b>13</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), led to a significant loss in activity in both the biochemical and cell-based assays. In addition, while the P4 methyl carbamate derivative <b>14</b> was active in both the biochemical assay and the replicon assay, it performed poorly in the 4 h rat screen compared to the prototype <b>6</b>. Efforts then turned to the optimization of the heterocycle attached to the P2 proline moiety in <b>6</b>. For example, replacing the phenyl moiety of <b>6</b> with a hydrogen atom provided quinoline <b>15</b> which maintained an acceptable level of potency. However, <b>15</b> performed poorly in the rat PK screen with exposures in both plasma and liver significantly lower than that observed for the parent compound <b>6</b>. A further simplification of the quinoline motif found in <b>15</b> to the corresponding pyridyl analogue <b>16</b> resulted in a significant loss in inhibitory activity in both the enzyme and cell-based assays. Activity was restored by the addition of a phenyl ring to the 2-position of the pyridyl moiety to give <b>17</b>; however, cell-based activity for this compound remained modest, and exposure in the rat PK screen was poor. These data points returned attention to fused bicyclic ring systems as vehicles for further optimization. The C-2-linked quinoline <b>18</b> performed markedly better in the rat PK screen than the 7-methoxy, 4-substituted quinoline <b>15</b>, although the antiviral activity of <b>18</b> was 10-fold inferior to <b>15</b>. Interestingly, the C-2-linked isoquinoline <b>19</b>, which hybridized structural aspects derived from <b>15</b> and <b>18</b>, demonstrated an improvement in intrinsic activity compared to <b>18</b> while maintaining good exposure in the rat PK screen. To confirm these observations in the rat PK screen, isoquinoline <b>19</b> was dosed to rats in a more thorough study with the results demonstrating a significant improvement in the in vivo profile of this compound compared to quinoline derivative <b>6</b>. Specifically, dosing of a solution of <b>19</b> to rats at 15 mg/kg revealed an oral exposure of 2.6 μM·h, with <i>F</i> = 20%, which compared favorably to the 0.577 μM·h value and oral bioavailability of 9% previously noted for <b>6</b>. Moreover, clearance for <b>19</b> was moderate at 19 mL mg<sup>–1</sup> kg<sup>–1</sup>, an improvement over the rate of 55 mL min<sup>–1</sup> kg<sup>–1</sup> found with <b>6</b>. Finally, the half-life of 2.2 h measured for <b>19</b> was more than twice that of <b>6</b>. Thus, by reduction of the molecular size of the heterocycle found in <b>6</b> and replacement of the quinoline ring system with an isoquinoline moiety, the PK profile of <b>19</b> represented a substantial improvement. This data set suggested that further exploration of SARs in the isoquinoline series was warranted with the objective of improving the antiviral EC<sub>50</sub> toward genotypes 1a and 1b viruses to less than 20 nM while further optimizing the pharmacokinetic properties in rat.</div><div class="NLM_p">In several respects, the unsubstituted isoquinoline <b>19</b> proved to be a particularly useful template with which to further develop SAR. For example, on the basis of the model presented in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> A, the P2* (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) heterocycle of <b>19</b> largely overlaid the aliphatic region of the side chain of Arg155. Hence, it was anticipated that the judicious addition of small lipophilic substituents to the core of this ring system might be used to productively modulate potency, as had been described in related ring systems.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Additionally, a model of <b>19</b> bound to the enzyme demonstrates that the charged guanidine functionality at the terminus of Arg155 is proximal to the fused phenyl ring of the isoquinoline in <b>19</b>, and this observation raised the possibility of engineering and refining favorable electronic interactions between the inhibitor and enzyme. Moreover, the isoquinoline ring system offered the unique potential to explore substitution at the C4 position as a means of influencing potency. Finally, the observation that the exposure of isoquinoline <b>19</b> in the rat screen was substantially greater than that for the closely related quinoline analogue <b>15</b> suggested that modulating the polarity of the isoquinoline ring system through substituent effects might be a useful tool to further optimize PK properties.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A–H) Models of compounds <b>19</b>, <b>22</b>, <b>41</b>, <b>24</b>, and <b>31</b> bound to the active site of HCV NS3/4A protease.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401840s&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The SAR study that is summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> revealed that substitution at each position of the isoquinoline ring provided unique properties, driven by an interplay of steric and electronic effects between the substituent, the heterocycle, and the enzyme surface. In some examples, the SAR was relatively straightforward and readily interpretable. For example, a simple methyl group at C-4 (<b>22</b>) or C-6 (<b>33</b>) provided a several-fold increase in intrinsic activity (IC<sub>50</sub>) compared to the unsubstituted isoquinoline <b>19</b>, likely driven by van der Waals contact between the methyl substituent and the enzyme surface (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C). Similarly, the reduction in potency observed for the analogue substituted at C-8 with a simple methyl group (<b>41</b>) could readily be understood as the result of a steric clash between this substituent and alanine 156 of the enzyme (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>D). While the use of small isoquinoline substituents was emphasized, larger groups were also explored to a limited extent in order to establish the boundaries of SARs. A simple phenyl substituent at C-3 (<b>20</b>) or a morpholino group at C-6 (<b>29</b>) led to a modest increase in activity, whereas large substituents at C-5 were poorly tolerated (e.g., <b>24</b>), attributed to a steric clash with the EF loop of the enzyme (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>E).</div><div class="NLM_p">Interestingly, the relative conformation between the heterocycle ring system and the ring substituent was also an important contributing factor to potency. For example, the C-6 pyrrole analogue <b>30</b> demonstrated good activity in the enzyme inhibition assay, while the C-6 dimethylamide derivative <b>31</b> proved to be significantly less active. A model of <b>30</b> bound to the protease suggests that the C6 pyrrole substituent can readily assume a coplanar arrangement with the aromatic ring system. In contrast, the C-6 amide group of <b>31</b> and the isoquinoline ring adopt an orthogonal orientation (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>G), a conformation driven by A<sub>1,3</sub> strain between the amide group and the isoquinoline ring.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The significance of a coplanar orientation between the C-6 substituent and the isoquinoline ring was also apparent when comparing the relative activity of the methyl analogue <b>33</b> and the corresponding <i>tert</i>-butyl analogue <b>34</b>. The reason for the loss in activity associated with an orthogonal orientation of the amide in <b>31</b> or the bulky <i>tert</i>-butyl group in <b>34</b> is not fully understood. However, on the basis of modeling studies, it appears that when bound to the enzyme, these C-6 groups alter the relative conformation of the C-1 alkoxyproline moiety with respect to the isoquinoline ring, more specifically, by reducing the planarity defined by the C-4 proline O–C-1 carbon–N2 nitrogen bond of the isoquinoline ring. Hence, the binding interface between the P2* of <b>31</b> (or <b>34</b>) and the enzyme is compromised with this compound compared to <b>19</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>H).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Profiling Data for Isoquinoline-Based HCV NS3 Inhibitors<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0014.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0015.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">The asterisk (∗) indicates that this compound was dosed as a mixture of diastereoisomers epimeric at the C2 position of the P1 cyclopropane ring.</p></div></div><div></div></div><div class="NLM_p">The role of electronic effects was also examined in each of the fused aromatic rings of the P2* heterocycle. Interestingly, these effects proved to be minimal at C-4, since both electron withdrawing and electron donating groups engendered good activity in the enzyme inhibition assay, as exemplified by the comparison between chloro derivative <b>21</b> and the methoxy analogue <b>23</b>. However, a significant electronic effect was noted for substituents at C-6 of the isoquinoline ring. For example, the C-6 methoxy derivative <b>35</b> demonstrated excellent activity in the biochemical screen, whereas the corresponding C-6 chloro analogue <b>32</b> exhibited more modest activity in this assay. It was proposed that the differing impact of these substituents on intrinsic potency may be a consequence of their opposing influence on the electronic surface of the heterocyclic ring. A cocrystal structure of <b>35</b> with the NS3/4A enzyme (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>a) was obtained that confirmed the proposed acylsulfonamide conformation of <b>6</b> with respect to backbone orientation and interactions with the enzyme as described. Further analysis of the cocrystal structure of <b>35</b> illustrates the position of the isoquinoline ring with respect to the protein and highlights potential binding interactions between them. As previously noted, the isoquinoline of <b>35</b> is positioned over the side chain of Arg155, with the terminus of this amino acid in a region proximal to the fused phenyl ring of the isoquinoline core. The C-6 methoxy group of <b>35</b> adopts a coplanar arrangement with respect to the aromatic ring and the terminal methyl group projects in the direction of the EF loop.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> This binding conformation of the methoxy group potentiates its electron releasing effect which increases electron density of the isoquinoline ring and, since the diffused negative surface charge is proximal to the positively charged terminus of Arg155, may result in increased binding affinity for this compound compared to the des-methoxy analogue <b>19</b>. On the other hand, the Cl substituent in <b>32</b> withdraws electron density from the ring, thus decreasing the potential for a favorable cation−π interaction between the isoquinoline ring system and the guanidine terminus of Arg155.<a onclick="showRef(event, 'ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41">(39-41)</a> This rationale for the difference in potency between <b>32</b> and <b>35</b> was further confirmed by a detailed analysis of the electrostatic potential (ESP) generated by the functionalized heterocycles within these analogues in the presence of protein, which was represented as a field of partial changes. Plots of the field-induced electrostatic potential for the functionalized isoquinolines present in compounds <b>32</b> and <b>35</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>b) provides a pictorial representation of these presumed electronic effects. As shown, the C-6 methoxy group of <b>35</b> introduces a build-up of negative potential within the isoquinoline core while the C-6 Cl substituent of <b>32</b> depletes electron density within this ring system, with partial negative charge localized on this atom. This electronic effect proved to be specific for position 6 of the isoquinoline ring, as the intrinsic enzyme inhibitory activities of the C-5 chloro and C-5 methoxy analogues <b>25</b> and <b>27</b>, respectively, are similar. This observation can be rationalized in a similar fashion based on ESP plots where the reduced effectiveness of the C-5 chloro atom of <b>25</b> to withdraw electron density from the isoquinoline ring system is evident.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0005.jpeg" id="GRAPHIC-d1971e1560-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) X-ray cocrystallographic structure of <b>35</b> bound to NS3 Protease. (b) Electrostatic potential maps for analogues <b>35</b>, <b>32</b>, <b>25</b>, and <b>36</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401840s&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Interestingly, while the C-6 chloro derivative <b>25</b> was less active than the corresponding methoxy analogue <b>35</b>, an electron withdrawing cyano group at C-6 (<b>36</b>) was equipotent to <b>35</b>. The apparent discrepancy between the activity of <b>25</b> and <b>36</b> can be reconciled based on the distinct mode of interaction of <b>36</b> with the enzyme. Specifically, an analysis of the field-induced electrostatic potential of <b>36</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>b) indicates that a large charge density of negative potential is localized at the terminus of the cyano substituent. This is of relevance since in the bound conformation this group is proximal to the positively charged center of Arg155, which results in a dominant and favorable local interaction. This analysis is consistent with reported crystal structures of structurally differentiated cyano compounds in which the cyano moiety is docked over the charged terminus of an arginine.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The potential electronic interaction between the terminus of the cyano group in <b>36</b> and Arg155 complements the interactions of <b>35</b> and Arg155 in which a cation−π interaction is induced by the methoxy group of <b>35</b>. Hence, there appear to exist two distinct modes by which C-6 substituents attached to the isoquinoline ring system can induce a favorable electronic interaction with Arg155 of the enzyme.</div><div class="NLM_p">The observation that substituents at the C-6 position of the isoquinoline ring system could influence binding by potentially modifying electron density in the ring was supported by the activity of the C-6 hydroxy analogue <b>37</b>, which was equipotent to <b>35</b> in the enzyme inhibition assay. However, the IC<sub>50</sub> results for the C-5 and C-6 fluoro analogues <b>28</b> and <b>38</b>, respectively, were confounding because both compounds demonstrated a similar reduction in potency in contrast to the corresponding chloro analogues <b>25</b> and <b>32</b>. This suggested that further evaluation of the underlying electronic factors governing potency was required, yet such a study was beyond the scope of this immediate work.</div><div class="NLM_p">Nevertheless, the data presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> demonstrated that small substituents could be used to modulate enzyme inhibitory potency (IC<sub>50</sub>) within the isoquinoline series, and this effect extended to the cell-based replicon assay. However, while the activity of analogues in the replicon assay generally tracked with intrinsic enzyme inhibitory activity (IC<sub>50</sub>), a precipitous drop-off in antiviral activity was observed with analogues bearing polar substituents, as in <b>36</b> and <b>37</b>.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> In addition, in the in vitro cytotoxicity assay, SAR emerged in which lower CC<sub>50</sub> values were observed for isoquinoline analogues incorporating substituents with a greater lipophilic character. For example, the C-3 phenyl derivative <b>20</b> and C-6 <i>tert</i>-butyl analogue <b>34</b> exhibited CC<sub>50</sub> values of less than 20 μM, while the CC<sub>50</sub> values for the chloro analogues <b>21</b>, <b>25</b>, and <b>32</b> were less than 46 μM.</div><div class="NLM_p">The performance of isoquinoline derivatives in the rat screen was also influenced by the nature and site of attachment of the substituent to the heterocycle core. Most notably, the C-5-substituted isoquinolines <b>26</b> and <b>27</b> demonstrated higher plasma levels but lower liver levels in rats following oral administration when compared to the corresponding C-4 isomers <b>22</b> and <b>23</b>, respectively. Hence, on the basis of these limited rat screen data, it appeared that isoquinolines with substituents in the nitrogen-containing ring (<b>22</b>, <b>23</b>) presented in vivo profiles distinct from those analogues bearing substituents in the adjacent all-carbon ring. The rat screen result for the C-6 methoxy analogue <b>35</b> was consistent with this observation, since both plasma and liver levels were elevated compared to the prototype <b>19</b>. The significantly higher exposure observed with <b>35</b> in the rat screen and in subsequent full PK studies when compared to either the C-5 isomer <b>27</b> or the unsubstituted isoquinoline <b>19</b> provided a striking example of the impact of small structural changes on the in vivo performance of molecules in this series.</div><div class="NLM_p">In considering the profiling results on the compounds compiled in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, the C-4 and C-6 methoxy isoquinoline analogues <b>23</b> and <b>35</b>, respectively, emerged as optimal with respect to activity in the cell-based assay, in vitro cytotoxicity profile, and exposure in the coarse rat screen, and hence, these compounds were evaluated more extensively. Although the oral bioavailability of <b>23</b> after dosing to rats as a solution in PEG-400/ethanol (90/10, v/v) was modest, the compound was not detectable in plasma at the 24 h time point. Interestingly, the liver levels of <b>23</b> measured 24 h after po dosing were high (4.2 μM). After iv dosing, the clearance of <b>23</b> was high and the 24 h liver concentration was similarly high at 8.0 μM. Thus, after po or iv dosing, <b>23</b> was cleared rapidly from plasma and partitioned into the liver, resulting in low plasma exposure and high C<sub>24</sub> liver levels. The high clearance observed for <b>23</b> coupled with the low plasma exposure after po dosing was not consistent with the targeted PK profile, and this compound was not progressed further. In contrast, the PK profile of <b>35</b>, a regiosiomer of compound <b>23</b>, was more favorable. The oral bioavailability of <b>35</b> after solution dosing was 18%, with plasma exposure of this compound relatively high at 14 μM·h. At the 24 h time point, the concentration of <b>35</b> in plasma was 8 nM, while the liver concentration was elevated relative to plasma at 730 nM. After iv dosing, the clearance of <b>35</b> from plasma was low at 4.4 mL min<sup>–1</sup> kg<sup>–1</sup>, resulting in a substantial half-life of ∼4 h. The sustained plasma levels of <b>35</b> over 24 h after po dosing, coupled with the high EC<sub>50</sub> multiples of this compound in the liver at the 24 h time point, focused attention on this compound as a program lead.</div><div class="NLM_p">Given the structural similarity of analogues <b>35</b> and <b>23</b>, the significant difference in clearance rates in rat for these compounds warranted further consideration. Interestingly, despite this differential in clearance, the in vitro stability of <b>35</b> and <b>23</b> in a rat liver microsomal assay was quite similar, with each having a <i>t</i><sub>1/2</sub> of greater than 60 min. Moreover, while the liver-to-plasma ratios for each of these compounds 24 h after dosing was high, the compound with the higher clearance, <b>23</b>, also demonstrated a higher liver-to-plasma ratio. These results were suggestive of transporters playing a role in governing the in vivo disposition of these compounds, as noted for <b>6</b>. Additionally, the profile of the regioisomeric analogues <b>23</b> and <b>35</b> provide yet a further illustration of the significant impact of relatively small structural changes within a large molecule on the PK properties of compounds in this series.</div><div class="NLM_p">In an effort to further optimize the properties of the 6-methoxyisoquinoline <b>35</b>, select structural changes were made to the P2* region and subsequently on the peptidic scaffold of this compound. For example, replacing the methoxy group at the C6 position of the isoquinoline ring with an ethoxy or amine substituent resulted in analogues <b>39</b> and <b>29</b>, respectively, which exhibited potency similar to that of <b>35</b>; however, both compounds were observed to have low exposure in the rat PK screen compared to the prototype. As previously noted, the O-demethylated analogue of <b>35</b>, compound <b>37</b>, was suitably potent in the enzyme inhibition assay; however, the antiviral activity of <b>37</b> in the replicon was poor and well below the targeted potency. Thus, a methoxy group at the C6 position of the isoquinoline ring system was optimal with respect to potency and PK.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Profiling Data for Analogues of <b>35</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0016.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0017.gif" alt="" id="fx8" /></img><div></div></div><div class="NLM_p">The potency of <b>35</b> was improved 6-fold by the addition of a second methoxy group to the C-4 position of the isoquinoline ring system to give <b>42</b>; however, the oral exposure of this compound was poor. Additionally, the in vivo clearance of <b>42</b> was relatively high compared to <b>35</b>, and for these reasons this compound was not considered for further study. Nevertheless, the potency observed with <b>42</b> prompted the synthesis of heterocycles in which the electronic properties of the nitrogen-containing ring system in <b>35</b> were modified. The enzyme inhibitory activity of the C-3 linked isoquinoline <b>43</b> and the quinazoline analogue <b>44</b> was comparable to <b>35</b>, while the antiviral activity in the cell-based replicon for both compounds was lower. However, the plasma exposure of both isoquinoline <b>43</b> and quinazoline <b>44</b> in the rat screen was significantly less than that observed for <b>35</b>. Consistent with this observation are the previously noted results for quinoline analogue <b>15</b> which was also inferior to isoquinoline <b>35</b>. The observed discrepancy in rat PK performance between the lead isoquinoline <b>35</b> and the isomeric isoquinoline <b>43</b> and quinoline <b>15</b> is noteworthy. Moreover, the observation that isoquinolines performed better than the corresponding quinoline in the rat screen has proved to be a general phenomenon.<a onclick="showRef(event, 'cit31r'); return false;" href="javascript:void(0);" class="ref cit31r">(31r)</a> For example, the C-3 phenylisoquinoline <b>45</b> had exposure in both liver and plasma that was more than 10-fold greater than that observed for the corresponding quinoline <b>6</b>. The superior performance of isoquinolines in the rat screen compared to structurally similar quinolines once again underscores the impact of small structural changes on the PK profile of compounds in this tripeptide acylsulfonamide series.</div><div class="NLM_p">Additional structural changes were also probed at the P1, P2, and P3 subsites of <b>35</b>, but in each case the resulting analogue had inferior properties. Saturation of the olefin at P1 provided <b>47</b>, which retained antiviral activity but demonstrated poor oral exposure in rats. A similar result was found with <b>48</b> in which the P4 <i>tert</i>-butyl group is replaced with a tetrahydrofuranyl moiety. Interestingly, the P3 valine derivative <b>49</b> demonstrated a similar PK profile to <b>35</b>; however, the cell-based replicon inhibitory activity was ∼3-fold less than that observed for <b>35</b>. To provide an additional point of reference of the impact of the acylsulfonamide group with respect to both the potency and PK properties of <b>35</b>, the carboxylic acid analogue <b>50</b> was prepared. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, the NS3/4A inhibitory activity and antiviral properties of <b>50</b> were considerably poorer, with an IC<sub>50</sub> of 247 nM and an EC<sub>50</sub> of 2000 nM, values that are approximately 120-fold less than those observed for acylsulfonamide <b>35</b>. The performance of <b>50</b> in the rat screen was also poor, with compound not detectable in either the plasma or the liver after intraduodenal dosing. The comparative profiles of acylsulfonamide <b>35</b> and carboxylic acid <b>50</b> further underscore the significant advantage offered by the acylsulfonamide moiety within this chemical series in terms of both potency and PK.</div><div class="NLM_p">From this survey of analogues in the tripeptidic acylsulfonamide chemotype, <b>35</b> (BMS-605339) emerged as the most promising HCV inhibitor. The antiviral activity of <b>35</b> in the cell-based replicon assay was 8.3 nM against GT-1a and 2.8 nM versus GT-1b, while the in vitro cytotoxicity profile of <b>33</b> in a hepatotoma-derived cell line was also favorable (CC<sub>50</sub> = 167 μM), providing a significant in vitro therapeutic index. The selectivity of <b>35</b> for the HCV NS3 protease was examined by evaluating its effects against a range of serine and cysteine proteases in enzyme assays. This compound displayed >1000-fold selectivity for the HCV protease versus cellular proteases including the most homologous protease, GBV-B NS3. The anti-HCV specificity of <b>35</b> was examined in different cell culture systems. This compound was inactive against bovine viral diarrhea virus (BVDV), canine parainfluenza virus, and HIV. In addition, the PK properties of <b>35</b> in the rat represented a marked improvement over the early isoquinoline lead <b>19</b>, as <b>35</b> demonstrated greater plasma and liver exposure following oral adminstration, lower clearance, and a longer half-life (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Given this favorable profile, <b>35</b> was progressed into PK studies in higher species.</div><div class="NLM_p">The oral bioavailability of <b>35</b> in the dog was 51%, with moderate to high clearance and a relatively short plasma half-life. Pharmacokinetic studies in monkeys indicated that the <b>35</b> was poorly absorbed (oral bioavailability less than 1%), with moderate clearance and a short half-life. Consistent with this observation, <b>35</b> was rapidly metabolized in monkey liver microsomes in vitro, suggesting that the poor bioavailability of <b>35</b> after oral dosing to monkeys was a consequence of a significant first-pass effect. In contrast, <b>35</b> proved to be more stable in rat, dog, and human liver microsomes.</div><div class="NLM_p">In an effort to gain insight into the hepatic exposure of <b>35</b> in different species following oral administration, additional studies were conducted in both the rat and dog. After dosing to rats at 15 mg/kg, <b>35</b> demonstrated liver levels that were higher than plasma. For example, rat liver levels for <b>35</b> 24 h after dosing were 0.733 μM while plasma levels were measured as 0.005 μM. A similar hepatotropic distribution of <b>35</b> was observed in dogs 24 h after dosing at 14 mg/kg, where liver levels were measured at 384 nM and plasma levels at 6 nM. The liver-to-plasma ratios of <b>35</b> 24 h after oral dosing to rat and dog were 136 and 75, respectively. The high liver-to-plasma ratio observed in multiple species again suggested the possibility of transporters playing a role in the uptake of compounds into the liver. High and sustained concentrations of compound in the liver were considered a favorable distribution profile in the context of treating hepatitis C virus infection, and further studies directed at developing an understanding of the hepatotropic distribution were conducted. In general, studies on the cellular uptake of <b>35</b> into hepatocytes established the role of an energy-dependent process and the <i>K</i><sub>m</sub> values for this cellular uptake process were similar across species (1.4–5.5 μM), suggestive of similar kinetics.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> On the basis of these preliminary findings, the elevated liver levels of <b>35</b> after oral dosing in both rat and dog appeared to be mediated, at least in part, by an active transport process. In addition, by extrapolation of the available in vitro and in vivo data, the human liver disposition of <b>35</b> was predicted to be high relative to plasma. Thus, while the PK profile of <b>35</b> was different among each of the three preclinical species in which it was evaluated, the sustained and elevated liver levels observed after po dosing to the rat and dog in conjunction with the active uptake process observed in vitro across species provided the confidence to progress <b>35</b> into advanced profiling and toxicology studies.</div><div class="NLM_p">Compound <b>35</b> was extensively profiled in vitro in an effort to define off-target liabilities and assess the potential risk of such findings in a clinical setting. This compound was found to be a P-glycoprotein (P-gp) substrate and a mild inhibitor of CYP 3A4 (IC<sub>50</sub> ≈ 2.0 μM). However, the inhibitory effect was not time-dependent and there was no evidence implicating <b>35</b> as an inducer of CYP 3A4 expression. The in vitro toxicology profile of <b>35</b> was also favorable, as there was no evidence of mutagenicity in either the Ames or in vitro micronucleus assay. The in vivo toxicology assessment of <b>35</b> was also supportive of the clinical development of this compound based on <i>C</i><sub>max</sub> and AUC margins for a projected human clinical dose, including a reduction in heart rate observed in dogs.</div><div class="NLM_p">Compound <b>35</b> was advanced into phase 1 clinical trials where the initial study examined administration of the compound to healthy volunteers at doses of 10, 30, 60, and 120 mg. Plasma drug levels increased with each incremental dose with the average <i>C</i><sub>max</sub> observed at ∼1.5 h, indicating relatively rapid absorption of drug. The terminal half-life was 4–8 h, and compound was detectable in plasma 24 h after administration across the dose range. Compound <b>35</b> was administered to human subjects infected with genotype 1 hepatitis C virus at doses of 10, 60, and 120 mg. The antiviral response was dose-dependent with a mean 1.8 log<sub>10</sub> reduction in viral load observed 12 h after a single 120 mg dose of <b>35</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). While the antiviral response of <b>35</b> in human subjects was favorable, clinically important electrocardiographic changes were noted in one healthy volunteer and one HCV-infected subject following the administration of a 120 mg dose of drug.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Mean reduction in HCV plasma level following single oral doses of <b>35</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401840s&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Note that while these transient electrocardiographic findings, which are manifested in mild bradycardia, PR-interval prolongation, and junctional rhythm disturbances, were asymptomatic in their presentation, the potential risk associated with the administration of this drug to the HCV-infected population was nonetheless deemed significant. These findings caused the cessation of clinical trials on <b>35</b> and prompted a detailed investigation of this cardiac finding, since humans appeared to be significantly more sensitive than anticipated from initial preclinical evaluations. The results of these studies will be described in a forthcoming publication.</div><div class="NLM_p">Acylsulfonamide tripeptide <b>35</b> was synthesized by the coupling of three constituent fragments (Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), and this general approach was used to provide access to the analogues described herein.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The synthesis of intermediate <b>54</b> began with the construction of the isoquinoline heterocycle <b>53</b>, which was available by a scalable, two-step sequence starting with 3-methoxycinnamic acid (<b>51</b>). This commercially available acid was subjected to a Curtius rearrangement followed by electrocyclization to afford the isoquinolone ring system in <b>52</b>.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Intermediate <b>52</b> was converted to 1-chloro-6-methoxyisoquinoline (<b>53</b>) under standard conditions, and this activated aromatic derivative was coupled with N-protected 4-hydroxyproline under basic conditions to provide the P2 element <b>54</b>. The P1–P1′ moiety <b>58</b> was synthesized by coupling the Boc-protected vinylcyclopropylamino acid <b>55</b><a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> with cyclopropylsulfonamide (<b>56</b>),<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> followed by CF<sub>3</sub>CO<sub>2</sub>H-induced unmasking of the amine. The amine <b>58</b> was coupled efficiently at room temperature with the proline derivative <b>54</b> using HATU as the coupling reagent to provide the dipeptide acylsulfonamide <b>59</b>. The Boc group in <b>59</b> was removed under acidic conditions which directly provided the HCl salt of amine <b>60</b>, a compound that cleanly coupled to commercially available <i>tert</i>-butylglycine (<b>61</b>) to provide <b>35</b> in excellent yield. Compound <b>35</b> crystallized from ethanol as the free acid which in the solid state revealed an intramolecular hydrogen bond between the sulfonamide NH and the carbonyl of the P3 <i>tert</i>-butylglycine moiety (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><figure id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0008.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of P2–P2* and P1–P1′<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401840s&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EtOC(O)Cl, TEA, acetone, 0 °C; (b) NaN<sub>3</sub>, rt; (c) Ph<sub>2</sub>CH<sub>2</sub>, Bu<sub>3</sub>N, 210 °C, 49% overall for three steps; (d) POCl<sub>3</sub>, reflux, 88%; (e) <i>N</i>-Boc-3-(<i>R</i>)-hydroxy-<span class="smallcaps smallerCapital">l</span>-proline, <i>t</i>-BuOK, DMSO, 10 °C to rt, 100%; (f) CDI, cyclopropanesulfonamide (<b>56</b>), reflux to rt, 100%; (g) TFA, CH<sub>2</sub>Cl<sub>2</sub>, then HCl, ether, 98%.</p></p></figure><figure id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0009.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Coupling of Fragments for the Synthesis of <b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401840s&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HATU, Hunig’s base (<i>i</i>-Pr<sub>2</sub>NEt), <b>58</b>, DCM, 0 °C to rt, 64%; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, then HCl, ether, 100%; (c) HATU, Hunig’s base, <i>N</i>-Boc-<i>tert</i>-butyl-<span class="smallcaps smallerCapital">l</span>-glycine (<b>61</b>), DCM, 0 °C to rt, 78%.</p></p></figure><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Single crystal X-ray structure of <b>35</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401840s&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48731" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48731" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The discovery of <b>35</b>, a potent tripeptidic inhibitor of HCV NS3 protease, has been described along with the preclinical profiling that supported advancement of this compound into clinical trials. This compound incorporates a cyclopropylacylsulfonamide P1′ moiety as a key structural motif that is associated with markedly enhanced potency compared to the carboxylic acid prototype in a series of tripeptide inhibitors. In the development of the acylsulfonamide chemotype, the utility of P2* as a vehicle to modulate both potency and PK properties was realized. Notably, subtle structural changes were found to exert a significant impact on both potency and PK parameters with the C-6 methoxyisoquinoline present in <b>35</b> found to be optimal. The compound exhibited variable oral bioavailability between rat and dog, and yet high concentrations of drug was observed in the liver after oral dosing to both species. The antiviral activity of <b>35</b> following administration of a single dose to HCV genotype 1 infected patients was significant, with a mean 1.8 log<sub>10</sub> reduction in viral load measured at 12 h after a single 120 mg dose. However, clinical trials of <b>35</b> were terminated because of a cardiovascular liability assessed in more than one subject at the 120 mg dose. Although exposure margins in preclinical toxicology studies with <b>35</b> were sufficient to advance this compound into clinical trials, humans proved to be significantly more sensitive to the cardiovascular effects of <b>35</b> than the dog. These findings were fully integrated into the program which subsequently led to the discovery of asunaprevir (BMS-650032), a compound currently in advanced clinical trials for the treatment of HCV infection.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50, 51)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43216" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43216" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All reagents were purchased from commercial suppliers and used without purification unless otherwise noted. All anhydrous reactions were performed under a nitrogen atmosphere using SureSeal solvents from Aldrich. Proton nuclear magnetic resonance (<sup>1</sup>H NMR) spectra were recorded on a Bruker AM FT 300 MHz spectrometer, a Bruker Avance<sup>III</sup> 500 MHz spectrometer, or a Bruker Ultrashield 400 MHz spectrometer, each equipped with a 5 mm TXI cryoprobe. All spectra were determined in the solvents indicated and residual protio-solvent was used as internal standard for chemical shift assignments. Multiplicity patterns are designated as follows: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad; dd, doublet of doublets; dt, doublet of triplets; dq, doublet of quartets. Most spectra were analyzed using the ACDLABS SpecManager 12.0 program software. Note that at ambient temperature in DMSO-<i>d</i><sub>6</sub>, most of the final products exist predominantly as a mixture of rotamers.</div><div class="NLM_p">All compounds were determined to be at a purity level of greater than 95% as detemined by liquid chromatography methodologies. Liquid chromatography/mass spectrometry (LCMS) was performed on a Shimadzu LC instrument coupled to a Water Micromass ZQ instrument, and the LCMS conditions are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. LCMS Conditions Used in the Characterization of All Compounds Found in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">LCMS condition<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">Col<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">GT<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">FR<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">Sol A<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center">Sol B<a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method A</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">A1</td><td class="colsep0 rowsep0" align="left">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method B</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">A1</td><td class="colsep0 rowsep0" align="left">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method C</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">A1</td><td class="colsep0 rowsep0" align="left">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method D</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">A1</td><td class="colsep0 rowsep0" align="left">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method E</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">A1</td><td class="colsep0 rowsep0" align="left">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method F</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">A1</td><td class="colsep0 rowsep0" align="left">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method G</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">A1</td><td class="colsep0 rowsep0" align="left">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method H</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">A1</td><td class="colsep0 rowsep0" align="left">B1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Gradient = 0% B to 100% B; wavelengh (λ) = 220 nm; injection volume = 5 μL unless otherwise stated.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Col = column, where column 1 is Phenomenex-Luna C18 (2.0 mm × 50 mm, 3 μm); column 2 is Phenomenex-Luna C18 (2.0 mm × 30 mm, 3 μm); column 3 is XTERRA C18 (3.0 mm × 50 mm, S7); column 4 is Phenomenex-Luna C18 (3.0 mm × 50 mm, 5 μm); column 5 is YMC ODS C18 S7 (3.0 mm × 50 mm); column 6 is XTERRA C18 (4.6 mm × 50 mm, S7).</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">GT = gradient time (min).</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">FR = flow rate (mL/min).</p></div><div class="footnote" id="t5fn5"><sup>e</sup><p class="last">Sol A = solvent A, where solvent A1 is 0.1% TFA/10% MeOH/90% H<sub>2</sub>O.</p></div><div class="footnote" id="t5fn6"><sup>f</sup><p class="last">Sol B = solvent B, where solvent B1 is 0.1% TFA/90% MeOH/10% H<sub>2</sub>O.</p></div></div></div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Preparation of 6-Methoxy-2<i>H</i>-isoquinolin-1-one (<b>52</b>)</h3><div class="NLM_p last">To a stirred solution of 3-methoxycinnamic acid <b>51</b> (200 g, 1.12 mol) and Et<sub>3</sub>N (227 g, 2.25 mol) in acetone (1.5 L) maintained at 0 °C was added ethyl chloroformate (188 g, 1.68 mol) dropwise over 45 min. After the mixture was stirred at this temperature for 1 h, aqueous NaN<sub>3</sub> (118 g, 1.81 mol) in H<sub>2</sub>O (181 mL) was added over 10 min, and the reaction mixture was stirred for 16 h at ambient temperature. H<sub>2</sub>O (1.8 L) was added to the reaction mixture, and the volatile components were removed in vacuo. The resulting slurry was extracted 3 times with toluene (the following volumes of toluene were employed: 800, 500, and 300 mL), and the combined organic layers were dried over MgSO<sub>4</sub> and filtered. The filtrate was concentrated in vacuo to a volume of approximately 1.2 L (to remove residual acetone) and diluted to 1.5 L with toluene. This solution containing the acylazide intermediate was added dropwise over 2.5 h to a mixture of diphenylmethane (900 mL) and tributylamine (535 mL) maintained at 190 °C. In the course of this addition, toluene was removed from the reaction mixture by distillation. After the addition of the intermediate acylazide was complete, the temperature of the reaction mixture was raised to 210 °C. After 2 h, the reaction mixture was cooled to room temperature and the precipitated product collected by filtration. The filter cake was washed several times with hexanes and allowed to dry in air to give <b>52</b> as a light yellow solid (96.6 g, 49%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.07 (br s, 1H), 8.08 (d, <i>J</i> = 9.0 Hz, 1H), 7.20–7.10 (m, 2H), 7.05 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 6.48 (d, <i>J</i> = 7.0 Hz, 1H), 3.87 (s, 3H). LCMS (method A): <i>t</i><sub>R</sub> = 0.82 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>10</sub>H<sub>9</sub>NO<sub>2</sub>: 175.06. Found: 175.87 (M + H)<sup>+</sup>.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Preparation of 1-Chloro-6-methoxyisoquinoline (<b>53</b>)</h3><div class="NLM_p last">A mixture of <b>52</b> (93.5 g, 0.534 mol) in POCl<sub>3</sub> (900 mL) was heated at a gentle reflux for 3 h and then concentrated in vacuo. Cold H<sub>2</sub>O (500 mL) and EtOAc (500 mL) were added to the crude reaction mixture. The resulting bilayer was chilled in an ice bath and, with rapid stirring, brought to a pH of 7 by the slow addition of solid NaHCO<sub>3</sub>. The organic layer was removed and the remaining aqueous phase extracted with EtOAc (4 × 350 mL). The combined organic extracts were washed sequentially with saturated aqueous NaHCO<sub>3</sub> (2 × 250 mL) and brine (200 mL), dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated in vacuo to provide a yellow-brown solid. The residue was purified by flash chromatography over silica gel using CH<sub>2</sub>Cl<sub>2</sub> as eluent, and the mixed fractions were combined and rechromatographed with a mixture of hexanes and EtOAc (7:1) to afford <b>53</b> (91.3 g, 88.3%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.23 (d, <i>J</i> = 9.5 Hz, 1H), 8.10 (d, <i>J</i> = 6.0 Hz, 1H), 7.69 (d, <i>J</i> = 5.5 Hz, 1H), 7.38–7.34 (m, 2H), 3.98 (s, 3H). LCMS (method A): <i>t</i><sub>R</sub> = 1.42 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>10</sub>H<sub>8</sub>ClNO: 193.03. Found: 193.91 (M + H)<sup>+</sup>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Preparation of <i>N</i>-Boc-3-(<i>R</i>)-(6-methoxy-1-oxo-isoquinoline)-<span class="smallcaps smallerCapital">l</span>-proline (<b>54</b>)</h3><div class="NLM_p last"><i>N</i>-Boc-3-(<i>R</i>)-hydroxy-<span class="smallcaps smallerCapital">l</span>-proline (25.0 g, 0.108 mol) was added in small portions to a stirred suspension of potassium <i>tert</i>-butoxide (28.1 g, 0.238 mol) in DMSO (432 mL) in a 1 L three-neck flask equipped with an overhead stirrer. The resulting heterogeneous reaction mixture was stirred at room temperature for 2 h before addition of <b>53</b> (21.6 g, 0.111 mol) as a solid in small portions. The reaction mixture was stirred at ambient temperature for 12 h, quenched with H<sub>2</sub>O (100 mL), and extracted with EtOAc (2 × 200 mL). The aqueous and DMSO mixture was treated with 10% aqueous citric acid (200 mL) and extracted with EtOAc (4 × 500 mL). The combined organic layers were washed sequentially with H<sub>2</sub>O and brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo to provide <b>54</b> (46g, quantitative yield) as a yellow solid which was used without further purification. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.07 (d, <i>J</i> = 8.5 Hz, 1H), 7.88–7.87 (m, 1H), 7.25–7.24 (m, 1H), 7.18–7.16 (m, 2H), 5.73 (b, 1H), 4.52–4.44 (m, 1H), 3.92 (s, 3H), 3.87–3.80 (m, 2H), 2.72–2.66 (m, 1H), 2.43–2.38 (m, 1H), 1.42 and 1.44 (s, s, rotamers, 9H). LCMS (method A): <i>t</i><sub>R</sub> = 1.62 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>24</sub>N<sub>2</sub>O<sub>6</sub>: 388.16. Found: 388.94 (M + H)<sup>+</sup>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Preparation of 2-[[[(1<i>R</i>,2<i>S</i>)-1-[[(Cyclopropylsulfonyl)amino]carbonyl]-2-ethenylcyclopropyl]amino]carbonyl]-4-[(6-methoxy-1-isoquinolinyl)oxy]-(2<i>S</i>,4<i>R</i>)-1-pyrrolidinecarboxylic Acid, 1,1-Dimethylethyl Ester (<b>59</b>)</h3><div class="NLM_p last">DIPEA (38.3 g, 342 mmol) was added to a stirred mixture of <b>54</b> (33.22 g, 85.5 mmol), HATU (48.75 g, 128 mmol), and (1-(<i>R</i>)-amino-2-(<i>S</i>)-vinylcyclopropanecarbonyl)amide HCl salt (<b>58</b>) (25.02 g, 94.1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 L) at 0 °C. After the mixture was stirred at ambient temperature for 12 h, the solvent was removed in vacuo and the residue stirred with EtOAc (1 L) and filtered. The filtrate was washed twice with ice cold 5% citric acid (aq) and brine, dried over MgSO<sub>4</sub>, and filtered. The filtrate was evaporated in vacuo and residue recrystallized from MeOH (210 mL) to yield <b>59</b> (26.5 g) of the desired product as a white cube. The mother liquor was evaporated in vacuo and the residue purified through a plug of silica gel eluted with hexane–EtOAc (2:1) to yield an additional 10.5 g of <b>59</b> as a foam. Recrystallization from MeOH (50 mL) yielded an additional 6.5 g of <b>59</b> to afford a combined yield of 64.3%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.07 (d, <i>J</i> = 9.0 Hz, 1H), 7.88 (d, <i>J</i> = 6.0 Hz, 1H), 7.26 (d, <i>J</i> = 6.0 Hz, 1H), 7.20–7.17 (m, 2H), 5.81–5.72 (m, 2H), 5.32 (d, <i>J</i> = 18.0 Hz, 1H), 5.13 (d, <i>J</i> = 10.5 Hz, 1H), 4.42–4.40 (m, 1H), 3.93 (s, 3H), 3.89–3.86 (m, 1H), 3.80 (d, <i>J</i> = 12.5 Hz, 1H), 2.98–2.94 (m, 1H), 2.57–2.53 (m, 1H), 2.30–2.24 (m, 2H), 1.88 (dd, <i>J</i> = 8.09, 5.34 Hz, 1H), 1.45–1.42 (m, 10H), 1.27–1.24 (m, 1H), 1.20–1.16 (m, 1H), 1.08–1.05 (m, 2H). LCMS (method A): <i>t</i><sub>R</sub> = 1.74 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>36</sub>N<sub>4</sub>O<sub>8</sub>S: 600.23. Found: 601.00 (M + H)<sup>+</sup>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Preparation of 2-[[[(1<i>R</i>,2<i>S</i>)-1-[[(Cyclopropylsulfonyl)amino]carbonyl]-2-ethenylcyclopropyl]amino]carbonyl]-4-[(6-methoxy-1-isoquinolinyl)oxy]-(2<i>S</i>,4<i>R</i>)-1-pyrrolidine HCl Salt (<b>60</b>)</h3><div class="NLM_p last">To an ice cold solution of <b>59</b> (32.83 g, 54.7 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (100 mL) was added TFA (100 mL), and the solution was allowed to warm to ambient temperature and stirred for 2 h. The solvent was removed in vacuo, the residue triturated with 1 M HCl in Et<sub>2</sub>O, filtered, and the solid washed with Et<sub>2</sub>O. The solid was stirred in 1 M HCl in Et<sub>2</sub>O (200 mL) for 12 h, filtered, and washed with Et<sub>2</sub>O to give <b>60</b> as a slightly hygroscopic white solid (32.2 g). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 9.14 (b, 1H), 8.34 (d, <i>J</i> = 9.0 Hz, 1H), 7.90 (d, <i>J</i> = 6.5 Hz, 1H), 7.47 (d, <i>J</i> = 6.0 Hz, 1H), 7.34–7.30 (m, 2H), 5.97 (b, 1H), 5.62–5.69 (m, 1H), 5.33 (d, <i>J</i> = 18.0 Hz, 1H), 5.16 (d, <i>J</i> = 10.5 Hz, 1H), 4.42–4.40 (m, 1H), 3.98 (s, 3H), 3.88 (d, <i>J</i> = 12.5 Hz, 2H), 2.95–2.95 (m, 1H), 2.48–2.42 (m, 1H), 2.37–2.32 (m, 1H), 1.97–1.95 (m, 1H), 1.40–1.37 (m, 1H), 1.31–1.26 (m, 1H), 1.20–1.03 (m, 4H). LCMS (method A): <i>t</i><sub>R</sub> = 1.12 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>28</sub>N<sub>4</sub>O<sub>6</sub>S: 500.17. Found: 500.93 (M + H)<sup>+</sup>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Preparation of <i>tert-</i>Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((6-methoxyisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>35</b>)</h3><div class="NLM_p last">DIPEA (32.0 g, 286 mmol) was added dropwise to a suspension of <b>60</b> (32.1 g, 56.02 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (500 mL), and the mixture was stirred at 0 °C. After 30 min, HATU (31.9 g, 84.0 mmol) and <i>N</i>-Boc-<i>tert</i>-butyl-<span class="smallcaps smallerCapital">l</span>-glycine (14.2 g, 61.62 mmol) were added as solids in one portion to the mixture which had turned into a slightly brownish solution. The mixture was warmed to ambient temperature, stirred for 4 h and the solvent removed in vacuo. The residue was stirred with EtOAc (1 L), filtered and the filtrate washed with ice cold 5% aqueous citric acid (twice, keeping the aqueous phase acidic) and brine, respectively. The organic layer was dried over MgSO<sub>4</sub>, filtered and the filtrate evaporated in vacuo. The residue was purified through a plug of silica gel, eluting with hexane–EtOAc (1.5:1) to yield 39.0 g of a foam that was recrystallized from IPA (1 L) to furnish <b>35</b> (33.5 g, 77.5%) as white flakes with purity determined as 97.9% by HPLC. The following spectral data were obtained from a sample recrystallized from MeOH–H<sub>2</sub>O: <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.09 (d, <i>J</i> = 9.0 Hz, 1H), 7.88 (d, <i>J</i> = 6.0 Hz, 1H), 7.25 (d, <i>J</i> = 6.0 Hz, 1H), 7.18 (s, 1H), 7.10–7.08 (m, 1H), 6.60 (d, <i>J</i> = 10.0 Hz, 1H), 5.81 (b, 1H), 5.74–5.69 (m, 1H), 5.28 (d, <i>J</i> = 18.0 Hz, 1H), 5.12 (d, <i>J</i> = 10.5 Hz, 1H), 4.51–4.49 (m, 1H), 4.24–4.21 (m, 1H), 4.06–4.02 (m, 1H), 3.92 (s, 3H), 2.97–2.91 (m, 1H), 2.61–2.55 (m, 1H), 2.30–2.20 (m, 2H), 1.88–1.85 (m, 1H), 1.45–1.40 (m, 1H), 1.27 (s, 9H), 1.25–1.23 (m, 1H), 1.08–1.00 (m, 12H). LCMS (method A): <i>t</i><sub>R</sub> = 1.75 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>47</sub>N<sub>5</sub>O<sub>9</sub>S: 713.31. Found: 714.11 (M + H)<sup>+</sup>; Anal. Calcd for C<sub>35</sub>H<sub>47</sub>N<sub>5</sub>O<sub>9</sub>S·0.5H<sub>2</sub>O: C, 58.16; H, 6.69; N, 9.69. Found: C, 58.01; H, 6.46; N, 9.55.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> <i>tert</i>-Butyl ((2<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-4-((7-Methoxy-2-phenylquinolin-4-yl)oxy)-2-((1-((methylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>3</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.36 (d, <i>J</i> = 9.2 Hz, 1H), 8.15–8.06 (m, <i>J</i> = 7.6 Hz, 2H), 7.84–7.72 (m, 3H), 7.68 (br s, 1H), 7.57 (br s, 1H), 7.43 (d, <i>J</i> = 7.0 Hz, 1H), 5.88 (br s, 1H), 5.84–5.72 (m, 1H), 5.33 (d, <i>J</i> = 17.1 Hz, 1H), 5.17 (d, <i>J</i> = 10.1 Hz, 1H), 4.73–4.56 (m, 2H), 4.27–4.14 (m, 2H), 4.13–3.99 (m, 3H), 3.23 (br s, 3H), 2.85–2.75 (m, 1H), 2.53–2.39 (m, 1H), 2.34–2.19 (m, 1H), 1.93 (dd, <i>J</i> = 7.9, 5.5 Hz, 1H), 1.53–1.42 (m, 1H), 1.22 (s, 9H), 1.06 (br s, 9H). LCMS (method D): <i>t</i><sub>R</sub> = 2.71 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>39</sub>H<sub>49</sub>N<sub>5</sub>O<sub>9</sub>S: 763.33. Found: 764.25 (M + H)<sup>+</sup>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Ethylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((7-methoxy-2-phenylquinolin-4-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>4</b>)</h3><div class="NLM_p last"><sup>l</sup>H NMR: (500 MHz, CD<sub>3</sub>OD) δ 8.10–8.03 (m, 3H), 7.47–7.54 (m, 3H), 7.37 (s, 1H), 7.24 (s, 1H), 7.06 (d, <i>J =</i> 9 Hz, 5.89–5.75 (m, 1H), 5.53 (m, 1H), 5.23 (d, <i>J =</i> 17 Hz, 1H), 5.05 (d, <i>J =</i> 10 Hz, 1H), 4.51–4.57 (m, 2H), 4.25 (m, 1H), 4.02–4.14 (m, 1H), 3.93 (s, 3H), 3.03–3.30 (m, 2H), 2.66–2.77 (m, 1H), 2.41 (m, 1H), 2.09–2.18 (m, 1H), 1.83 (m, 1H), 1.26 (s, 9H), 1.24–1.38 (m,3H), 1.03 (s, 9H). LCMS (method D): <i>t</i><sub>R</sub> = 2.76 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>40</sub>H<sub>51</sub>N<sub>5</sub>O<sub>9</sub>S: 777.34. Found: 778.25 (M + H)<sup>+</sup>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Isopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((7-methoxy-2-phenylquinolin-4-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>5</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.37 (d, <i>J</i> = 9.3 Hz, 1H), 8.13–8.07 (m, 2H), 7.84–7.73 (m, 3H), 7.68 (s, 1H), 7.58–7.52 (m, 1H), 7.42 (dd, <i>J</i> = 9.3, 2.3 Hz, 1H), 5.86 (br s, 1H), 5.74 (dt, <i>J</i> = 17.1, 9.6 Hz, 1H), 5.33 (d, <i>J</i> = 17.1 Hz, 1H), 5.17 (dd, <i>J</i> = 10.4, 1.5 Hz, 1H), 4.71 (d, <i>J</i> = 12.7 Hz, 1H), 4.64 (dd, <i>J</i> = 10.4, 7.0 Hz, 1H), 4.19 (s, 1H), 4.18–4.12 (m, 1H), 4.08 (s, 3H), 3.87–3.75 (m, <i>J</i> = 13.8, 6.8, 6.8 Hz, 1H), 2.79 (dd, <i>J</i> = 14.0, 6.8 Hz, 1H), 2.50–2.40 (m, 1H), 2.28 (q, <i>J</i> = 8.9 Hz, 1H), 1.92 (dd, <i>J</i> = 8.1, 5.5 Hz, 1H), 1.44 (dd, <i>J</i> = 9.5, 5.5 Hz, 1H), 1.37 (d, <i>J</i> = 7.0 Hz, 6H), 1.21 (s, 9H), 1.06 (s, 9H). LCMS (method D): <i>t</i><sub>R</sub> = 2.84 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>41</sub>H<sub>53</sub>N<sub>5</sub>O<sub>9</sub>S: 791.36. Found: 792.25 (M + H)<sup>+</sup>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((7-methoxy-2-phenylquinolin-4-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>6</b>)</h3><div class="NLM_p last"><sup>l</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.07–8.04 (m, 3H) 7.55–7.47 (m, 3H), 7.37 (d, <i>J =</i> 2 Hz, 1H), 7.23 (s, 1H), 7.07–7.05 (m, 1H), 5.84–5.77 (m, 1H), 5.53 (m, 1H), 5.25 (d, <i>J =</i> 17.1 Hz, 1H), 5.07 (d, <i>J =</i> 10.1 Hz, 1H), 4.55–4.50 (m, 2H), 4.25 (s, 1H), 4.10–4.08 (m, 1H), 3.93 (s, 3H), 2.84 (bs, 1H), 2.60–2.70 (m, 1H), 2.35–2.40 (m, 1H), 2.15–2.20 (m, 1H), 1.85–1.83), (m, 1H), 1.41–1.38 (m, 1H), 1.27 (s, 9H), 1.17 (s, 2H), 1.03 (s, 9H), 1.10–0.80 (m, 2H). LCMS (method D): <i>t</i><sub>R</sub> = 2.80 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>41</sub>H<sub>51</sub>N<sub>5</sub>O<sub>9</sub>S: 789.34. Found: 790.25 (M + H)<sup>+</sup>.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclobutylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((7-methoxy-2-phenylquinolin-4-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>7</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.11–8.00 (m, 3H), 7.58–7.45 (m, 3H), 7.39 (d, <i>J</i> = 2.3 Hz, 1H), 7.25 (s, 1H), 7.07 (dd, <i>J</i> = 9.2, 2.1 Hz, 1H), 5.77–5.62 (m, 1H), 5.56 (br s, 1H), 5.26 (d, <i>J</i> = 17.1 Hz, 1H), 5.10 (d, <i>J</i> = 10.3 Hz, 1H), 4.62–4.46 (m, 2H), 4.38–4.23 (m, 2H), 4.14–4.06 (m, 1H), 3.94 (s, 3H), 2.66 (dd, <i>J</i> = 13.8, 6.8 Hz, 1H), 2.55–2.42 (m, 2H), 2.37–2.12 (m, 4H), 2.07–1.90 (m, 2H), 1.83 (dd, <i>J</i> = 8.1, 5.3 Hz, 1H), 1.47–1.34 (m, 1H), 1.31–1.21 (m, 9H), 1.08–0.93 (m, 10H). LCMS (method B): <i>t</i><sub>R</sub> = 2.38 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>42</sub>H<sub>53</sub>N<sub>5</sub>O<sub>9</sub>S: 803.36. Found: 804.29 (M + H)<sup>+</sup>.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopentylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((7-methoxy-2-phenylquinolin-4-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>8</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.59–7.46 (m, 3H), 7.05–6.86 (m, 3H), 6.85 (d, <i>J</i> = 2 0.2 Hz, 1H), 6.67 (s, 1H), 6.53 (dd, <i>J</i> = 9.1, 2.2 Hz, 1H), 5.36–5.14 (m, 1H), 5.00 (br s, 1H), 4.80–4.62 (m, 1H), 4.56 (d, <i>J</i> = 10.2 Hz, 1H), 4.03–3.92 (m, 2H), 3.80–3.66 (m, 1H), 3.64–3.52 (m, 1H), 3.41 (s, 3H), 2.22–2.05 (m, <i>J</i> = 13.2, 7.0 Hz, 1H), 1.95–1.74 (m, 1H), 1.74–1.57 (m, 1H), 1.53–1.31 (m, 6H), 1.29–1.04 (m, 6H), 0.77 (s, 8H), 0.51 (s, 9H). LCMS (method D): <i>t</i><sub>R</sub> = 2.93 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>43</sub>H<sub>55</sub>N<sub>5</sub>O<sub>9</sub>S: 817.37. Found: 818.30 (M + H)<sup>+</sup>.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclohexylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((7-methoxy-2-phenylquinolin-4-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>9</b>)</h3><div class="NLM_p last"><sup>l</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.99–8.07 (m. 3H), 7.47–7.55 (ml 3H), 7.37 (d, <i>J</i> = 2.2 Hz), 7.18 (s, 1H), 7.05 (dd, <i>J</i> = 9, 2 Hz, 1H), 5.69–5.84 (m, 1H), 5.51 (m, H), 5.21–5.28 (m, 1H), 5.05–5.09 (m, 1H), 4.47–4.56 (m, 2H), 4.24–4.28 (m, 1H), 4.04–4.13 (m, 1H), 3.94 (s, 3H), 3.41 (m, 1H), 2.63–2.69 (m, 1H), 2.30–2.49 (m, 1H), 2.04–2.23 (m, 3H), 1.73–1.92 (m, 3H), 1.59–1.73 (m, 1H), 1.29 (s, 9H), 1.14–1.55 (m, 6H), 1.03 (s, 9H). LCMS (method D): <i>t</i><sub>R</sub> = 3.01 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>44</sub>H<sub>57</sub>N<sub>5</sub>O<sub>9</sub>S: 831.39. Found: 832.30 (M + H)<sup>+</sup>.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-4-((7-Methoxy-2-phenylquinolin-4-yl)oxy)-2-(((1<i>R</i>,2<i>S</i>)-1-((phenylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>10</b>)</h3><div class="NLM_p last"><sup>l</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.10 (d, <i>J</i> = 9 Hz, 1H), 8.05, 8.04 (2s, 2H), 7.96–7.97 (m, 2H), 7.61–7.65 (m, 1H), 7.49–7.58 (m, 5H), 7.40 (d, <i>J</i> = 2 Hz, 1H), 7.27 (s, 1H), 7.10 (dd, <i>J</i> = 9, 2 Hz, 1H), 5.57 (m, 1H), 5.37–5.46 (m, 1H), 5.15 (d, <i>J</i> = 17 Hz, 1H), 4.91 (d, <i>J</i> = 10 Hz, 1H), 4.52–4.57 (m, 2H), 4.25–4.29 (m, 1H), 4.11 (dd, <i>J</i> = 12, 2.6 Hz, 1H), 3.95 (s, 3H), 2.64–2.72 (m, 1H), 2.30–2.39 (m, 1H), 2.11–2.16 (m, 1H), 1.71 (dd, <i>J</i> = 8, 5.5 Hz, 1H), 1.31–1.34 (m, 1H), 1.28 (s, 9H), 1.06 (s, 9H). LCMS (method D): <i>t</i><sub>R</sub> = 2.881 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>44</sub>H<sub>51</sub>N<sub>5</sub>O<sub>9</sub>S: 825.34. Found: 826.30 (M + H)<sup>+</sup>.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>tert</i>-Butyl (1-((2<i>S</i>,4<i>R</i>)-2-((1-((Cyclopropylsulfonyl)carbamoyl)cyclopropyl)carbamoyl)-4-((7-methoxy-2-phenylquinolin-4-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>11</b>)</h3><div class="NLM_p last"><sup>l</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.07–8.03 (m, 3H), 7.47–7.57 (m, 3H), 7.38 (d, <i>J =</i> 2.2 Hz, 1H), 7.38–7.36 (m, 1H), 7.24 (s, 1H), 6.67 (d, <i>J =</i> 9.5 Hz, NH), 5.56 (s, 1H), 4.53–4.48 (m, 1H), 4.26 (d, <i>J =</i> 9.2 Hz, 1H), 4.07–4.13 (m, 1H), 3.94 (s, 3H), 3.01–2.92 (m, 1H), 2.65 (dd, <i>J =</i> 13.7, 6.8 Hz, 1H), 2.37–2.27 (m, 1H), 1.65–1.52 (m, 11H), 1.44–1.52 (m, 1H), 1.26 (s, 9H), 1.03 (s, 9H). LCMS (method D): <i>t</i><sub>R</sub> = 2.71 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>39</sub>H<sub>49</sub>N<sub>5</sub>O<sub>9</sub>S: 763.33. Found: 764.25 (M + H)<sup>+</sup>.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>tert</i>-Butyl (2-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((7-methoxy-2-phenylquinolin-4-yl)oxy)pyrrolidin-1-yl)-2-oxoethyl)carbamate (<b>12</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.99–8.12 (m, 3H), 7.59–7.46 (m, 3H), 7.40 (d, <i>J</i> = 2.52 Hz, 1H), 7.28 (s, 1H), 7.15 (dd, <i>J</i> = 2.52, 9.06 Hz, 1H), 5.80–5.60 (m, 2H), 5.30 (dd, <i>J</i> = 1.51, 17.12 Hz, 1H), 5.15–5.06 (m, 1H), 4.55 (dd, <i>J</i> = 7.43, 9.44 Hz, 1H), 4.15–3.98 (m, 3H), 3.95 (s, 3H), 3.89–3.80 (m, 1H), 3.00–2.89 (m, 1H), 2.65 (dd, <i>J</i> = 7.18, 13.98 Hz, 1H), 2.40 (ddd, <i>J</i> = 4.15, 9.82, 13.98 Hz, 1H), 2.24 (q, <i>J</i> = 8.81 Hz, 1H), 1.87 (dd, <i>J</i> = 5.29, 8.06 Hz, 1H), 1.50 (s, 1H), 1.44–0.98 (m, 13H). LCMS (method B): <i>t</i><sub>R</sub> = 2.03 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>37</sub>H<sub>43</sub>N<sub>5</sub>O<sub>9</sub>S: 733.28. Found: 734.28 (M + H)<sup>+</sup>.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (2<i>S</i>,4<i>R</i>)-1-(2-Amino-3,3-dimethylbutanoyl)-<i>N</i>-((1<i>R</i>,2<i>R</i>)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-4-((7-methoxy-2-phenylquinolin-4-yl)oxy)pyrrolidine-2-carboxamide (<b>13</b>)</h3><div class="NLM_p last"><sup>l</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.48 (m, 1H), 8.15 (m, 2H), 7.74 (m, 3H), 7.63 (s, 2H), 7.47 (m, 1H), 5.90 (m, 1H), 5.76–5.65 (m, 1H), 5.32 (d, <i>J =</i> 17 Hz, 1H), 5.13 (d, <i>J =</i>10 Hz, 1H), 4.76 (m, 1H), 4.56 (m, 1H), 4.19 (m, 2H), 4.06 (s, 3H), 2.95 (s, 1H), 2.84 (m, 1H), 2.43 (m, 1H), 2.33 (m, 1H), 1.89 (m, 1H), 1.42 (m, 1H), 1.17 (s, 9H), 1.04–1.33 (m, 4H). LCMS (method D): <i>t</i><sub>R</sub> = 2.24 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>43</sub>N<sub>5</sub>O<sub>7</sub>S: 689.29. Found: 690.25 (M + H)<sup>+</sup>.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Methyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((7-methoxy-2-phenylquinolin-4-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>14</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.36 (d, <i>J</i> = 9.5 Hz, 1H), 8.09 (dd, <i>J</i> = 6.9, 1.7 Hz, 1H), 7.79–7.72 (m, 3H), 7.65 (s, 1H), 7.54 (d, <i>J</i> = 2.1 Hz, 1H), 7.43 (dd, <i>J</i> = 9.3, 2.3 Hz, 1H), 5.86 (br s, 1H), 5.77–5.70 (m, 1H), 5.30 (dd, <i>J</i> = 17.1, 1.2 Hz, 1H), 5.13 (dd, <i>J</i> = 10.4, 1.5 Hz, 1H), 4.64–4.58 (m, 2H), 4.23 (s, 1H), 4.14 (dd, <i>J</i> = 12.2, 3.1 Hz, 1H), 4.06 (s, 3H), 3.38 (s, 3H), 2.97–2.92 (m, 1H), 2.77 (dd, <i>J</i> = 13.9, 6.9 Hz, 1H), 2.46–2.40 (m, 1H), 2.24 (q, <i>J</i> = 8.7 Hz, 1H), 1.90 (q, <i>J</i> = 5.7 Hz, 1H), 1.44 (q, <i>J</i> = 5.2 Hz, 1H), 1.22–1.26 (m, 2H), 1.11–1.07 (m, 2H), 1.05 (s, 9H). LCMS (method E): <i>t</i><sub>R</sub> = 1.47 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>38</sub>H<sub>45</sub>N<sub>5</sub>O<sub>9</sub>S: 747.29. Found: 748.45 (M + H)<sup>+</sup>.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>tert</i>-Butyl ((2<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-((1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((7-methoxyquinolin-4-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>15</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.62 (d, <i>J</i> = 5.1 Hz, 1H), 8.18–8.07 (m, 1H), 7.28 (s, 1H), 7.11 (d, <i>J</i> = 9.1 Hz, 1H), 6.99–6.88 (m, 1H), 6.08–5.75 (m, 1H), 5.48–5.39 (m, 1H), 5.30–5.15 (m, <i>J</i> = 17.2 Hz, 1H), 5.08–4.92 (m, 1H), 4.68–4.40 (m, 2H), 4.28–4.21 (m, 1H), 4.18–4.06 (m, 1H), 3.97–3.89 (m, 3H), 2.84–2.64 (m, 2H), 2.60–2.44 (m, 1H), 2.20–2.05 (m, 1H), 1.95–1.74 (m, 1H), 1.33–1.21 (m, 9H), 1.06 (s, 9H), 1.51–0.82 (m, 5H). LCMS (method D): <i>t</i><sub>R</sub> = 2.66 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>47</sub>N<sub>5</sub>O<sub>9</sub>S: 713.31. Found: 714.25 (M + H)<sup>+</sup>.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-(pyridin-4-yloxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>16</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.35 (d, <i>J</i> = 5.54 Hz, 2H), 6.99 (d, <i>J</i> = 5.79 Hz, 2H), 5.75 (ddd, <i>J</i> = 9.06, 10.26, 17.19 Hz, 1H), 5.33–5.24 (m, 2H), 5.10 (dd, <i>J</i> = 1.64, 10.20 Hz, 1H), 4.39 (dd, <i>J</i> = 6.92, 10.45 Hz, 1H), 4.28–4.17 (m, 2H), 4.06–3.98 (m, 1H), 2.92 (tt, <i>J</i> = 4.78, 8.06 Hz, 1H), 2.46 (dd, <i>J</i> = 7.18, 13.47 Hz, 1H), 2.29–2.16 (m, 2H), 1.85 (dd, <i>J</i> = 5.41, 8.18 Hz, 1H), 1.46–1.38 (m, 1H), 1.36–1.17 (m, 11H), 1.09–0.94 (m, 11H). LCMS (method B): <i>t</i><sub>R</sub> = 1.96 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>43</sub>N<sub>5</sub>O<sub>8</sub>S: 633.28. Found: 634.25 (M + H)<sup>+</sup>.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((2-phenylpyridin-4-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>17</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.43 (d, <i>J</i> = 5.8 Hz, 1H), 7.87 (dd, <i>J</i> = 8.1, 1.5 Hz, 2H), 7.55–7.28 (m, 4H), 6.97 (dd, <i>J</i> = 5.8, 2.0 Hz, 1H), 6.68 (d, <i>J</i> = 9.6 Hz, 1H), 5.75 (ddd, <i>J</i> = 17.2, 10.3, 8.9 Hz, 1H), 5.36 (br s, 1H), 5.29 (dd, <i>J</i> = 17.1, 1.3 Hz, 1H), 5.14–5.08 (m, 1H), 4.43 (dd, <i>J</i> = 10.4, 6.9 Hz, 1H), 4.33–4.18 (m, 2H), 4.09–3.99 (m, 1H), 2.93 (tt, <i>J</i> = 8.1, 4.8 Hz, 1H), 2.50 (dd, <i>J</i> = 13.5, 6.7 Hz, 1H), 2.31–2.15 (m, 2H), 1.86 (dd, <i>J</i> = 8.2, 5.4 Hz, 1H), 1.48–1.37 (m, 1H), 1.32–0.96 (m, 22H). LCMS (method B): <i>t</i><sub>R</sub> = 2.14 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>47</sub>N<sub>5</sub>O<sub>8</sub>S: 709.31. Found: 710.31 (M + H)<sup>+</sup>.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-(quinolin-2-yloxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>18</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 9.18 (d, 1H), 8.13 (d, <i>J</i> = 7.5 Hz, 1H), 7.82–7.78 (m, 2H), 7.64 (t, <i>J</i> = 7.5 Hz, 1H), 7.42 (t, <i>J</i> = 7.5 Hz, 1H), 6.92–6.90 (m, 1H), 5.92 (b, 1H), 5.78–5.73 (m, 1H), 5.32 (d, <i>J</i> = 17.0 Hz, 1H), 5.13 (d, <i>J</i> = 10 Hz, 1H), 4.51–4.47 (m, 1H), 4.15–4.09 (m, 1H), 4.14–4.10 (m, 1H), 2.98–2.89 (m, 1H), 2.57–2.52 (m, 1H), 2.30–2.23 (m, 2H), 1.91–1.87 (m, 1H), 1.47–1.44 (m, 1H), 1.26–1.17 (m, 10H), 1.08–1.01 (m, 12H). LCMS (method A): <i>t</i><sub>R</sub> = 1.75 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>45</sub>N<sub>5</sub>O<sub>8</sub>S: 683.30. Found: 684.07 (M + H)<sup>+</sup>.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-(isoquinolin-1-yloxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>19</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 9.18 (b, 1H), 8.20 (d, <i>J</i> = 8.4 Hz, 1H), 7.97 (d, <i>J</i> = 6 Hz, 1H), 7.80 (d, <i>J</i> = 8.1 Hz, 1H), 7.70 (t, <i>J</i> = 7.5 Hz, 1H), 7.52 (t, <i>J</i> = 7.4 Hz, 1H), 7.32 (d, <i>J</i> = 6 Hz, 1H), 5.88 (b, 1H), 5.82–5.70 (m, 1H), 5.27 (d, <i>J</i> = 16.8 Hz, 1H), 5.12 (d, <i>J</i> = 10.2 Hz, 1H), 4.57–4.45 (m, 2H), 4.26 (b, 1H), 4.11–4.06 (m, 1H), 2.99–2.92 (m, 1H), 2.67–2.60 (m, 1H), 2.34–2.22 (m, 2H), 1.90–1.86 (m, 1H), 1.46–1.42 (m, 1H), 1.27–1.15 (m, 10H), 1.09–1.00 (m, 12H). LCMS (method A): <i>t</i><sub>R</sub> = 1.80 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>45</sub>N<sub>5</sub>O<sub>8</sub>S: 683.30. Found: 684.07 (M + H)<sup>+</sup>.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Compound <b>19a</b></h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.22 (d, <i>J</i> = 8.0 Hz, 1H), 7.98 (d, <i>J</i> = 5.8 Hz, 1H), 7.82 (d, <i>J</i> = 8.3 Hz, 1H), 7.76–7.68 (m, 1H), 7.58–7.51 (m, 1H), 7.34 (d, <i>J</i> = 5.8 Hz, 1H), 6.71–6.57 (m, 1H), 5.90 (br s, 1H), 5.78 (dt, <i>J</i> = 17.3, 8.7 Hz, 1H), 5.39–5.27 (m, 1H), 5.18–5.10 (m, 1H), 4.65–4.45 (m, 2H), 4.27 (t, <i>J</i> = 9.2 Hz, 1H), 4.10 (d, <i>J</i> = 11.3 Hz, 1H), 2.97 (dq, <i>J</i> = 12.4, 4.0 Hz, 1H), 2.73–2.60 (m, 1H), 2.39–2.23 (m, 2H), 1.93–1.78 (m, 1H), 1.49–1.39 (m, 1H), 1.34–0.98 (m, 21H). LCMS (method H): <i>t</i><sub>R</sub> = 3.21 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>45</sub>N<sub>5</sub>O<sub>8</sub>S: 683.30. Found: 684.5 (M + H)<sup>+</sup>.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((3-phenylisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>20</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.20–8.16 (m, 3H), 7.89–7.85 (m, 2H), 7.70 (t, <i>J</i> = 7.5 Hz, 1H), 7.49–7.46 (m, 3H), 7.40–7.37 (m, 1H), 6.10 (b, 1H), 5.79–5.72 (m, 1H), 5.29 (d, <i>J</i> = 18.0 Hz, 1H), 5.12 (d, <i>J</i> = 10.5 Hz, 1H), 4.58–4.55 (m, 1H), 4.48–4.46 (m, 1H), 4.30–4.18 (m, 2H), 2.97–2.93 (m, 1H), 2.75–2.70 (m, 1H), 2.41–2.36 (m, 1H), 2.26–2.21 (m, 1H), 1.90–1.87 (m, 1H), 1.46–1.43 (m, 1H), 1.30–1.26 (m, 10H), 1.09–0.92 (m, 12H). LCMS (method F): <i>t</i><sub>R</sub> = 2.08 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>40</sub>H<sub>49</sub>N<sub>5</sub>O<sub>8</sub>S: 759.33. Found: 760.11 (M + H)<sup>+</sup>.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-4-((4-Chloroisoquinolin-1-yl)oxy)-2-(((1<i>R</i>,2<i>S</i>)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>21</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.25 (d, <i>J</i> = 8.31 Hz, 1H), 8.11 (d, <i>J</i> = 8.56 Hz, 1H), 8.06 (s, 1H), 7.86 (t, <i>J</i> = 7.70 Hz, 1H), 7.63 (t, <i>J</i> = 7.58 Hz, 1H), 6.60 (d, <i>J</i> = 8.80 Hz, 1H), 5.85 (s, 1H), 5.81–5.70 (m, 1H), 5.29 (d, <i>J</i> = 17.12 Hz, 1H), 5.12 (d, <i>J</i> = 10.76 Hz, 1H), 4.59–4.46 (m, 2H), 4.22 (d, <i>J</i> = 9.29 Hz, 1H), 4.06 (dd, <i>J</i> = 11.49, 2.45 Hz, 1H), 2.98–2.89 (m, 1H), 2.63 (dd, <i>J</i> = 13.82, 6.97 Hz, 1H), 2.36–2.18 (m, 2H), 1.88 (dd, <i>J</i> = 7.83, 5.62 Hz, 1H), 1.44 (dd, <i>J</i> = 9.41, 5.26 Hz, 1H), 1.28–1.23 (m, 1H), 1.20 (s, 9H), 1.11–1.05 (m, 3H), 1.03 (s, 9H). LCMS (method C): <i>t</i><sub>R</sub> = 2.49 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>44</sub>ClN<sub>5</sub>O<sub>8</sub>S: 717.26. Found: 718.25 (M + H)<sup>+</sup>.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((4-methylisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>22</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.22 (d, <i>J</i> = 8.3 Hz, 1H), 7.91 (d, <i>J</i> = 8.1 Hz, 1H), 7.80 (s, 1H), 7.76 (t, <i>J</i> = 8.1 Hz, 1H), 7.53 (t, <i>J</i> = 7.8 Hz, 1H), 6.63 (d, <i>J</i> = 8.6 Hz, 1H), 5.77 (m, 2H), 5.29 (d, <i>J</i> = 17.1 Hz, 1H), 5.12 (d, <i>J</i> = 10.0 Hz, 1H), 4.53 (dd, <i>J</i> = 10.3, 6.6 Hz, 1H), 4.45 (d, <i>J</i> = 11.3 Hz, 1H), 4.25 (m, 1H), 4.06 (dd, <i>J</i> = 12.0, 3.4 Hz, 1H), 2.94 (m, 1H), 2.62 (dd, <i>J</i> = 13.7, 7.1 Hz, 1H), 2.49 (s, 3H), 2.26 (m, 2H), 1.88 (dd, <i>J</i> = 8.1, 5.4 Hz, 1H), 1.44 (dd, <i>J</i> = 9.5, 5.1 Hz, 1H), 1.26 (m, 10H),1.04 (m, 12H). LCMS (method A): <i>t</i><sub>R</sub> = 1.82 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>47</sub>N<sub>5</sub>O<sub>8</sub>S: 697.31. Found: 720.37 (M + Na)<sup>+</sup>.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((4-methoxyisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>23</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.42 (s, 1H), 8.87 (br s, 1H), 8.17 (d, <i>J</i> = 8.3 Hz, 1H), 8.07 (d, <i>J</i> = 8.3 Hz, 1H), 7.81 (t, <i>J</i> = 7.5 Hz, 1H), 7.69–7.55 (m, 2H), 6.62 (d, <i>J</i> = 8.3 Hz, 1H), 5.73 (br s, 1H), 5.70–5.55 (m, 1H), 5.24 (d, <i>J</i> = 16.8 Hz, 1H), 5.16–5.05 (m, 1H), 4.49–4.31 (m, 2H), 4.08 (d, <i>J</i> = 8.3 Hz, 1H), 3.99 (s, 3H), 3.97–3.82 (m, 1H), 2.99–2.87 (m, 1H), 2.48–2.70 (m, 1H), 2.24–2.10 (m, 2H), 1.72 (dd, <i>J</i> = 7.9, 5.4 Hz, 1H), 1.43–1.32 (m, 1H), 1.29–0.93 (m, 22H). LCMS (method H): <i>t</i><sub>R</sub> = 3.22 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>47</sub>N<sub>5</sub>O<sub>9</sub>S: 713.31. Found: 736.29 (M + Na)<sup>+</sup>.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((5-morpholinoisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>24</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.41 (br s, 1H), 8.87 (br s, 1H), 8.02 (d, <i>J</i> = 6.1 Hz, 1H), 7.90 (d, <i>J</i> = 8.4 Hz, 1H), 7.53 (d, <i>J</i> = 5.8 Hz, 1H), 7.50–7.43 (m, 1H), 7.36 (d, <i>J</i> = 7.3 Hz, 1H), 6.61 (d, <i>J</i> = 7.9 Hz, 1H), 5.78 (br s, 1H), 5.67–5.56 (m, 1H), 5.23 (d, <i>J</i> = 17.2 Hz, 1H), 5.10 (d, <i>J</i> = 11.6 Hz, 1H), 4.48–4.35 (m, 2H), 4.07 (d, <i>J</i> = 8.4 Hz, 1H), 3.95 (d, <i>J</i> = 8.9 Hz, 1H), 3.86 (t, <i>J</i> = 4.4 Hz, 4H), 3.06–2.90 (m, 6H), 2.24–2.11 (m, 2H), 1.71 (dd, <i>J</i> = 7.9, 5.3 Hz, 1H), 1.43–0.92 (m, 23H). LCMS (method D): <i>t</i><sub>R</sub> = 3.25 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>38</sub>H<sub>52</sub>N<sub>6</sub>O<sub>9</sub>S: 768.35. Found: 769.52 (M + H)<sup>+</sup>.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-4-((5-Chloroisoquinolin-1-yl)oxy)-2-(((1<i>R</i>,2<i>S</i>)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)scarbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>25</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.13 (d, <i>J</i> = 8.3 Hz, 1H), 8.05 (d, <i>J</i> = 6.1 Hz, 1H), 7.76 (d, <i>J</i> = 7.6 Hz, 1H), 7.57 (d, <i>J</i> = 6.1 Hz, 1H), 7.42 (t, <i>J</i> = 7.9 Hz, 1H), 6.52 (d, <i>J</i> = 9.3 Hz, 1H), 5.82 (s, 1H), 5.76–5.64 (m, 1H), 5.24 (d, <i>J</i> = 16.9 Hz, 1H), 5.06 (d, <i>J</i> = 10.3 Hz, 1H), 4.52–4.41 (m, 2H), 4.16 (d, <i>J</i> = 9.3 Hz, 1H), 4.01 (dd, <i>J</i> = 11.9, 2.8 Hz, 1H), 2.92–2.84 (m, 1H), 2.58 (dd, <i>J</i> = 13.8, 7.0 Hz, 1H), 2.30–2.12 (m, 2H), 1.82 (dd, <i>J</i> = 7.9, 5.5 Hz, 1H), 1.38 (dd, <i>J</i> = 9.4, 5.3 Hz, 1H), 1.24–1.16 (m, 1H), 1.15 (s, 9H), 1.05–0.99 (m, 3H), 0.97 (s, 9H). LCMS (method C): <i>t</i><sub>R</sub> = 2.46 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>44</sub>ClN<sub>5</sub>O<sub>8</sub>S: 717.26. Found: 718.25 (M + H)<sup>+</sup>.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((5-methylsisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>26</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.06 (d, <i>J</i> = 8.3 Hz, 1H), 8.00 (d, <i>J</i> = 6.1 Hz, 1H), 7.53 (d, <i>J</i> = 7.1 Hz, 1H), 7.44 (d, <i>J</i> = 5.9 Hz, 1H), 7.39 (t, <i>J</i> = 7.7 Hz, 1H), 6.62 (d, <i>J</i> = 9.3 Hz, 1H), 5.86 (s, 1H), 5.81–5.70 (m, 1H), 5.29 (d, <i>J</i> = 16.9 Hz, 1H), 5.12 (d, <i>J</i> = 10.5 Hz, 1H), 4.53 (dd, <i>J</i> = 10.3, 7.1 Hz, 1H), 4.46 (d, <i>J</i> = 11.5 Hz, 1H), 4.25 (d, <i>J</i> = 9.5 Hz, 1H), 4.07 (dd, <i>J</i> = 11.9, 3.3 Hz, 1H), 2.98–2.90 (m, 1H), 2.66–2.58 (m, 4H), 2.34–2.18 (m, 2H), 1.87 (dd, <i>J</i> = 8.1, 5.4 Hz, 1H), 1.47–1.40 (m, 1H), 1.30–1.17 (m, 1H), 1.23 (s, 9H), 1.10–0.96 (m, 3H), 1.03 (s, 9H). LCMS (method C): <i>t</i><sub>R</sub> = 2.41 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>47</sub>N<sub>5</sub>O<sub>8</sub>S: 697.31. Found: 698.30 (M + H)<sup>+</sup>.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((5-methoxyisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>27</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.89 (d, <i>J</i> = 5.9 Hz, 1H), 7.68 (d, <i>J</i> = 8.3 Hz, 1H), 7.54 (d, <i>J</i> = 5.9 Hz, 1H), 7.37 (t, <i>J</i> = 7.9 Hz, 1H), 7.08 (d, <i>J</i> = 7.6 Hz, 1H), 6.55 (d, <i>J</i> = 9.5 Hz, 1H), 5.79 (s, 1H), 5.81–5.70 (m, 1H), 5.23 (d, <i>J</i> = 16.9 Hz, 1H), 5.06 (d, <i>J</i> = 10.0 Hz, 1H), 4.47 (dd, <i>J</i> = 9.7, 7.0 Hz, 1H), 4.39 (d, <i>J</i> = 12.2 Hz, 1H), 4.20 (d, <i>J</i> = 9.1 Hz, 1H), 4.01 (dd, <i>J</i> = 11.9, 3.3 Hz, 1H), 3.93 (s, 3H), 2.98–2.90 (m, 1H), 2.56 (dd, <i>J</i> = 13.6, 6.7 Hz, 1H), 2.34–2.18 (m, 2H), 1.82 (dd, <i>J</i> = 8.1, 5.6 Hz, 1H), 1.47–1.40 (m, 1H), 1.30–1.19 (m, 1H), 1.25 (s, 9H), 1.10–0.99 (m, 3H), 1.03 (s, 9H). LCMS (method C): <i>t</i><sub>R</sub> = 2.37 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>47</sub>N<sub>5</sub>O<sub>9</sub>S: 713.31. Found: 714.25 (M + H)<sup>+</sup>.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((5-fluoroisoquinolin-1-yl)oxy)spyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>28</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.06 (d, <i>J</i> = 6.1 Hz, 1H), 8.02 (d, <i>J</i> = 8.1 Hz, 1H), 7.47 (m, 3H), 6.59 (d, <i>J</i> = 9.1 Hz, 1H), 5.89 (s, 1H), 5.75 (m, 1H), 5.29 (d, <i>J</i> = 17.4 Hz, 1H), 5.12 (dd, <i>J</i> = 10.3, 1.5 Hz, 1H), 4.52 (m, 2H), 4.23 (d, <i>J</i> = 9.3 Hz, 1H), 4.07 (dd, <i>J</i> = 11.9, 3.1 Hz, 1H), 2.94 (m, 1H), 2.63 (dd, <i>J</i> = 13.8, 7.0 Hz, 1H), 2.28 (m, 2H), 1.88 (dd, <i>J</i> = 8.1, 5.4 Hz, 1H), 1.44 (dd, <i>J</i> = 9.5, 5.4 Hz, 1H), 1.25 (m, 10H), 1.05 (m, 12H). LCMS (method D): <i>t</i><sub>R</sub> = 3.28 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>44</sub>FN<sub>5</sub>O<sub>8</sub>S: 701.29. Found: 724.02 (M + Na)<sup>+</sup>.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((6-morpholinoisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>29</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.06 (d, <i>J</i> = 9.1 Hz, 1H), 7.84 (d, <i>J</i> = 6.0 Hz, 1H), 7.40–7.03 (m, 3H), 6.63 (d, <i>J</i> = 9.3 Hz, 1H), 5.95–5.70 (m, 3H), 5.33 (d, <i>J</i> = 17.0 Hz, 2H), 5.15 (d, <i>J</i> = 10.7 Hz, 1H), 4.68–4.50 (m, 3H), 4.43 (d, <i>J</i> = 11.7 Hz, 1H), 4.29 (d, <i>J</i> = 9.1 Hz, 1H), 4.18–4.01 (m, 1H), 3.97 (s, 3H), 3.05–2.90 (m, 1H), 2.61–2.55 (m, 1H), 2.45–2.22 (m, 2H), 1.91–1.87 (m, 1H), 1.58–1.42 (m, 1H), 1.39 (s, 9H), 1.15–0.94 (m, 13H). LCMS (method A): <i>t</i><sub>R</sub> = 1.70 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>38</sub>H<sub>52</sub>N<sub>6</sub>O<sub>9</sub>S: 768.35. Found: 769.14 (M + H)<sup>+</sup>.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-4-((6-(1<i>H</i>-Pyrazol-1-yl)isoquinolin-1-yl)oxy)-2-(((1<i>R</i>,2<i>S</i>)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>30</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.42 (d, <i>J</i> = 4.5 Hz, 1H), 8.31 (d, <i>J</i> = 15 Hz, 1H), 8.15 (s, 1H), 8.01 (d, <i>J</i> = 10 Hz, 1H), 7.80 (d, <i>J</i> = 2.5 Hz, 1H), 7.40 (d, <i>J</i> = 10 Hz, 1H), 6.61–6.59 (m, 1H), 5.89 (b, 1H), 5.83–5.70 (m, 1H), 5.29 (d, <i>J</i> = 18 Hz, 1H), 5.13 (d, <i>J</i> = 10.5 Hz, 1H), 4.60–4.46 (m, 2H), 4.24 (b, 1H), 4.11–4.07 (m, 1H), 2.98–2.92 (m, 1H), 2.68–2.61 (m, 1H), 2.29–2.22 (m, 2H), 1.91–1.87 (m, 1H), 1.47–1.43 (m, 1H), 1.27–1.23 (m, 10H), 1.10–1.04 (m, 12H). LCMS (method F): <i>t</i><sub>R</sub> = 1.77 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>37</sub>H<sub>47</sub>N<sub>7</sub>O<sub>8</sub>S: 749.32. Found: 750.06 (M + H)<sup>+</sup>.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((6-(dimethylcarbamoyl)isoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>31</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.27 (d, <i>J</i> = 8.6 Hz, 1H), 8.03 (d, <i>J</i> = 5.9 Hz, 1H), 7.86 (s, 1H), 7.51 (d, <i>J</i> = 8.8 Hz, 1H), 7.39 (m, 1H), 5.90 (br s, 1H), 5.67–5.45 (m, 1H), 5.37–5.22 (m, 1H), 5.20–5.03 (m, 1H), 4.68–4.53 (m, 1H), 4.50–4.36 (m, 1H), 4.34–4.17 (m, 1H), 4.14–3.98 (m, 1H), 3.19–3.07 (m, 3H), 3.03–2.89 (m, 4H), 2.65–2.54 (m, 2H), 2.52–2.40 (m, 1H), 2.35–2.14 (m, 1H), 2.00–1.74 (m, 1H), 1.25–1.18 (m, 11H), 1.02 (m, 11H). LCMS (method C): <i>t</i><sub>R</sub> = 2.45 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>37</sub>H<sub>50</sub>N<sub>6</sub>O<sub>9</sub>S: 754.34. Found: 777.43 (M + Na)<sup>+</sup>.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-4-((6-Chloroisoquinolin-1-yl)oxy)-2-(((1<i>R</i>,2<i>S</i>)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>32</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.18 (d, <i>J</i> = 9.0 Hz, 1H), 8.01 (d, <i>J</i> = 6.0 Hz, 1H), 7.86 (s, 1H), 7.47 (d, <i>J</i> = 9.0 Hz, 1H), 7.29 (d, <i>J</i> = 6.0 Hz, 1H), 6.58 (d, <i>J</i> = 10.0 Hz, 1H), 5.88 (b, 1H), 5.80–5.72 (m, 1H), 5.29 (d, <i>J</i> = 18.0 Hz, 1H), 5.10 (d, <i>J</i> = 10.5 Hz, 1H), 4.56–4.53 (m, 1H), 4.47–4.45 (m, 1H), 4.23–4.21 (m, 1H), 4.08–4.06 (m, 1H), 2.97–2.92 (m, 1H), 2.64–2.60 (m, 1H), 2.31–2.22 (m, 2H), 1.90–1.87 (m, 1H), 1.46–1.43 (m, 1H), 1.26–1.20 (m, 10H), 1.11–0.99 (m, 12H). LCMS (method A): <i>t</i><sub>R</sub> = 1.94 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>44</sub>ClN<sub>5</sub>O<sub>8</sub>S: 717.26. Found: 718.25 (M + H)<sup>+</sup>.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((6-methylisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>33</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.07 (d, <i>J</i> = 8.6 Hz, 1H), 7.90 (s, 1H), 7.58 (s, 1H), 7.35 (d, <i>J</i> = 8.1 Hz, 1H), 7.24 (d, <i>J</i> = 5.9 Hz, 1H), 5.83 (br s, 1H), 5.79–5.60 (m, 1H), 5.28 (d, <i>J</i> = 17.1 Hz, 1H), 5.10 (d, <i>J</i> = 11.5 Hz, 1H), 4.59–4.47 (m, 1H), 4.43 (d, <i>J</i> = 11.7 Hz, 1H), 4.23 (s, 1H), 4.05 (dd, <i>J</i> = 12.0, 3.4 Hz, 1H), 3.08–2.84 (m, 1H), 2.61 (dd, <i>J</i> = 13.9, 6.6 Hz, 1H), 2.49 (s, 3H), 2.35–2.11 (m, 2H), 1.86 (dd, <i>J</i> = 8.1, 5.6 Hz, 1H), 1.52–1.33 (m, 1H), 1.29–1.17 (m, 9H), 1.14–1.03 (m, 2H), 1.03–0.92 (m, 11H). LCMS (method A): <i>t</i><sub>R</sub> = 2.68 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>47</sub>N5O<sub>8</sub>S: 697.31. Found: 720.37 (M + Na)<sup>+</sup>.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-4-((6-(<i>tert</i>-Butyl)isoquinolin-1-yl)oxy)-2-(((1<i>R</i>,2<i>S</i>)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>34</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.28–8.07 (m, 1H), 8.04–7.87 (m, 1H), 7.78 (s, 1H), 7.72–7.60 (m, 1H), 7.38–7.22 (m, 1H), 6.00–5.86 (m, 1H), 5.86–5.71 (m, 1H), 5.33 (d, <i>J</i> = 17.3 Hz, 1H), 5.15 (d, <i>J</i> = 11.0 Hz, 1H), 4.64 (s, 1H), 4.56 (d, <i>J</i> = 10.0 Hz, 1H), 4.48 (d, <i>J</i> = 11.3 Hz, 1H), 4.28 (d, <i>J</i> = 9.3 Hz, 1H), 4.17–3.98 (m, 1H), 3.06–2.90 (m, 1H), 2.72–2.59 (m, 1H), 2.47–2.16 (m, 2H), 1.91 (dd, <i>J</i> = 8.3, 5.5 Hz, 1H), 1.54–1.38 (m, 9H), 1.35–1.18 (m, 11H), 1.12–0.96 (m, 11H). LCMS (method A): <i>t</i><sub>R</sub> = 2.35 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>38</sub>H<sub>53</sub>N<sub>5</sub>O<sub>8</sub>S: 739.36. Found: 740.35 (M + H)<sup>+</sup>.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-4-((6-Cyanoisoquinolin-1-yl)oxy)-2-(((1<i>R</i>,2<i>S</i>)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>36</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.42–8.24 (m, 2H), 8.14 (d, <i>J</i> = 5.8 Hz, 1H), 7.72 (d, <i>J</i> = 7.6 Hz, 1H), 7.44 (d, <i>J</i> = 5.5 Hz, 1H), 5.91 (br s, 1H), 5.82–5.65 (m, 1H), 5.30 (d, <i>J</i> = 17.1 Hz, 1H), 5.13 (d, <i>J</i> = 10.4 Hz, 1H), 4.64–4.51 (m, 1H), 4.47 (br s, 1H), 4.29–4.00 (m, 2H), 3.04–2.83 (m, 1H), 2.64 (dd, <i>J</i> = 13.7, 6.7 Hz, 1H), 2.42–2.15 (m, 2H), 1.89 (dd, <i>J</i> = 8.2, 5.5 Hz, 1H), 1.45 (s, 2H), 1.37–1.13 (m, 10H), 0.90 (d, <i>J</i> = 3.7 Hz, 10H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>44</sub>N<sub>6</sub>O<sub>8</sub>S: 708.29. Found: 709.40 (M + H)<sup>+</sup>.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((6-hydroxyisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>37</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.03 (d, <i>J</i> = 8.4 Hz, 1H), 7.79 (d, <i>J</i> = 6.0 Hz, 1H), 7.09 (d, <i>J</i> = 6.0 Hz, 1H), 7.00 (d, <i>J</i> = 8.4 Hz, 1H), 6.99 (s, 1H), 5.79–5.70 (m, 2H), 5.29 (d, <i>J</i> = 17.4 Hz, 1H), 5.10 (d, <i>J</i> = 11.2 Hz, 1H), 4.52–4.36 (m, 2H), 4.24 (s, 1H), 4.08–4.02 (m, 1H), 2.92–2.88 (m, 1H), 2.62–2.58 (m, 1H), 2.26–2.18 (m, 2H), 1.94–1.84 (m, 1H), 1.48–1.38 (m, 1H), 1.32–0.99 (m, 23H). LCMS (method A): <i>t</i><sub>R</sub> = 1.52 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>45</sub>N<sub>5</sub>O<sub>9</sub>S: 699.29. Found: 700.18 (M + H)<sup>+</sup>.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((6-fluoroisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>38</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.24 (dd, <i>J</i> = 9.0, 5.9 Hz, 1H), 7.96 (d, <i>J</i> = 6.1 Hz, 1H), 7.88 (s, 1H), 7.47 (dd, <i>J</i> = 9.7, 2.1 Hz, 1H), 7.32–7.23 (m, 2H), 6.59 (d, <i>J</i> = 9.0 Hz, 1H), 5.85 (br s, 1H), 5.74 (dt, <i>J</i> = 17.1, 9.6 Hz, 1H), 5.28 (d, <i>J</i> = 16.9 Hz, 1H), 5.10 (dd, <i>J</i> = 10.4, 1.3 Hz, 1H), 4.52 (dd, <i>J</i> = 10.1, 7.2 Hz, 1H), 4.44 (d, <i>J</i> = 11.7 Hz, 1H), 4.22 (d, <i>J</i> = 9.5 Hz, 1H), 4.05 (dd, <i>J</i> = 11.9, 3.3 Hz, 1H), 2.97–2.89 (m, 1H), 2.60 (dd, <i>J</i> = 13.8, 7.0 Hz, 1H), 2.32–2.17 (m, 2H), 1.86 (dd, <i>J</i> = 8.2, 5.5 Hz, 1H), 1.42 (dd, <i>J</i> = 9.3, 5.4 Hz, 1H), 1.22 (s, 8H), 1.08–1.03 (m, 2H), 1.01 (s, 9H). LCMS (method G): <i>t</i><sub>R</sub> = 3.81 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>44</sub>FN<sub>5</sub>O<sub>8</sub>S: 701.29. Found: 702.28 (M + H)<sup>+</sup>.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((6-ethoxyisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>39</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.08 (d, <i>J</i> = 8.8 Hz, 1H), 7.87 (d, <i>J</i> = 5.8 Hz, 1H), 7.22 (d, <i>J</i> = 5.8 Hz, 1H), 7.15 (s, 1H), 7.10–7.07 (m, 1H), 5.83 (s, 1H), 5.78–5.72 (m, 1H), 5.12 (d, <i>J</i> = 17.4 Hz, 1H), 4.54–4.49 (m, 1H), 4.42 (d, <i>J</i> = 11.3 Hz, 1H), 4.17 (q, <i>J</i> = 7.0 Hz, 2H), 4.09–4.03 (m, 1H), 2.97–2.91 (m, 1H), 2.63–2.57 (m, 1H), 2.32–2.19 (m, 2H), 1.90–1.85 (m, 1H), 1.46–1.42 (m, 1H), 1.31–1.24 (m, 10H), 1.09–0.98 (m, 15H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>49</sub>N<sub>5</sub>O<sub>9</sub>S: 727.33. Found: 728.38 (M + H)<sup>+</sup>.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((7-methylisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>40</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD)) δ 7.93 (s, 1H), 7.89 (d, <i>J</i> = 5.9 Hz, 1H), 7.71 (d, <i>J</i> = 8.3 Hz, 1H), 7.55 (d, <i>J</i> = 8.3 Hz, 1H), 7.28 (d, <i>J</i> = 5.9 Hz, 1H), 5.87 (s, 1H), 5.82–5.70 (m, 1H), 5.30 (d, <i>J</i> = 17.1 Hz, 1H), 5.12 (dd, <i>J</i> = 10.3, 1.5 Hz, 1H), 4.57 (dd, <i>J</i> = 10.0, 7.1 Hz, 1H), 4.42 (d, <i>J</i> = 12.0 Hz, 1H), 4.23 (s, 1H), 4.09 (dd, <i>J</i> = 11.7, 3.2 Hz, 1H), 2.98–2.90 (m, 1H), 2.61 (dd, <i>J</i> = 13.8, 6.7 Hz, 1H), 2.50 (s, 3H), 2.36–2.18 (m, 2H), 1.88 (dd, <i>J</i> = 8.2, 5.5 Hz, 1H), 1.45 (dd, <i>J</i> = 9.4, 5.5 Hz, 1H), 1.29–1.21 (m, 1H), 1.18 (s, 9H), 1.10–1.05 (m, 2H), 1.05–0.99 (m, 1H), 1.02 (s, 9H). LCMS (method C): <i>t</i><sub>R</sub> = 2.32 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>45</sub>CN<sub>5</sub>O<sub>8</sub>S: 697.31. Found: 698.35 (M + H)<sup>+</sup>.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((8-methylisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>41</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.42 (s, 1H), 8.94 (br s, 1H), 7.95 (d, <i>J</i> = 5.6 Hz, 1H), 7.68 (d, <i>J</i> = 7.9 Hz, 1H), 7.56 (t, <i>J</i> = 7.6 Hz, 1H), 7.40–7.29 (m, 2H), 6.47 (d, <i>J</i> = 8.5 Hz, 1H), 5.89 (br s, 1H), 5.68–5.55 (m, 1H), 5.24 (d, <i>J</i> = 17.4 Hz, 1H), 5.11 (d, <i>J</i> = 10.7 Hz, 1H), 4.52–4.40 (m, 1H), 4.30 (d, <i>J</i> = 11.6 Hz, 1H), 4.06 (d, <i>J</i> = 8.7 Hz, 1H), 3.94 (d, <i>J</i> = 9.6 Hz, 1H), 2.93 (d, <i>J</i> = 4.7 Hz, 2H), 2.73 (s, 3H), 2.26–2.13 (m, 2H), 1.72 (dd, <i>J</i> = 7.7, 5.6 Hz, 1H), 1.41–1.32 (m, 2H), 1.28–0.91 (m, 21H). LCMS (method D): <i>t</i><sub>R</sub> = 3.31 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>47</sub>N<sub>5</sub>O<sub>8</sub>S: 697.31. Found: 720.45 (M + Na)<sup>+</sup>.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((4,6-dimethoxyisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>42</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.43 (s, 1H), 8.88 (br s, 1H), 8.08 (d, <i>J</i> = 9.0 Hz, 1H), 7.61 (s, 1H), 7.35 (d, <i>J</i> = 2.3 Hz, 1H), 7.16 (d, <i>J</i> = 8.3 Hz, 1H), 6.61 (d, <i>J</i> = 8.3 Hz, 1H), 5.71 (br s, 1H), 5.69–5.55 (m, 1H), 5.25 (d, <i>J</i> = 17.1 Hz, 1H), 5.16–5.08 (m, 1H), 4.46–4.28 (m, 2H), 4.08 (d, <i>J</i> = 8.3 Hz, 1H), 4.01–3.86 (m, 7H), 2.99–2.92 (m, 1H), 2.48–2.46 (m, 1H), 2.22–2.12 (m, 2H), 1.72 (dd, <i>J</i> = 7.9, 5.4 Hz, 1H), 1.41–1.34 (m, 1H), 1.31–0.92 (m, 22H); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.04 (d, <i>J</i> = 9.05 Hz, 1H), 7.48 (s, 1H), 7.40 (d, <i>J</i> = 2.20 Hz, 1H), 7.12 (d, <i>J</i> = 9.05 Hz, 1H), 5.75 (m, 2H), 5.29 (d, <i>J</i> = 16.87 Hz, 1H), 5.12 (d, <i>J</i> = 10.52 Hz, 1H), 4.50 (m, 1H), 4.39 (d, <i>J</i> = 11.98 Hz, 1H), 4.24 (s, 1H), 4.04 (dd, <i>J</i> = 11.74, 2.93 Hz, 1H), 3.99 (s, 3H), 3.92 (s, 3H), 2.94 (m, 1H), 2.58 (dd, <i>J</i> = 13.57, 6.97 Hz, 1H), 2.24 (m, 2H), 1.87 (dd, <i>J</i> = 8.07, 5.62 Hz, 1H), 1.43 (m, 1H), 1.21 (m, 10H), 1.07 (m, 12H). LCMS (method H): <i>t</i><sub>R</sub> = 3.22 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>49</sub>N<sub>5</sub>O<sub>10</sub>S: 743.32. Found: 744.34 (M + H)<sup>+</sup>.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((7-methoxyisoquinolin-4-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>43</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.77 (s, 1H), 8.07 (d, <i>J</i> = 9.0 Hz, 1H), 7.97 (s, 1H), 7.40 (d, <i>J</i> = 1.7 Hz, 1H), 7.30 (d, <i>J</i> = 9.3 Hz, 1H), 5.82–5.62 (m, 1H), 5.40 (br s, 1H), 5.27 (d, <i>J</i> = 17.4 Hz, 1H), 5.10 (d, <i>J</i> = 11.2 Hz, 1H), 4.55–4.38 (m, 2H), 3.93 (s, 3H), 2.98–2.84 (m, 1H), 2.61 (dd, <i>J</i> = 13.6, 6.7 Hz, 1H), 2.34–2.13 (m, 2H), 1.85 (dd, <i>J</i> = 8.1, 5.6 Hz, 1H), 1.27 (s, 9H), 1.25–1.18 (m, 4H), 1.10–1.04 (m, 3H), 1.03–0.99 (m, 9H). LCMS (method C): <i>t</i><sub>R</sub> = 1.42 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>47</sub>N<sub>5</sub>O<sub>9</sub>S: 713.31. Found: 714.20 (M + H)<sup>+</sup>.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((7-methoxyquinazolin-4-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>44</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.71 (s, 1H), 8.09 (d, <i>J</i> = 9.0 Hz, 1H), 7.26–7.18 (m, 2H), 5.93 (br s, 1H), 5.84 (dt, <i>J</i> = 17.2, 9.7 Hz, 1H), 5.30–5.22 (m, 1H), 5.08 (dd, <i>J</i> = 10.4, 1.6 Hz, 1H), 4.66–4.53 (m, 2H), 4.21 (s, 1H), 4.16–4.08 (m, 1H), 3.98 (s, 3H), 2.95–2.85 (m, 1H), 2.75–2.66 (m, 1H), 2.45 (ddd, <i>J</i> = 14.1, 10.1, 4.4 Hz, 1H), 2.19–2.10 (m, 1H), 1.86 (dd, <i>J</i> = 7.8, 5.1 Hz, 1H), 1.47 (d, <i>J</i> = 5.4 Hz, 1H), 1.38 (dd, <i>J</i> = 9.4, 5.3 Hz, 1H), 1.24–1.12 (m, 9H), 1.09–0.93 (m, 12H). LCMS (method D): <i>t</i><sub>R</sub> = 3.03 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>46</sub>N<sub>6</sub>O<sub>9</sub>S: 714.30. Found: 737.28 (M + Na)<sup>+</sup>.</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((6-methoxy-3-phenylisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>45</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.23–7.98 (m, 3H), 7.77 (br s, 1H), 7.56–7.33 (m, 3H), 7.26 (br s, 1H), 7.06 (d, <i>J</i> = 8.2 Hz, 1H), 6.05 (br s, 1H), 5.86–5.67 (m, 1H), 5.29 (d, <i>J</i> = 17.1 Hz, 1H), 5.12 (d, <i>J</i> = 10.1 Hz, 1H), 4.55 (d, <i>J</i> = 7.6 Hz, 1H), 4.42 (d, <i>J</i> = 10.7 Hz, 1H), 4.33–4.10 (m, 2H), 3.94 (s, 3H), 2.95 (dq, <i>J</i> = 8.4, 4.1 Hz, 1H), 2.68 (d, <i>J</i> = 6.4 Hz, 1H), 2.43–2.16 (m, 2H), 1.89 (d, <i>J</i> = 5.8 Hz, 1H), 1.45 (d, <i>J</i> = 4.9 Hz, 1H), 1.37–1.16 (m, 10H), 1.13–0.89 (m, 12H). LCMS (method F): <i>t</i><sub>R</sub> = 2.18 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>41</sub>H<sub>51</sub>N<sub>5</sub>O<sub>9</sub>S: 789.34. Found: 790.10 (M + H)<sup>+</sup>.</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>S</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((6-methoxyisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>46</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.14 (d, <i>J</i> = 8.9 Hz, 1H), 7.88 (d, <i>J</i> = 6.1 Hz, 1H), 7.32–7.10 (m, 3H), 6.76 (d, <i>J</i> = 10.0 Hz, 1H), 6.58 (b, 1H), 5.76–5.69 (m, 1H), 5.28 (d, <i>J</i> = 8.0 Hz, 1H), 5.12 (d, <i>J</i> = 10.5 Hz, 1H), 4.51–4.49 (m, 1H), 4.24–4.21 (m, 1H), 4.06–4.02 (m, 1H), 3.92 (s, 3H), 2.97–2.91 (m, 1H), 2.61–2.55 (m, 1H), 2.30–2.20 (m, 2H), 1.88–1.85 (m, 1H), 1.45–1.40 (m, 1H), 1.27 (s, 9H), 1.25–1.23 (m, 1H), 1.08–1.00 (m, 12H). LCMS (method A): <i>t</i><sub>R</sub> = 1.75 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>47</sub>N<sub>5</sub>O<sub>9</sub>S: 713.31. Found: 714.11 (M + H)<sup>+</sup>.</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>R</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-ethylcyclopropyl)carbamoyl)-4-((6-methoxyisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>47</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.08 (d, <i>J</i> = 9.0 Hz, 1H), 7.88 (d, <i>J</i> = 6.0 Hz, 1H), 7.24 (d, <i>J</i> = 6.0 Hz, 1H), 7.18 (d, <i>J</i> = 1.5 Hz,1H), 7.10–7.08 (m, 1H), 6.59 (d, <i>J</i> = 10.0 Hz, 1H), 5.81 (b, 1H), 4.51–4.49 (m, 1H), 4.42–4.40 (m, 1H), 4.24–4.21 (m, 1H), 4.06–4.02 (m, 1H), 3.92 (s, 3H), 2.98–2.94 (m, 1H), 2.61–2.55 (m, 1H), 2.27–2.25 (m, 1H), 1.65–1.51 (m, 4H), 1.27 (s, 9H), 1.24–1.21 (m, 2H), 1.09–1.07 (m, 2H), 1.04 (s, 9H), 0.99–0.96 (m, 4H). LCMS (method A): <i>t</i><sub>R</sub> = 1.70 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>49</sub>N<sub>5</sub>O<sub>9</sub>S: 715.33. Found: 716.11 (M + H)<sup>+</sup>.</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> (<i>S</i>)-Tetrahydrofuran-3-yl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((6-methoxyisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate (<b>48</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.07 (d, <i>J</i> = 9.0 Hz, 1H), 7.89 (d, <i>J</i> = 6.0 Hz, 1H), 7.25 (d, <i>J</i> = 6.0 Hz, 1H), 7.20 (s, 1H), 7.13 (d, <i>J</i> = 9.0 Hz, 1H), 7.06 (d, <i>J</i> = 10.0 Hz, 1H), 5.85 (b, 1H), 5.80–5.73 (m, 1H), 5.28 (d, <i>J</i> = 18.0 Hz, 1H), 5.12 (d, <i>J</i> = 10.5 Hz, 1H), 4.77–4.75 (m, 1H), 4.59–4.55 (m, 1H), 4.42–4.40 (m, 1H), 4.29–4.27 (m, 1H), 4.09–4.05 (m, 1H), 3.93 (s, 3H), 3.72–3.66 (m, 4H), 2.97–2.91 (m, 1H), 2.61–2.55 (m, 1H), 2.30–2.20 (m, 2H), 1.90–1.85 (m, 2H), 1.71–1.64 (m, 1H), 1.46–1.38 (m, 1H), 1.26–1.23 (m, 2H), 1.08–1.03 (m, 11H). LCMS (method A): <i>t</i><sub>R</sub> = 1.52 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>45</sub>N<sub>5</sub>O<sub>10</sub>S: 727.29. Found: 728.06 (M + H)<sup>+</sup>.</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> <i>tert</i>-Butyl ((<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-2-(((1<i>R</i>,2<i>S</i>)-1-((Cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)-4-((6-methoxyisoquinolin-1-yl)oxy)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate (<b>49</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.10 (d, <i>J</i> = 9.0 Hz, 1H), 7.88 (d, <i>J</i> = 6.0 Hz, 1H), 7.25 (d, <i>J</i> = 6.0 Hz, 1H), 7.18 (s, 1H), 7.10 (d, <i>J</i> = 9.0 Hz, 1H), 5.86 (b, 1H), 5.81–5.74 (m, 1H), 5.32 (d, <i>J</i> = 18.1 Hz, 1H), 5.12 (d, <i>J</i> = 10.5 Hz, 1H), 4.55–4.47 (m, 1H), 4.06–4.03 (m, 2H), 3.92 (s, 3H), 2.97–2.94 (m, 1H), 2.61–2.57 (m, 1H), 2.35–2.22 (m, 2H), 1.89–1.88 (m, 1H), 1.43–1.40 (m, 1H), 1.25–1.21 (m, 10H), 1.09–1.07 (m, 3H), 0.98–0.94 (m, 6H). LCMS (method A): <i>t</i><sub>R</sub> = 1.71 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>45</sub>N<sub>5</sub>O<sub>9</sub>S: 699.29. Found: 700.07 (M + H)<sup>+</sup>.</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (1<i>R</i>,2<i>S</i>)-1-((2<i>S</i>,4<i>R</i>)-1-((<i>S</i>)-2-((<i>tert</i>-Butoxycarbonyl)amino)-3,3-dimethylbutanoyl)-4-((6-methoxyisoquinolin-1-yl)oxy)pyrrolidine-2-carboxamido)-2-vinylcyclopropanecarboxylic Acid (<b>50</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.05 (d, <i>J</i> = 8.9 Hz, 1H), 7.89 (d, <i>J</i> = 5.8 Hz, 1H), 7.12 (d, <i>J</i> = 5.5 Hz, 1H), 7.10–7.02 (m, 2H), 6.98 (s, 1H), 5.85–5.66 (m, 2H), 5.23 (d, <i>J</i> = 17.1 Hz, 1H), 5.08 (d, <i>J</i> = 10.4 Hz, 1H), 4.55 (t, <i>J</i> = 7.8 Hz, 1H), 4.40 (d, <i>J</i> = 11.3 Hz, 1H), 4.32 (d, <i>J</i> = 9.5 Hz, 1H), 4.01 (d, <i>J</i> = 8.2 Hz, 1H), 3.90 (s, 3H), 2.61–2.48 (m, 2H), 2.11–2.03 (m, 1H), 1.93 (t, <i>J</i> = 6.4 Hz, 1H), 1.38–1.28 (m, 9H), 1.24–1.19 (m, 1H), 1.00 (s, 9H). LCMS (method D): <i>t</i><sub>R</sub> = 3.09 min. LCMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>42</sub>N<sub>4</sub>O<sub>8</sub>: 610.30. Found: 611.25 (M + H)<sup>+</sup>.</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Sample Analysis</h3><div class="NLM_p">Samples from in vitro and in vivo studies were analyzed by LC/MS/MS. Protein-containing samples (plasma, microsomal incubates) were treated with two volumes of ACN containing an internal standard. After the precipitated proteins were removed by centrifugation, the resulting supernatants were transferred to autosampler vials and 5 μL was injected onto an HPLC column for analysis. Tissue samples were weighed and homogenized in 2 volumes of a solution containing 20% Hanks buffered salt solution/80% ACN and centrifuged. An aliquot of each tissue supernatant was removed and processed as described for plasma samples. The HPLC system consisted of two Shimadzu LC10AD pumps (Columbia, MD), a Shimadzu SIL-HTC autosampler, and a Hewlett-Packard series 1100 column compartment (Palo Alto, CA). The column was a YMC Pro C18 (2.0 mm × 50 mm, 3 μm particles), maintained at 60 °C. The mobile phase consisted of solvent A (10 mM ammonium formate and 0.1% formic acid in water) and solvent B (10 mM ammonium formate and 0.1% formic acid in methanol) at a flow rate of 0.3 mL/min. The initial mobile phase composition was 95% A/5% B which was changed to 15% A/85% B over 2 min and held at that composition for an additional 2 min. The mobile phase was then returned to initial conditions and the column re-equilibrated. The total analysis time was 5 min.</div><div class="NLM_p last">The HPLC was interfaced to a Micromass Quattro tandem mass spectrometer (Beverly, MA) equipped with an electrospray ionization source. Ions representing the (M + H)<sup>+</sup> species for both BMS-605339 and the internal standard were selected in MS1 and collisionally dissociated with argon at a pressure of 2 × 10<sup>–3</sup> Torr to form specific product ions which were subsequently monitored by MS2. The selected reaction monitoring transitions used were 714.7 → 439.1 for BMS-605339 and 485.2 → 381.3 for the internal standard. The LLQ of BMS-605339 was 5 nM in all samples, which measured concentrations of at least two-thirds of the quality control samples with 20% of nominal values.</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Microsomal Metabolic Stability</h3><div class="NLM_p last">The metabolic stability of 35 was investigated in pooled liver microsomes from human, mouse, rat, dog, and monkey. The concentrations of CYP P450 protein in these preparations were 0.38, 0.52, 0.89, and 1.4 nmol/mg microsomal protein in human, rat, dog, and monkey, respectively. Incubation mixtures were prepared in triplicate for each species and consisted of BMS-605339 (3 μM) in potassium phosphate buffer (0.1 M, pH 7.4) at 37 °C, liver microsomes (protein concentration 0.9 mg/mL), magnesium chloride (0.033 mM), and a NADPH-regenerating system (NADPH, 0.43 mg/mL; glucose 6-phosphate, 0.52 mg/mL; glucose 6-phosphate dehydrogenase, 0.6 units/mL). The total concentration of ACN in the incubation mixtures was <0.5%. After a 2 min preincubation, each reaction was initiated by the addition of cofactors and continued for 10 min. Reactions were terminated by adding an aliquot (100 μL) of the incubation mixture to 200 μL of cold acetonitrile containing an internal standard. Following vortex-mixing and centrifugation (3200 rpm ×10 min), aliquots (10 μL) of the supernatant fluids were analyzed for BMS-605339 by LC/MS/MS.</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> In Vivo Pharmacokinetic Studies</h3><div class="NLM_p last">All animal studies were performed under the approval of the Bristol-Myers Squibb Animal Care and Use Committee and in accordance with the American Association for Accreditation of Laboratory Animal Care (AAALAC).</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Rat</h3><div class="NLM_p">Male Sprague–Dawley rats (300–350 g) with cannulae implanted in the duodenum were used. After dosing, serial blood samples (0.3 mL) were obtained from the appropriate cannula of each rat by collection into EDTA-containing tubes (Becton Dickinson, Franklin Lakes, NJ) and centrifuged to separate plasma. Plasma was frozen until analysis.</div><div class="NLM_p">For iv studies, BMS-605339 was dissolved (2–5 mg/mL) in a vehicle of PEG-400/ethanol (90/10, v/v) and dosed (1–2 mL/kg) as a 10 min constant rate infusion into the jugular vein, with serial blood samples collected before dosing and at 10, 15, 30, 45, 60 min and 2, 4, 6, 8, and 24 h after dosing (<i>n</i> = 3 rats/dose group).</div><div class="NLM_p">For po solution dosing, BMS-605339 was administered by gastric gavage as an aqueous solution (PEG-400/ethanol (90/10, v/v) containing either amorphous material. Serial blood samples were collected before dosing and at 15, 30, 45, 60 min and 2, 4, 6, 8, and 24 h after dosing (<i>n</i> = 3 rats/dose group). Prior to all po dosing, the rats were fasted overnight with free access to water.</div><div class="NLM_p last">To assess liver exposure, in several studies livers were removed from rats at various times after dosing. The tissues were rinsed, blotted dry, weighed, and stored frozen until analysis.</div></div><div id="sec4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Monkey</h3><div class="NLM_p">Pharmacokinetics studies of BMS-606339 were conducted in a crossover fashion in three male cynomolgus monkeys (9 ± 1 kg) bearing vascular access ports to facilitate blood collection. There was a 2-week washout period between the iv and po studies. For iv administration, BMS-605339 was infused via the venous port over 5 min at a constant rate of 0.2 mL min<sup>–1</sup> kg<sup>–1</sup>. Serial blood samples were collected from the arterial port before dosing and 5, 10, 15, 30, 45, 60 min and 2, 4, 6, 8, and 24 h after dosing.</div><div class="NLM_p last">In the po study, the monkeys were fasted overnight prior to dosing. BMS-605339 was administered by oral gavage (3 mg/kg). Serial blood samples were collected before dosing and 15, 30, 45, 60 min and 2, 4, 6, 8, and 24 h after dosing. The vehicle for both dosing routes was PEG-400/water (85:15), in which BMS-605339 was dissolved at 3 mg/mL.</div></div><div id="sec4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Dog</h3><div class="NLM_p">Male beagle dogs (9–12 kg) bearing venous and arterial vascular access ports were administered iv or po (solution suspension or capsule) doses of BMS-605339. There was at least a 1-week washout period between studies. For iv dosing, BMS-605339 was infused into the venous port at a constant rate over 5 min and serial blood samples (0.3 mL) were collected into EDTA-containing tubes (Becton Dickinson, Franklin Lakes, NJ) from the arterial port before dosing and at 5, 10, 15, 30, 45, 60 min and 2, 4, 6, 8, and 24 h after dosing. Plasma prepared from the collected blood samples was stored frozen until analysis. The dosing vehicle for iv administration to dogs was PEG-400/water (85:15, v/v).</div><div class="NLM_p">Prior to all po dosing, the dogs were fasted overnight. BMS-605339 was administered by oral gavage or capsule as a PEG-400/water (85:15) solution. Additionally a 3 mg/kg dose was administered as an aqueous suspension (0.75% methylcellulose/0.1% Tween-80 in water) of crystalline (0.40 μm particles) material. After all dosing, serial blood samples were collected at 15, 30, 45, 60 min and at 2, 4, 6, 8, and 24 h.</div><div class="NLM_p last">In a study to evaluate the liver exposure of BMS-605339 in dogs, three dogs (7–9 kg) were administered 120 mg of BMS-605339 contained in three capsules (PEG-900 proprietary formulation). At 2, 8, and 24 h after dosing, dogs were euthanized and samples of liver, spleen, bile, and urine were obtained. Following removal, tissue samples were rinsed, blotted dry, weighed, and stored frozen until processed for analysis. Blood samples were collected at intervals from all dogs until the time of euthanasia. Plasma prepared from the collected blood samples was stored frozen until analysis.</div></div><div id="sec4_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Data Analysis</h3><div class="NLM_p last">The pharmacokinetics parameters of BMS-605339 were obtained by noncompartmental analysis of plasma concentration versus time data (KINETICA software, version 2.4, InnaPhase Corporation, Philadelphia, PA). The peak concentration (<i>C</i><sub>max</sub>) and time for <i>C</i><sub>max</sub> (<i>T</i><sub>max</sub>) were recorded directly from experimental observations. The area under the curve from time zero to the last sampling time (AUC<sub>(0–<i>T</i>)</sub>) and the area under the curve from time zero to infinity (AUC<sub>(INF)</sub>) were calculated using a combination of linear and log trapezoidal summations. The whole body plasma clearance (CL<sub>p</sub>), steady-state volume of distribution (<i>V</i><sub>ss</sub>), apparent terminal <i>T</i><sub>1/2</sub>, and mean residence time (MRT) were estimated following intravenous administration. The absolute oral bioavailability (<i>F</i>) was estimated as the ratio of dose-normalized AUC values following po and iv doses.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74"><a href="/doi/suppl/10.1021/jm401840s">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25335" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25335" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental details of biological assays, synthetic intermediates, and p<i>K</i><sub>a</sub> determinations. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401840s/suppl_file/jm401840s_si_001.pdf">jm401840s_si_001.pdf (155.64 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm401840s" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60336" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60336" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul M. Scola</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#075766726b295464686b6647656a742964686a"><span class="__cf_email__" data-cfemail="025263776e2c51616d6e6342606f712c616d6f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan Xiangdong Wang</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew C. Good</span> - <span class="hlFld-Affiliation affiliation">Department of Computer-Assisted Drug Design, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li-Qiang Sun</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keith D. Combrink</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey A. Campbell</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jie Chen</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yong Tu</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ny Sin</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian L. Venables</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sing-Yuen Sit</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan Chen</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony Cocuzza</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donna M. Bilder</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stanley D’Andrea</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara Zheng</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Piyasena Hewawasam</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Min Ding</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jan Thuring</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianqing Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Discovery Chemical Synthesis, Bristol-Myers
Squibb Research and Development, P.O.
Box 4000, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis Hernandez</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fei Yu</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Falk</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guangzhi Zhai</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amy K. Sheaffer</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chaoqun Chen</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Min S. Lee</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diana Barry</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jay O. Knipe</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenying Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yong-Hae Han</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan Jenkins</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christoph Gesenberg</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qi Gao</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Development, Bristol-Myers Squibb Research and Development, 1 Squibb Drive, New Brunswick, New Jersey 08903, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael W. Sinz</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth S. Santone</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tatyana Zvyaga</span> - <span class="hlFld-Affiliation affiliation">Department of
Lead Discovery and Optimization, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramkumar Rajamani</span> - <span class="hlFld-Affiliation affiliation">Department of Computer-Assisted Drug Design, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Herbert E. Klei</span> - <span class="hlFld-Affiliation affiliation">Department of Computer-Assisted Drug Design, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard J. Colonno</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis M. Grasela</span> - <span class="hlFld-Affiliation affiliation">Department of Early Clinical and Translational
Research, Discovery Medicine—Virology, Bristol-Myers Squibb Research and Development, Hopewell, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric Hughes</span> - <span class="hlFld-Affiliation affiliation">Department of Early Clinical and Translational
Research, Discovery Medicine—Virology, Bristol-Myers Squibb Research and Development, Hopewell, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Caly Chien</span> - <span class="hlFld-Affiliation affiliation">Department of Early Clinical and Translational
Research, Discovery Medicine—Virology, Bristol-Myers Squibb Research and Development, Hopewell, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen Adams</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul C. Levesque</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Danshi Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jialong Zhu</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas A. Meanwell</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fiona McPhee</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1971e7183-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i75">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10133" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10133" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Xiaohua Stella Huang for NMR studies and the Discovery Chemistry Synthesis Group, including Henry Wong and Ashok Trehan, for their support.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i76" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i76"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i77" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i77"> Abbreviations Used</h2><tr><td class="NLM_term">Cyp 3A4</td><td class="NLM_def"><p class="first last">cytochrome P450 3A4</p></td></tr><tr><td class="NLM_term">CDI</td><td class="NLM_def"><p class="first last">carbonyldiimidazole</p></td></tr><tr><td class="NLM_term">GT</td><td class="NLM_def"><p class="first last">genotyope</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxide hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HCV</td><td class="NLM_def"><p class="first last">hepatitis C virus</p></td></tr><tr><td class="NLM_term">NS3/4A</td><td class="NLM_def"><p class="first last">nonstructural protein 3/4A</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">pegylated</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">SVR</td><td class="NLM_def"><p class="first last">sustained viral response</p></td></tr><tr><td class="NLM_term">t.i.d.</td><td class="NLM_def"><p class="first last">three times a day</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i78">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13537" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13537" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 51 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Kim, W. R.</span><span> </span><span class="NLM_article-title">Global epidemiology and burden of hepatitis C</span> <span class="citation_source-journal">Microbes Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1219</span><span class="NLM_x">–</span> <span class="NLM_lpage">1225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.1016%2FS1286-4579%2802%2901649-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=12467763" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=1219-1225&author=W.+R.+Kim&title=Global+epidemiology+and+burden+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS1286-4579%2802%2901649-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1286-4579%252802%252901649-0%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DW.%2BR.%26atitle%3DGlobal%2520epidemiology%2520and%2520burden%2520of%2520hepatitis%2520C%26jtitle%3DMicrobes%2520Infect.%26date%3D2002%26volume%3D4%26spage%3D1219%26epage%3D1225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">WHO</span><span> </span><span class="NLM_article-title">Hepatitis C global prevalence (update)</span> <span class="citation_source-journal">Wkly. Epidemiol. Rec.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=10645164" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1999&pages=425-427&author=+WHO&title=Hepatitis+C+global+prevalence+%28update%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWHO%26atitle%3DHepatitis%2520C%2520global%2520prevalence%2520%2528update%2529%26jtitle%3DWkly.%2520Epidemiol.%2520Rec.%26date%3D1999%26volume%3D74%26spage%3D425%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Hanafiah, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groeger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaxman, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiersma, S. T.</span><span> </span><span class="NLM_article-title">Global epidemiology of hepatits C virus infection: new estimates of age-specific antibody to HCV seroprevalence</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1333</span><span class="NLM_x">–</span> <span class="NLM_lpage">1342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=1333-1342&author=K.+M.+Hanafiahauthor=J.+Groegerauthor=A.+D.+Flaxmanauthor=S.+T.+Wiersma&title=Global+epidemiology+of+hepatits+C+virus+infection%3A+new+estimates+of+age-specific+antibody+to+HCV+seroprevalence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanafiah%26aufirst%3DK.%2BM.%26aulast%3DGroeger%26aufirst%3DJ.%26aulast%3DFlaxman%26aufirst%3DA.%2BD.%26aulast%3DWiersma%26aufirst%3DS.%2BT.%26atitle%3DGlobal%2520epidemiology%2520of%2520hepatits%2520C%2520virus%2520infection%253A%2520new%2520estimates%2520of%2520age-specific%2520antibody%2520to%2520HCV%2520seroprevalence%26jtitle%3DHepatology%26date%3D2013%26volume%3D57%26spage%3D1333%26epage%3D1342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Hajarazadeh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grebely, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dore, G. J.</span><span> </span><span class="NLM_article-title">Epidemiology and natural history of HCV infection</span> <span class="citation_source-journal">Nat. Rev. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.1038%2Fnrgastro.2013.107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=23817321" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=553-562&author=B.+Hajarazadehauthor=J.+Grebelyauthor=G.+J.+Dore&title=Epidemiology+and+natural+history+of+HCV+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrgastro.2013.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrgastro.2013.107%26sid%3Dliteratum%253Aachs%26aulast%3DHajarazadeh%26aufirst%3DB.%26aulast%3DGrebely%26aufirst%3DJ.%26aulast%3DDore%26aufirst%3DG.%2BJ.%26atitle%3DEpidemiology%2520and%2520natural%2520history%2520of%2520HCV%2520infection%26jtitle%3DNat.%2520Rev.%2520Gastroenterol.%2520Hepatol.%26date%3D2013%26volume%3D10%26spage%3D553%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Liang, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, T.</span><span> </span><span class="NLM_article-title">Pathogenesis of hepatitis C-associated hepatocellular carcinoma</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">S62</span><span class="NLM_x">–</span> <span class="NLM_lpage">S71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.1053%2Fj.gastro.2004.09.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=15508105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVGmtb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2004&pages=S62-S71&author=T.+J.+Liangauthor=T.+Heller&title=Pathogenesis+of+hepatitis+C-associated+hepatocellular+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis of hepatitis C-associated hepatocellular carcinoma</span></div><div class="casAuthors">Liang, T. Jake; Heller, Theo</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">5, Suppl. 1</span>),
    <span class="NLM_cas:pages">S62-S71</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Epidemiol., clin., and virol. data have shown a close assocn. between chronic infection with hepatitis C virus (HCV) and the development of hepatocellular carcinoma (HCC).  In many countries of the developed world, HCV infection accounts for more than half of the cases of HCC.  HCC usually arises after 2-4 decades of infection, typically in the context of an underlying cirrhosis.  Treatment of hepatitis C with interferon-alpha can lead to sustained clearance of HCV, and small prospective studies as well as larger retrospective analyses suggest that interferon therapy leads to a decrease in the incidence of HCC.  Without a reliable tissue culture system or a small animal model of HCV infection, anal. of the mechanisms by which HCV leads to cancer has been difficult.  Nevertheless, both in vitro expression systems and in vivo transgenic mice studies suggest that HCV has an inherent carcinogenic potential.  Understanding the pathogenesis of HCV-assocd. HCC is important in developing effective means of prevention and treatment of this highly malignant form of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ3d-IaWg73rVg90H21EOLACvtfcHk0lghZVR9biS-kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVGmtb7F&md5=57f58df6ef197dcf191bfb8d5e53301f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2004.09.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2004.09.017%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DT.%2BJ.%26aulast%3DHeller%26aufirst%3DT.%26atitle%3DPathogenesis%2520of%2520hepatitis%2520C-associated%2520hepatocellular%2520carcinoma%26jtitle%3DGastroenterology%26date%3D2004%26volume%3D127%26spage%3DS62%26epage%3DS71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Pawlotsky, J.-M.</span><span> </span><span class="NLM_article-title">Pathophysiology of hepatitis C virus infection and related liver disease</span> <span class="citation_source-journal">Trends Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=96-102&author=J.-M.+Pawlotsky&title=Pathophysiology+of+hepatitis+C+virus+infection+and+related+liver+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPawlotsky%26aufirst%3DJ.-M.%26atitle%3DPathophysiology%2520of%2520hepatitis%2520C%2520virus%2520infection%2520and%2520related%2520liver%2520disease%26jtitle%3DTrends%2520Microbiol.%26date%3D2004%26volume%3D12%26spage%3D96%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Zein, N. N.</span><span> </span><span class="NLM_article-title">Clinical significance of hepatitis C virus genotypes</span> <span class="citation_source-journal">Clin. Microbiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.1128%2FCMR.13.2.223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=10755999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtVOqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2000&pages=223-235&author=N.+N.+Zein&title=Clinical+significance+of+hepatitis+C+virus+genotypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical significance of hepatitis C virus genotypes</span></div><div class="casAuthors">Zein, Nizar N.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-235</span>CODEN:
                <span class="NLM_cas:coden">CMIREX</span>;
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review with 149 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIyz_GrutS8LVg90H21EOLACvtfcHk0lhPiYQtDuFFyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtVOqs7k%253D&md5=c3dbf9e23541db288f77cfabdf5c2e45</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1128%2FCMR.13.2.223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.13.2.223%26sid%3Dliteratum%253Aachs%26aulast%3DZein%26aufirst%3DN.%2BN.%26atitle%3DClinical%2520significance%2520of%2520hepatitis%2520C%2520virus%2520genotypes%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2000%26volume%3D13%26spage%3D223%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Nakano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, G. M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, G. M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizokami, M.</span><span> </span><span class="NLM_article-title">An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region</span> <span class="citation_source-journal">Liver Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=339-345&author=T.+Nakanoauthor=G.+M.+G.+Lauauthor=G.+M.+L.+Lauauthor=M.+Sugiyamaauthor=M.+Mizokami&title=An+updated+analysis+of+hepatitis+C+virus+genotypes+and+subtypes+based+on+the+complete+coding+region"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakano%26aufirst%3DT.%26aulast%3DLau%26aufirst%3DG.%2BM.%2BG.%26aulast%3DLau%26aufirst%3DG.%2BM.%2BL.%26aulast%3DSugiyama%26aufirst%3DM.%26aulast%3DMizokami%26aufirst%3DM.%26atitle%3DAn%2520updated%2520analysis%2520of%2520hepatitis%2520C%2520virus%2520genotypes%2520and%2520subtypes%2520based%2520on%2520the%2520complete%2520coding%2520region%26jtitle%3DLiver%2520Int.%26date%3D2012%26volume%3D32%26spage%3D339%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Hoofnagle, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeff, L. B.</span><span> </span><span class="NLM_article-title">Peginterferon and ribavirin for chronic hepatitis C</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">2444</span><span class="NLM_x">–</span> <span class="NLM_lpage">2451</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.1056%2FNEJMct061675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=17151366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12nt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=2444-2451&author=J.+H.+Hoofnagleauthor=L.+B.+Seeff&title=Peginterferon+and+ribavirin+for+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Peginterferon and ribavirin for chronic hepatitis C</span></div><div class="casAuthors">Hoofnagle, Jay H.; Seeff, Leonard B.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2444-2451</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  A 44-yr-old woman with chronic hepatitis C has intermittent fatigue and persistent elevations in serum alanine aminotransferase levels.  She has had hepatitis C for 10 years.  The diagnosis was made after she attempted to donate blood and was found to have antibodies against the hepatitis C virus (HCV).  On questioning, she reports having used illicit injection drugs in her early 20s.  The phys. examn. is normal except for obesity.  The results of lab. tests show an alanine aminotransferase level of 86 U per L (normal value, <42); the alk. phosphatase level, direct and total bilirubin levels, albumin level, prothrombin time, and complete blood count are normal.  The serum HCV RNA level is 3.5 million IU per mL (genotype 1), and a liver biopsy specimen shows bridging fibrosis.  The patient is evaluated by a hepatologist, who recommends treatment with pegylated interferon and ribavirin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEoSFaZ9BVhbVg90H21EOLACvtfcHk0lhPiYQtDuFFyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12nt7%252FK&md5=fc356db5608b52c75cd96a652f8c2d4a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1056%2FNEJMct061675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMct061675%26sid%3Dliteratum%253Aachs%26aulast%3DHoofnagle%26aufirst%3DJ.%2BH.%26aulast%3DSeeff%26aufirst%3DL.%2BB.%26atitle%3DPeginterferon%2520and%2520ribavirin%2520for%2520chronic%2520hepatitis%2520C%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D2444%26epage%3D2451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Pearlman, B. L.</span><span> </span><span class="NLM_article-title">Extended-therapy duration for chronic hepatitis C genotype 1: the long and the short of it</span> <span class="citation_source-journal">World J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3621</span><span class="NLM_x">–</span> <span class="NLM_lpage">3627</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.3748%2Fwjg.14.3621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=18595128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1WlsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=3621-3627&author=B.+L.+Pearlman&title=Extended-therapy+duration+for+chronic+hepatitis+C+genotype+1%3A+the+long+and+the+short+of+it"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Extended-therapy duration for chronic hepatitis C, genotype 1: the long and the short of it</span></div><div class="casAuthors">Pearlman, Brian L.</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3621-3627</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">World Journal of Gastroenterology</span>)
        </div><div class="casAbstract">A review.  With pegylated interferon and ribavirin, more than half of all chronically-infected hepatitis C patients can achieve a sustained virol. response; however, patients with genotype 1 infections and those with other poor prognostic factors have relatively inferior treatment response rates.  Since new therapies are still years away from approval, it is incumbent upon providers to maximize the therapeutic efficacy of today's treatment.  The later the virus is undetectable in serum during treatment, the less likely it will be eradicated.  Patients with a delayed or slow virol. response to therapy (at least a 2-log10 decrease in baseline hepatitis C RNA yet detectable viremia at 12 wk of therapy and undetectable virus 12 wk subsequently) may, therefore, benefit from an extended therapy course beyond one of std. duration.  Although higher rates of treatment discontinuation may plague this approach, 72 wk of treatment for genotype 1-infected slow-responders may improve response rates and diminish relapse rates relative to those of 48 wk.  Based on data from both viral kinetic and clin. studies, therapy prolongation in slow responders may be a reasonable strategy to improve response rates in these treatment-refractory patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpESyXqxBkZLrVg90H21EOLACvtfcHk0lhPiYQtDuFFyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1WlsrjF&md5=527190cf013a69c7e84fdd4452f97747</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3748%2Fwjg.14.3621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.14.3621%26sid%3Dliteratum%253Aachs%26aulast%3DPearlman%26aufirst%3DB.%2BL.%26atitle%3DExtended-therapy%2520duration%2520for%2520chronic%2520hepatitis%2520C%2520genotype%25201%253A%2520the%2520long%2520and%2520the%2520short%2520of%2520it%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2008%26volume%3D14%26spage%3D3621%26epage%3D3627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Hadziyannis, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sette, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diago, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramadori, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodenheimer, H.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzetto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pockros, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackrill, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">PEGASYS International Study Group.</span><span> </span><span class="NLM_article-title">Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose</span> <span class="citation_source-journal">Ann. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.7326%2F0003-4819-140-5-200403020-00010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=14996676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitlOktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2004&pages=346-355&author=S.+J.+Hadziyannisauthor=H.+Setteauthor=T.+R.+Morganauthor=V.+Balanauthor=M.+Diagoauthor=P.+Marcellinauthor=G.+Ramadoriauthor=H.+Bodenheimerauthor=D.+Bernsteinauthor=M.+Rizzettoauthor=S.+Zeuzemauthor=P.+J.+Pockrosauthor=A.+Linauthor=A.+M.+Ackrillauthor=PEGASYS+International+Study+Group.&title=Peginterferon-%CE%B12a+and+ribavirin+combination+therapy+in+chronic+hepatitis+C%3A+a+randomized+study+of+treatment+duration+and+ribavirin+dose"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose</span></div><div class="casAuthors">Hadziyannis, Stephanos J.; Sette, Hoel, Jr.; Morgan, Timothy R.; Balan, Vijayan; Diago, Moises; Marcellin, Patrick; Ramadori, Giuliano; Bodenheimer, Henry, Jr.; Bernstein, David; Rizzetto, Mario; Zeuzem, Stefan; Pockros, Paul J.; Lin, Amy; Ackrill, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Internal Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">346-355</span>CODEN:
                <span class="NLM_cas:coden">AIMEAS</span>;
        ISSN:<span class="NLM_cas:issn">0003-4819</span>.
    
            (<span class="NLM_cas:orgname">American College of Physicians-American Society of Internal Medicine</span>)
        </div><div class="casAbstract">Treatment with pegylated interferon (peginterferon) and ribavirin for 48 wk is more effective than conventional interferon and ribavirin in patients with chronic hepatitis C.  Objective: To assess the efficacy and safety of 24 or 48 wk of treatment with peginterferon-α2a plus a low or std. dose of ribavirin.  Design: Randomized, double-blind trial.  Setting: 99 international centers.  Patients: 1311 patients with chronic hepatitis C.  Intervention: Peginterferon-α2a, 180 μg/wk, for 24 or 48 wk plus a low-dose (800 mg/d) or std. wt.-based dose (1000 or 1200 mg/d) of ribavirin.  Measurement: Sustained virol. response: undetectable HCV RNA concn. at the end of treatment and during 12 to 24 wk of follow-up.  Results: Overall and in patients infected with HCV genotype 1, 48 wk of treatment was statistically superior to 24 wk and std.-dose ribavirin was statistically superior to low-dose ribavirin.  In patients with HCV genotype 1, abs. differences in sustained virol. response rates between 48 and 24 wk of treatment were 11.2% (95% CI, 3.6% to 18.9%) and 11.9% (CI, 4.7% to 18.9%), resp., between std.- and low-dose ribavirin.  Sustained virol. response rates for peginterferon-α2a and std.-dose ribavirin for 48 wk were 63% (CI, 59% to 68%) overall and 52% (CI, 46% to 58%) in patients with HCV genotype 1.  In patients with HCV genotypes 2 or 3, the sustained virol. response rates in the 4 treatment groups were not statistically significantly different.  Conclusion: Treatment with peginterferon-α2a and ribavirin may be individualized by genotype.  Patients with HCV genotype 1 require treatment for 48 wk and a std. dose of ribavirin; those with HCV genotypes 2 or 3 seem to be adequately treated with a low dose of ribavirin for 24 wk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDnDyBicuGj7Vg90H21EOLACvtfcHk0lgxwz1IiWCmfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitlOktrg%253D&md5=0e5ff18b054a10ab2051ba6c094626d0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-140-5-200403020-00010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-140-5-200403020-00010%26sid%3Dliteratum%253Aachs%26aulast%3DHadziyannis%26aufirst%3DS.%2BJ.%26aulast%3DSette%26aufirst%3DH.%26aulast%3DMorgan%26aufirst%3DT.%2BR.%26aulast%3DBalan%26aufirst%3DV.%26aulast%3DDiago%26aufirst%3DM.%26aulast%3DMarcellin%26aufirst%3DP.%26aulast%3DRamadori%26aufirst%3DG.%26aulast%3DBodenheimer%26aufirst%3DH.%26aulast%3DBernstein%26aufirst%3DD.%26aulast%3DRizzetto%26aufirst%3DM.%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DPockros%26aufirst%3DP.%2BJ.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DAckrill%26aufirst%3DA.%2BM.%26aulast%3D%26atitle%3DPeginterferon-%25CE%25B12a%2520and%2520ribavirin%2520combination%2520therapy%2520in%2520chronic%2520hepatitis%2520C%253A%2520a%2520randomized%2520study%2520of%2520treatment%2520duration%2520and%2520ribavirin%2520dose%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D2004%26volume%3D140%26spage%3D346%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, G.</span><span> </span><span class="NLM_article-title">Challenges and successes in developing new therapies for hepatitis C</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=953-960&author=R.+De+Francescoauthor=G.+Migliaccio&title=Challenges+and+successes+in+developing+new+therapies+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DMigliaccio%26aufirst%3DG.%26atitle%3DChallenges%2520and%2520successes%2520in%2520developing%2520new%2520therapies%2520for%2520hepatitis%2520C%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D953%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Malcolm, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gheyas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skelton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1013-1020&author=B.+A.+Malcolmauthor=R.+Liuauthor=F.+Lahserauthor=S.+Agrawalauthor=B.+Belangerauthor=N.+Butkiewiczauthor=R.+Chaseauthor=F.+Gheyasauthor=A.+Hartauthor=D.+Heskauthor=P.+Ingravalloauthor=C.+Jiangauthor=R.+Kongauthor=J.+Luauthor=J.+Pichardoauthor=A.+Prongayauthor=A.+Skeltonauthor=X.+Tongauthor=S.+Venkatramanauthor=E.+Xiaauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=SCH+503034%2C+a+mechanism-based+inhibitor+of+hepatitis+C+virus+NS3+protease%2C+suppresses+polyprotein+maturation+and+enhances+the+antiviral+activity+of+alpha+interferon+in+replicon+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalcolm%26aufirst%3DB.%2BA.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DLahser%26aufirst%3DF.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DBelanger%26aufirst%3DB.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DGheyas%26aufirst%3DF.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DSkelton%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DSCH%2520503034%252C%2520a%2520mechanism-based%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520protease%252C%2520suppresses%2520polyprotein%2520maturation%2520and%2520enhances%2520the%2520antiviral%2520activity%2520of%2520alpha%2520interferon%2520in%2520replicon%2520cells%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D1013%26epage%3D1020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrn, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandorkar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinehart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalkeri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaczkowski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span> </span><span class="NLM_article-title">Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=899-909&author=R.+B.+Perniauthor=S.+J.+Almquistauthor=R.+A.+Byrnauthor=G.+Chandorkarauthor=P.+R.+Chaturvediauthor=L.+F.+Courtneyauthor=C.+J.+Deckerauthor=K.+Dinehartauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=A.+Heiserauthor=G.+Kalkeriauthor=E.+Kolaczkowskiauthor=K.+Linauthor=Y.-P.+Luongauthor=B.+G.+Raoauthor=W.+P.+Taylorauthor=J.+A.+Thomsonauthor=R.+D.+Tungauthor=Y.+Weiauthor=A.+D.+Kwongauthor=C.+Lin&title=Preclinical+profile+of+VX-950%2C+a+potent%2C+selective%2C+and+orally+bioavailable+inhibitor+of+hepatitis+C+virus+NS3-4A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DAlmquist%26aufirst%3DS.%2BJ.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DChandorkar%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DP.%2BR.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDecker%26aufirst%3DC.%2BJ.%26aulast%3DDinehart%26aufirst%3DK.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DHeiser%26aufirst%3DA.%26aulast%3DKalkeri%26aufirst%3DG.%26aulast%3DKolaczkowski%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.-P.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DTaylor%26aufirst%3DW.%2BP.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DLin%26aufirst%3DC.%26atitle%3DPreclinical%2520profile%2520of%2520VX-950%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D899%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Farnik, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span> </span><span class="NLM_article-title">New antiviral therapies in the management of HCV infection</span> <span class="citation_source-journal">Antiviral Ther</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">783</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=771-783&author=H.+Farnikauthor=S.+Zeuzem&title=New+antiviral+therapies+in+the+management+of+HCV+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFarnik%26aufirst%3DH.%26aulast%3DZeuzem%26aufirst%3DS.%26atitle%3DNew%2520antiviral%2520therapies%2520in%2520the%2520management%2520of%2520HCV%2520infection%26jtitle%3DAntiviral%2520Ther%26date%3D2012%26volume%3D17%26spage%3D771%26epage%3D783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Fried, M. W.</span><span> </span><span class="NLM_article-title">Side effects of therapy of hepatitis C and their management</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">S237</span><span class="NLM_x">–</span> <span class="NLM_lpage">S244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=S237-S244&author=M.+W.+Fried&title=Side+effects+of+therapy+of+hepatitis+C+and+their+management"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFried%26aufirst%3DM.%2BW.%26atitle%3DSide%2520effects%2520of%2520therapy%2520of%2520hepatitis%2520C%2520and%2520their%2520management%26jtitle%3DHepatology%26date%3D2002%26volume%3D36%26spage%3DS237%26epage%3DS244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span>Incivek (telaprevir) in combination with drugs peginterferon alfa and ribavirin (Incivek combination treatment): drug safety communication—serious skin reactions. <a href="http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm332860.htm" class="extLink">http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm332860.htm</a> (posted by the FDA on December 19, 2012.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Incivek+%28telaprevir%29+in+combination+with+drugs+peginterferon+alfa+and+ribavirin+%28Incivek+combination+treatment%29%3A+drug+safety+communication%E2%80%94serious+skin+reactions.+http%3A%2F%2Fwww.fda.gov%2FSafety%2FMedWatch%2FSafetyInformation%2FSafetyAlertsforHumanMedicalProducts%2Fucm332860.htm+%28posted+by+the+FDA+on+December+19%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Maasoumy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manns, M. P.</span><span> </span><span class="NLM_article-title">Optimal treatment with boceprevir for chronic HCV infection</span> <span class="citation_source-journal">Liver Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">14</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=14-22&issue=Suppl.+1&author=B.+Maasoumyauthor=M.+P.+Manns&title=Optimal+treatment+with+boceprevir+for+chronic+HCV+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaasoumy%26aufirst%3DB.%26aulast%3DManns%26aufirst%3DM.%2BP.%26atitle%3DOptimal%2520treatment%2520with%2520boceprevir%2520for%2520chronic%2520HCV%2520infection%26jtitle%3DLiver%2520Int.%26date%3D2013%26volume%3D33%26issue%3DSuppl.%25201%26spage%3D14%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Manns, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Hahn, T.</span><span> </span><span class="NLM_article-title">Novel therapies for hepatitis C—One pill fits all?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=595-610&author=M.+P.+Mannsauthor=T.+von+Hahn&title=Novel+therapies+for+hepatitis+C%E2%80%94One+pill+fits+all%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%2BP.%26aulast%3Dvon%2BHahn%26aufirst%3DT.%26atitle%3DNovel%2520therapies%2520for%2520hepatitis%2520C%25E2%2580%2594One%2520pill%2520fits%2520all%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D595%26epage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Ingallinella, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taliani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingenito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinkuhler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessi, A.</span><span> </span><span class="NLM_article-title">Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">8906</span><span class="NLM_x">–</span> <span class="NLM_lpage">8914</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi980314n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=8906-8914&author=P.+Ingallinellaauthor=S.+Altamuraauthor=E.+Bianchiauthor=M.+Talianiauthor=R.+Ingenitoauthor=R.+Corteseauthor=R.+De+Francescoauthor=C.+Steinkuhlerauthor=A.+Pessi&title=Potent+peptide+inhibitors+of+human+hepatitis+C+virus+NS3+protease+are+obtained+by+optimizing+the+cleavage+products"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fbi980314n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi980314n%26sid%3Dliteratum%253Aachs%26aulast%3DIngallinella%26aufirst%3DP.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DBianchi%26aufirst%3DE.%26aulast%3DTaliani%26aufirst%3DM.%26aulast%3DIngenito%26aufirst%3DR.%26aulast%3DCortese%26aufirst%3DR.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DSteinkuhler%26aufirst%3DC.%26aulast%3DPessi%26aufirst%3DA.%26atitle%3DPotent%2520peptide%2520inhibitors%2520of%2520human%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520are%2520obtained%2520by%2520optimizing%2520the%2520cleavage%2520products%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D8906%26epage%3D8914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Imperiali, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeles, R. H.</span><span> </span><span class="NLM_article-title">Extended binding inhibitors of chymotrypsin that interact with leaving group subsites S1′–S3′</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">4474</span><span class="NLM_x">–</span> <span class="NLM_lpage">4477</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00388a044" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1987&pages=4474-4477&author=B.+Imperialiauthor=R.+H.+Abeles&title=Extended+binding+inhibitors+of+chymotrypsin+that+interact+with+leaving+group+subsites+S1%E2%80%B2%E2%80%93S3%E2%80%B2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fbi00388a044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00388a044%26sid%3Dliteratum%253Aachs%26aulast%3DImperiali%26aufirst%3DB.%26aulast%3DAbeles%26aufirst%3DR.%2BH.%26atitle%3DExtended%2520binding%2520inhibitors%2520of%2520chymotrypsin%2520that%2520interact%2520with%2520leaving%2520group%2520subsites%2520S1%25E2%2580%25B2%25E2%2580%2593S3%25E2%2580%25B2%26jtitle%3DBiochemistry%26date%3D1987%26volume%3D26%26spage%3D4474%26epage%3D4477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Llinas-Brunet, M.; Bailey, M. D.; Cameron, D.; Faucher, A.-M; Ghiro, E.; Goudreau, N.; Halmos, T.; Poupart, M.-A.; Rancourt, J.; Tsantrizos, Y. S.; Wernic, D. M.; Simoneau, B.</span><span> </span><span class="NLM_article-title">Preparation of hepatitis C inhibitory tripeptides</span>. World Patent Application WO 2000/0009543, February 24,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=M.+Llinas-Brunet&author=M.+D.+Bailey&author=D.+Cameron&author=A.-M+Faucher&author=E.+Ghiro&author=N.+Goudreau&author=T.+Halmos&author=M.-A.+Poupart&author=J.+Rancourt&author=Y.+S.+Tsantrizos&author=D.+M.+Wernic&author=B.+Simoneau&title=Preparation+of+hepatitis+C+inhibitory+tripeptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520hepatitis%2520C%2520inhibitory%2520tripeptides%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Campbell, J. A.; Good, A.</span> World Patent Application WO-2002/060926 A2, August 8,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Campbell%2C+J.+A.%3B+Good%2C+A.+World+Patent+Application+WO-2002%2F060926+A2%2C+August+8%2C+2002."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DJ.%2BA.%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="note"><p class="first last">The measured p<i>K</i><sub>a</sub> value for compound <b>7</b> is 5. See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for a general proceedure.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Schaaf, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, H.-J.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of carboxyl-terminus modified prostaglandin analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1340</span><span class="NLM_x">–</span> <span class="NLM_lpage">1346</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00197a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1979&pages=1340-1346&author=T.+K.+Schaafauthor=H.-J.+Hess&title=Synthesis+and+biological+activity+of+carboxyl-terminus+modified+prostaglandin+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm00197a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00197a012%26sid%3Dliteratum%253Aachs%26aulast%3DSchaaf%26aufirst%3DT.%2BK.%26aulast%3DHess%26aufirst%3DH.-J.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520carboxyl-terminus%2520modified%2520prostaglandin%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1979%26volume%3D22%26spage%3D1340%26epage%3D1346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of some recent tactical applications of bioisosteres in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+applications+of+bioisosteres+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520applications%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, B.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.-L.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6827</span><span class="NLM_x">–</span> <span class="NLM_lpage">6832</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=6827-6832&author=X.+Luauthor=H.+Zhangauthor=X.+Liauthor=G.+Chenauthor=Q.-S.+Liauthor=Y.+Luoauthor=B.-F.+Ruanauthor=X.-W.+Chenauthor=H.-L.+Zhu&title=Design%2C+synthesis+and+biological+evaluation+of+pyridine+acyl+sulfonamide+derivatives+as+novel+COX-2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DQ.-S.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DRuan%26aufirst%3DB.-F.%26aulast%3DChen%26aufirst%3DX.-W.%26aulast%3DZhu%26aufirst%3DH.-L.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520pyridine%2520acyl%2520sulfonamide%2520derivatives%2520as%2520novel%2520COX-2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D6827%26epage%3D6832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Anilkumar, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selyutin, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenblum, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. X</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesburg, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duca, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavalas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sannigrahi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velazquez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vibulbhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, N.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, G. F</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlowski, J. A.,  II.</span><span> </span><span class="NLM_article-title">Novel HCV NS5B polymerase inhibitors: discovery of indole C2 acyl sulfonamides</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">713</span><span class="NLM_x">–</span> <span class="NLM_lpage">717</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=713-717&author=G.+N.+Anilkumarauthor=O.+Selyutinauthor=S.+B.+Rosenblumauthor=Q.+Zengauthor=Y.+Jiangauthor=T.-Y.+Chanauthor=H.+Puauthor=L.+Wangauthor=F.+Bennettauthor=K.+X+Chenauthor=C.+A.+Lesburgauthor=J.+Ducaauthor=S.+Gavalasauthor=Y.+Huangauthor=P.+Pintoauthor=M.+Sannigrahiauthor=F.+Velazquezauthor=S.+Venkatramanauthor=B.+Vibulbhanauthor=S.+Agrawalauthor=E.+Ferrariauthor=C.-K.+Jiangauthor=H.-C.+Huangauthor=N.-Y.+Shihauthor=G.+F+Njorogeauthor=J.+A.+Kozlowski&title=Novel+HCV+NS5B+polymerase+inhibitors%3A+discovery+of+indole+C2+acyl+sulfonamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnilkumar%26aufirst%3DG.%2BN.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DChan%26aufirst%3DT.-Y.%26aulast%3DPu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%2BX%26aulast%3DLesburg%26aufirst%3DC.%2BA.%26aulast%3DDuca%26aufirst%3DJ.%26aulast%3DGavalas%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DSannigrahi%26aufirst%3DM.%26aulast%3DVelazquez%26aufirst%3DF.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DFerrari%26aufirst%3DE.%26aulast%3DJiang%26aufirst%3DC.-K.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DShih%26aufirst%3DN.-Y.%26aulast%3DNjoroge%26aufirst%3DG.%2BF%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DNovel%2520HCV%2520NS5B%2520polymerase%2520inhibitors%253A%2520discovery%2520of%2520indole%2520C2%2520acyl%2520sulfonamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D713%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Glunz, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delucca, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nirschl, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigelt, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheney, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anumula, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luettgen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendina, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harpel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knabb, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priestley, E. S.</span><span> </span><span class="NLM_article-title">Nonbenzamidine acylsulfonamide tissue factor-factor VIIa inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">5244</span><span class="NLM_x">–</span> <span class="NLM_lpage">5248</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5244-5248&author=P.+W.+Glunzauthor=X.+Zhangauthor=Y.+Zouauthor=I.+Deluccaauthor=A.+H.+Nirschlauthor=X.+Chengauthor=C.+A.+Weigeltauthor=D.+L.+Cheneyauthor=A.+Weiauthor=R.+Anumulaauthor=J.+M.+Luettgenauthor=A.+R.+Rendinaauthor=M.+Harpelauthor=G.+Luoauthor=R.+Knabbauthor=P.+C.+Wongauthor=R.+R.+Wexlerauthor=E.+S.+Priestley&title=Nonbenzamidine+acylsulfonamide+tissue+factor-factor+VIIa+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlunz%26aufirst%3DP.%2BW.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DDelucca%26aufirst%3DI.%26aulast%3DNirschl%26aufirst%3DA.%2BH.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DWeigelt%26aufirst%3DC.%2BA.%26aulast%3DCheney%26aufirst%3DD.%2BL.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DAnumula%26aufirst%3DR.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DHarpel%26aufirst%3DM.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DKnabb%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DPriestley%26aufirst%3DE.%2BS.%26atitle%3DNonbenzamidine%2520acylsulfonamide%2520tissue%2520factor-factor%2520VIIa%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5244%26epage%3D5248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Pietschmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">The hepatitis C virus replicon system and its application to molecular studies</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">664</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=657-664&author=T.+Pietschmannauthor=R.+Bartenschlager&title=The+hepatitis+C+virus+replicon+system+and+its+application+to+molecular+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPietschmann%26aufirst%3DT.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DThe%2520hepatitis%2520C%2520virus%2520replicon%2520system%2520and%2520its%2520application%2520to%2520molecular%2520studies%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2001%26volume%3D4%26spage%3D657%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1356</span><span class="NLM_x">–</span> <span class="NLM_lpage">1360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.1002%2Fanie.200390347" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlygsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=1356-1360&author=Y.+S.+Tsantrizosauthor=G.+Bolgerauthor=P.+Bonneauauthor=D.+R.+Cameronauthor=N.+Goudreauauthor=G.+Kukoljauthor=S.+R.+LaPlanteauthor=M.+Llinas-Brunetauthor=H.+Narauthor=D.+Lamarre&title=Macrocyclic+inhibitors+of+the+NS3+protease+as+potential+therapeutic+agents+of+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection</span></div><div class="casAuthors">Tsantrizos, Youla S.; Bolger, Gordon; Bonneau, Pierre; Cameron, Dale R.; Goudreau, Nathalie; Kukolj, George; LaPlante, Steven R.; Llinas-Brunet, Montse; Nar, Herbert; Lamarre, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1356-1360</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A novel class of selective inhibitors of the hepatitis C virus NS3 protease, an enzyme which is essential for viral replication in vivo, was developed.  The inhibitors are based on the structure-activity relationship between a substrate-based peptidomimetic ligand and the HCV NS3 serine protease.  The designed HCV inhibitor and its satd. analogs are the first inhibitors of the NS3 protease which inhibit HCV RNA replication in the cell-based replicon assay.  In addn., they are orally absorbed and stable to metabolic breakdown.  Thus, these compds. show many of the desirable properties of a druglike archetype and could lead t a clin. useful antiviral agent for the treatment of hepatitis C viral infections in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCij3shP5tmLVg90H21EOLACvtfcHk0lg4XGITkLT0kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlygsrc%253D&md5=e0a3c98ee0096bfc3d058bf0b92b81c3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fanie.200390347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200390347%26sid%3Dliteratum%253Aachs%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DNar%26aufirst%3DH.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DMacrocyclic%2520inhibitors%2520of%2520the%2520NS3%2520protease%2520as%2520potential%2520therapeutic%2520agents%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D1356%26epage%3D1360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitlik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britt, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Court, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farmer, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Drie, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span> </span><span class="NLM_article-title">Inhibitors of hepatitis C virus NS3/4A protease 2. Warhead SAR and optimization</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1441</span><span class="NLM_x">–</span> <span class="NLM_lpage">1446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1441-1446&author=R.+B.+Perniauthor=J.+Pitlikauthor=S.+D.+Brittauthor=J.+J.+Courtauthor=L.+F.+Courtneyauthor=D.+D.+Deiningerauthor=L.+J.+Farmerauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=R.+B.+Levinauthor=C.+Linauthor=K.+Linauthor=Y.-C.+Moonauthor=Y.-P.+Luongauthor=E.+T.+O%E2%80%99Malleyauthor=B.+G.+Raoauthor=J.+A.+Thomsonauthor=R.+D.+Tungauthor=J.+H.+Van+Drieauthor=Y.+Wei&title=Inhibitors+of+hepatitis+C+virus+NS3%2F4A+protease+2.+Warhead+SAR+and+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DPitlik%26aufirst%3DJ.%26aulast%3DBritt%26aufirst%3DS.%2BD.%26aulast%3DCourt%26aufirst%3DJ.%2BJ.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDeininger%26aufirst%3DD.%2BD.%26aulast%3DFarmer%26aufirst%3DL.%2BJ.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DLevin%26aufirst%3DR.%2BB.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DMoon%26aufirst%3DY.-C.%26aulast%3DLuong%26aufirst%3DY.-P.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DE.%2BT.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DVan%2BDrie%26aufirst%3DJ.%2BH.%26aulast%3DWei%26aufirst%3DY.%26atitle%3DInhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%25202.%2520Warhead%2520SAR%2520and%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D1441%26epage%3D1446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="note"><p class="first last">The cyclopropylacylsulfonamide motif has been widely adopted in HCV NS3 inhibitor design:</p></div><div class="NLM_citation" id="cit31a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Johansson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poliakov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerblom, E. A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiklund, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winiwarter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, A.</span><span> </span><span class="NLM_article-title">Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-length NS3 (protease-helicase/NTPase): a comparative study of different C-terminals</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2551</span><span class="NLM_x">–</span> <span class="NLM_lpage">2568</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=2551-2568&author=A.+Johanssonauthor=A.+Poliakovauthor=E.+A+Kerblomauthor=K.+Wiklundauthor=G.+Lindebergauthor=S.+Winiwarterauthor=U.+H.+Danielsonauthor=B.+Samuelssonauthor=A.+Hallberg&title=Acyl+sulfonamides+as+potent+protease+inhibitors+of+the+hepatitis+C+virus+full-length+NS3+%28protease-helicase%2FNTPase%29%3A+a+comparative+study+of+different+C-terminals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DA.%26aulast%3DPoliakov%26aufirst%3DA.%26aulast%3DKerblom%26aufirst%3DE.%2BA%26aulast%3DWiklund%26aufirst%3DK.%26aulast%3DLindeberg%26aufirst%3DG.%26aulast%3DWiniwarter%26aufirst%3DS.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DHallberg%26aufirst%3DA.%26atitle%3DAcyl%2520sulfonamides%2520as%2520potent%2520protease%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520full-length%2520NS3%2520%2528protease-helicase%252FNTPase%2529%253A%2520a%2520comparative%2520study%2520of%2520different%2520C-terminals%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D2551%26epage%3D2568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Oertqvist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aakerblom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gossas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabnis, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fransson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandstroem, A.</span><span> </span><span class="NLM_article-title">Phenylglycine as a novel P2 scaffold in hepatitis C virus NS3 protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1448</span><span class="NLM_x">–</span> <span class="NLM_lpage">1474</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=1448-1474&author=P.+Oertqvistauthor=S.+D.+Petersonauthor=E.+Aakerblomauthor=T.+Gossasauthor=Y.+A.+Sabnisauthor=R.+Franssonauthor=G.+Lindebergauthor=U.+H.+Danielsonauthor=A.+Karlenauthor=A.+Sandstroem&title=Phenylglycine+as+a+novel+P2+scaffold+in+hepatitis+C+virus+NS3+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOertqvist%26aufirst%3DP.%26aulast%3DPeterson%26aufirst%3DS.%2BD.%26aulast%3DAakerblom%26aufirst%3DE.%26aulast%3DGossas%26aufirst%3DT.%26aulast%3DSabnis%26aufirst%3DY.%2BA.%26aulast%3DFransson%26aufirst%3DR.%26aulast%3DLindeberg%26aufirst%3DG.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DKarlen%26aufirst%3DA.%26aulast%3DSandstroem%26aufirst%3DA.%26atitle%3DPhenylglycine%2520as%2520a%2520novel%2520P2%2520scaffold%2520in%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D1448%26epage%3D1474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Roenn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gossas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabnis, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daoud, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aakerblom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandstroem, A.</span><span> </span><span class="NLM_article-title">Evaluation of a diverse set of potential P1 carboxylic acid bioisosteres in hepatitis C virus NS3 protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4057</span><span class="NLM_x">–</span> <span class="NLM_lpage">4068</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=4057-4068&author=R.+Roennauthor=T.+Gossasauthor=Y.+A.+Sabnisauthor=H.+Daoudauthor=E.+Aakerblomauthor=U.+H.+Danielsonauthor=A.+Sandstroem&title=Evaluation+of+a+diverse+set+of+potential+P1+carboxylic+acid+bioisosteres+in+hepatitis+C+virus+NS3+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoenn%26aufirst%3DR.%26aulast%3DGossas%26aufirst%3DT.%26aulast%3DSabnis%26aufirst%3DY.%2BA.%26aulast%3DDaoud%26aufirst%3DH.%26aulast%3DAakerblom%26aufirst%3DE.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DSandstroem%26aufirst%3DA.%26atitle%3DEvaluation%2520of%2520a%2520diverse%2520set%2520of%2520potential%2520P1%2520carboxylic%2520acid%2520bioisosteres%2520in%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D4057%26epage%3D4068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Baeck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, P.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waangsell, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorstensson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kvarnstroem, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayesa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waehling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelcman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstroem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Classon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rydergård, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span> </span><span class="NLM_article-title">Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: use of cyclopentane and cyclopentene P2-motifs</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">7184</span><span class="NLM_x">–</span> <span class="NLM_lpage">7202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=7184-7202&author=M.+Baeckauthor=P.-O.+Johanssonauthor=F.+Waangsellauthor=F.+Thorstenssonauthor=I.+Kvarnstroemauthor=S.+Ayesaauthor=H.+Waehlingauthor=M.+Pelcmanauthor=K.+Janssonauthor=S.+Lindstroemauthor=H.+Wallbergauthor=B.+Classonauthor=C.+Ryderg%C3%A5rdauthor=L.+Vrangauthor=E.+Hamelinkauthor=A.+Hallbergauthor=A.+Rosenquistauthor=B.+Samuelsson&title=Novel+potent+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3+protease%3A+use+of+cyclopentane+and+cyclopentene+P2-motifs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaeck%26aufirst%3DM.%26aulast%3DJohansson%26aufirst%3DP.-O.%26aulast%3DWaangsell%26aufirst%3DF.%26aulast%3DThorstensson%26aufirst%3DF.%26aulast%3DKvarnstroem%26aufirst%3DI.%26aulast%3DAyesa%26aufirst%3DS.%26aulast%3DWaehling%26aufirst%3DH.%26aulast%3DPelcman%26aufirst%3DM.%26aulast%3DJansson%26aufirst%3DK.%26aulast%3DLindstroem%26aufirst%3DS.%26aulast%3DWallberg%26aufirst%3DH.%26aulast%3DClasson%26aufirst%3DB.%26aulast%3DRyderg%25C3%25A5rd%26aufirst%3DC.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DHallberg%26aufirst%3DA.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26atitle%3DNovel%2520potent%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%253A%2520use%2520of%2520cyclopentane%2520and%2520cyclopentene%2520P2-motifs%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D7184%26epage%3D7202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Naud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forgione, P.</span><span> </span><span class="NLM_article-title">Potent triazolyl-proline-based inhibitors of HCV NS3 protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3400</span><span class="NLM_x">–</span> <span class="NLM_lpage">3404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3400-3404&author=J.+Naudauthor=C.+Lemkeauthor=N.+Goudreauauthor=E.+Beaulieuauthor=P.+D.+Whiteauthor=M.+Llinas-Brunetauthor=P.+Forgione&title=Potent+triazolyl-proline-based+inhibitors+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNaud%26aufirst%3DJ.%26aulast%3DLemke%26aufirst%3DC.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DBeaulieu%26aufirst%3DE.%26aulast%3DWhite%26aufirst%3DP.%2BD.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DForgione%26aufirst%3DP.%26atitle%3DPotent%2520triazolyl-proline-based%2520inhibitors%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3400%26epage%3D3404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvador-Oden, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickstrom, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Vreken, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pille, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">Structure–activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4853</span><span class="NLM_x">–</span> <span class="NLM_lpage">4858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4853-4858&author=P.+Raboissonauthor=H.+de+Kockauthor=A.+Rosenquistauthor=M.+Nilssonauthor=L.+Salvador-Odenauthor=T.-I.+Linauthor=N.+Roueauthor=V.+Ivanovauthor=H.+Wahlingauthor=K.+Wickstromauthor=E.+Hamelinkauthor=M.+Edlundauthor=L.+Vrangauthor=S.+Vendevilleauthor=W.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=C.+Bouttonauthor=O.+Lenzauthor=F.+Delouvroyauthor=G.+Pilleauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=B.+Samuelssonauthor=K.+Simmen&title=Structure%E2%80%93activity+relationship+study+on+a+novel+series+of+cyclopentane-containing+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3%2F4A+protease+leading+to+the+discovery+of+TMC435350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DSalvador-Oden%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3DRoue%26aufirst%3DN.%26aulast%3DIvanov%26aufirst%3DV.%26aulast%3DWahling%26aufirst%3DH.%26aulast%3DWickstrom%26aufirst%3DK.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DBoutton%26aufirst%3DC.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DPille%26aufirst%3DG.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520study%2520on%2520a%2520novel%2520series%2520of%2520cyclopentane-containing%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520leading%2520to%2520the%2520discovery%2520of%2520TMC435350%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4853%26epage%3D4858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Cummings, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fellander, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraznenok, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nystrom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">Induced-fit binding of the macrocyclic noncovalent inhibitor TMC435 to its HCV NS3/NS4A protease target</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1652</span><span class="NLM_x">–</span> <span class="NLM_lpage">1655</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31g&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.1002%2Fanie.200906696" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31g&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVaktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=1652-1655&author=M.+D.+Cummingsauthor=J.+Lindbergauthor=T.-I.+Linauthor=H.+de+Kockauthor=O.+Lenzauthor=E.+Liljaauthor=S.+Fellanderauthor=V.+Baraznenokauthor=S.+Nystromauthor=M.+Nilssonauthor=L.+Vrangauthor=M.+Edlundauthor=A.+Rosenquistauthor=B.+Samuelssonauthor=P.+Raboissonauthor=K.+Simmen&title=Induced-fit+binding+of+the+macrocyclic+noncovalent+inhibitor+TMC435+to+its+HCV+NS3%2FNS4A+protease+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31gR"><div class="casContent"><span class="casTitleNuber">31g</span><div class="casTitle"><span class="NLM_cas:atitle">Induced-Fit Binding of the Macrocyclic Noncovalent Inhibitor TMC435 to its HCV NS3/NS4A Protease Target</span></div><div class="casAuthors">Cummings, Maxwell D.; Lindberg, Jimmy; Lin, Tse-I.; de Kock, Herman; Lenz, Oliver; Lilja, Elisabet; Fellander, Sara; Baraznenok, Vera; Nystrom, Susanne; Nilsson, Magnus; Vrang, Lotta; Edlund, Michael; Rosenquist, Asa; Samuelsson, Bertil; Raboisson, Pierre; Simmen, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1652-1655, S1652/1-S1652/11</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We have detd. the crystal structure of the macrocyclic inhibitor TMC435 bound to its HCV NS3/4A protease target at a resoln. of 2.4 Å, providing at. detail of induced fit to an extended S2 subsite.  The complex structure helps to rationalize the impact of key modifications in the optimization path that led to 1, and is guiding our understanding of resistance patterns.  Future modeling and structure-based design efforts aimed at NS3/NS4A protease should benefit from the new structure, which represents the first example of a noncovalent NS3/NS4A protease-inhibitor complex deposited in the PDB and details the induced fit involved in accommodating a large P2 substituent.  Inhibitors with large P2 groups that occupy the extended S2 subsite probe the crystallog. obsd. helicase-protease interface, and it is hoped that future studies will clarify the relevance of interfacial contacts to protease activity and protease inhibitor binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAEYqCPA57hLVg90H21EOLACvtfcHk0liNOz8k1hPRAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVaktbs%253D&md5=535b340784d1af62df32e8cf3bd3fe87</span></div><a href="/servlet/linkout?suffix=cit31g&amp;dbid=16384&amp;doi=10.1002%2Fanie.200906696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200906696%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DLindberg%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DLilja%26aufirst%3DE.%26aulast%3DFellander%26aufirst%3DS.%26aulast%3DBaraznenok%26aufirst%3DV.%26aulast%3DNystrom%26aufirst%3DS.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DInduced-fit%2520binding%2520of%2520the%2520macrocyclic%2520noncovalent%2520inhibitor%2520TMC435%2520to%2520its%2520HCV%2520NS3%252FNS4A%2520protease%2520target%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D1652%26epage%3D1655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Vreken, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">Discovery of novel potent and selective dipeptide hepatitis C virus NS3/4A serine protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5095</span><span class="NLM_x">–</span> <span class="NLM_lpage">5100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5095-5100&author=P.+Raboissonauthor=T.-I.+Linauthor=H.+de+Kockauthor=S.+Vendevilleauthor=W.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=O.+Lenzauthor=F.+Delouvroyauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=M.+Nilssonauthor=A.+Rosenquistauthor=B.+Samuelssonauthor=K.+Simmen&title=Discovery+of+novel+potent+and+selective+dipeptide+hepatitis+C+virus+NS3%2F4A+serine+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520novel%2520potent%2520and%2520selective%2520dipeptide%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520serine%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5095%26epage%3D5100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonov, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Classon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayesa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, P.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahnberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eneroth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikstrom, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Vreken, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Dooren, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kindermans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span> </span><span class="NLM_article-title">Discovery of novel, potent and bioavailable proline-urea based macrocyclic HCV NS3/4A protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6189</span><span class="NLM_x">–</span> <span class="NLM_lpage">6193</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6189-6193&author=S.+Vendevilleauthor=M.+Nilssonauthor=H.+de+Kockauthor=T.-I.+Linauthor=D.+Antonovauthor=B.+Classonauthor=S.+Ayesaauthor=V.+Ivanovauthor=P.-O.+Johanssonauthor=P.+Kahnbergauthor=A.+Enerothauthor=K.+Wikstromauthor=L.+Vrangauthor=M.+Edlundauthor=S.+Lindstr%C3%B6mauthor=W.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=O.+Lenzauthor=F.+Delouvroyauthor=M.+Van+Doorenauthor=N.+Kindermansauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=A.+Rosenquistauthor=B.+Samuelssonauthor=K.+Simmenauthor=P.+Raboisson&title=Discovery+of+novel%2C+potent+and+bioavailable+proline-urea+based+macrocyclic+HCV+NS3%2F4A+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3DAntonov%26aufirst%3DD.%26aulast%3DClasson%26aufirst%3DB.%26aulast%3DAyesa%26aufirst%3DS.%26aulast%3DIvanov%26aufirst%3DV.%26aulast%3DJohansson%26aufirst%3DP.-O.%26aulast%3DKahnberg%26aufirst%3DP.%26aulast%3DEneroth%26aufirst%3DA.%26aulast%3DWikstrom%26aufirst%3DK.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DVan%2BDooren%26aufirst%3DM.%26aulast%3DKindermans%26aufirst%3DN.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26aulast%3DRaboisson%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520novel%252C%2520potent%2520and%2520bioavailable%2520proline-urea%2520based%2520macrocyclic%2520HCV%2520NS3%252F4A%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6189%26epage%3D6193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belfrage, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstroem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waehling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayesa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahnberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelcman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benkestock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agback, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terelius, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikström, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rydergård, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eneroth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of potent inhibitors of the hepatitis C virus NS3/4A protease: exploration of P2 quinazoline substituents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4004</span><span class="NLM_x">–</span> <span class="NLM_lpage">4011</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4004-4011&author=M.+Nilssonauthor=A.+K.+Belfrageauthor=S.+Lindstroemauthor=H.+Waehlingauthor=C.+Lindquistauthor=S.+Ayesaauthor=P.+Kahnbergauthor=M.+Pelcmanauthor=K.+Benkestockauthor=T.+Agbackauthor=L.+Vrangauthor=Y.+Tereliusauthor=K.+Wikstr%C3%B6mauthor=E.+Hamelinkauthor=C.+Ryderg%C3%A5rdauthor=M.+Edlundauthor=A.+Enerothauthor=P.+Raboissonauthor=T.-I.+Linauthor=H.+de+Kockauthor=P.+Wigerinckauthor=K.+Simmenauthor=B.+Samuelssonauthor=A.+Rosenquist&title=Synthesis+and+SAR+of+potent+inhibitors+of+the+hepatitis+C+virus+NS3%2F4A+protease%3A+exploration+of+P2+quinazoline+substituents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DBelfrage%26aufirst%3DA.%2BK.%26aulast%3DLindstroem%26aufirst%3DS.%26aulast%3DWaehling%26aufirst%3DH.%26aulast%3DLindquist%26aufirst%3DC.%26aulast%3DAyesa%26aufirst%3DS.%26aulast%3DKahnberg%26aufirst%3DP.%26aulast%3DPelcman%26aufirst%3DM.%26aulast%3DBenkestock%26aufirst%3DK.%26aulast%3DAgback%26aufirst%3DT.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DTerelius%26aufirst%3DY.%26aulast%3DWikstr%25C3%25B6m%26aufirst%3DK.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DRyderg%25C3%25A5rd%26aufirst%3DC.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DEneroth%26aufirst%3DA.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DSimmen%26aufirst%3DK.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DRosenquist%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520potent%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%253A%2520exploration%2520of%2520P2%2520quinazoline%2520substituents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4004%26epage%3D4011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Lampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrenberg, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafsson, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aakerblom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandstroem, A.</span><span> </span><span class="NLM_article-title">Improved P2 phenylglycine-based hepatitis C virus NS3 protease inhibitors with alkenylic prime-side substituents</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5413</span><span class="NLM_x">–</span> <span class="NLM_lpage">5424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31k&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.1016%2Fj.bmc.2010.05.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31k&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=20541424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31k&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BC3cXoslans78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5413-5424&author=A.+Lampaauthor=A.+E.+Ehrenbergauthor=S.+S.+Gustafssonauthor=A.+Vemaauthor=E.+Aakerblomauthor=G.+Lindebergauthor=A.+Karlenauthor=U.+H.+Danielsonauthor=A.+Sandstroem&title=Improved+P2+phenylglycine-based+hepatitis+C+virus+NS3+protease+inhibitors+with+alkenylic+prime-side+substituents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31kR"><div class="casContent"><span class="casTitleNuber">31k</span><div class="casTitle"><span class="NLM_cas:atitle">Improved P2 phenylglycine-based hepatitis C virus NS3 protease inhibitors with alkenylic prime-side substituents</span></div><div class="casAuthors">Lampa, Anna; Ehrenberg, Angelica E.; Gustafsson, Sofia S.; Vema, Aparna; Aakerblom, Eva; Lindeberg, Gunnar; Karlen, Anders; Danielson, U. Helena; Sandstroem, Anja</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5413-5424</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Phenylglycine has proven to be a useful P2 residue in HCV NS3 protease inhibitors.  A novel π-π-interaction between the phenylglycine and the catalytic H57 residue of the protease was postulated, and it was hypothesized that the introduction of a vinyl on the phenylglycine might strengthen this π-π-interaction.  Thus, a series of acyclic vinylated phenylglycine-based HCV NS3 protease inhibitors, e.g., I, was synthesized and their inhibitory potency evaluated.  Surprisingly, inhibitors based on both D- and L-phenylglycine were found to be effective inhibitors, with a slight preference for the D-epimers.  Furthermore, prime-side alkenylic extension of the C-terminal acylsulfonamide group gave significantly improved inhibitors with potencies in the nanomolar range (∼35 nM), potencies which were retained on mutant variants of the protease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1S6r1UZnWFrVg90H21EOLACvtfcHk0li8uTnOxMts_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXoslans78%253D&md5=53f795b5eba3e0b2d27e74fd504229a0</span></div><a href="/servlet/linkout?suffix=cit31k&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.05.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.05.027%26sid%3Dliteratum%253Aachs%26aulast%3DLampa%26aufirst%3DA.%26aulast%3DEhrenberg%26aufirst%3DA.%2BE.%26aulast%3DGustafsson%26aufirst%3DS.%2BS.%26aulast%3DVema%26aufirst%3DA.%26aulast%3DAakerblom%26aufirst%3DE.%26aulast%3DLindeberg%26aufirst%3DG.%26aulast%3DKarlen%26aufirst%3DA.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DSandstroem%26aufirst%3DA.%26atitle%3DImproved%2520P2%2520phenylglycine-based%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitors%2520with%2520alkenylic%2520prime-side%2520substituents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5413%26epage%3D5424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Oertqvist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gising, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrenberg, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larhed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandstroem, A.</span><span> </span><span class="NLM_article-title">Discovery of achiral inhibitors of the hepatitis C virus NS3 protease based on 2(1<i>H</i>)-pyrazinones</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6512</span><span class="NLM_x">–</span> <span class="NLM_lpage">6525</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=6512-6525&author=P.+Oertqvistauthor=J.+Gisingauthor=A.+E.+Ehrenbergauthor=A.+Vemaauthor=A.+Borgauthor=A.+Karlenauthor=M.+Larhedauthor=U.+H+Danielsonauthor=A.+Sandstroem&title=Discovery+of+achiral+inhibitors+of+the+hepatitis+C+virus+NS3+protease+based+on+2%281H%29-pyrazinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOertqvist%26aufirst%3DP.%26aulast%3DGising%26aufirst%3DJ.%26aulast%3DEhrenberg%26aufirst%3DA.%2BE.%26aulast%3DVema%26aufirst%3DA.%26aulast%3DBorg%26aufirst%3DA.%26aulast%3DKarlen%26aufirst%3DA.%26aulast%3DLarhed%26aufirst%3DM.%26aulast%3DDanielson%26aufirst%3DU.%2BH%26aulast%3DSandstroem%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520achiral%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520based%2520on%25202%25281H%2529-pyrazinones%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D6512%26epage%3D6525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Oertqvist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrenberg, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roenn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aekerblom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandstroem, A.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of HCV NS3 protease inhibitors evaluated on the drug-resistant variants A156T and D168V</span> <span class="citation_source-journal">Antiviral Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">852</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=841-852&author=P.+Oertqvistauthor=A.+Vemaauthor=A.+E.+Ehrenbergauthor=G.+Dahlauthor=R.+Roennauthor=E.+Aekerblomauthor=A.+Karlenauthor=U.+H.+Danielsonauthor=A.+Sandstroem&title=Structure%E2%80%93activity+relationships+of+HCV+NS3+protease+inhibitors+evaluated+on+the+drug-resistant+variants+A156T+and+D168V"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOertqvist%26aufirst%3DP.%26aulast%3DVema%26aufirst%3DA.%26aulast%3DEhrenberg%26aufirst%3DA.%2BE.%26aulast%3DDahl%26aufirst%3DG.%26aulast%3DRoenn%26aufirst%3DR.%26aulast%3DAekerblom%26aufirst%3DE.%26aulast%3DKarlen%26aufirst%3DA.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DSandstroem%26aufirst%3DA.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520HCV%2520NS3%2520protease%2520inhibitors%2520evaluated%2520on%2520the%2520drug-resistant%2520variants%2520A156T%2520and%2520D168V%26jtitle%3DAntiviral%2520Ther.%26date%3D2010%26volume%3D15%26spage%3D841%26epage%3D852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Ding, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvest, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazmierski, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, Z.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoue, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7317</span><span class="NLM_x">–</span> <span class="NLM_lpage">7322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7317-7322&author=C.+Z.+Dingauthor=Y.-K.+Zhangauthor=X.+Liauthor=Y.+Liuauthor=S.+Zhangauthor=Y.+Zhouauthor=J.+J.+Plattnerauthor=S.+J.+Bakerauthor=L.+Liuauthor=M.+Duanauthor=R.+L.+Jarvestauthor=J.+Jiauthor=W.+M.+Kazmierskiauthor=M.+D.+Tallantauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=R.+M.+Crosbyauthor=A.+A.+Wangauthor=Z.-J.+Niauthor=W.+Zoueauthor=J.+Wright&title=Synthesis+and+biological+evaluations+of+P4-benzoxaborole-substituted+macrocyclic+inhibitors+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31n&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DJarvest%26aufirst%3DR.%2BL.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DTallant%26aufirst%3DM.%2BD.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DWang%26aufirst%3DA.%2BA.%26aulast%3DNi%26aufirst%3DZ.-J.%26aulast%3DZoue%26aufirst%3DW.%26aulast%3DWright%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluations%2520of%2520P4-benzoxaborole-substituted%2520macrocyclic%2520inhibitors%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7317%26epage%3D7322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Duan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazmierski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gartland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamatake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span> </span><span class="NLM_article-title">Discovery of novel P3-oxo inhibitor of hepatitis C virus NS3/4A serine protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2993</span><span class="NLM_x">–</span> <span class="NLM_lpage">2996</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2993-2996&author=M.+Duanauthor=W.+Kazmierskiauthor=R.+Crosbyauthor=M.+Gartlandauthor=J.+Jiauthor=M.+Tallantauthor=A.+Wangauthor=R.+Hamatakeauthor=L.+Wrightauthor=M.+Wuauthor=Y.-K.+Zhangauthor=C.+Z.+Dingauthor=X.+Liauthor=Y.+Liuauthor=S.+Zhangauthor=Y.+Zhouauthor=J.+J.+Plattnerauthor=S.+J.+Baker&title=Discovery+of+novel+P3-oxo+inhibitor+of+hepatitis+C+virus+NS3%2F4A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31o&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DKazmierski%26aufirst%3DW.%26aulast%3DCrosby%26aufirst%3DR.%26aulast%3DGartland%26aufirst%3DM.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DTallant%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DHamatake%26aufirst%3DR.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26atitle%3DDiscovery%2520of%2520novel%2520P3-oxo%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520serine%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2993%26epage%3D2996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Kazmierski, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamatake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvest, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creech, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span> </span><span class="NLM_article-title">Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutants</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3021</span><span class="NLM_x">–</span> <span class="NLM_lpage">3026</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201278q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31p&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVWltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3021-3026&author=W.+M.+Kazmierskiauthor=R.+Hamatakeauthor=M.+Duanauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=R.+L.+Jarvestauthor=J.-J.+Jiauthor=J.+P.+Cooperauthor=M.+D.+Tallantauthor=R.+M.+Crosbyauthor=K.+Creechauthor=A.+Wangauthor=X.+Liauthor=S.+Zhangauthor=Y.-Y.+Zhangauthor=Y.+Liuauthor=C.+Z.+Dingauthor=Y.+Zhouauthor=J.+J.+Plattnerauthor=S.+J.+Bakerauthor=W.+Buauthor=L.+Liu&title=Discovery+of+novel+urea-based+hepatitis+C+protease+inhibitors+with+high+potency+against+protease-inhibitor-resistant+mutants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31pR"><div class="casContent"><span class="casTitleNuber">31p</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutants</span></div><div class="casAuthors">Kazmierski, Wieslaw M.; Hamatake, Robert; Duan, Maosheng; Wright, Lois L.; Smith, Gary K.; Jarvest, Richard L.; Ji, Jing-Jing; Cooper, Joel P.; Tallant, Matthew D.; Crosby, Renae M.; Creech, Katrina; Wang, Amy; Li, Xianfeng; Zhang, Suoming; Zhang, Yong-Kang; Liu, Yang; Ding, Charles Z.; Zhou, Yasheen; Plattner, Jacob J.; Baker, Stephen J.; Bu, Wei; Liu, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3021-3026</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Urea-based inhibitors were prepd. and characterized in replicase HCV protease-resistant mutants assay.  Several compds., exemplified by I, were found to be more potent in HCV replicon assays than leading second generation inhibitors such as danoprevir and TMC-435350.  Addnl., following oral administration, inhibitor I was found in rat liver in significantly higher concns. than those reported for both danoprevir and TMC-435350, suggesting that inhibitor I has the combination of anti-HCV and pharmacokinetic properties that warrants further development of this series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZf8snkMwqSrVg90H21EOLACvtfcHk0ljBwCxzRW0lJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVWltb0%253D&md5=43f9016626357a5fea8d6d1e9784e2d8</span></div><a href="/servlet/linkout?suffix=cit31p&amp;dbid=16384&amp;doi=10.1021%2Fjm201278q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201278q%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DHamatake%26aufirst%3DR.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DJarvest%26aufirst%3DR.%2BL.%26aulast%3DJi%26aufirst%3DJ.-J.%26aulast%3DCooper%26aufirst%3DJ.%2BP.%26aulast%3DTallant%26aufirst%3DM.%2BD.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DCreech%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.-Y.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520novel%2520urea-based%2520hepatitis%2520C%2520protease%2520inhibitors%2520with%2520high%2520potency%2520against%2520protease-inhibitor-resistant%2520mutants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3021%26epage%3D3026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31q"><span><span class="NLM_label">(q) </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swestock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span> </span><span class="NLM_article-title">Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2443</span><span class="NLM_x">–</span> <span class="NLM_lpage">2463</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9015526" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31q&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitV2gsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2443-2463&author=J.+A.+McCauleyauthor=C.+J.+McIntyreauthor=M.+T.+Ruddauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=J.+W.+Butcherauthor=K.+F.+Gilbertauthor=K.+J.+Bushauthor=M.+K.+Hollowayauthor=J.+Swestockauthor=B.-L.+Wanauthor=S.+S.+Carrollauthor=J.+M.+DiMuzioauthor=D.+J.+Grahamauthor=S.+W.+Ludmererauthor=S.-S.+Maoauthor=M.+W.+Stahlhutauthor=C.+M.+Fandozziauthor=N.+Trainorauthor=D.+B.+Olsenauthor=J.+P.+Vaccaauthor=N.+J.+Liverton&title=Discovery+of+vaniprevir+%28MK-7009%29%2C+a+macrocyclic+hepatitis+C+virus+NS3%2F4a+protease+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31qR"><div class="casContent"><span class="casTitleNuber">31q</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor</span></div><div class="casAuthors">McCauley, John A.; McIntyre, Charles J.; Rudd, Michael T.; Nguyen, Kevin T.; Romano, Joseph J.; Butcher, John W.; Gilbert, Kevin F.; Bush, Kimberly J.; Holloway, M. Katharine; Swestock, John; Wan, Bang-Lin; Carroll, Steven S.; DiMuzio, Jillian M.; Graham, Donald J.; Ludmerer, Steven W.; Mao, Shi-Shan; Stahlhut, Mark W.; Fandozzi, Christine M.; Trainor, Nicole; Olsen, David B.; Vacca, Joseph P.; Liverton, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2443-2463</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of HCV NS3/4a protease inhibitors which contain a P2 to P4 macrocyclic constraint was designed using a mol.-modeling derived strategy.  Exploration of the P2 heterocyclic region, the P2 to P4 linker, and the P1 side chain of this class of compds. via a modular synthetic strategy allowed for the optimization of enzyme potency, cellular activity, and rat liver exposure following oral dosing.  These studies led to the identification of clin. candidate vaniprevir, MK-7009, which is active against both the genotype 1 and genotype 2 NS3/4a protease enzymes and has good plasma exposure and excellent liver exposure in multiple species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_2CVs9I1H_7Vg90H21EOLACvtfcHk0ljBwCxzRW0lJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitV2gsr8%253D&md5=dc820c588d5482f6913091a87eaf9af1</span></div><a href="/servlet/linkout?suffix=cit31q&amp;dbid=16384&amp;doi=10.1021%2Fjm9015526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9015526%26sid%3Dliteratum%253Aachs%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DSwestock%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDiscovery%2520of%2520vaniprevir%2520%2528MK-7009%2529%252C%2520a%2520macrocyclic%2520hepatitis%2520C%2520virus%2520NS3%252F4a%2520protease%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2443%26epage%3D2463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31r"><span><span class="NLM_label">(r) </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A protease</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">4607</span><span class="NLM_x">–</span> <span class="NLM_lpage">4609</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja711120r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=4607-4609&author=N.+J.+Livertonauthor=M.+K.+Hollowayauthor=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=J.+W.+Butcherauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=C.+Fandozziauthor=K.+F.+Gilbertauthor=S.-S.+Maoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=M.+Stahlhutauthor=B.-L.+Wanauthor=D.+B.+Olsenauthor=J.+P.+Vacca&title=Molecular+modeling+based+approach+to+potent+P2-P4+macrocyclic+inhibitors+of+hepatitis+C+NS3%2F4A+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31r&amp;dbid=16384&amp;doi=10.1021%2Fja711120r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja711120r%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMolecular%2520modeling%2520based%2520approach%2520to%2520potent%2520P2-P4%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4A%2520protease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D4607%26epage%3D4609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31s"><span><span class="NLM_label">(s) </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, C. W.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span> </span><span class="NLM_article-title">Bismacrocyclic inhibitors of hepatitis C NS3/4a protease</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">9104</span><span class="NLM_x">–</span> <span class="NLM_lpage">9107</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=9104-9107&author=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=K.+T.+Nguyenauthor=C.+J.+McIntyreauthor=J.+J.+Romanoauthor=K.+J.+Bushauthor=S.+L.+Vargaauthor=C.+W.+Rossauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=M.+W.+Stahlhutauthor=D.+B.+Olsenauthor=T.+A.+Lyleauthor=J.+P.+Vaccaauthor=N.+J.+Liverton&title=Bismacrocyclic+inhibitors+of+hepatitis+C+NS3%2F4a+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31s&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DVarga%26aufirst%3DS.%2BL.%26aulast%3DRoss%26aufirst%3DC.%2BW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DBismacrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4a%2520protease%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2008%26volume%3D47%26spage%3D9104%26epage%3D9107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31t"><span><span class="NLM_label">(t) </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescenzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palumbi, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Muzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donghi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span> </span><span class="NLM_article-title">Inhibitors of the hepatitis C virus NS3 protease with basic amine functionality at the P3-amino acid N-terminus: discovery and optimization of a new series of P2-P4 macrocycles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4820</span><span class="NLM_x">–</span> <span class="NLM_lpage">4837</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900372w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4820-4837&author=S.+Harperauthor=M.+Ferraraauthor=B.+Crescenziauthor=M.+Pompeiauthor=M.+C.+Palumbiauthor=J.+M.+Di+Muzioauthor=M.+Donghiauthor=F.+Fioreauthor=U.+Kochauthor=N.+J.+Livertonauthor=S.+Pesciauthor=A.+Petrocchiauthor=M.+Rowleyauthor=V.+Summaauthor=C.+Gardelli&title=Inhibitors+of+the+hepatitis+C+virus+NS3+protease+with+basic+amine+functionality+at+the+P3-amino+acid+N-terminus%3A+discovery+and+optimization+of+a+new+series+of+P2-P4+macrocycles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31t&amp;dbid=16384&amp;doi=10.1021%2Fjm900372w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900372w%26sid%3Dliteratum%253Aachs%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DPompei%26aufirst%3DM.%26aulast%3DPalumbi%26aufirst%3DM.%2BC.%26aulast%3DDi%2BMuzio%26aufirst%3DJ.%2BM.%26aulast%3DDonghi%26aufirst%3DM.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DPesci%26aufirst%3DS.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DGardelli%26aufirst%3DC.%26atitle%3DInhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520with%2520basic%2520amine%2520functionality%2520at%2520the%2520P3-amino%2520acid%2520N-terminus%253A%2520discovery%2520and%2520optimization%2520of%2520a%2520new%2520series%2520of%2520P2-P4%2520macrocycles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4820%26epage%3D4837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31u"><span><span class="NLM_label">(u) </span><span class="NLM_contrib-group">Di Francesco, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dessole, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Muzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span> </span><span class="NLM_article-title">Novel macrocyclic inhibitors of hepatitis C NS3/4A protease featuring a 2-amino-1,3-thiazole as a P4 carbamate replacement</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7014</span><span class="NLM_x">–</span> <span class="NLM_lpage">7028</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900524b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31u&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWgt7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7014-7028&author=M.+E.+Di+Francescoauthor=G.+Dessoleauthor=E.+Niziauthor=P.+Paceauthor=U.+Kochauthor=F.+Fioreauthor=S.+Pesciauthor=J.+Di+Muzioauthor=E.+Monteagudoauthor=M.+Rowleyauthor=V.+Summa&title=Novel+macrocyclic+inhibitors+of+hepatitis+C+NS3%2F4A+protease+featuring+a+2-amino-1%2C3-thiazole+as+a+P4+carbamate+replacement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31uR"><div class="casContent"><span class="casTitleNuber">31u</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease Featuring a 2-Amino-1,3-thiazole as a P4 Carbamate Replacement</span></div><div class="casAuthors">Di Francesco, M. Emilia; Dessole, Gabriella; Nizi, Emanuela; Pace, Paola; Koch, Uwe; Fiore, Fabrizio; Pesci, Silvia; Di Muzio, Jillian; Monteagudo, Edith; Rowley, Michael; Summa, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7014-7028</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of P2-P4 macrocyclic inhibitors of HCV NS3/4A protease characterized by high levels of potency and liver exposure was recently reported.  Within this novel class of inhibitors, a structurally diverse series of compds. I [X = isoquinoline-1,7-diyl, 2-phenylquinoline-4,6-diyl, 2-carbonyl-1,3-dihydroisoindolyl; Y = (CH2)2, (CH2)3, CH2CMe2; Z = thiazol-2,4-diyl, 1,3,4-oxadiazol-2,5-diyl; R1 = i-Pr, t-Bu, cyclohexyl, (S)-EtCHMe, cyclopentyl; R2 = H2C:CH, Et] featuring a 2-amino-1,3-thiazole as replacement of the carbamate in P4 was identified.  Optimization studies focused on structural modifications in the P3, P2, and P1 regions of the macrocycle as well as on the linker chain and resulted in the discovery of several analogs characterized by excellent levels of enzyme and cellular activity.  Among these, I [double bond; X = 2-carbonyl-1,3-dihydroisoindolyl; Y = (CH2)3; Z = thiazol-2,4-diyl; R1 = (S)-EtCHMe; R2 = H2C:CH] displayed an attractive pharmacokinetic profile in preclin. species and showed sustained liver levels following oral administration in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIFtigQW8FUrVg90H21EOLACvtfcHk0lhm5xfKVZ5Iug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWgt7fN&md5=76e409fa1d0e9812ee78c4eeabca21ce</span></div><a href="/servlet/linkout?suffix=cit31u&amp;dbid=16384&amp;doi=10.1021%2Fjm900524b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900524b%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BFrancesco%26aufirst%3DM.%2BE.%26aulast%3DDessole%26aufirst%3DG.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DPace%26aufirst%3DP.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DPesci%26aufirst%3DS.%26aulast%3DDi%2BMuzio%26aufirst%3DJ.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DNovel%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4A%2520protease%2520featuring%2520a%25202-amino-1%252C3-thiazole%2520as%2520a%2520P4%2520carbamate%2520replacement%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7014%26epage%3D7028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31v"><span><span class="NLM_label">(v) </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swestock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span> </span><span class="NLM_article-title">Discovery of MK-1220: a macrocyclic inhibitor of hepatitis C virus NS3/4A protease with improved preclinical plasma exposure</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml1002426" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=207-212&author=M.+T.+Ruddauthor=J.+A.+McCauleyauthor=J.+W.+Butcherauthor=J.+J.+Romanoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=K.+F.+Gilbertauthor=K.+J.+Bushauthor=M.+K.+Hollowayauthor=J.+Swestockauthor=B.-L.+Wanauthor=S.+S.+Carrollauthor=J.+M.+DiMuzioauthor=D.+J.+Grahamauthor=S.+W.+Ludmererauthor=M.+W.+Stahlhutauthor=C.+M.+Fandozziauthor=N.+Trainorauthor=D.+B.+Olsenauthor=J.+P.+Vaccaauthor=N.+J.+Liverton&title=Discovery+of+MK-1220%3A+a+macrocyclic+inhibitor+of+hepatitis+C+virus+NS3%2F4A+protease+with+improved+preclinical+plasma+exposure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31v&amp;dbid=16384&amp;doi=10.1021%2Fml1002426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1002426%26sid%3Dliteratum%253Aachs%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DSwestock%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDiscovery%2520of%2520MK-1220%253A%2520a%2520macrocyclic%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520with%2520improved%2520preclinical%2520plasma%2520exposure%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D207%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31w"><span><span class="NLM_label">(w) </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiFilippo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescenzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burlein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHale, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianetti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span> </span><span class="NLM_article-title">Discovery of MK-5172, a macrocyclic hepatitis C virus NS3/4a protease inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300017p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31w&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFyjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=332-336&author=S.+Harperauthor=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=M.+Ferraraauthor=M.+DiFilippoauthor=B.+Crescenziauthor=U.+Kochauthor=A.+Petrocchiauthor=M.+K.+Hollowayauthor=J.+W.+Butcherauthor=J.+J.+Romanoauthor=K.+J.+Bushauthor=K.+F.+Gilbertauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=E.+Niziauthor=S.+S.+Carrollauthor=S.+W.+Ludmererauthor=C.+Burleinauthor=J.+M.+DiMuzioauthor=D.+J.+Grahamauthor=C.+M.+McHaleauthor=M.+W.+Stahlhutauthor=D.+B.+Olsenauthor=E.+Monteagudoauthor=S.+Cianettiauthor=C.+Giulianoauthor=V.+Pucciauthor=N.+Trainorauthor=C.+M.+Fandozziauthor=M.+Rowleyauthor=P.+J.+Colemanauthor=J.+P.+Vaccaauthor=V.+Summaauthor=N.+J.+Liverton&title=Discovery+of+MK-5172%2C+a+macrocyclic+hepatitis+C+virus+NS3%2F4a+protease+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31wR"><div class="casContent"><span class="casTitleNuber">31w</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor</span></div><div class="casAuthors">Harper, Steven; McCauley, John A.; Rudd, Michael T.; Ferrara, Marco; DiFilippo, Marcello; Crescenzi, Benedetta; Koch, Uwe; Petrocchi, Alessia; Holloway, M. Katharine; Butcher, John W.; Romano, Joseph J.; Bush, Kimberly J.; Gilbert, Kevin F.; McIntyre, Charles J.; Nguyen, Kevin T.; Nizi, Emanuela; Carroll, Steven S.; Ludmerer, Steven W.; Burlein, Christine; DiMuzio, Jillian M.; Graham, Donald J.; McHale, Carolyn M.; Stahlhut, Mark W.; Olsen, David B.; Monteagudo, Edith; Cianetti, Simona; Giuliano, Claudio; Pucci, Vincenzo; Trainor, Nicole; Fandozzi, Christine M.; Rowley, Michael; Coleman, Paul J.; Vacca, Joseph P.; Summa, Vincenzo; Liverton, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">332-336</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of HCV NS3/4a protease inhibitors contg. a P2 to P4 macrocyclic constraint was designed using a mol. modeling-derived strategy.  Building on the profile of previous clin. compds. and exploring the P2 and linker regions of the series allowed for optimization of broad genotype and mutant enzyme potency, cellular activity, and rat liver exposure following oral dosing.  These studies led to the identification of clin. candidate 15 (MK-5172), which is active against genotype 1-3 NS3/4a and clin. relevant mutant enzymes and has good plasma exposure and excellent liver exposure in multiple species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAzCaAN9VqJrVg90H21EOLACvtfcHk0lgyFRVrXZBqWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFyjurg%253D&md5=efc04ad0ad47aef13b367fc38d6bbf63</span></div><a href="/servlet/linkout?suffix=cit31w&amp;dbid=16384&amp;doi=10.1021%2Fml300017p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300017p%26sid%3Dliteratum%253Aachs%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DDiFilippo%26aufirst%3DM.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DBurlein%26aufirst%3DC.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DMcHale%26aufirst%3DC.%2BM.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DCianetti%26aufirst%3DS.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DPucci%26aufirst%3DV.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDiscovery%2520of%2520MK-5172%252C%2520a%2520macrocyclic%2520hepatitis%2520C%2520virus%2520NS3%252F4a%2520protease%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D332%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31x"><span><span class="NLM_label">(x) </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burlein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span> </span><span class="NLM_article-title">Development of potent macrocyclic inhibitors of genotype 3a HCV NS3/4A protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7201</span><span class="NLM_x">–</span> <span class="NLM_lpage">7206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7201-7206&author=M.+T.+Ruddauthor=J.+A.+McCauleyauthor=J.+J.+Romanoauthor=J.+W.+Butcherauthor=K.+Bushauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=K.+F.+Gilbertauthor=T.+A.+Lyleauthor=M.+K+Hollowayauthor=B.-L.+Wanauthor=J.+P.+Vaccaauthor=V.+Summaauthor=S.+Harperauthor=M.+Rowleyauthor=S.+S.+Carrollauthor=C.+Burleinauthor=J.+M.+DiMuzioauthor=A.+Gatesauthor=D.+J.+Grahamauthor=Q.+Huangauthor=S.+W.+Ludmererauthor=S.+McClainauthor=C.+McHaleauthor=M.+Stahlhutauthor=C.+Fandozziauthor=A.+Taylorauthor=N.+Trainorauthor=D.+B.+Olsenauthor=N.+J.+Liverton&title=Development+of+potent+macrocyclic+inhibitors+of+genotype+3a+HCV+NS3%2F4A+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31x&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DBush%26aufirst%3DK.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DHolloway%26aufirst%3DM.%2BK%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DBurlein%26aufirst%3DC.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGates%26aufirst%3DA.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMcClain%26aufirst%3DS.%26aulast%3DMcHale%26aufirst%3DC.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DTaylor%26aufirst%3DA.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDevelopment%2520of%2520potent%2520macrocyclic%2520inhibitors%2520of%2520genotype%25203a%2520HCV%2520NS3%252F4A%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7201%26epage%3D7206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31y"><span><span class="NLM_label">(y) </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burlein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span> </span><span class="NLM_article-title">Development of macrocyclic inhibitors of HCV NS3/4A protease with cyclic constrained P2-P4 linkers</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7207</span><span class="NLM_x">–</span> <span class="NLM_lpage">7213</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7207-7213&author=M.+T.+Ruddauthor=C.+J.+McIntyreauthor=J.+J.+Romanoauthor=J.+W.+Butcherauthor=M.+K.+Hollowayauthor=K.+Bushauthor=K.+T.+Nguyenauthor=K.+F.+Gilbertauthor=T.+A.+Lyleauthor=N.+J.+Livertonauthor=B.-L+Wanauthor=V.+Summaauthor=S.+Harperauthor=M.+Rowleyauthor=J.+P.+Vaccaauthor=S.+S.+Carrollauthor=C.+Burleinauthor=J.+M.+DiMuzioauthor=A.+Gatesauthor=D.+J.+Grahamauthor=Q.+Huangauthor=S.+W.+Ludmererauthor=S.+McClainauthor=C.+McHaleauthor=M.+Stahlhutauthor=C.+Fandozziauthor=A.+Taylorauthor=N.+Trainorauthor=D.+B.+Olsenauthor=J.+A.+McCauley&title=Development+of+macrocyclic+inhibitors+of+HCV+NS3%2F4A+protease+with+cyclic+constrained+P2-P4+linkers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31y&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DBush%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DWan%26aufirst%3DB.-L%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DBurlein%26aufirst%3DC.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGates%26aufirst%3DA.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMcClain%26aufirst%3DS.%26aulast%3DMcHale%26aufirst%3DC.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DTaylor%26aufirst%3DA.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26atitle%3DDevelopment%2520of%2520macrocyclic%2520inhibitors%2520of%2520HCV%2520NS3%252F4A%2520protease%2520with%2520cyclic%2520constrained%2520P2-P4%2520linkers%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7207%26epage%3D7213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31z"><span><span class="NLM_label">(z) </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazmierski, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamatake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvest, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creech, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span> </span><span class="NLM_article-title">Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groups</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7351</span><span class="NLM_x">–</span> <span class="NLM_lpage">7356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7351-7356&author=X.+Liauthor=Y.+Liuauthor=Y.-K.+Zhangauthor=J.+J.+Plattnerauthor=S.+J.+Bakerauthor=W.+Buauthor=L.+Liuauthor=Y.+Zhouauthor=C.+Z.+Dingauthor=S.+Zhangauthor=W.+M.+Kazmierskiauthor=R.+Hamatakeauthor=M.+Duanauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=R.+L.+Jarvestauthor=J.-J.+Jiauthor=J.+P.+Cooperauthor=M.+D.+Tallantauthor=R.+M.+Crosbyauthor=K.+Creechauthor=A.+Wang&title=Synthesis+and+antiviral+activity+of+novel+HCV+NS3+protease+inhibitors+with+P4+capping+groups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31z&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DHamatake%26aufirst%3DR.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DJarvest%26aufirst%3DR.%2BL.%26aulast%3DJi%26aufirst%3DJ.-J.%26aulast%3DCooper%26aufirst%3DJ.%2BP.%26aulast%3DTallant%26aufirst%3DM.%2BD.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DCreech%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520antiviral%2520activity%2520of%2520novel%2520HCV%2520NS3%2520protease%2520inhibitors%2520with%2520P4%2520capping%2520groups%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7351%26epage%3D7356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31aa"><span><span class="NLM_label">(aa) </span><span class="NLM_contrib-group">Bilodeau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhardwaj, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordeleau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forgione, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolicoeur, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemke, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Meara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span> </span><span class="NLM_article-title">Synthesis and optimization of a novel series of HCV NS3 protease inhibitors: 4-arylproline analogs</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4267</span><span class="NLM_x">–</span> <span class="NLM_lpage">4271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4267-4271&author=F.+Bilodeauauthor=M.+D.+Baileyauthor=P.+K.+Bhardwajauthor=J.+Bordeleauauthor=P.+Forgioneauthor=M.+Garneauauthor=E.+Ghiroauthor=V.+Gorysauthor=T.+Halmosauthor=E.+S.+Jolicoeurauthor=M.+Leblancauthor=C.+T.+Lemkeauthor=J.+Naudauthor=J.+O%E2%80%99Mearaauthor=P.+W.+Whiteauthor=M.+Llin%C3%A0s-Brunet&title=Synthesis+and+optimization+of+a+novel+series+of+HCV+NS3+protease+inhibitors%3A+4-arylproline+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31aa&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBilodeau%26aufirst%3DF.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBhardwaj%26aufirst%3DP.%2BK.%26aulast%3DBordeleau%26aufirst%3DJ.%26aulast%3DForgione%26aufirst%3DP.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DJolicoeur%26aufirst%3DE.%2BS.%26aulast%3DLeblanc%26aufirst%3DM.%26aulast%3DLemke%26aufirst%3DC.%2BT.%26aulast%3DNaud%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DJ.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520optimization%2520of%2520a%2520novel%2520series%2520of%2520HCV%2520NS3%2520protease%2520inhibitors%253A%25204-arylproline%2520analogs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4267%26epage%3D4271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31ab"><span><span class="NLM_label">(ab) </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemke, C. T.</span><span> </span><span class="NLM_article-title">Discovery of novel P2 substituted 4-biaryl proline inhibitors of hepatitis C virus NS3 serine protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4436</span><span class="NLM_x">–</span> <span class="NLM_lpage">4440</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4436-4440&author=M.+D.+Baileyauthor=T.+Halmosauthor=C.+T.+Lemke&title=Discovery+of+novel+P2+substituted+4-biaryl+proline+inhibitors+of+hepatitis+C+virus+NS3+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31ab&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DLemke%26aufirst%3DC.%2BT.%26atitle%3DDiscovery%2520of%2520novel%2520P2%2520substituted%25204-biaryl%2520proline%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520serine%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4436%26epage%3D4440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31ac"><span><span class="NLM_label">(ac) </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordeleau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemke, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Meara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span> </span><span class="NLM_article-title">Peptide backbone replacement of hepatitis C virus NS3 serine protease C-terminal cleavage product analogs: discovery of potent succinamide inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4447</span><span class="NLM_x">–</span> <span class="NLM_lpage">4452</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4447-4452&author=M.+D.+Baileyauthor=J.+Bordeleauauthor=M.+Garneauauthor=M.+Leblancauthor=C.+T.+Lemkeauthor=J.+O%E2%80%99Mearaauthor=P.+W.+Whiteauthor=M.+Llinas-Brunet&title=Peptide+backbone+replacement+of+hepatitis+C+virus+NS3+serine+protease+C-terminal+cleavage+product+analogs%3A+discovery+of+potent+succinamide+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31ac&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBordeleau%26aufirst%3DJ.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DLeblanc%26aufirst%3DM.%26aulast%3DLemke%26aufirst%3DC.%2BT.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DJ.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26atitle%3DPeptide%2520backbone%2520replacement%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520serine%2520protease%2520C-terminal%2520cleavage%2520product%2520analogs%253A%2520discovery%2520of%2520potent%2520succinamide%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4447%26epage%3D4452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31ad"><span><span class="NLM_label">(ad) </span><span class="NLM_contrib-group">Moreau, B.; O’Meara, J. A.; Bordeleau, J.; Garneau, M.; Godbout, C.; Gorys, V.; Leblanc, M.; Villemure, E.; White, P. W.; Llinas-Brunet, M.</span><span> </span><span class="NLM_article-title">Discovery of hepatitis C Virus NS3-4A protease inhibitors with improved barrier to resistance and favorable liver distribution</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/jm400121t</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm400121t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=B.+Moreau&author=J.+A.+O%E2%80%99Meara&author=J.+Bordeleau&author=M.+Garneau&author=C.+Godbout&author=V.+Gorys&author=M.+Leblanc&author=E.+Villemure&author=P.+W.+White&author=M.+Llinas-Brunet&title=Discovery+of+hepatitis+C+Virus+NS3-4A+protease+inhibitors+with+improved+barrier+to+resistance+and+favorable+liver+distribution&doi=10.1021%2Fjm400121t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31ad&amp;dbid=16384&amp;doi=10.1021%2Fjm400121t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400121t%26sid%3Dliteratum%253Aachs%26aulast%3DMoreau%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520hepatitis%2520C%2520Virus%2520NS3-4A%2520protease%2520inhibitors%2520with%2520improved%2520barrier%2520to%2520resistance%2520and%2520favorable%2520liver%2520distribution%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26doi%3D10.1021%2Fjm400121t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31ae"><span><span class="NLM_label">(ae) </span><span class="NLM_contrib-group">Seiwert, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebryany, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kossen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, P. T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misialek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoycheva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condroski, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hingorani, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beigelman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, L. M.</span><span> </span><span class="NLM_article-title">Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227)</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4432</span><span class="NLM_x">–</span> <span class="NLM_lpage">4441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=4432-4441&author=S.+D.+Seiwertauthor=S.+W.+Andrewsauthor=Y.+Jiangauthor=V.+Serebryanyauthor=H.+Tanauthor=K.+Kossenauthor=P.+T.+R.+Rajagopalanauthor=S.+Misialekauthor=S.+K.+Stevensauthor=A.+Stoychevaauthor=J.+Hongauthor=S.+R.+Limauthor=X.+Qinauthor=R.+Riegerauthor=K.+R.+Condroskiauthor=H.+Zhangauthor=M.+G.+Doauthor=C.+Lemieuxauthor=G.+P.+Hingoraniauthor=D.+P.+Hartleyauthor=J.+A.+Joseyauthor=L.+Panauthor=L.+Beigelmanauthor=L.+M.+Blatt&title=Preclinical+characteristics+of+the+hepatitis+C+virus+NS3%2F4A+protease+inhibitor+ITMN-191+%28R7227%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31ae&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeiwert%26aufirst%3DS.%2BD.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DKossen%26aufirst%3DK.%26aulast%3DRajagopalan%26aufirst%3DP.%2BT.%2BR.%26aulast%3DMisialek%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DStoycheva%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DS.%2BR.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DRieger%26aufirst%3DR.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DDo%26aufirst%3DM.%2BG.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DHingorani%26aufirst%3DG.%2BP.%26aulast%3DHartley%26aufirst%3DD.%2BP.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26atitle%3DPreclinical%2520characteristics%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520inhibitor%2520ITMN-191%2520%2528R7227%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D4432%26epage%3D4441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31af"><span><span class="NLM_label">(af) </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condroski, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebryany, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenglowsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madduru, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodard, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geck Do, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandhuber, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stengel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beigelman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiwert, S. D.</span><span> </span><span class="NLM_article-title">Discovery of danoprevir (ITMN-191/R7227), a highly selective and potent Inhibitor of hepatitis C virus (HCV) NS3/4A protease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1021/jm400164c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400164c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Y.+Jiangauthor=S.+W.+Andrewsauthor=K.+R.+Condroskiauthor=B.+Buckmanauthor=V.+Serebryanyauthor=S.+Wenglowskyauthor=A.+L.+Kennedyauthor=M.+R.+Madduruauthor=B.+Wangauthor=M.+Lyonauthor=G.+A.+Dohertyauthor=B.+T.+Woodardauthor=C.+Lemieuxauthor=M.+Geck+Doauthor=H.+Zhangauthor=J.+Ballardauthor=G.+Vigersauthor=B.+J.+Brandhuberauthor=P.+Stengelauthor=J.+A.+Joseyauthor=L.+Beigelmanauthor=L.+Blattauthor=S.+D.+Seiwert&title=Discovery+of+danoprevir+%28ITMN-191%2FR7227%29%2C+a+highly+selective+and+potent+Inhibitor+of+hepatitis+C+virus+%28HCV%29+NS3%2F4A+protease&doi=10.1021%2Fjm400164c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31af&amp;dbid=16384&amp;doi=10.1021%2Fjm400164c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400164c%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DBuckman%26aufirst%3DB.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DWenglowsky%26aufirst%3DS.%26aulast%3DKennedy%26aufirst%3DA.%2BL.%26aulast%3DMadduru%26aufirst%3DM.%2BR.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DLyon%26aufirst%3DM.%26aulast%3DDoherty%26aufirst%3DG.%2BA.%26aulast%3DWoodard%26aufirst%3DB.%2BT.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DGeck%2BDo%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBallard%26aufirst%3DJ.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DBrandhuber%26aufirst%3DB.%2BJ.%26aulast%3DStengel%26aufirst%3DP.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DL.%26aulast%3DSeiwert%26aufirst%3DS.%2BD.%26atitle%3DDiscovery%2520of%2520danoprevir%2520%2528ITMN-191%252FR7227%2529%252C%2520a%2520highly%2520selective%2520and%2520potent%2520Inhibitor%2520of%2520hepatitis%2520C%2520virus%2520%2528HCV%2529%2520NS3%252F4A%2520protease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26doi%3D10.1021%2Fjm400164c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Vispo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, V.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of new oral hepatitis C antiviral drugs</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.1517%2F17425255.2013.729577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=23094639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVGmsL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=5-16&author=E.+Vispoauthor=P.+Barreiroauthor=V.+Soriano&title=Pharmacokinetics+of+new+oral+hepatitis+C+antiviral+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of new oral hepatitis C antiviral drugs</span></div><div class="casAuthors">Vispo, Eugenia; Barreiro, Pablo; Soriano, Vicente</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-16</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Approx. 175 million people worldwide are chronically infected with the hepatitis C virus (HCV), representing 3% of the total world population.  Until recently, the only available therapeutic option for these patients was the combination of pegylated IFN-α plus ribavirin that overall resulted in HCV eradication in less than a half of cases.  The development of new therapies with greater efficacy has been eagerly awaited but new challenges have emerged, with drug interactions being among the most challenging.Areas covered: This review updates the main pharmacokinetic and pharmacodynamic characteristics of the most promising new oral direct-acting antivirals (DAA) for hepatitis C. Given that a large proportion of chronic hepatitis C patients receive other medications, drug interactions are further discussed.Expert opinion: The recent approval of the first HCV genotype 1 protease inhibitors is a landmark step in the fight against the HCV pandemic.  The benefit of higher rates of response along with shorter duration of treatment is counterbalanced by significant drug interactions and unprecedented complexities in the use of these drugs and management of their side effects.  The knowledge of key pharmacol. parameters of distinct DAA is important for care providers in charge of chronic hepatitis C patients as it will avoid the danger of unexpected drug interactions.  This concern must be particularly emphasized in special group populations, such as in HIV-HCV coinfected individuals and transplant patients, in whom interactions between DAA and antiretrovirals or immunosuppressants, resp., are frequent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQKHyYbjQVarVg90H21EOLACvtfcHk0lieZG2KVSnuZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVGmsL3I&md5=a9e2a8f9c9c5556d8ca8dea1054195cc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1517%2F17425255.2013.729577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2013.729577%26sid%3Dliteratum%253Aachs%26aulast%3DVispo%26aufirst%3DE.%26aulast%3DBarreiro%26aufirst%3DP.%26aulast%3DSoriano%26aufirst%3DV.%26atitle%3DPharmacokinetics%2520of%2520new%2520oral%2520hepatitis%2520C%2520antiviral%2520drugs%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2013%26volume%3D9%26spage%3D5%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Reddy, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morcos, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lave, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P.</span><span> </span><span class="NLM_article-title">Pharmacokinetic/pharmacodynamic predictors of clinical potency for hepatitis C virus nonnucleoside polymerase and protease inhibitors</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3144</span><span class="NLM_x">–</span> <span class="NLM_lpage">3156</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=3144-3156&author=M.+B.+Reddyauthor=P.+N.+Morcosauthor=S.+Le+Pogamauthor=Y.+Ouauthor=K.+Frankauthor=T.+Laveauthor=P.+Smith&title=Pharmacokinetic%2Fpharmacodynamic+predictors+of+clinical+potency+for+hepatitis+C+virus+nonnucleoside+polymerase+and+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DM.%2BB.%26aulast%3DMorcos%26aufirst%3DP.%2BN.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DOu%26aufirst%3DY.%26aulast%3DFrank%26aufirst%3DK.%26aulast%3DLave%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DP.%26atitle%3DPharmacokinetic%252Fpharmacodynamic%2520predictors%2520of%2520clinical%2520potency%2520for%2520hepatitis%2520C%2520virus%2520nonnucleoside%2520polymerase%2520and%2520protease%2520inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D3144%26epage%3D3156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Lindenbach, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Unravelling hepatitis C virus replication from genome to function</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">938</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.1038%2Fnature04077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=16107832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXotFent7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=933-938&author=B.+D.+Lindenbachauthor=C.+M.+Rice&title=Unravelling+hepatitis+C+virus+replication+from+genome+to+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Unravelling hepatitis C virus replication from genome to function</span></div><div class="casAuthors">Lindenbach, Brett D.; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">436</span>
        (<span class="NLM_cas:issue">7053</span>),
    <span class="NLM_cas:pages">933-938</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the discovery of the hepatitis C virus over 15 years ago, scientists have raced to develop diagnostics, study the virus and find new therapies.  Yet virtually every attempt to dissect this pathogen has met with roadblocks that impeded progress.  Its replication was restricted to humans or exptl. infected chimpanzees, and efficient growth of the virus in cell culture failed until very recently.  Nevertheless hard-fought progress has been made and the first wave of antiviral drugs is entering clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI6vc6EOs8vLVg90H21EOLACvtfcHk0lieZG2KVSnuZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXotFent7o%253D&md5=553517cac32b797ef7a2d07f496a7b5c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnature04077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04077%26sid%3Dliteratum%253Aachs%26aulast%3DLindenbach%26aufirst%3DB.%2BD.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DUnravelling%2520hepatitis%2520C%2520virus%2520replication%2520from%2520genome%2520to%2520function%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D933%26epage%3D938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1420</span><span class="NLM_x">–</span> <span class="NLM_lpage">1456</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx200211v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptlCitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1420-1456&author=N.+A.+Meanwell&title=Improving+drug+candidates+by+design%3A+a+focus+on+physicochemical+properties+as+a+means+of+improving+compound+disposition+and+safety"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1420-1456</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of small mol. drug candidates from the discovery phase to a marketed product continues to be a challenging enterprise with very low success rates that have fostered the perception of poor productivity by the pharmaceutical industry.  Although there have been significant advances in preclin. profiling that have improved compd. triaging and altered the underlying reasons for compd. attrition, the failure rates have not appreciably changed.  As part of an effort to more deeply understand the reasons for candidate failure, there has been considerable interest in analyzing the physicochem. properties of marketed drugs for the purpose of comparing with drugs in discovery and development as a means capturing recent trends in drug design.  The scenario that has emerged is one in which contemporary drug discovery is thought to be focused too heavily on advancing candidates with profiles that are most easily satisfied by mols. with increased mol. wt. and higher overall lipophilicity.  The preponderance of mols. expressing these properties is frequently a function of increased arom. ring count when compared with that of the drugs launched in the latter half of the 20th century and may reflect a preoccupation with maximizing target affinity rather than taking a more holistic approach to drug design.  These attributes not only present challenges for formulation and absorption but also may influence the manifestation of toxicity during development.  By providing some definition around the optimal physicochem. properties assocd. with marketed drugs, guidelines for drug design have been developed that are based largely on calcd. parameters and which may readily be applied by medicinal chemists as an aid to understanding candidate quality.  The physicochem. properties of a mol. that are consistent with the potential for good oral absorption were initially defined by Lipinski, with addnl. insights allowing further refinement, while deeper analyses have explored the correlation with metabolic stability and toxicity.  These insights have been augmented by careful analyses of physicochem. aspects of drug-target interactions, with thermodn. profiling indicating that the signature of best-in-class drugs is a dependence on enthalpy to drive binding energetics rather than entropy, which is dependent on lipophilicity.  Optimization of the entropic contribution to the binding energy of a ligand to its target is generally much easier than refining the enthalpic element.  Consequently, in the absence of a fundamental understanding of the thermodn. complexion of an interaction, the design of mols. with increased lipophilicity becomes almost inevitable.  The application of ligand efficiency, a measure of affinity per heavy atom, group efficiency, which assesses affinity in the context of structural changes, and lipophilic ligand efficiency, which relates potency to lipophilicity, offer less sophisticated but practically useful anal. algorithms to assess the quality of drug-target interactions.  These parameters are readily calcd. and can be applied to lead optimization programs in a fashion that helps to maximize potency while minimizing the kind of lipophilic burden that has been dubbed "mol. obesity".  Several recently described lead optimization campaigns provide illustrative, informative, and productive examples of the effect of paying close attention to carefully controlling physicochem. properties by monitoring ligand efficiency and lipophilic ligand efficiency.  However, to be successful during the lead optimization phase, drug candidate identification programs will need to adopt a holistic approach that integrates multiple parameters, many of which will have unique dependencies on both the drug target and the specific chemotype under prosecution.  Nevertheless, there are many important drug targets that necessitate working in space beyond that which has been defined by the retrospective analyses of marketed drugs and which will require adaptation of some of the guideposts that are useful in directing lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQrUfIwZiIR7Vg90H21EOLACvtfcHk0liuD5prfCjxiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptlCitLs%253D&md5=9ddcf6dc81bf8ab0441df5037979ff4e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Ftx200211v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200211v%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DImproving%2520drug%2520candidates%2520by%2520design%253A%2520a%2520focus%2520on%2520physicochemical%2520properties%2520as%2520a%2520means%2520of%2520improving%2520compound%2520disposition%2520and%2520safety%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1420%26epage%3D1456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span> </span><span class="NLM_article-title">A systematic approach to the optimization of substrate-based inhibitors of the hepatitis C virus NS3 protease: discovery of potent and specific tripeptide inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">6584</span><span class="NLM_x">–</span> <span class="NLM_lpage">6594</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0494523" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6584-6594&issue=26&author=M.+Llin%C3%A0s-Brunetauthor=M.+D.+Baileyauthor=E.+Ghiroauthor=V.+Gorysauthor=T.+Halmosauthor=M.+Poirierauthor=J.+Rancourtauthor=N.+Goudreau&title=A+systematic+approach+to+the+optimization+of+substrate-based+inhibitors+of+the+hepatitis+C+virus+NS3+protease%3A+discovery+of+potent+and+specific+tripeptide+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm0494523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0494523%26sid%3Dliteratum%253Aachs%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DGoudreau%26aufirst%3DN.%26atitle%3DA%2520systematic%2520approach%2520to%2520the%2520optimization%2520of%2520substrate-based%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%253A%2520discovery%2520of%2520potent%2520and%2520specific%2520tripeptide%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D26%26spage%3D6584%26epage%3D6594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Johnson, F.</span><span> </span><span class="NLM_article-title">Allylic strain in six-membered rings</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr60254a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1968&pages=375-413&author=F.+Johnson&title=Allylic+strain+in+six-membered+rings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fcr60254a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr60254a001%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DF.%26atitle%3DAllylic%2520strain%2520in%2520six-membered%2520rings%26jtitle%3DChem.%2520Rev.%26date%3D1968%26volume%3D68%26spage%3D375%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Anderson, G. M.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domelsmith, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houk, K. N.</span><span> </span><span class="NLM_article-title">Methoxy group nonplanarity in <i>o</i>-dimethoxybenzenes. Simple predictive models for conformations and rotational barriers in alkoxyaromatics</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">2344</span><span class="NLM_x">–</span> <span class="NLM_lpage">2352</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00503a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1979&pages=2344-2352&author=G.+M.+Andersonauthor=P.+A.+Kollmanauthor=L.+N.+Domelsmithauthor=K.+N.+Houk&title=Methoxy+group+nonplanarity+in+o-dimethoxybenzenes.+Simple+predictive+models+for+conformations+and+rotational+barriers+in+alkoxyaromatics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fja00503a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00503a018%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DG.%2BM.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26aulast%3DDomelsmith%26aufirst%3DL.%2BN.%26aulast%3DHouk%26aufirst%3DK.%2BN.%26atitle%3DMethoxy%2520group%2520nonplanarity%2520in%2520o-dimethoxybenzenes.%2520Simple%2520predictive%2520models%2520for%2520conformations%2520and%2520rotational%2520barriers%2520in%2520alkoxyaromatics%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1979%26volume%3D101%26spage%3D2344%26epage%3D2352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Mecozzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doughtery, D. A.</span><span> </span><span class="NLM_article-title">Cation–pi interactions in aromatics of biological and medicinal interest: electrostatic potential surfaces as a useful qualitative guide</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">10566</span><span class="NLM_x">–</span> <span class="NLM_lpage">10571</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=10566-10571&author=S.+Mecozziauthor=A.+P.+Westauthor=D.+A.+Doughtery&title=Cation%E2%80%93pi+interactions+in+aromatics+of+biological+and+medicinal+interest%3A+electrostatic+potential+surfaces+as+a+useful+qualitative+guide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMecozzi%26aufirst%3DS.%26aulast%3DWest%26aufirst%3DA.%2BP.%26aulast%3DDoughtery%26aufirst%3DD.%2BA.%26atitle%3DCation%25E2%2580%2593pi%2520interactions%2520in%2520aromatics%2520of%2520biological%2520and%2520medicinal%2520interest%253A%2520electrostatic%2520potential%2520surfaces%2520as%2520a%2520useful%2520qualitative%2520guide%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1996%26volume%3D93%26spage%3D10566%26epage%3D10571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Hansch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikaitani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lien, E. J.</span><span> </span><span class="NLM_article-title">Aromatic substituent constants for structure–activity correlations</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1207</span><span class="NLM_x">–</span> <span class="NLM_lpage">1216</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00269a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1973&pages=1207-1216&author=C.+Hanschauthor=A.+Leoauthor=S.+H.+Ungerauthor=K.+H.+Kimauthor=D.+Nikaitaniauthor=E.+J.+Lien&title=Aromatic+substituent+constants+for+structure%E2%80%93activity+correlations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm00269a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00269a003%26sid%3Dliteratum%253Aachs%26aulast%3DHansch%26aufirst%3DC.%26aulast%3DLeo%26aufirst%3DA.%26aulast%3DUnger%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DNikaitani%26aufirst%3DD.%26aulast%3DLien%26aufirst%3DE.%2BJ.%26atitle%3DAromatic%2520substituent%2520constants%2520for%2520structure%25E2%2580%2593activity%2520correlations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1973%26volume%3D16%26spage%3D1207%26epage%3D1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Dougherty, D. A.</span><span> </span><span class="NLM_article-title">The cation−π interaction</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">885</span><span class="NLM_x">–</span> <span class="NLM_lpage">893</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar300265y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2013&pages=885-893&author=D.+A.+Dougherty&title=The+cation%E2%88%92%CF%80+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Far300265y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far300265y%26sid%3Dliteratum%253Aachs%26aulast%3DDougherty%26aufirst%3DD.%2BA.%26atitle%3DThe%2520cation%25E2%2588%2592%25CF%2580%2520interaction%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2013%26volume%3D46%26spage%3D885%26epage%3D893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fleming, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravikumar, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shook, B. C.</span><span> </span><span class="NLM_article-title">Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">7902</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100762r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7902-17&issue=22&author=F.+F.+Flemingauthor=L.+Yaoauthor=P.+C.+Ravikumarauthor=L.+Funkauthor=B.+C.+Shook&title=Nitrile-containing+pharmaceuticals%3A+efficacious+roles+of+the+nitrile+pharmacophore"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=10.1021%2Fjm100762r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100762r%26sid%3Dliteratum%253Aachs%26aulast%3DFleming%26aufirst%3DF.%2BF.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DRavikumar%26aufirst%3DP.%2BC.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DShook%26aufirst%3DB.%2BC.%26atitle%3DNitrile-containing%2520pharmaceuticals%253A%2520efficacious%2520roles%2520of%2520the%2520nitrile%2520pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D22%26spage%3D7902%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit42b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wheeler, S. E.</span><span> </span><span class="NLM_article-title">Understanding substituent effects in noncovalent interactions involving aromatic rings</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1038</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar300109n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFWgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2013&pages=1029-1038&author=S.+E.+Wheeler&title=Understanding+substituent+effects+in+noncovalent+interactions+involving+aromatic+rings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42bR"><div class="casContent"><span class="casTitleNuber">42b</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding Substituent Effects in Noncovalent Interactions Involving Aromatic Rings</span></div><div class="casAuthors">Wheeler, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1029-1038</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Noncovalent interactions involving arom. rings such as π-stacking, cation/π, and anion/π interactions are central to many areas of modern chem.  Decades of exptl. studies have provided key insights into the impact of substituents on these interactions, leading to the development of simple intuitive models.  However, gas-phase computational studies have raised some doubts about the phys. underpinnings of these widespread models.  In this Account we review our recent efforts to unravel the origin of substituent effects in π-stacking and ion/π interactions through computational studies of model noncovalent dimers.  First, however, we dispel the notion that so-called arom. interactions depend on the aromaticity of the interacting rings by studying model π-stacked dimers in which the aromaticity of one of the monomers can be "switched off".  Somewhat surprisingly, the results show that not only is aromaticity unnecessary for π-stacking interactions, but it actually hinders these interactions to some extent.  Consequently, when thinking about π-stacking interactions, researchers should consider broader classes of planar mols., not just arom. systems.  Conventional models maintain that substituent effects in π-stacking interactions result from changes in the aryl π-system.  This view suggests that π-stacking interactions are maximized when one ring is substituted with electron-withdrawing groups and the other with electron donors.  In contrast to these prevailing models, we have shown that substituent effects in π-stacking interactions can be described in terms of direct, local interactions between the substituents and the nearby vertex of the other arene.  As a result, in polysubstituted π-stacked dimers the substituents operate independently unless they are in each other's local environment.  This means that in π-stacked dimers in which one arene is substituted with electron donors and the other with electron acceptors the interactions will be enhanced only to the extent provided by each substituent on its own, unless the substituents on opposing rings are in close proximity.  Overall, this local, direct interaction model predicts that substituent effects in π-stacking interactions will be additive and transferable and will also depend on the relative position of substituents on opposing rings.  For cation/π and anion/π interactions, similar π-resonance-based models pervade the literature.  Again, computational results indicate that substituent effects in model ion/π complexes can be described primarily in terms of direct interactions between the ion and the substituent.  Changes in the aryl π-system do not significantly affect these interactions.  We also present a simple electrostatic model that further demonstrates this effect and suggests that the dominant interaction for simple substituents is the interaction of the charged ion with the local dipole assocd. with the substituents.  Finally, we discuss substituent effects in electrostatic potentials (ESPs), which are widely used in discussions of noncovalent interactions.  In the past, widespread misconceptions have confused the relationship between changes in ESPs and local changes in the electron d.  We have shown that computed ESP plots of diverse substituted arenes can be reproduced without altering the aryl π-d.  This is because substituent-induced changes in the ESP above the center of aryl rings result primarily from through-space effects of substituents rather than through changes in the distribution of the π-electron d.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCxWKVlXTL2LVg90H21EOLACvtfcHk0lj1ANzwv8C9Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFWgu7k%253D&md5=045fc22890c76cf01d324cfcc2e44760</span></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=10.1021%2Far300109n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far300109n%26sid%3Dliteratum%253Aachs%26aulast%3DWheeler%26aufirst%3DS.%2BE.%26atitle%3DUnderstanding%2520substituent%2520effects%2520in%2520noncovalent%2520interactions%2520involving%2520aromatic%2520rings%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2013%26volume%3D46%26spage%3D1029%26epage%3D1038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Yedidi, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fyvie, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garimella, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wingfield, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuya, H.</span><span> </span><span class="NLM_article-title">P2′ benzene carboxylic acid moiety is associated with decrease in cellular uptake: evaluation of novel nonpeptidic HIV-1 protease inhibitors containing P2 bis-tetrahydrofuran moiety</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">4920</span><span class="NLM_x">–</span> <span class="NLM_lpage">4927</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=4920-4927&issue=10&author=R.+S.+Yedidiauthor=K.+Maedaauthor=W.+S.+Fyvieauthor=M.+Steffeyauthor=D.+A.+Davisauthor=I.+Palmerauthor=M.+Aokiauthor=J.+D.+Kaufmanauthor=S.+J.+Stahlauthor=H.+Garimellaauthor=D.+Dasauthor=P.+T.+Wingfieldauthor=A.+K.+Ghoshauthor=H.+Mitsuya&title=P2%E2%80%B2+benzene+carboxylic+acid+moiety+is+associated+with+decrease+in+cellular+uptake%3A+evaluation+of+novel+nonpeptidic+HIV-1+protease+inhibitors+containing+P2+bis-tetrahydrofuran+moiety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYedidi%26aufirst%3DR.%2BS.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DFyvie%26aufirst%3DW.%2BS.%26aulast%3DSteffey%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DD.%2BA.%26aulast%3DPalmer%26aufirst%3DI.%26aulast%3DAoki%26aufirst%3DM.%26aulast%3DKaufman%26aufirst%3DJ.%2BD.%26aulast%3DStahl%26aufirst%3DS.%2BJ.%26aulast%3DGarimella%26aufirst%3DH.%26aulast%3DDas%26aufirst%3DD.%26aulast%3DWingfield%26aufirst%3DP.%2BT.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DMitsuya%26aufirst%3DH.%26atitle%3DP2%25E2%2580%25B2%2520benzene%2520carboxylic%2520acid%2520moiety%2520is%2520associated%2520with%2520decrease%2520in%2520cellular%2520uptake%253A%2520evaluation%2520of%2520novel%2520nonpeptidic%2520HIV-1%2520protease%2520inhibitors%2520containing%2520P2%2520bis-tetrahydrofuran%2520moiety%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26issue%3D10%26spage%3D4920%26epage%3D4927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Han, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cliff Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, D. A.</span><span> </span><span class="NLM_article-title">Transporter studies with the 3-<i>O</i>-sulfate conjugate of 17α-ethinylestradiol: human liver drug transporters</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1072</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1072-82&issue=7&author=Y.+Hanauthor=D.+Buslerauthor=Y.+Hongauthor=Y.+Tianauthor=C.+Cliff+Chenauthor=D.+A.+Rodrigues&title=Transporter+studies+with+the+3-O-sulfate+conjugate+of+17%CE%B1-ethinylestradiol%3A+human+liver+drug+transporters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DY.%26aulast%3DBusler%26aufirst%3DD.%26aulast%3DHong%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DCliff%2BChen%26aufirst%3DC.%26aulast%3DRodrigues%26aufirst%3DD.%2BA.%26atitle%3DTransporter%2520studies%2520with%2520the%25203-O-sulfate%2520conjugate%2520of%252017%25CE%25B1-ethinylestradiol%253A%2520human%2520liver%2520drug%2520transporters%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26issue%3D7%26spage%3D1072%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit44b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">Hepatocyte uptake experiments were performed according to the silicone oil layer method (ref <a onclick="showRef(event, 'cit44a'); return false;" href="javascript:void(0);" class="ref cit44a">44a</a>). Fresh rat hepatocytes were isolated from SD rats. Fresh dog and cryopreserved human hepatocytes were purchased from Cellzdirect (Durham, NC) and In Vitro Technologies (Baltimore, MD), respectively. In brief, hepatocyte uptake was initiated by adding a solution of [3H]BMS-605339 to cell suspensions (1 mL, 2 ×10<sup>6</sup> cells/mL) that had been preincubated at 37 °C for 3 min in Krebs–Henseleit buffer. At 20 s and 1 min, 200 μL aliquots of each cell suspension were placed in centrifuge tubes containing 50 μL of 3 M KOH and were covered by 100 μL of a mixture of silicone/mineral oil (density, 1.015). The samples were then centrifuged to sediment the hepatocytes into the 3 M KOH layer, and both cell and medium radioactivity was determined in a liquid scintillation spectrophotometer. To evaluate if BMS-605339 uptake is energy-dependent, ice-cold cells were preincubated at 4 °C for 3 min and uptake determinations performed as described for the 37 °C experiments. To obtain <i>K</i><sub>m</sub> values for hepatocytic uptake of [<sup>3</sup>H]BMS-605339, the uptake was measured at different concentrations of [<sup>3</sup>H]BMS-605339 (0.5–250 μM).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hepatocyte+uptake+experiments+were+performed+according+to+the+silicone+oil+layer+method+%28ref+44a%29.+Fresh+rat+hepatocytes+were+isolated+from+SD+rats.+Fresh+dog+and+cryopreserved+human+hepatocytes+were+purchased+from+Cellzdirect+%28Durham%2C+NC%29+and+In+Vitro+Technologies+%28Baltimore%2C+MD%29%2C+respectively.+In+brief%2C+hepatocyte+uptake+was+initiated+by+adding+a+solution+of+%5B3H%5DBMS-605339+to+cell+suspensions+%281+mL%2C+2+%C3%97106+cells%2FmL%29+that+had+been+preincubated+at+37+%C2%B0C+for+3+min+in+Krebs%E2%80%93Henseleit+buffer.+At+20+s+and+1+min%2C+200+%CE%BCL+aliquots+of+each+cell+suspension+were+placed+in+centrifuge+tubes+containing+50+%CE%BCL+of+3+M+KOH+and+were+covered+by+100+%CE%BCL+of+a+mixture+of+silicone%2Fmineral+oil+%28density%2C+1.015%29.+The+samples+were+then+centrifuged+to+sediment+the+hepatocytes+into+the+3+M+KOH+layer%2C+and+both+cell+and+medium+radioactivity+was+determined+in+a+liquid+scintillation+spectrophotometer.+To+evaluate+if+BMS-605339+uptake+is+energy-dependent%2C+ice-cold+cells+were+preincubated+at+4+%C2%B0C+for+3+min+and+uptake+determinations+performed+as+described+for+the+37+%C2%B0C+experiments.+To+obtain+Km+values+for+hepatocytic+uptake+of+%5B3H%5DBMS-605339%2C+the+uptake+was+measured+at+different+concentrations+of+%5B3H%5DBMS-605339+%280.5%E2%80%93250+%CE%BCM%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Wang, Z. A.; Sun, L.-Q.; Sit, S.-Y.; Sin, N.; Scola, P. M.; Hewawasam, P.; Good, A. C.; Chen, Y.; Campbell, J. A.</span><span> </span><span class="NLM_article-title">Preparation of peptides as hepatitis C virus inhibitors</span>. World Patent Application WO-2003/099274 A1, December 4,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=Z.+A.+Wang&author=L.-Q.+Sun&author=S.-Y.+Sit&author=N.+Sin&author=P.+M.+Scola&author=P.+Hewawasam&author=A.+C.+Good&author=Y.+Chen&author=J.+A.+Campbell&title=Preparation+of+peptides+as+hepatitis+C+virus+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%2BA.%26atitle%3DPreparation%2520of%2520peptides%2520as%2520hepatitis%2520C%2520virus%2520inhibitors%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Briet, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookes, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davenport, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, F. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabin, V.</span><span> </span><span class="NLM_article-title">Synthesis of novel substituted isoquinolones</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5761</span><span class="NLM_x">–</span> <span class="NLM_lpage">5766</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=5761-5766&author=N.+Brietauthor=M.+H.+Brookesauthor=R.+J.+Davenportauthor=F.+C.+A.+Galvinauthor=P.+J.+Gilbertauthor=S.+R.+Mackauthor=V.+Sabin&title=Synthesis+of+novel+substituted+isoquinolones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBriet%26aufirst%3DN.%26aulast%3DBrookes%26aufirst%3DM.%2BH.%26aulast%3DDavenport%26aufirst%3DR.%2BJ.%26aulast%3DGalvin%26aufirst%3DF.%2BC.%2BA.%26aulast%3DGilbert%26aufirst%3DP.%2BJ.%26aulast%3DMack%26aufirst%3DS.%2BR.%26aulast%3DSabin%26aufirst%3DV.%26atitle%3DSynthesis%2520of%2520novel%2520substituted%2520isoquinolones%26jtitle%3DTetrahedron%26date%3D2002%26volume%3D58%26spage%3D5761%26epage%3D5766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2267</span><span class="NLM_x">–</span> <span class="NLM_lpage">2270</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=2267-2270&author=M.+Llinas-Brunetauthor=M.+Baileyauthor=G.+Fazalauthor=E.+Ghiroauthor=V.+Gorysauthor=S.+Gouletauthor=T.+Halmosauthor=R.+Mauriceauthor=M.+Poirierauthor=M.-A.+Poupartauthor=J.+Rancourtauthor=D.+Thibeaultauthor=D.+Wernicauthor=D.+Lamarre&title=Highly+potent+and+selective+peptide-based+inhibitors+of+the+hepatitis+C+virus+serine+protease%3A+towards+smaller+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DFazal%26aufirst%3DG.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DMaurice%26aufirst%3DR.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DWernic%26aufirst%3DD.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DHighly%2520potent%2520and%2520selective%2520peptide-based%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520serine%2520protease%253A%2520towards%2520smaller%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D2267%26epage%3D2270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scola, P. M.</span><span> </span><span class="NLM_article-title">A facile synthesis of 1-substituted cyclopropylsulfonamides</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">728</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=725-728&author=J.+Liauthor=D.+Smithauthor=H.+S.+Wongauthor=J.+A.+Campbellauthor=N.+A.+Meanwellauthor=P.+M.+Scola&title=A+facile+synthesis+of+1-substituted+cyclopropylsulfonamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DWong%26aufirst%3DH.%2BS.%26aulast%3DCampbell%26aufirst%3DJ.%2BA.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DScola%26aufirst%3DP.%2BM.%26atitle%3DA%2520facile%2520synthesis%2520of%25201-substituted%2520cyclopropylsulfonamides%26jtitle%3DSynlett%26date%3D2006%26spage%3D725%26epage%3D728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="note"><p class="first last">Crystal structure data (CCDC 984481) has been deposited to Cambridge Structure Database.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">McPhee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheaffer, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friborg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaniewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosure, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scola, P.</span><span> </span><span class="NLM_article-title">Preclinical profile and characterization of the hepatitis C virus NS3 protease inhibitor asunaprevir (BMS-650032)</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5387</span><span class="NLM_x">–</span> <span class="NLM_lpage">5396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=5387-5396&author=F.+McPheeauthor=A.+K.+Sheafferauthor=J.+Friborgauthor=D.+Hernandezauthor=P.+Falkauthor=G.+Zhaiauthor=S.+Levineauthor=S.+Chaniewskiauthor=F.+Yuauthor=D.+Barryauthor=C.+Chenauthor=M.+S.+Leeauthor=K.+Mosureauthor=L.-Q.+Sunauthor=M.+Sinzauthor=N.+A.+Meanwellauthor=R.+J.+Colonnoauthor=J.+Knipeauthor=P.+Scola&title=Preclinical+profile+and+characterization+of+the+hepatitis+C+virus+NS3+protease+inhibitor+asunaprevir+%28BMS-650032%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DSheaffer%26aufirst%3DA.%2BK.%26aulast%3DFriborg%26aufirst%3DJ.%26aulast%3DHernandez%26aufirst%3DD.%26aulast%3DFalk%26aufirst%3DP.%26aulast%3DZhai%26aufirst%3DG.%26aulast%3DLevine%26aufirst%3DS.%26aulast%3DChaniewski%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DBarry%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DSun%26aufirst%3DL.-Q.%26aulast%3DSinz%26aufirst%3DM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DKnipe%26aufirst%3DJ.%26aulast%3DScola%26aufirst%3DP.%26atitle%3DPreclinical%2520profile%2520and%2520characterization%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitor%2520asunaprevir%2520%2528BMS-650032%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D5387%26epage%3D5396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Lok, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martorell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everson, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghalib, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reindollar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustgi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wind-Rotolo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrova, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquinelli, C.</span><span> </span><span class="NLM_article-title">Preliminary study of two antiviral agents for hepatitis C genotype 1</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">366</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.1056%2FNEJMoa1104430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=22256805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1yltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2012&pages=216-224&author=A.+S.+Lokauthor=D.+F.+Gardinerauthor=E.+Lawitzauthor=C.+Martorellauthor=G.+T.+Eversonauthor=R.+Ghalibauthor=R.+Reindollarauthor=V.+Rustgiauthor=F.+McPheeauthor=M.+Wind-Rotoloauthor=A.+Perssonauthor=K.+Zhuauthor=D.+I.+Dimitrovaauthor=T.+Eleyauthor=T.+Guoauthor=D.+M.+Graselaauthor=C.+Pasquinelli&title=Preliminary+study+of+two+antiviral+agents+for+hepatitis+C+genotype+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Preliminary study of two antiviral agents for hepatitis C genotype 1</span></div><div class="casAuthors">Lok, Anna S.; Gardiner, David F.; Lawitz, Eric; Martorell, Claudia; Everson, Gregory T.; Ghalib, Reem; Reindollar, Robert; Rustgi, Vinod; McPhee, Fiona; Wind-Rotolo, Megan; Persson, Anna; Zhu, Kurt; Dimitrova, Dessislava I.; Eley, Timothy; Guo, Tong; Grasela, Dennis M.; Pasquinelli, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">216-224</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Patients with chronic hepatitis C virus (HCV) infection who have not had a response to therapy with peginterferon and ribavirin may benefit from the addn. of multiple direct-acting antiviral agents to their treatment regimen.  METHODS: This open-label, phase 2a study included an exploratory cohort of 21 patients with chronic HCV genotype 1 infection who had not had a response to previous therapy (i.e., had not had ≥2 log10 decline in HCV RNA after ≥12 wk of treatment with peginterferon and ribavirin).  We randomly assigned patients to receive the NS5A replication complex inhibitor daclatasvir (60 mg once daily) and the NS3 protease inhibitor asunaprevir (600 mg twice daily) alone (group A, 11 patients) or in combination with peginterferon alfa-2a and ribavirin (group B, 10 patients) for 24 wk.  The primary end point was the percentage of patients with a sustained virol. response 12 wk after the end of the treatment period.  RESULTS: A total of 4 patients in group A (36%; 2 of 9 with HCV genotype la and 2 of 2 with genotype lb) had a sustained virol. response at 12 wk after treatment and also at 24 wk after treatment.  Six patients (all with HCV genotype la) had viral breakthrough while receiving therapy, and resistance mutations to both antiviral agents were found in all cases; 1 patient had a viral response at the end of treatment but had a relapse after the treatment period.  All 10 patients in group B had a sustained virol. response at 12 wk after treatment, and 9 had a sustained virol. response at 24 wk after treatment Diarrhea was the most common adverse event in both groups.  Six patients had transient elevations of alanine aminotransferase levels to more than 3 times the upper limit of the normal range.  CONCLUSIONS: This preliminary study involving patients with HCV genotype 1 infection who had not had a response to prior therapy showed that a sustained virol. response can be achieved with two direct-acting antiviral agents only.  In addn., a high rate of sustained virol. response was achieved when the two direct-acting antiviral agents were combined with peginterferon alfa-2a and ribavirin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiY7QiDziiRbVg90H21EOLACvtfcHk0ljUa5JDuug1Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1yltrw%253D&md5=5b986bac6ea53144898c91e8e2eaf5bc</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1104430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1104430%26sid%3Dliteratum%253Aachs%26aulast%3DLok%26aufirst%3DA.%2BS.%26aulast%3DGardiner%26aufirst%3DD.%2BF.%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DMartorell%26aufirst%3DC.%26aulast%3DEverson%26aufirst%3DG.%2BT.%26aulast%3DGhalib%26aufirst%3DR.%26aulast%3DReindollar%26aufirst%3DR.%26aulast%3DRustgi%26aufirst%3DV.%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DWind-Rotolo%26aufirst%3DM.%26aulast%3DPersson%26aufirst%3DA.%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DDimitrova%26aufirst%3DD.%2BI.%26aulast%3DEley%26aufirst%3DT.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DPasquinelli%26aufirst%3DC.%26atitle%3DPreliminary%2520study%2520of%2520two%2520antiviral%2520agents%2520for%2520hepatitis%2520C%2520genotype%25201%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D366%26spage%3D216%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':[],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27a','cit27b','cit27c'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31a','cit31b','cit31c','cit31d','cit31e','cit31f','cit31g','cit31h','cit31i','cit31j','cit31k','cit31l','cit31m','cit31n','cit31o','cit31p','cit31q','cit31r','cit31s','cit31t','cit31u','cit31v','cit31w','cit31x','cit31y','cit31z','cit31aa','cit31ab','cit31ac','cit31ad','cit31ae','cit31af'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42a','cit42b'],'ref43':['cit43'],'ref44':['cit44a','cit44b'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':[],'ref50':['cit50'],'ref51':['cit51']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 47 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Li-Qiang Sun, Eric Mull, Stanley D’Andrea, Barbara Zheng, Sheldon Hiebert, Eric Gillis, Michael Bowsher, Sarkunam Kandhasamy, Venkata Rao Baratam, Sunitha Puttaswamy, Nagalakshmi Pulicharla, Sureshbabu Vishwakrishnan, Subba Reddy, Ravi Trivedi, Sarmistha Sinha, Sankar Sivaprasad, Abhijith Rao, Salil Desai, Kaushik Ghosh, Rushith Anumula, Amit Kumar, Ramkumar Rajamani, Ying-Kai Wang, Hua Fang, Arvind Mathur, Richard Rampulla, Tatyana A. Zvyaga, Kathy Mosure, Susan Jenkins, Paul Falk, Debarati M. Tagore, Chaoqun Chen, Kishore Rendunchintala, James Loy, Nicholas A. Meanwell, Fiona McPhee, <span class="NLM_string-name hlFld-ContribAuthor">Paul M. Scola</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14740-14760. <a href="https://doi.org/10.1021/acs.jmedchem.0c01296" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01296</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01296%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BBMS-986144%25252C%252Ba%252BThird-Generation%25252C%252BPan-Genotype%252BNS3%25252F4A%252BProtease%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DSun%26aufirst%3DLi-Qiang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D24072020%26date%3D23112020%26volume%3D63%26issue%3D23%26spage%3D14740%26epage%3D14760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nicholas A. Meanwell, Gunda I. Georg, <span class="NLM_string-name hlFld-ContribAuthor">Shaomeng Wang</span>. </span><span class="cited-content_cbyCitation_article-title">The 2020 Nobel Prize in Physiology or Medicine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13197-13204. <a href="https://doi.org/10.1021/acs.jmedchem.0c01877" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01877</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01877%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252B2020%252BNobel%252BPrize%252Bin%252BPhysiology%252Bor%252BMedicine%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2020%26date%3D2020%26date%3D05112020%26volume%3D63%26issue%3D22%26spage%3D13197%26epage%3D13204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wan-Na  Chen</span> and <span class="hlFld-ContribAuthor ">Gottfried  Otting</span>  . </span><span class="cited-content_cbyCitation_article-title">Using tert-Butyl Groups in a Ligand To Identify Its Binding Site on a Protein. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (2)
                                     , 109-113. <a href="https://doi.org/10.1021/acsmedchemlett.7b00464" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00464</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00464%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DUsing%252Btert-Butyl%252BGroups%252Bin%252Ba%252BLigand%252BTo%252BIdentify%252BIts%252BBinding%252BSite%252Bon%252Ba%252BProtein%26aulast%3DChen%26aufirst%3DWan-Na%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D10112017%26date%3D12012018%26date%3D17012018%26date%3D08022018%26date%3D12012018%26volume%3D9%26issue%3D2%26spage%3D109%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Zheng</span>, <span class="hlFld-ContribAuthor ">Stanley V.  D’Andrea</span>, <span class="hlFld-ContribAuthor ">Li-Qiang  Sun</span>, <span class="hlFld-ContribAuthor ">Alan Xiangdong  Wang</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Peter  Hrnciar</span>, <span class="hlFld-ContribAuthor ">Jacques  Friborg</span>, <span class="hlFld-ContribAuthor ">Paul  Falk</span>, <span class="hlFld-ContribAuthor ">Dennis  Hernandez</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Amy K.  Sheaffer</span>, <span class="hlFld-ContribAuthor ">Jay O.  Knipe</span>, <span class="hlFld-ContribAuthor ">Kathy  Mosure</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Andrew C.  Good</span>, <span class="hlFld-ContribAuthor ">Kevin  Kish</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Tredup</span>, <span class="hlFld-ContribAuthor ">Herbert E.  Klei</span>, <span class="hlFld-ContribAuthor ">Manjula  Paruchuri</span>, <span class="hlFld-ContribAuthor ">Alicia  Ng</span>, <span class="hlFld-ContribAuthor ">Qi  Gao</span>, <span class="hlFld-ContribAuthor ">Richard A.  Rampulla</span>, <span class="hlFld-ContribAuthor ">Arvind  Mathur</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Fiona  McPhee</span>, and <span class="hlFld-ContribAuthor ">Paul M.  Scola</span>  . </span><span class="cited-content_cbyCitation_article-title">Potent Inhibitors of Hepatitis C Virus NS3 Protease: Employment of a Difluoromethyl Group as a Hydrogen-Bond Donor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (2)
                                     , 143-148. <a href="https://doi.org/10.1021/acsmedchemlett.7b00503" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00503</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00503%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPotent%252BInhibitors%252Bof%252BHepatitis%252BC%252BVirus%252BNS3%252BProtease%25253A%252BEmployment%252Bof%252Ba%252BDifluoromethyl%252BGroup%252Bas%252Ba%252BHydrogen-Bond%252BDonor%26aulast%3DZheng%26aufirst%3DBarbara%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D04122017%26date%3D19012018%26date%3D24012018%26date%3D08022018%26date%3D19012018%26volume%3D9%26issue%3D2%26spage%3D143%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark A. T.  Blaskovich</span>  . </span><span class="cited-content_cbyCitation_article-title">Unusual Amino Acids in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (24)
                                     , 10807-10836. <a href="https://doi.org/10.1021/acs.jmedchem.6b00319" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00319%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUnusual%252BAmino%252BAcids%252Bin%252BMedicinal%252BChemistry%26aulast%3DBlaskovich%26aufirst%3DMark%2BA.%2BT.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D02032016%26date%3D30092016%26date%3D22122016%26date%3D02092016%26volume%3D59%26issue%3D24%26spage%3D10807%26epage%3D10836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tanaji T.  Talele</span>  . </span><span class="cited-content_cbyCitation_article-title">The “Cyclopropyl Fragment” is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (19)
                                     , 8712-8756. <a href="https://doi.org/10.1021/acs.jmedchem.6b00472" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00472%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252B%2525E2%252580%25259CCyclopropyl%252BFragment%2525E2%252580%25259D%252Bis%252Ba%252BVersatile%252BPlayer%252Bthat%252BFrequently%252BAppears%252Bin%252BPreclinical%25252FClinical%252BDrug%252BMolecules%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D30032016%26date%3D30062016%26date%3D13102016%26date%3D14062016%26volume%3D59%26issue%3D19%26spage%3D8712%26epage%3D8756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Qiang  Sun</span>, <span class="hlFld-ContribAuthor ">Eric  Mull</span>, <span class="hlFld-ContribAuthor ">Barbara  Zheng</span>, <span class="hlFld-ContribAuthor ">Stanley  D’Andrea</span>, <span class="hlFld-ContribAuthor ">Qian  Zhao</span>, <span class="hlFld-ContribAuthor ">Alan Xiangdong  Wang</span>, <span class="hlFld-ContribAuthor ">Ny  Sin</span>, <span class="hlFld-ContribAuthor ">Brian L.  Venables</span>, <span class="hlFld-ContribAuthor ">Sing-Yuen  Sit</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Anthony  Cocuzza</span>, <span class="hlFld-ContribAuthor ">Donna M.  Bilder</span>, <span class="hlFld-ContribAuthor ">Arvind  Mathur</span>, <span class="hlFld-ContribAuthor ">Richard  Rampulla</span>, <span class="hlFld-ContribAuthor ">Bang-Chi  Chen</span>, <span class="hlFld-ContribAuthor ">Theerthagiri  Palani</span>, <span class="hlFld-ContribAuthor ">Sivakumar  Ganesan</span>, <span class="hlFld-ContribAuthor ">Pirama Nayagam  Arunachalam</span>, <span class="hlFld-ContribAuthor ">Paul  Falk</span>, <span class="hlFld-ContribAuthor ">Steven  Levine</span>, <span class="hlFld-ContribAuthor ">Chaoqun  Chen</span>, <span class="hlFld-ContribAuthor ">Jacques  Friborg</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Dennis  Hernandez</span>, <span class="hlFld-ContribAuthor ">Amy K.  Sheaffer</span>, <span class="hlFld-ContribAuthor ">Jay O.  Knipe</span>, <span class="hlFld-ContribAuthor ">Yong-Hae  Han</span>, <span class="hlFld-ContribAuthor ">Richard  Schartman</span>, <span class="hlFld-ContribAuthor ">Maria  Donoso</span>, <span class="hlFld-ContribAuthor ">Kathy  Mosure</span>, <span class="hlFld-ContribAuthor ">Michael W.  Sinz</span>, <span class="hlFld-ContribAuthor ">Tatyana  Zvyaga</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Kevin  Kish</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Tredup</span>, <span class="hlFld-ContribAuthor ">Herbert E.  Klei</span>, <span class="hlFld-ContribAuthor ">Qi  Gao</span>, <span class="hlFld-ContribAuthor ">Alicia  Ng</span>, <span class="hlFld-ContribAuthor ">Luciano  Mueller</span>, <span class="hlFld-ContribAuthor ">Dennis M.  Grasela</span>, <span class="hlFld-ContribAuthor ">Stephen  Adams</span>, <span class="hlFld-ContribAuthor ">James  Loy</span>, <span class="hlFld-ContribAuthor ">Paul C.  Levesque</span>, <span class="hlFld-ContribAuthor ">Huabin  Sun</span>, <span class="hlFld-ContribAuthor ">Hong  Shi</span>, <span class="hlFld-ContribAuthor ">Lucy  Sun</span>, <span class="hlFld-ContribAuthor ">William  Warner</span>, <span class="hlFld-ContribAuthor ">Danshi  Li</span>, <span class="hlFld-ContribAuthor ">Jialong  Zhu</span>, <span class="hlFld-ContribAuthor ">Ying-Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Hua  Fang</span>, <span class="hlFld-ContribAuthor ">Mark I.  Cockett</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Fiona  McPhee</span>, and <span class="hlFld-ContribAuthor ">Paul M.  Scola</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily Dosing. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (17)
                                     , 8042-8060. <a href="https://doi.org/10.1021/acs.jmedchem.6b00821" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00821%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252BAcyclic%25252C%252BTripeptidic%25252C%252BAcyl%252BSulfonamide%252BInhibitor%252Bof%252BHepatitis%252BC%252BVirus%252BNS3%252BProtease%252Bas%252Ba%252BBack-up%252Bto%252BAsunaprevir%252Bwith%252Bthe%252BPotential%252Bfor%252BOnce-Daily%252BDosing%26aulast%3DSun%26aufirst%3DLi-Qiang%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D01062016%26date%3D26082016%26date%3D08092016%26volume%3D59%26issue%3D17%26spage%3D8042%26epage%3D8060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">2015 Philip S. Portoghese Medicinal Chemistry Lectureship. Curing Hepatitis C Virus Infection with Direct-Acting Antiviral Agents: The Arc of a Medicinal Chemistry Triumph. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (16)
                                     , 7311-7351. <a href="https://doi.org/10.1021/acs.jmedchem.6b00915" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00915</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00915%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2015%252BPhilip%252BS.%252BPortoghese%252BMedicinal%252BChemistry%252BLectureship.%252BCuring%252BHepatitis%252BC%252BVirus%252BInfection%252Bwith%252BDirect-Acting%252BAntiviral%252BAgents%25253A%252BThe%252BArc%252Bof%252Ba%252BMedicinal%252BChemistry%252BTriumph%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D18062016%26date%3D08082016%26date%3D25082016%26volume%3D59%26issue%3D16%26spage%3D7311%26epage%3D7351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Gutiérrez</span>, <span class="hlFld-ContribAuthor ">Anna  Coppola</span>, <span class="hlFld-ContribAuthor ">David  Sucunza</span>, <span class="hlFld-ContribAuthor ">Carolina  Burgos</span>, and <span class="hlFld-ContribAuthor ">Juan J.  Vaquero</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of 1-Substituted Isoquinolines by Heterocyclization of TosMIC Derivatives: Total Synthesis of Cassiarin A. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2016,</strong> <em>18 </em>
                                    (14)
                                     , 3378-3381. <a href="https://doi.org/10.1021/acs.orglett.6b01521" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b01521</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b01521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b01521%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Bof%252B1-Substituted%252BIsoquinolines%252Bby%252BHeterocyclization%252Bof%252BTosMIC%252BDerivatives%25253A%252BTotal%252BSynthesis%252Bof%252BCassiarin%252BA%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DSara%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D26052016%26date%3D28062016%26date%3D15072016%26volume%3D18%26issue%3D14%26spage%3D3378%26epage%3D3381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2016,</strong> <em>29 </em>
                                    (4)
                                     , 564-616. <a href="https://doi.org/10.1021/acs.chemrestox.6b00043" title="DOI URL">https://doi.org/10.1021/acs.chemrestox.6b00043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrestox.6b00043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrestox.6b00043%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DImproving%252BDrug%252BDesign%25253A%252BAn%252BUpdate%252Bon%252BRecent%252BApplications%252Bof%252BEfficiency%252BMetrics%25252C%252BStrategies%252Bfor%252BReplacing%252BProblematic%252BElements%25252C%252Band%252BCompounds%252Bin%252BNontraditional%252BDrug%252BSpace%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D03022016%26date%3D14032016%26date%3D18042016%26volume%3D29%26issue%3D4%26spage%3D564%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santhosh F.  Neelamkavil</span>, <span class="hlFld-ContribAuthor ">Sony  Agrawal</span>, <span class="hlFld-ContribAuthor ">Thomas  Bara</span>, <span class="hlFld-ContribAuthor ">Chad  Bennett</span>, <span class="hlFld-ContribAuthor ">Sathesh  Bhat</span>, <span class="hlFld-ContribAuthor ">Dipshikha  Biswas</span>, <span class="hlFld-ContribAuthor ">Linda  Brockunier</span>, <span class="hlFld-ContribAuthor ">Nicole  Buist</span>, <span class="hlFld-ContribAuthor ">Duane  Burnette</span>, <span class="hlFld-ContribAuthor ">Mark  Cartwright</span>, <span class="hlFld-ContribAuthor ">Samuel  Chackalamannil</span>, <span class="hlFld-ContribAuthor ">Robert  Chase</span>, <span class="hlFld-ContribAuthor ">Mariappan  Chelliah</span>, <span class="hlFld-ContribAuthor ">Austin  Chen</span>, <span class="hlFld-ContribAuthor ">Martin  Clasby</span>, <span class="hlFld-ContribAuthor ">Vincent J.  Colandrea</span>, <span class="hlFld-ContribAuthor ">Ian W.  Davies</span>, <span class="hlFld-ContribAuthor ">Keith  Eagen</span>, <span class="hlFld-ContribAuthor ">Zhuyan  Guo</span>, <span class="hlFld-ContribAuthor ">Yongxin  Han</span>, <span class="hlFld-ContribAuthor ">John  Howe</span>, <span class="hlFld-ContribAuthor ">Charles  Jayne</span>, <span class="hlFld-ContribAuthor ">Hubert  Josien</span>, <span class="hlFld-ContribAuthor ">Stacia  Kargman</span>, <span class="hlFld-ContribAuthor ">Karen  Marcantonio</span>, <span class="hlFld-ContribAuthor ">Shouwu  Miao</span>, <span class="hlFld-ContribAuthor ">Randy  Miller</span>, <span class="hlFld-ContribAuthor ">Andrew  Nolting</span>, <span class="hlFld-ContribAuthor ">Patrick  Pinto</span>, <span class="hlFld-ContribAuthor ">Murali  Rajagopalan</span>, <span class="hlFld-ContribAuthor ">Rebecca T.  Ruck</span>, <span class="hlFld-ContribAuthor ">Unmesh  Shah</span>, <span class="hlFld-ContribAuthor ">Aileen  Soriano</span>, <span class="hlFld-ContribAuthor ">Donald  Sperbeck</span>, <span class="hlFld-ContribAuthor ">Francisco  Velazquez</span>, <span class="hlFld-ContribAuthor ">Jin  Wu</span>, <span class="hlFld-ContribAuthor ">Yan  Xia</span>, and <span class="hlFld-ContribAuthor ">Srikanth  Venkatraman</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of MK-8831, A Novel Spiro-Proline Macrocycle as a Pan-Genotypic HCV-NS3/4a Protease Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (1)
                                     , 111-116. <a href="https://doi.org/10.1021/acsmedchemlett.5b00425" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00425%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BMK-8831%25252C%252BA%252BNovel%252BSpiro-Proline%252BMacrocycle%252Bas%252Ba%252BPan-Genotypic%252BHCV-NS3%25252F4a%252BProtease%252BInhibitor%26aulast%3DNeelamkavil%26aufirst%3DSanthosh%2BF.%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D09112015%26date%3D22122015%26date%3D23122015%26date%3D14012016%26date%3D22122015%26volume%3D7%26issue%3D1%26spage%3D111%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan E.  Gable</span>, <span class="hlFld-ContribAuthor ">Timothy M.  Acker</span>, and <span class="hlFld-ContribAuthor ">Charles S.  Craik</span>  . </span><span class="cited-content_cbyCitation_article-title">Current and Potential Treatments for Ubiquitous but Neglected Herpesvirus Infections. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2014,</strong> <em>114 </em>
                                    (22)
                                     , 11382-11412. <a href="https://doi.org/10.1021/cr500255e" title="DOI URL">https://doi.org/10.1021/cr500255e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr500255e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr500255e%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DCurrent%252Band%252BPotential%252BTreatments%252Bfor%252BUbiquitous%252Bbut%252BNeglected%252BHerpesvirus%252BInfections%26aulast%3DGable%26aufirst%3DJonathan%2BE.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D13052014%26date%3D02102014%26date%3D26112014%26volume%3D114%26issue%3D22%26spage%3D11382%26epage%3D11412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul M.  Scola</span>, <span class="hlFld-ContribAuthor ">Li-Qiang  Sun</span>, <span class="hlFld-ContribAuthor ">Alan Xiangdong  Wang</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Ny  Sin</span>, <span class="hlFld-ContribAuthor ">Brian L.  Venables</span>, <span class="hlFld-ContribAuthor ">Sing-Yuen  Sit</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Anthony  Cocuzza</span>, <span class="hlFld-ContribAuthor ">Donna M.  Bilder</span>, <span class="hlFld-ContribAuthor ">Stanley V.  D’Andrea</span>, <span class="hlFld-ContribAuthor ">Barbara  Zheng</span>, <span class="hlFld-ContribAuthor ">Piyasena  Hewawasam</span>, <span class="hlFld-ContribAuthor ">Yong  Tu</span>, <span class="hlFld-ContribAuthor ">Jacques  Friborg</span>, <span class="hlFld-ContribAuthor ">Paul  Falk</span>, <span class="hlFld-ContribAuthor ">Dennis  Hernandez</span>, <span class="hlFld-ContribAuthor ">Steven  Levine</span>, <span class="hlFld-ContribAuthor ">Chaoqun  Chen</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Amy K.  Sheaffer</span>, <span class="hlFld-ContribAuthor ">Guangzhi  Zhai</span>, <span class="hlFld-ContribAuthor ">Diana  Barry</span>, <span class="hlFld-ContribAuthor ">Jay O.  Knipe</span>, <span class="hlFld-ContribAuthor ">Yong-Hae  Han</span>, <span class="hlFld-ContribAuthor ">Richard  Schartman</span>, <span class="hlFld-ContribAuthor ">Maria  Donoso</span>, <span class="hlFld-ContribAuthor ">Kathy  Mosure</span>, <span class="hlFld-ContribAuthor ">Michael W.  Sinz</span>, <span class="hlFld-ContribAuthor ">Tatyana  Zvyaga</span>, <span class="hlFld-ContribAuthor ">Andrew C.  Good</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Kevin  Kish</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Tredup</span>, <span class="hlFld-ContribAuthor ">Herbert E.  Klei</span>, <span class="hlFld-ContribAuthor ">Qi  Gao</span>, <span class="hlFld-ContribAuthor ">Luciano  Mueller</span>, <span class="hlFld-ContribAuthor ">Richard J.  Colonno</span>, <span class="hlFld-ContribAuthor ">Dennis M.  Grasela</span>, <span class="hlFld-ContribAuthor ">Stephen P.  Adams</span>, <span class="hlFld-ContribAuthor ">James  Loy</span>, <span class="hlFld-ContribAuthor ">Paul C.  Levesque</span>, <span class="hlFld-ContribAuthor ">Huabin  Sun</span>, <span class="hlFld-ContribAuthor ">Hong  Shi</span>, <span class="hlFld-ContribAuthor ">Lucy  Sun</span>, <span class="hlFld-ContribAuthor ">William  Warner</span>, <span class="hlFld-ContribAuthor ">Danshi  Li</span>, <span class="hlFld-ContribAuthor ">Jialong  Zhu</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, and <span class="hlFld-ContribAuthor ">Fiona  McPhee</span>  . </span><span class="cited-content_cbyCitation_article-title">The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 1730-1752. <a href="https://doi.org/10.1021/jm500297k" title="DOI URL">https://doi.org/10.1021/jm500297k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500297k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500297k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252BAsunaprevir%252B%252528BMS-650032%252529%25252C%252BAn%252BOrally%252BEfficacious%252BNS3%252BProtease%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DScola%26aufirst%3DPaul%2BM.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D24022014%26date%3D05032014%26date%3D13032014%26date%3D24022014%26volume%3D57%26issue%3D5%26spage%3D1730%26epage%3D1752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T.  Ghiasi</span>, <span class="hlFld-ContribAuthor ">S.  Ahmadi</span>, <span class="hlFld-ContribAuthor ">E.  Ahmadi</span>, <span class="hlFld-ContribAuthor ">M.R.  Talei Bavil Olyai</span>, <span class="hlFld-ContribAuthor ">Z.  Khodadadi</span>. </span><span class="cited-content_cbyCitation_article-title">The index of ideality of correlation: QSAR studies of hepatitis C virus NS3/4A protease inhibitors using SMILES descriptors. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2021,</strong> <em>32 </em>
                                    (6)
                                     , 495-520. <a href="https://doi.org/10.1080/1062936X.2021.1925344" title="DOI URL">https://doi.org/10.1080/1062936X.2021.1925344</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2021.1925344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2021.1925344%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DThe%252Bindex%252Bof%252Bideality%252Bof%252Bcorrelation%25253A%252BQSAR%252Bstudies%252Bof%252Bhepatitis%252BC%252Bvirus%252BNS3%25252F4A%252Bprotease%252Binhibitors%252Busing%252BSMILES%252Bdescriptors%26aulast%3DGhiasi%26aufirst%3DT.%26date%3D2021%26date%3D2021%26volume%3D32%26issue%3D6%26spage%3D495%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karol R.  Francisco</span>, <span class="hlFld-ContribAuthor ">Carmine  Varricchio</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Paniak</span>, <span class="hlFld-ContribAuthor ">Marisa C.  Kozlowski</span>, <span class="hlFld-ContribAuthor ">Andrea  Brancale</span>, <span class="hlFld-ContribAuthor ">Carlo  Ballatore</span>. </span><span class="cited-content_cbyCitation_article-title">Structure property relationships of N-acylsulfonamides and related bioisosteres. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>218 </em>, 113399. <a href="https://doi.org/10.1016/j.ejmech.2021.113399" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113399</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113399%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%252Bproperty%252Brelationships%252Bof%252BN-acylsulfonamides%252Band%252Brelated%252Bbioisosteres%26aulast%3DFrancisco%26aufirst%3DKarol%2BR.%26date%3D2021%26volume%3D218%26spage%3D113399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">The Design and Application of Bioisosteres in Drug Design. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-81. <a href="https://doi.org/10.1002/0471266949.bmc259" title="DOI URL">https://doi.org/10.1002/0471266949.bmc259</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc259%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDesign%252Band%252BApplication%252Bof%252BBioisosteres%252Bin%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D81%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad Usman  Ashraf</span>, <span class="hlFld-ContribAuthor ">Kanzal  Iman</span>, <span class="hlFld-ContribAuthor ">Muhammad Farhan  Khalid</span>, <span class="hlFld-ContribAuthor ">Hafiz Muhammad  Salman</span>, <span class="hlFld-ContribAuthor ">Talha  Shafi</span>, <span class="hlFld-ContribAuthor ">Momal  Rafi</span>, <span class="hlFld-ContribAuthor ">Nida  Javaid</span>, <span class="hlFld-ContribAuthor ">Rashid  Hussain</span>, <span class="hlFld-ContribAuthor ">Fayyaz  Ahmad</span>, <span class="hlFld-ContribAuthor ">Syed  Shahzad‐Ul‐Hussan</span>, <span class="hlFld-ContribAuthor ">Shaper  Mirza</span>, <span class="hlFld-ContribAuthor ">Muhammad  Shafiq</span>, <span class="hlFld-ContribAuthor ">Samia  Afzal</span>, <span class="hlFld-ContribAuthor ">Sadia  Hamera</span>, <span class="hlFld-ContribAuthor ">Saima  Anwar</span>, <span class="hlFld-ContribAuthor ">Romena  Qazi</span>, <span class="hlFld-ContribAuthor ">Muhammad  Idrees</span>, <span class="hlFld-ContribAuthor ">Sohail A.  Qureshi</span>, <span class="hlFld-ContribAuthor ">Safee Ullah  Chaudhary</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of efficacious pangenotypic hepatitis C virus therapies. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (3)
                                     , 1091-1136. <a href="https://doi.org/10.1002/med.21554" title="DOI URL">https://doi.org/10.1002/med.21554</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21554%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DEvolution%252Bof%252Befficacious%252Bpangenotypic%252Bhepatitis%252BC%252Bvirus%252Btherapies%26aulast%3DAshraf%26aufirst%3DMuhammad%2BUsman%26date%3D2019%26date%3D2018%26volume%3D39%26issue%3D3%26spage%3D1091%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lidija  Senerovic</span>, <span class="hlFld-ContribAuthor ">Dejan  Opsenica</span>, <span class="hlFld-ContribAuthor ">Ivana  Moric</span>, <span class="hlFld-ContribAuthor ">Ivana  Aleksic</span>, <span class="hlFld-ContribAuthor ">Marta  Spasić</span>, <span class="hlFld-ContribAuthor ">Branka  Vasiljevic</span>. </span><span class="cited-content_cbyCitation_article-title">Quinolines and Quinolones as Antibacterial, Antifungal, Anti-virulence, Antiviral and Anti-parasitic Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 37-69. <a href="https://doi.org/10.1007/5584_2019_428" title="DOI URL">https://doi.org/10.1007/5584_2019_428</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/5584_2019_428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F5584_2019_428%26sid%3Dliteratum%253Aachs%26atitle%3DQuinolines%252Band%252BQuinolones%252Bas%252BAntibacterial%25252C%252BAntifungal%25252C%252BAnti-virulence%25252C%252BAntiviral%252Band%252BAnti-parasitic%252BAgents%26aulast%3DSenerovic%26aufirst%3DLidija%26date%3D2019%26date%3D2019%26spage%3D37%26epage%3D69%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DAdvances%252Bin%252BMicrobiology%25252C%252BInfectious%252BDiseases%252Band%252BPublic%252BHealth%26aulast%3DDonelli%26aufirst%3DGianfranco%26date%3D2020%26volume%3D1282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John A.  McCauley</span>, <span class="hlFld-ContribAuthor ">Michael T.  Rudd</span>. </span><span class="cited-content_cbyCitation_article-title">The Invention of Grazoprevir: An HCV NS3/4a Protease Inhibitor. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 355-387. <a href="https://doi.org/10.1007/7355_2018_41" title="DOI URL">https://doi.org/10.1007/7355_2018_41</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2018_41&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2018_41%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BInvention%252Bof%252BGrazoprevir%25253A%252BAn%252BHCV%252BNS3%25252F4a%252BProtease%252BInhibitor%26aulast%3DMcCauley%26aufirst%3DJohn%2BA.%26date%3D2019%26date%3D2019%26spage%3D355%26epage%3D387%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHCV%25253A%252BThe%252BJourney%252Bfrom%252BDiscovery%252Bto%252Ba%252BCure%26aulast%3DSofia%26aufirst%3DMichael%2BJ.%26date%3D2019%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keith F.  McDaniel</span>, <span class="hlFld-ContribAuthor ">Yi-Yin  Ku</span>, <span class="hlFld-ContribAuthor ">Ying  Sun</span>, <span class="hlFld-ContribAuthor ">Hui-Ju  Chen</span>, <span class="hlFld-ContribAuthor ">Jason  Shanley</span>, <span class="hlFld-ContribAuthor ">Timothy  Middleton</span>, <span class="hlFld-ContribAuthor ">Yat Sun  Or</span>, <span class="hlFld-ContribAuthor ">Dale  Kempf</span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery and Development of HCV NS3 Protease Inhibitor Paritaprevir. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 389-413. <a href="https://doi.org/10.1007/7355_2018_42" title="DOI URL">https://doi.org/10.1007/7355_2018_42</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2018_42&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2018_42%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDiscovery%252Band%252BDevelopment%252Bof%252BHCV%252BNS3%252BProtease%252BInhibitor%252BParitaprevir%26aulast%3DMcDaniel%26aufirst%3DKeith%2BF.%26date%3D2019%26date%3D2019%26spage%3D389%26epage%3D413%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHCV%25253A%252BThe%252BJourney%252Bfrom%252BDiscovery%252Bto%252Ba%252BCure%26aulast%3DSofia%26aufirst%3DMichael%2BJ.%26date%3D2019%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guoqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Jun  Ma</span>, <span class="hlFld-ContribAuthor ">Li-Juan  Jiang</span>, <span class="hlFld-ContribAuthor ">Yonghua  Gai</span>, <span class="hlFld-ContribAuthor ">Jiang  Long</span>, <span class="hlFld-ContribAuthor ">Bin  Wang</span>, <span class="hlFld-ContribAuthor ">Keith F.  McDaniel</span>, <span class="hlFld-ContribAuthor ">Yat Sun  Or</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Development of the Next-Generation HCV NS3 Protease Inhibitor Glecaprevir. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 415-440. <a href="https://doi.org/10.1007/7355_2018_55" title="DOI URL">https://doi.org/10.1007/7355_2018_55</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2018_55&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2018_55%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252Bthe%252BNext-Generation%252BHCV%252BNS3%252BProtease%252BInhibitor%252BGlecaprevir%26aulast%3DWang%26aufirst%3DGuoqiang%26date%3D2019%26date%3D2019%26spage%3D415%26epage%3D440%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHCV%25253A%252BThe%252BJourney%252Bfrom%252BDiscovery%252Bto%252Ba%252BCure%26aulast%3DSofia%26aufirst%3DMichael%2BJ.%26date%3D2019%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Paul M.  Scola</span>, <span class="hlFld-ContribAuthor ">Li-Qiang  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery and Early Clinical Evaluation of the HCV NS3/4A Protease Inhibitor Asunaprevir (BMS-650032). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 317-354. <a href="https://doi.org/10.1007/7355_2018_58" title="DOI URL">https://doi.org/10.1007/7355_2018_58</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2018_58&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2018_58%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDiscovery%252Band%252BEarly%252BClinical%252BEvaluation%252Bof%252Bthe%252BHCV%252BNS3%25252F4A%252BProtease%252BInhibitor%252BAsunaprevir%252B%252528BMS-650032%252529%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2019%26date%3D2019%26spage%3D317%26epage%3D354%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHCV%25253A%252BThe%252BJourney%252Bfrom%252BDiscovery%252Bto%252Ba%252BCure%26aulast%3DSofia%26aufirst%3DMichael%2BJ.%26date%3D2019%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdelrahman  Hamdi</span>, <span class="hlFld-ContribAuthor ">Mathieu Y.  Laurent</span>, <span class="hlFld-ContribAuthor ">Annie  Hémon-Ribaud</span>, <span class="hlFld-ContribAuthor ">Amany S.  Mostafa</span>, <span class="hlFld-ContribAuthor ">Mohammed A.M.  Massoud</span>, <span class="hlFld-ContribAuthor ">Khalid B.  Selim</span>, <span class="hlFld-ContribAuthor ">Gilles  Dujardin</span>. </span><span class="cited-content_cbyCitation_article-title">1,3-Dipolar cycloaddition of vinyloxy quinolines with α-alkoxy carbonyl aldonitrones or cyclic surrogates: A comparative study for an asymmetric access to trans 4-quinolinoxy oxaprolines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2019,</strong> <em>75 </em>
                                    (3)
                                     , 429-440. <a href="https://doi.org/10.1016/j.tet.2018.12.019" title="DOI URL">https://doi.org/10.1016/j.tet.2018.12.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.12.019%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3D1%25252C3-Dipolar%252Bcycloaddition%252Bof%252Bvinyloxy%252Bquinolines%252Bwith%252B%2525CE%2525B1-alkoxy%252Bcarbonyl%252Baldonitrones%252Bor%252Bcyclic%252Bsurrogates%25253A%252BA%252Bcomparative%252Bstudy%252Bfor%252Ban%252Basymmetric%252Baccess%252Bto%252Btrans%252B4-quinolinoxy%252Boxaprolines%26aulast%3DHamdi%26aufirst%3DAbdelrahman%26date%3D2019%26volume%3D75%26issue%3D3%26spage%3D429%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoliang  Zhuo</span>, <span class="hlFld-ContribAuthor ">Ying-Zi  Wang</span>, <span class="hlFld-ContribAuthor ">Kap-Sun  Yeung</span>, <span class="hlFld-ContribAuthor ">Juliang  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiaohua Stella  Huang</span>, <span class="hlFld-ContribAuthor ">Kyle E.  Parcella</span>, <span class="hlFld-ContribAuthor ">Kyle J.  Eastman</span>, <span class="hlFld-ContribAuthor ">John F.  Kadow</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Yue-Zhong  Shu</span>, <span class="hlFld-ContribAuthor ">Benjamin M.  Johnson</span>. </span><span class="cited-content_cbyCitation_article-title">Bioactivation of cyclopropyl rings by P450: an observation encountered during the optimisation of a series of hepatitis C virus NS5B inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Xenobiotica</span><span> <strong>2018,</strong> <em>48 </em>
                                    (12)
                                     , 1215-1226. <a href="https://doi.org/10.1080/00498254.2017.1409915" title="DOI URL">https://doi.org/10.1080/00498254.2017.1409915</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00498254.2017.1409915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00498254.2017.1409915%26sid%3Dliteratum%253Aachs%26jtitle%3DXenobiotica%26atitle%3DBioactivation%252Bof%252Bcyclopropyl%252Brings%252Bby%252BP450%25253A%252Ban%252Bobservation%252Bencountered%252Bduring%252Bthe%252Boptimisation%252Bof%252Ba%252Bseries%252Bof%252Bhepatitis%252BC%252Bvirus%252BNS5B%252Binhibitors%26aulast%3DZhuo%26aufirst%3DXiaoliang%26date%3D2018%26date%3D2017%26volume%3D48%26issue%3D12%26spage%3D1215%26epage%3D1226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">O. A.  Tevs</span>, <span class="hlFld-ContribAuthor ">Ya. V.  Veremeychik</span>, <span class="hlFld-ContribAuthor ">O. A.  Lodochnikova</span>, <span class="hlFld-ContribAuthor ">V. V.  Plemenkov</span>, <span class="hlFld-ContribAuthor ">I. A.  Litvinov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Hybrid Pharmacophores Based on Adducts of N-Sulfinylaniline and Norbornadiene. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of General Chemistry</span><span> <strong>2018,</strong> <em>88 </em>
                                    (11)
                                     , 2438-2441. <a href="https://doi.org/10.1134/S1070363218110300" title="DOI URL">https://doi.org/10.1134/S1070363218110300</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070363218110300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070363218110300%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520General%2520Chemistry%26atitle%3DSynthesis%252Bof%252BHybrid%252BPharmacophores%252BBased%252Bon%252BAdducts%252Bof%252BN-Sulfinylaniline%252Band%252BNorbornadiene%26aulast%3DTevs%26aufirst%3DO.%2BA.%26date%3D2018%26date%3D2018%26volume%3D88%26issue%3D11%26spage%3D2438%26epage%3D2441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian L.  Venables</span>, <span class="hlFld-ContribAuthor ">Ny  Sin</span>, <span class="hlFld-ContribAuthor ">Alan Xiangdong  Wang</span>, <span class="hlFld-ContribAuthor ">Li-Qiang  Sun</span>, <span class="hlFld-ContribAuthor ">Yong  Tu</span>, <span class="hlFld-ContribAuthor ">Dennis  Hernandez</span>, <span class="hlFld-ContribAuthor ">Amy  Sheaffer</span>, <span class="hlFld-ContribAuthor ">Min  Lee</span>, <span class="hlFld-ContribAuthor ">Cindy  Dunaj</span>, <span class="hlFld-ContribAuthor ">Guangzhi  Zhai</span>, <span class="hlFld-ContribAuthor ">Diana  Barry</span>, <span class="hlFld-ContribAuthor ">Jacques  Friborg</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Jay  Knipe</span>, <span class="hlFld-ContribAuthor ">Jason  Sandquist</span>, <span class="hlFld-ContribAuthor ">Paul  Falk</span>, <span class="hlFld-ContribAuthor ">Dawn  Parker</span>, <span class="hlFld-ContribAuthor ">Andrew C.  Good</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Fiona  McPhee</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Paul M.  Scola</span>. </span><span class="cited-content_cbyCitation_article-title">P3-P4 ureas and reverse carbamates as potent HCV NS3 protease inhibitors: Effective transposition of the P4 hydrogen bond donor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (10)
                                     , 1853-1859. <a href="https://doi.org/10.1016/j.bmcl.2018.04.009" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.04.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.04.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DP3-P4%252Bureas%252Band%252Breverse%252Bcarbamates%252Bas%252Bpotent%252BHCV%252BNS3%252Bprotease%252Binhibitors%25253A%252BEffective%252Btransposition%252Bof%252Bthe%252BP4%252Bhydrogen%252Bbond%252Bdonor%26aulast%3DVenables%26aufirst%3DBrian%2BL.%26date%3D2018%26volume%3D28%26issue%3D10%26spage%3D1853%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Bowsher</span>, <span class="hlFld-ContribAuthor ">Sheldon  Hiebert</span>, <span class="hlFld-ContribAuthor ">Rongti  Li</span>, <span class="hlFld-ContribAuthor ">Alan X.  Wang</span>, <span class="hlFld-ContribAuthor ">Jacques  Friborg</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Dennis  Hernandez</span>, <span class="hlFld-ContribAuthor ">Ying-Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Herbert  Klei</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Kathy  Mosure</span>, <span class="hlFld-ContribAuthor ">Jay O.  Knipe</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Fiona  McPhee</span>, <span class="hlFld-ContribAuthor ">Paul M.  Scola</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery and optimization of naphthalene-linked P2-P4 Macrocycles as inhibitors of HCV NS3 protease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (1)
                                     , 43-48. <a href="https://doi.org/10.1016/j.bmcl.2017.11.005" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.11.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.11.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdiscovery%252Band%252Boptimization%252Bof%252Bnaphthalene-linked%252BP2-P4%252BMacrocycles%252Bas%252Binhibitors%252Bof%252BHCV%252BNS3%252Bprotease%26aulast%3DBowsher%26aufirst%3DMichael%26date%3D2018%26volume%3D28%26issue%3D1%26spage%3D43%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandra  Ammazzalorso</span>, <span class="hlFld-ContribAuthor ">Barbara  De Filippis</span>, <span class="hlFld-ContribAuthor ">Letizia  Giampietro</span>, <span class="hlFld-ContribAuthor ">Rosa  Amoroso</span>. </span><span class="cited-content_cbyCitation_article-title">N
              -acylsulfonamides: Synthetic routes and biological potential in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2017,</strong> <em>90 </em>
                                    (6)
                                     , 1094-1105. <a href="https://doi.org/10.1111/cbdd.13043" title="DOI URL">https://doi.org/10.1111/cbdd.13043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13043%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DN%252B-acylsulfonamides%25253A%252BSynthetic%252Broutes%252Band%252Bbiological%252Bpotential%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DAmmazzalorso%26aufirst%3DAlessandra%26date%3D2017%26date%3D2017%26volume%3D90%26issue%3D6%26spage%3D1094%26epage%3D1105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xufeng  Nie</span>, <span class="hlFld-ContribAuthor ">Yachuan  Wang</span>, <span class="hlFld-ContribAuthor ">Lijun  Yang</span>, <span class="hlFld-ContribAuthor ">Zaijun  Yang</span>, <span class="hlFld-ContribAuthor ">Tairan  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">Highly stereoselective synthesis of 1-cyanocyclopropane-carboxamides from 3-substituted-2-cyanoacrylamides with N -tosylhydrazones under metal-free conditions. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (31)
                                     , 3003-3007. <a href="https://doi.org/10.1016/j.tetlet.2017.05.070" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.05.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.05.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.05.070%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DHighly%252Bstereoselective%252Bsynthesis%252Bof%252B1-cyanocyclopropane-carboxamides%252Bfrom%252B3-substituted-2-cyanoacrylamides%252Bwith%252BN%252B-tosylhydrazones%252Bunder%252Bmetal-free%252Bconditions%26aulast%3DNie%26aufirst%3DXufeng%26date%3D2017%26volume%3D58%26issue%3D31%26spage%3D3003%26epage%3D3007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zijian  Qin</span>, <span class="hlFld-ContribAuthor ">Maolin  Wang</span>, <span class="hlFld-ContribAuthor ">Aixia  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR studies of the bioactivity of hepatitis C virus (HCV) NS3/4A protease inhibitors by multiple linear regression (MLR) and support vector machine (SVM). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (13)
                                     , 2931-2938. <a href="https://doi.org/10.1016/j.bmcl.2017.05.001" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.05.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.05.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DQSAR%252Bstudies%252Bof%252Bthe%252Bbioactivity%252Bof%252Bhepatitis%252BC%252Bvirus%252B%252528HCV%252529%252BNS3%25252F4A%252Bprotease%252Binhibitors%252Bby%252Bmultiple%252Blinear%252Bregression%252B%252528MLR%252529%252Band%252Bsupport%252Bvector%252Bmachine%252B%252528SVM%252529%26aulast%3DQin%26aufirst%3DZijian%26date%3D2017%26volume%3D27%26issue%3D13%26spage%3D2931%26epage%3D2938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guangdi  Li</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>. </span><span class="cited-content_cbyCitation_article-title">Current therapy for chronic hepatitis C: The role of direct-acting antivirals. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2017,</strong> <em>142 </em>, 83-122. <a href="https://doi.org/10.1016/j.antiviral.2017.02.014" title="DOI URL">https://doi.org/10.1016/j.antiviral.2017.02.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2017.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2017.02.014%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DCurrent%252Btherapy%252Bfor%252Bchronic%252Bhepatitis%252BC%25253A%252BThe%252Brole%252Bof%252Bdirect-acting%252Bantivirals%26aulast%3DLi%26aufirst%3DGuangdi%26date%3D2017%26volume%3D142%26spage%3D83%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satya  P Gupta</span>. </span><span class="cited-content_cbyCitation_article-title">HCV NS3/4A Protease and its Emerging Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Analytical & Pharmaceutical Research</span><span> <strong>2017,</strong> <em>4 </em>
                                    (4)
                                     <a href="https://doi.org/10.15406/japlr.2017.04.00108" title="DOI URL">https://doi.org/10.15406/japlr.2017.04.00108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15406/japlr.2017.04.00108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15406%2Fjaplr.2017.04.00108%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Analytical%2520%2526%2520Pharmaceutical%2520Research%26atitle%3DHCV%252BNS3%25252F4A%252BProtease%252Band%252Bits%252BEmerging%252BInhibitors%26aulast%3DP%2BGupta%26aufirst%3DSatya%26date%3D2017%26date%3D2017%26volume%3D4%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huiqun  Wang</span>, <span class="hlFld-ContribAuthor ">Chenchen  Guo</span>, <span class="hlFld-ContribAuthor ">Bo-Zhen  Chen</span>, <span class="hlFld-ContribAuthor ">Mingjuan  Ji</span>. </span><span class="cited-content_cbyCitation_article-title">Computational study on the drug resistance mechanism of HCV NS3 protease to BMS-605339. </span><span class="cited-content_cbyCitation_journal-name">Biotechnology and Applied Biochemistry</span><span> <strong>2017,</strong> <em>64 </em>
                                    (2)
                                     , 153-164. <a href="https://doi.org/10.1002/bab.1479" title="DOI URL">https://doi.org/10.1002/bab.1479</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bab.1479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbab.1479%26sid%3Dliteratum%253Aachs%26jtitle%3DBiotechnology%2520and%2520Applied%2520Biochemistry%26atitle%3DComputational%252Bstudy%252Bon%252Bthe%252Bdrug%252Bresistance%252Bmechanism%252Bof%252BHCV%252BNS3%252Bprotease%252Bto%252BBMS-605339%26aulast%3DWang%26aufirst%3DHuiqun%26date%3D2017%26date%3D2016%26volume%3D64%26issue%3D2%26spage%3D153%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Colin R.  Groom</span>, <span class="hlFld-ContribAuthor ">Jason C.  Cole</span>. </span><span class="cited-content_cbyCitation_article-title">The use of small-molecule structures to complement protein–ligand crystal structures in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section D Structural Biology</span><span> <strong>2017,</strong> <em>73 </em>
                                    (3)
                                     , 240-245. <a href="https://doi.org/10.1107/S2059798317000675" title="DOI URL">https://doi.org/10.1107/S2059798317000675</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S2059798317000675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS2059798317000675%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520D%2520Structural%2520Biology%26atitle%3DThe%252Buse%252Bof%252Bsmall-molecule%252Bstructures%252Bto%252Bcomplement%252Bprotein%2525E2%252580%252593ligand%252Bcrystal%252Bstructures%252Bin%252Bdrug%252Bdiscovery%26aulast%3DGroom%26aufirst%3DColin%2BR.%26date%3D2017%26date%3D2017%26volume%3D73%26issue%3D3%26spage%3D240%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alan Xiangdong  Wang</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Qian  Zhao</span>, <span class="hlFld-ContribAuthor ">Li-Qiang  Sun</span>, <span class="hlFld-ContribAuthor ">Jacques  Friborg</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Dennis  Hernandez</span>, <span class="hlFld-ContribAuthor ">Andrew C.  Good</span>, <span class="hlFld-ContribAuthor ">Herbert E.  Klei</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Kathy  Mosure</span>, <span class="hlFld-ContribAuthor ">Jay O.  Knipe</span>, <span class="hlFld-ContribAuthor ">Danshi  Li</span>, <span class="hlFld-ContribAuthor ">Jialong  Zhu</span>, <span class="hlFld-ContribAuthor ">Paul C.  Levesque</span>, <span class="hlFld-ContribAuthor ">Fiona  McPhee</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Paul M.  Scola</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationships of 4-hydroxy-4-biaryl-proline acylsulfonamide tripeptides: A series of potent NS3 protease inhibitors for the treatment of hepatitis C virus. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (3)
                                     , 590-596. <a href="https://doi.org/10.1016/j.bmcl.2016.12.013" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.12.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.12.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-activity%252Brelationships%252Bof%252B4-hydroxy-4-biaryl-proline%252Bacylsulfonamide%252Btripeptides%25253A%252BA%252Bseries%252Bof%252Bpotent%252BNS3%252Bprotease%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bhepatitis%252BC%252Bvirus%26aulast%3DWang%26aufirst%3DAlan%2BXiangdong%26date%3D2017%26volume%3D27%26issue%3D3%26spage%3D590%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C. Nelson  Hayes</span>, <span class="hlFld-ContribAuthor ">Michio  Imamura</span>, <span class="hlFld-ContribAuthor ">Kazuaki  Chayama</span>. </span><span class="cited-content_cbyCitation_article-title">The practical management of chronic hepatitis C infection in Japan - dual therapy of daclatasvir + asunaprevir. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Gastroenterology & Hepatology</span><span> <strong>2017,</strong> <em>11 </em>
                                    (2)
                                     , 103-113. <a href="https://doi.org/10.1080/17474124.2017.1270205" title="DOI URL">https://doi.org/10.1080/17474124.2017.1270205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17474124.2017.1270205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17474124.2017.1270205%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Gastroenterology%2520%2526%2520Hepatology%26atitle%3DThe%252Bpractical%252Bmanagement%252Bof%252Bchronic%252Bhepatitis%252BC%252Binfection%252Bin%252BJapan%252B-%252Bdual%252Btherapy%252Bof%252Bdaclatasvir%252B%25252B%252Basunaprevir%26aulast%3DHayes%26aufirst%3DC.%2BNelson%26date%3D2017%26date%3D2016%26volume%3D11%26issue%3D2%26spage%3D103%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N.A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Direct-Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 553-627. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12406-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12406-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12406-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12406-0%26sid%3Dliteratum%253Aachs%26atitle%3DDirect-Acting%252BAntiviral%252BAgents%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DMeanwell%26aufirst%3DN.A.%26date%3D2017%26spage%3D553%26epage%3D627%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John A  McCauley</span>, <span class="hlFld-ContribAuthor ">Michael T  Rudd</span>. </span><span class="cited-content_cbyCitation_article-title">Hepatitis C virus NS3/4a protease inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Pharmacology</span><span> <strong>2016,</strong> <em>30 </em>, 84-92. <a href="https://doi.org/10.1016/j.coph.2016.07.015" title="DOI URL">https://doi.org/10.1016/j.coph.2016.07.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coph.2016.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coph.2016.07.015%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Pharmacology%26atitle%3DHepatitis%252BC%252Bvirus%252BNS3%25252F4a%252Bprotease%252Binhibitors%26aulast%3DMcCauley%26aufirst%3DJohn%2BA%26date%3D2016%26volume%3D30%26spage%3D84%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">O. A.  Tevs</span>, <span class="hlFld-ContribAuthor ">Ya. V.  Veremeichik</span>, <span class="hlFld-ContribAuthor ">D. N.  Shurpik</span>, <span class="hlFld-ContribAuthor ">O. A.  Lodochnikova</span>, <span class="hlFld-ContribAuthor ">V. V.  Plemenkov</span>. </span><span class="cited-content_cbyCitation_article-title">Acylated benzothiazinesulfoneamides: Synthesis and molecular structure. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of General Chemistry</span><span> <strong>2016,</strong> <em>86 </em>
                                    (8)
                                     , 1850-1853. <a href="https://doi.org/10.1134/S1070363216080120" title="DOI URL">https://doi.org/10.1134/S1070363216080120</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070363216080120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070363216080120%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520General%2520Chemistry%26atitle%3DAcylated%252Bbenzothiazinesulfoneamides%25253A%252BSynthesis%252Band%252Bmolecular%252Bstructure%26aulast%3DTevs%26aufirst%3DO.%2BA.%26date%3D2016%26date%3D2016%26volume%3D86%26issue%3D8%26spage%3D1850%26epage%3D1853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anirban  Sarkar</span>, <span class="hlFld-ContribAuthor ">Sougata  Santra</span>, <span class="hlFld-ContribAuthor ">Shrishnu Kumar  Kundu</span>, <span class="hlFld-ContribAuthor ">Alakananda  Hajra</span>, <span class="hlFld-ContribAuthor ">Grigory V.  Zyryanov</span>, <span class="hlFld-ContribAuthor ">Oleg N.  Chupakhin</span>, <span class="hlFld-ContribAuthor ">Valery N.  Charushin</span>, <span class="hlFld-ContribAuthor ">Adinath  Majee</span>. </span><span class="cited-content_cbyCitation_article-title">A decade update on solvent and catalyst-free neat organic reactions: a step forward towards sustainability. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2016,</strong> <em>18 </em>
                                    (16)
                                     , 4475-4525. <a href="https://doi.org/10.1039/C6GC01279E" title="DOI URL">https://doi.org/10.1039/C6GC01279E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6GC01279E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6GC01279E%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DA%252Bdecade%252Bupdate%252Bon%252Bsolvent%252Band%252Bcatalyst-free%252Bneat%252Borganic%252Breactions%25253A%252Ba%252Bstep%252Bforward%252Btowards%252Bsustainability%26aulast%3DSarkar%26aufirst%3DAnirban%26date%3D2016%26date%3D2016%26volume%3D18%26issue%3D16%26spage%3D4475%26epage%3D4525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nobuhisa  Akamatsu</span>, <span class="hlFld-ContribAuthor ">Yasuhiko  Sugawara</span>, <span class="hlFld-ContribAuthor ">Norihiro  Kokudo</span>. </span><span class="cited-content_cbyCitation_article-title">Asunaprevir (BMS-650032) for the treatment of hepatitis C virus. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Anti-infective Therapy</span><span> <strong>2015,</strong> <em>13 </em>
                                    (11)
                                     , 1307-1317. <a href="https://doi.org/10.1586/14787210.2015.1091724" title="DOI URL">https://doi.org/10.1586/14787210.2015.1091724</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1586/14787210.2015.1091724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1586%2F14787210.2015.1091724%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Anti-infective%2520Therapy%26atitle%3DAsunaprevir%252B%252528BMS-650032%252529%252Bfor%252Bthe%252Btreatment%252Bof%252Bhepatitis%252BC%252Bvirus%26aulast%3DAkamatsu%26aufirst%3DNobuhisa%26date%3D2015%26date%3D2015%26volume%3D13%26issue%3D11%26spage%3D1307%26epage%3D1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathleen W.  Mosure</span>, <span class="hlFld-ContribAuthor ">Jay O.  Knipe</span>, <span class="hlFld-ContribAuthor ">Marc  Browning</span>, <span class="hlFld-ContribAuthor ">Vinod  Arora</span>, <span class="hlFld-ContribAuthor ">Yue-Zhong  Shu</span>, <span class="hlFld-ContribAuthor ">Thomas  Phillip</span>, <span class="hlFld-ContribAuthor ">Fiona  Mcphee</span>, <span class="hlFld-ContribAuthor ">Paul  Scola</span>, <span class="hlFld-ContribAuthor ">Anand  Balakrishnan</span>, <span class="hlFld-ContribAuthor ">Matthew G.  Soars</span>, <span class="hlFld-ContribAuthor ">Kenneth  Santone</span>, <span class="hlFld-ContribAuthor ">Michael  Sinz</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Pharmacokinetics and In Vitro Metabolism of Asunaprevir (BMS-650032), a Potent Hepatitis C Virus NS3 Protease Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical Sciences</span><span> <strong>2015,</strong> <em>104 </em>
                                    (9)
                                     , 2813-2823. <a href="https://doi.org/10.1002/jps.24356" title="DOI URL">https://doi.org/10.1002/jps.24356</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jps.24356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjps.24356%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DPreclinical%252BPharmacokinetics%252Band%252BIn%252BVitro%252BMetabolism%252Bof%252BAsunaprevir%252B%252528BMS-650032%252529%25252C%252Ba%252BPotent%252BHepatitis%252BC%252BVirus%252BNS3%252BProtease%252BInhibitor%26aulast%3DMosure%26aufirst%3DKathleen%2BW.%26date%3D2015%26volume%3D104%26issue%3D9%26spage%3D2813%26epage%3D2823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erik  De Clercq</span>. </span><span class="cited-content_cbyCitation_article-title">Development of antiviral drugs for the treatment of hepatitis C at an accelerating pace. </span><span class="cited-content_cbyCitation_journal-name">Reviews in Medical Virology</span><span> <strong>2015,</strong> <em>25 </em>
                                    (4)
                                     , 254-267. <a href="https://doi.org/10.1002/rmv.1842" title="DOI URL">https://doi.org/10.1002/rmv.1842</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/rmv.1842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Frmv.1842%26sid%3Dliteratum%253Aachs%26jtitle%3DReviews%2520in%2520Medical%2520Virology%26atitle%3DDevelopment%252Bof%252Bantiviral%252Bdrugs%252Bfor%252Bthe%252Btreatment%252Bof%252Bhepatitis%252BC%252Bat%252Ban%252Baccelerating%252Bpace%26aulast%3DDe%2BClercq%26aufirst%3DErik%26date%3D2015%26date%3D2015%26volume%3D25%26issue%3D4%26spage%3D254%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sheng-Shun  Yang</span>, <span class="hlFld-ContribAuthor ">Jia-Horng  Kao</span>. </span><span class="cited-content_cbyCitation_article-title">Asunaprevir-containing regimens for the treatment of hepatitis C virus infection. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Gastroenterology & Hepatology</span><span> <strong>2015,</strong> <em>9 </em>
                                    (1)
                                     , 9-20. <a href="https://doi.org/10.1586/17474124.2014.953930" title="DOI URL">https://doi.org/10.1586/17474124.2014.953930</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1586/17474124.2014.953930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1586%2F17474124.2014.953930%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Gastroenterology%2520%2526%2520Hepatology%26atitle%3DAsunaprevir-containing%252Bregimens%252Bfor%252Bthe%252Btreatment%252Bof%252Bhepatitis%252BC%252Bvirus%252Binfection%26aulast%3DYang%26aufirst%3DSheng-Shun%26date%3D2015%26date%3D2014%26volume%3D9%26issue%3D1%26spage%3D9%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prasad B.  Wakchaure</span>, <span class="hlFld-ContribAuthor ">Sanjay R.  Borhade</span>, <span class="hlFld-ContribAuthor ">Anja  Sandström</span>, <span class="hlFld-ContribAuthor ">Per I.  Arvidsson</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Vinyl- and Aryl-Acyl Sulfonimidamides Through Pd-Catalyzed Carbonylation Using Mo(CO)
              6
              as ex situ CO Source. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>2015 </em>
                                    (1)
                                     , 213-219. <a href="https://doi.org/10.1002/ejoc.201403148" title="DOI URL">https://doi.org/10.1002/ejoc.201403148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201403148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201403148%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BVinyl-%252Band%252BAryl-Acyl%252BSulfonimidamides%252BThrough%252BPd-Catalyzed%252BCarbonylation%252BUsing%252BMo%252528CO%252529%252B6%252Bas%252Bex%252Bsitu%252BCO%252BSource%26aulast%3DWakchaure%26aufirst%3DPrasad%2BB.%26date%3D2015%26date%3D2014%26volume%3D2015%26issue%3D1%26spage%3D213%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tara L  Kieffer</span>, <span class="hlFld-ContribAuthor ">Shelley  George</span>. </span><span class="cited-content_cbyCitation_article-title">Resistance to hepatitis C virus protease inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Virology</span><span> <strong>2014,</strong> <em>8 </em>, 16-21. <a href="https://doi.org/10.1016/j.coviro.2014.04.008" title="DOI URL">https://doi.org/10.1016/j.coviro.2014.04.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coviro.2014.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coviro.2014.04.008%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Virology%26atitle%3DResistance%252Bto%252Bhepatitis%252BC%252Bvirus%252Bprotease%252Binhibitors%26aulast%3DKieffer%26aufirst%3DTara%2BL%26date%3D2014%26volume%3D8%26spage%3D16%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susan  Jenkins</span>, <span class="hlFld-ContribAuthor ">Paul  Scola</span>, <span class="hlFld-ContribAuthor ">Fiona  Mcphee</span>, <span class="hlFld-ContribAuthor ">Jay  Knipe</span>, <span class="hlFld-ContribAuthor ">Christoph  Gesenberg</span>, <span class="hlFld-ContribAuthor ">Michael  Sinz</span>, <span class="hlFld-ContribAuthor ">Vinod  Arora</span>, <span class="hlFld-ContribAuthor ">Gary  Pilcher</span>, <span class="hlFld-ContribAuthor ">Kenneth  Santone</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Pharmacokinetics and In Vitro Metabolism of BMS-605339: A Novel HCV NS3 Protease Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical Sciences</span><span> <strong>2014,</strong> <em>103 </em>
                                    (6)
                                     , 1891-1902. <a href="https://doi.org/10.1002/jps.23959" title="DOI URL">https://doi.org/10.1002/jps.23959</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jps.23959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjps.23959%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DPreclinical%252BPharmacokinetics%252Band%252BIn%252BVitro%252BMetabolism%252Bof%252BBMS-605339%25253A%252BA%252BNovel%252BHCV%252BNS3%252BProtease%252BInhibitor%26aulast%3DJenkins%26aufirst%3DSusan%26date%3D2014%26volume%3D103%26issue%3D6%26spage%3D1891%26epage%3D1902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401840s&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Details of the binding interactions of peptide inhibitor <b>1</b> bound to the NS3/4A complex.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401840s&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Surface of NS3/4A enzyme illustrating the S1 and S1′ subsites.  Close-up of 1 bound to NS3/4A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401840s&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0003.jpeg" id="rightTab-GRAPHIC-d1971e1052-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Model of acylsulfonamide <b>6</b> bound to the NS3/4A protease enzyme. (b) Key interactions between the acylsulfonamide moiety and the NS3 protein. (c) Cyclopropyl moiety bound to the S1′ pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401840s&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A–H) Models of compounds <b>19</b>, <b>22</b>, <b>41</b>, <b>24</b>, and <b>31</b> bound to the active site of HCV NS3/4A protease.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401840s&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0005.jpeg" id="rightTab-GRAPHIC-d1971e1560-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) X-ray cocrystallographic structure of <b>35</b> bound to NS3 Protease. (b) Electrostatic potential maps for analogues <b>35</b>, <b>32</b>, <b>25</b>, and <b>36</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401840s&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Mean reduction in HCV plasma level following single oral doses of <b>35</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401840s&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0008.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of P2–P2* and P1–P1′<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401840s&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EtOC(O)Cl, TEA, acetone, 0 °C; (b) NaN<sub>3</sub>, rt; (c) Ph<sub>2</sub>CH<sub>2</sub>, Bu<sub>3</sub>N, 210 °C, 49% overall for three steps; (d) POCl<sub>3</sub>, reflux, 88%; (e) <i>N</i>-Boc-3-(<i>R</i>)-hydroxy-<span class="smallcaps smallerCapital">l</span>-proline, <i>t</i>-BuOK, DMSO, 10 °C to rt, 100%; (f) CDI, cyclopropanesulfonamide (<b>56</b>), reflux to rt, 100%; (g) TFA, CH<sub>2</sub>Cl<sub>2</sub>, then HCl, ether, 98%.</p></p></figure><figure data-id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0009.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Coupling of Fragments for the Synthesis of <b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401840s&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HATU, Hunig’s base (<i>i</i>-Pr<sub>2</sub>NEt), <b>58</b>, DCM, 0 °C to rt, 64%; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, then HCl, ether, 100%; (c) HATU, Hunig’s base, <i>N</i>-Boc-<i>tert</i>-butyl-<span class="smallcaps smallerCapital">l</span>-glycine (<b>61</b>), DCM, 0 °C to rt, 78%.</p></p></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/medium/jm-2013-01840s_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Single crystal X-ray structure of <b>35</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm401840s/production/images/large/jm-2013-01840s_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401840s&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i78">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05435" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05435" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 51 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Kim, W. R.</span><span> </span><span class="NLM_article-title">Global epidemiology and burden of hepatitis C</span> <span class="citation_source-journal">Microbes Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1219</span><span class="NLM_x">–</span> <span class="NLM_lpage">1225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.1016%2FS1286-4579%2802%2901649-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=12467763" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=1219-1225&author=W.+R.+Kim&title=Global+epidemiology+and+burden+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS1286-4579%2802%2901649-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1286-4579%252802%252901649-0%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DW.%2BR.%26atitle%3DGlobal%2520epidemiology%2520and%2520burden%2520of%2520hepatitis%2520C%26jtitle%3DMicrobes%2520Infect.%26date%3D2002%26volume%3D4%26spage%3D1219%26epage%3D1225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">WHO</span><span> </span><span class="NLM_article-title">Hepatitis C global prevalence (update)</span> <span class="citation_source-journal">Wkly. Epidemiol. Rec.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=10645164" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1999&pages=425-427&author=+WHO&title=Hepatitis+C+global+prevalence+%28update%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWHO%26atitle%3DHepatitis%2520C%2520global%2520prevalence%2520%2528update%2529%26jtitle%3DWkly.%2520Epidemiol.%2520Rec.%26date%3D1999%26volume%3D74%26spage%3D425%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Hanafiah, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groeger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaxman, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiersma, S. T.</span><span> </span><span class="NLM_article-title">Global epidemiology of hepatits C virus infection: new estimates of age-specific antibody to HCV seroprevalence</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1333</span><span class="NLM_x">–</span> <span class="NLM_lpage">1342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=1333-1342&author=K.+M.+Hanafiahauthor=J.+Groegerauthor=A.+D.+Flaxmanauthor=S.+T.+Wiersma&title=Global+epidemiology+of+hepatits+C+virus+infection%3A+new+estimates+of+age-specific+antibody+to+HCV+seroprevalence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanafiah%26aufirst%3DK.%2BM.%26aulast%3DGroeger%26aufirst%3DJ.%26aulast%3DFlaxman%26aufirst%3DA.%2BD.%26aulast%3DWiersma%26aufirst%3DS.%2BT.%26atitle%3DGlobal%2520epidemiology%2520of%2520hepatits%2520C%2520virus%2520infection%253A%2520new%2520estimates%2520of%2520age-specific%2520antibody%2520to%2520HCV%2520seroprevalence%26jtitle%3DHepatology%26date%3D2013%26volume%3D57%26spage%3D1333%26epage%3D1342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Hajarazadeh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grebely, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dore, G. J.</span><span> </span><span class="NLM_article-title">Epidemiology and natural history of HCV infection</span> <span class="citation_source-journal">Nat. Rev. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.1038%2Fnrgastro.2013.107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=23817321" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=553-562&author=B.+Hajarazadehauthor=J.+Grebelyauthor=G.+J.+Dore&title=Epidemiology+and+natural+history+of+HCV+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrgastro.2013.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrgastro.2013.107%26sid%3Dliteratum%253Aachs%26aulast%3DHajarazadeh%26aufirst%3DB.%26aulast%3DGrebely%26aufirst%3DJ.%26aulast%3DDore%26aufirst%3DG.%2BJ.%26atitle%3DEpidemiology%2520and%2520natural%2520history%2520of%2520HCV%2520infection%26jtitle%3DNat.%2520Rev.%2520Gastroenterol.%2520Hepatol.%26date%3D2013%26volume%3D10%26spage%3D553%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Liang, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, T.</span><span> </span><span class="NLM_article-title">Pathogenesis of hepatitis C-associated hepatocellular carcinoma</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">S62</span><span class="NLM_x">–</span> <span class="NLM_lpage">S71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.1053%2Fj.gastro.2004.09.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=15508105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVGmtb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2004&pages=S62-S71&author=T.+J.+Liangauthor=T.+Heller&title=Pathogenesis+of+hepatitis+C-associated+hepatocellular+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis of hepatitis C-associated hepatocellular carcinoma</span></div><div class="casAuthors">Liang, T. Jake; Heller, Theo</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">5, Suppl. 1</span>),
    <span class="NLM_cas:pages">S62-S71</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Epidemiol., clin., and virol. data have shown a close assocn. between chronic infection with hepatitis C virus (HCV) and the development of hepatocellular carcinoma (HCC).  In many countries of the developed world, HCV infection accounts for more than half of the cases of HCC.  HCC usually arises after 2-4 decades of infection, typically in the context of an underlying cirrhosis.  Treatment of hepatitis C with interferon-alpha can lead to sustained clearance of HCV, and small prospective studies as well as larger retrospective analyses suggest that interferon therapy leads to a decrease in the incidence of HCC.  Without a reliable tissue culture system or a small animal model of HCV infection, anal. of the mechanisms by which HCV leads to cancer has been difficult.  Nevertheless, both in vitro expression systems and in vivo transgenic mice studies suggest that HCV has an inherent carcinogenic potential.  Understanding the pathogenesis of HCV-assocd. HCC is important in developing effective means of prevention and treatment of this highly malignant form of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ3d-IaWg73rVg90H21EOLACvtfcHk0lhp82v1aZr4BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVGmtb7F&md5=57f58df6ef197dcf191bfb8d5e53301f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2004.09.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2004.09.017%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DT.%2BJ.%26aulast%3DHeller%26aufirst%3DT.%26atitle%3DPathogenesis%2520of%2520hepatitis%2520C-associated%2520hepatocellular%2520carcinoma%26jtitle%3DGastroenterology%26date%3D2004%26volume%3D127%26spage%3DS62%26epage%3DS71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Pawlotsky, J.-M.</span><span> </span><span class="NLM_article-title">Pathophysiology of hepatitis C virus infection and related liver disease</span> <span class="citation_source-journal">Trends Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=96-102&author=J.-M.+Pawlotsky&title=Pathophysiology+of+hepatitis+C+virus+infection+and+related+liver+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPawlotsky%26aufirst%3DJ.-M.%26atitle%3DPathophysiology%2520of%2520hepatitis%2520C%2520virus%2520infection%2520and%2520related%2520liver%2520disease%26jtitle%3DTrends%2520Microbiol.%26date%3D2004%26volume%3D12%26spage%3D96%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Zein, N. N.</span><span> </span><span class="NLM_article-title">Clinical significance of hepatitis C virus genotypes</span> <span class="citation_source-journal">Clin. Microbiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.1128%2FCMR.13.2.223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=10755999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtVOqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2000&pages=223-235&author=N.+N.+Zein&title=Clinical+significance+of+hepatitis+C+virus+genotypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical significance of hepatitis C virus genotypes</span></div><div class="casAuthors">Zein, Nizar N.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-235</span>CODEN:
                <span class="NLM_cas:coden">CMIREX</span>;
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review with 149 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIyz_GrutS8LVg90H21EOLACvtfcHk0lhp82v1aZr4BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtVOqs7k%253D&md5=c3dbf9e23541db288f77cfabdf5c2e45</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1128%2FCMR.13.2.223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.13.2.223%26sid%3Dliteratum%253Aachs%26aulast%3DZein%26aufirst%3DN.%2BN.%26atitle%3DClinical%2520significance%2520of%2520hepatitis%2520C%2520virus%2520genotypes%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2000%26volume%3D13%26spage%3D223%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Nakano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, G. M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, G. M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizokami, M.</span><span> </span><span class="NLM_article-title">An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region</span> <span class="citation_source-journal">Liver Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=339-345&author=T.+Nakanoauthor=G.+M.+G.+Lauauthor=G.+M.+L.+Lauauthor=M.+Sugiyamaauthor=M.+Mizokami&title=An+updated+analysis+of+hepatitis+C+virus+genotypes+and+subtypes+based+on+the+complete+coding+region"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakano%26aufirst%3DT.%26aulast%3DLau%26aufirst%3DG.%2BM.%2BG.%26aulast%3DLau%26aufirst%3DG.%2BM.%2BL.%26aulast%3DSugiyama%26aufirst%3DM.%26aulast%3DMizokami%26aufirst%3DM.%26atitle%3DAn%2520updated%2520analysis%2520of%2520hepatitis%2520C%2520virus%2520genotypes%2520and%2520subtypes%2520based%2520on%2520the%2520complete%2520coding%2520region%26jtitle%3DLiver%2520Int.%26date%3D2012%26volume%3D32%26spage%3D339%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Hoofnagle, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeff, L. B.</span><span> </span><span class="NLM_article-title">Peginterferon and ribavirin for chronic hepatitis C</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">2444</span><span class="NLM_x">–</span> <span class="NLM_lpage">2451</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.1056%2FNEJMct061675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=17151366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12nt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=2444-2451&author=J.+H.+Hoofnagleauthor=L.+B.+Seeff&title=Peginterferon+and+ribavirin+for+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Peginterferon and ribavirin for chronic hepatitis C</span></div><div class="casAuthors">Hoofnagle, Jay H.; Seeff, Leonard B.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2444-2451</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  A 44-yr-old woman with chronic hepatitis C has intermittent fatigue and persistent elevations in serum alanine aminotransferase levels.  She has had hepatitis C for 10 years.  The diagnosis was made after she attempted to donate blood and was found to have antibodies against the hepatitis C virus (HCV).  On questioning, she reports having used illicit injection drugs in her early 20s.  The phys. examn. is normal except for obesity.  The results of lab. tests show an alanine aminotransferase level of 86 U per L (normal value, <42); the alk. phosphatase level, direct and total bilirubin levels, albumin level, prothrombin time, and complete blood count are normal.  The serum HCV RNA level is 3.5 million IU per mL (genotype 1), and a liver biopsy specimen shows bridging fibrosis.  The patient is evaluated by a hepatologist, who recommends treatment with pegylated interferon and ribavirin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEoSFaZ9BVhbVg90H21EOLACvtfcHk0ljTsIfi-t6AMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12nt7%252FK&md5=fc356db5608b52c75cd96a652f8c2d4a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1056%2FNEJMct061675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMct061675%26sid%3Dliteratum%253Aachs%26aulast%3DHoofnagle%26aufirst%3DJ.%2BH.%26aulast%3DSeeff%26aufirst%3DL.%2BB.%26atitle%3DPeginterferon%2520and%2520ribavirin%2520for%2520chronic%2520hepatitis%2520C%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D2444%26epage%3D2451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Pearlman, B. L.</span><span> </span><span class="NLM_article-title">Extended-therapy duration for chronic hepatitis C genotype 1: the long and the short of it</span> <span class="citation_source-journal">World J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3621</span><span class="NLM_x">–</span> <span class="NLM_lpage">3627</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.3748%2Fwjg.14.3621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=18595128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1WlsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=3621-3627&author=B.+L.+Pearlman&title=Extended-therapy+duration+for+chronic+hepatitis+C+genotype+1%3A+the+long+and+the+short+of+it"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Extended-therapy duration for chronic hepatitis C, genotype 1: the long and the short of it</span></div><div class="casAuthors">Pearlman, Brian L.</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3621-3627</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">World Journal of Gastroenterology</span>)
        </div><div class="casAbstract">A review.  With pegylated interferon and ribavirin, more than half of all chronically-infected hepatitis C patients can achieve a sustained virol. response; however, patients with genotype 1 infections and those with other poor prognostic factors have relatively inferior treatment response rates.  Since new therapies are still years away from approval, it is incumbent upon providers to maximize the therapeutic efficacy of today's treatment.  The later the virus is undetectable in serum during treatment, the less likely it will be eradicated.  Patients with a delayed or slow virol. response to therapy (at least a 2-log10 decrease in baseline hepatitis C RNA yet detectable viremia at 12 wk of therapy and undetectable virus 12 wk subsequently) may, therefore, benefit from an extended therapy course beyond one of std. duration.  Although higher rates of treatment discontinuation may plague this approach, 72 wk of treatment for genotype 1-infected slow-responders may improve response rates and diminish relapse rates relative to those of 48 wk.  Based on data from both viral kinetic and clin. studies, therapy prolongation in slow responders may be a reasonable strategy to improve response rates in these treatment-refractory patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpESyXqxBkZLrVg90H21EOLACvtfcHk0ljTsIfi-t6AMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1WlsrjF&md5=527190cf013a69c7e84fdd4452f97747</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3748%2Fwjg.14.3621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.14.3621%26sid%3Dliteratum%253Aachs%26aulast%3DPearlman%26aufirst%3DB.%2BL.%26atitle%3DExtended-therapy%2520duration%2520for%2520chronic%2520hepatitis%2520C%2520genotype%25201%253A%2520the%2520long%2520and%2520the%2520short%2520of%2520it%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2008%26volume%3D14%26spage%3D3621%26epage%3D3627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Hadziyannis, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sette, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diago, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramadori, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodenheimer, H.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzetto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pockros, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackrill, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">PEGASYS International Study Group.</span><span> </span><span class="NLM_article-title">Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose</span> <span class="citation_source-journal">Ann. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.7326%2F0003-4819-140-5-200403020-00010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=14996676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitlOktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2004&pages=346-355&author=S.+J.+Hadziyannisauthor=H.+Setteauthor=T.+R.+Morganauthor=V.+Balanauthor=M.+Diagoauthor=P.+Marcellinauthor=G.+Ramadoriauthor=H.+Bodenheimerauthor=D.+Bernsteinauthor=M.+Rizzettoauthor=S.+Zeuzemauthor=P.+J.+Pockrosauthor=A.+Linauthor=A.+M.+Ackrillauthor=PEGASYS+International+Study+Group.&title=Peginterferon-%CE%B12a+and+ribavirin+combination+therapy+in+chronic+hepatitis+C%3A+a+randomized+study+of+treatment+duration+and+ribavirin+dose"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose</span></div><div class="casAuthors">Hadziyannis, Stephanos J.; Sette, Hoel, Jr.; Morgan, Timothy R.; Balan, Vijayan; Diago, Moises; Marcellin, Patrick; Ramadori, Giuliano; Bodenheimer, Henry, Jr.; Bernstein, David; Rizzetto, Mario; Zeuzem, Stefan; Pockros, Paul J.; Lin, Amy; Ackrill, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Internal Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">346-355</span>CODEN:
                <span class="NLM_cas:coden">AIMEAS</span>;
        ISSN:<span class="NLM_cas:issn">0003-4819</span>.
    
            (<span class="NLM_cas:orgname">American College of Physicians-American Society of Internal Medicine</span>)
        </div><div class="casAbstract">Treatment with pegylated interferon (peginterferon) and ribavirin for 48 wk is more effective than conventional interferon and ribavirin in patients with chronic hepatitis C.  Objective: To assess the efficacy and safety of 24 or 48 wk of treatment with peginterferon-α2a plus a low or std. dose of ribavirin.  Design: Randomized, double-blind trial.  Setting: 99 international centers.  Patients: 1311 patients with chronic hepatitis C.  Intervention: Peginterferon-α2a, 180 μg/wk, for 24 or 48 wk plus a low-dose (800 mg/d) or std. wt.-based dose (1000 or 1200 mg/d) of ribavirin.  Measurement: Sustained virol. response: undetectable HCV RNA concn. at the end of treatment and during 12 to 24 wk of follow-up.  Results: Overall and in patients infected with HCV genotype 1, 48 wk of treatment was statistically superior to 24 wk and std.-dose ribavirin was statistically superior to low-dose ribavirin.  In patients with HCV genotype 1, abs. differences in sustained virol. response rates between 48 and 24 wk of treatment were 11.2% (95% CI, 3.6% to 18.9%) and 11.9% (CI, 4.7% to 18.9%), resp., between std.- and low-dose ribavirin.  Sustained virol. response rates for peginterferon-α2a and std.-dose ribavirin for 48 wk were 63% (CI, 59% to 68%) overall and 52% (CI, 46% to 58%) in patients with HCV genotype 1.  In patients with HCV genotypes 2 or 3, the sustained virol. response rates in the 4 treatment groups were not statistically significantly different.  Conclusion: Treatment with peginterferon-α2a and ribavirin may be individualized by genotype.  Patients with HCV genotype 1 require treatment for 48 wk and a std. dose of ribavirin; those with HCV genotypes 2 or 3 seem to be adequately treated with a low dose of ribavirin for 24 wk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDnDyBicuGj7Vg90H21EOLACvtfcHk0lgm3i8zdf-mCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitlOktrg%253D&md5=0e5ff18b054a10ab2051ba6c094626d0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-140-5-200403020-00010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-140-5-200403020-00010%26sid%3Dliteratum%253Aachs%26aulast%3DHadziyannis%26aufirst%3DS.%2BJ.%26aulast%3DSette%26aufirst%3DH.%26aulast%3DMorgan%26aufirst%3DT.%2BR.%26aulast%3DBalan%26aufirst%3DV.%26aulast%3DDiago%26aufirst%3DM.%26aulast%3DMarcellin%26aufirst%3DP.%26aulast%3DRamadori%26aufirst%3DG.%26aulast%3DBodenheimer%26aufirst%3DH.%26aulast%3DBernstein%26aufirst%3DD.%26aulast%3DRizzetto%26aufirst%3DM.%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DPockros%26aufirst%3DP.%2BJ.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DAckrill%26aufirst%3DA.%2BM.%26aulast%3D%26atitle%3DPeginterferon-%25CE%25B12a%2520and%2520ribavirin%2520combination%2520therapy%2520in%2520chronic%2520hepatitis%2520C%253A%2520a%2520randomized%2520study%2520of%2520treatment%2520duration%2520and%2520ribavirin%2520dose%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D2004%26volume%3D140%26spage%3D346%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, G.</span><span> </span><span class="NLM_article-title">Challenges and successes in developing new therapies for hepatitis C</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=953-960&author=R.+De+Francescoauthor=G.+Migliaccio&title=Challenges+and+successes+in+developing+new+therapies+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DMigliaccio%26aufirst%3DG.%26atitle%3DChallenges%2520and%2520successes%2520in%2520developing%2520new%2520therapies%2520for%2520hepatitis%2520C%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D953%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Malcolm, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gheyas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skelton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1013-1020&author=B.+A.+Malcolmauthor=R.+Liuauthor=F.+Lahserauthor=S.+Agrawalauthor=B.+Belangerauthor=N.+Butkiewiczauthor=R.+Chaseauthor=F.+Gheyasauthor=A.+Hartauthor=D.+Heskauthor=P.+Ingravalloauthor=C.+Jiangauthor=R.+Kongauthor=J.+Luauthor=J.+Pichardoauthor=A.+Prongayauthor=A.+Skeltonauthor=X.+Tongauthor=S.+Venkatramanauthor=E.+Xiaauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=SCH+503034%2C+a+mechanism-based+inhibitor+of+hepatitis+C+virus+NS3+protease%2C+suppresses+polyprotein+maturation+and+enhances+the+antiviral+activity+of+alpha+interferon+in+replicon+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalcolm%26aufirst%3DB.%2BA.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DLahser%26aufirst%3DF.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DBelanger%26aufirst%3DB.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DGheyas%26aufirst%3DF.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DSkelton%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DSCH%2520503034%252C%2520a%2520mechanism-based%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520protease%252C%2520suppresses%2520polyprotein%2520maturation%2520and%2520enhances%2520the%2520antiviral%2520activity%2520of%2520alpha%2520interferon%2520in%2520replicon%2520cells%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D1013%26epage%3D1020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrn, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandorkar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinehart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalkeri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaczkowski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span> </span><span class="NLM_article-title">Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=899-909&author=R.+B.+Perniauthor=S.+J.+Almquistauthor=R.+A.+Byrnauthor=G.+Chandorkarauthor=P.+R.+Chaturvediauthor=L.+F.+Courtneyauthor=C.+J.+Deckerauthor=K.+Dinehartauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=A.+Heiserauthor=G.+Kalkeriauthor=E.+Kolaczkowskiauthor=K.+Linauthor=Y.-P.+Luongauthor=B.+G.+Raoauthor=W.+P.+Taylorauthor=J.+A.+Thomsonauthor=R.+D.+Tungauthor=Y.+Weiauthor=A.+D.+Kwongauthor=C.+Lin&title=Preclinical+profile+of+VX-950%2C+a+potent%2C+selective%2C+and+orally+bioavailable+inhibitor+of+hepatitis+C+virus+NS3-4A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DAlmquist%26aufirst%3DS.%2BJ.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DChandorkar%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DP.%2BR.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDecker%26aufirst%3DC.%2BJ.%26aulast%3DDinehart%26aufirst%3DK.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DHeiser%26aufirst%3DA.%26aulast%3DKalkeri%26aufirst%3DG.%26aulast%3DKolaczkowski%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.-P.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DTaylor%26aufirst%3DW.%2BP.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DLin%26aufirst%3DC.%26atitle%3DPreclinical%2520profile%2520of%2520VX-950%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D899%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Farnik, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span> </span><span class="NLM_article-title">New antiviral therapies in the management of HCV infection</span> <span class="citation_source-journal">Antiviral Ther</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">783</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=771-783&author=H.+Farnikauthor=S.+Zeuzem&title=New+antiviral+therapies+in+the+management+of+HCV+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFarnik%26aufirst%3DH.%26aulast%3DZeuzem%26aufirst%3DS.%26atitle%3DNew%2520antiviral%2520therapies%2520in%2520the%2520management%2520of%2520HCV%2520infection%26jtitle%3DAntiviral%2520Ther%26date%3D2012%26volume%3D17%26spage%3D771%26epage%3D783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Fried, M. W.</span><span> </span><span class="NLM_article-title">Side effects of therapy of hepatitis C and their management</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">S237</span><span class="NLM_x">–</span> <span class="NLM_lpage">S244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=S237-S244&author=M.+W.+Fried&title=Side+effects+of+therapy+of+hepatitis+C+and+their+management"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFried%26aufirst%3DM.%2BW.%26atitle%3DSide%2520effects%2520of%2520therapy%2520of%2520hepatitis%2520C%2520and%2520their%2520management%26jtitle%3DHepatology%26date%3D2002%26volume%3D36%26spage%3DS237%26epage%3DS244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span>Incivek (telaprevir) in combination with drugs peginterferon alfa and ribavirin (Incivek combination treatment): drug safety communication—serious skin reactions. <a href="http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm332860.htm" class="extLink">http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm332860.htm</a> (posted by the FDA on December 19, 2012.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Incivek+%28telaprevir%29+in+combination+with+drugs+peginterferon+alfa+and+ribavirin+%28Incivek+combination+treatment%29%3A+drug+safety+communication%E2%80%94serious+skin+reactions.+http%3A%2F%2Fwww.fda.gov%2FSafety%2FMedWatch%2FSafetyInformation%2FSafetyAlertsforHumanMedicalProducts%2Fucm332860.htm+%28posted+by+the+FDA+on+December+19%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Maasoumy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manns, M. P.</span><span> </span><span class="NLM_article-title">Optimal treatment with boceprevir for chronic HCV infection</span> <span class="citation_source-journal">Liver Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">14</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=14-22&issue=Suppl.+1&author=B.+Maasoumyauthor=M.+P.+Manns&title=Optimal+treatment+with+boceprevir+for+chronic+HCV+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaasoumy%26aufirst%3DB.%26aulast%3DManns%26aufirst%3DM.%2BP.%26atitle%3DOptimal%2520treatment%2520with%2520boceprevir%2520for%2520chronic%2520HCV%2520infection%26jtitle%3DLiver%2520Int.%26date%3D2013%26volume%3D33%26issue%3DSuppl.%25201%26spage%3D14%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Manns, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Hahn, T.</span><span> </span><span class="NLM_article-title">Novel therapies for hepatitis C—One pill fits all?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=595-610&author=M.+P.+Mannsauthor=T.+von+Hahn&title=Novel+therapies+for+hepatitis+C%E2%80%94One+pill+fits+all%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%2BP.%26aulast%3Dvon%2BHahn%26aufirst%3DT.%26atitle%3DNovel%2520therapies%2520for%2520hepatitis%2520C%25E2%2580%2594One%2520pill%2520fits%2520all%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D595%26epage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Ingallinella, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taliani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingenito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinkuhler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessi, A.</span><span> </span><span class="NLM_article-title">Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">8906</span><span class="NLM_x">–</span> <span class="NLM_lpage">8914</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi980314n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=8906-8914&author=P.+Ingallinellaauthor=S.+Altamuraauthor=E.+Bianchiauthor=M.+Talianiauthor=R.+Ingenitoauthor=R.+Corteseauthor=R.+De+Francescoauthor=C.+Steinkuhlerauthor=A.+Pessi&title=Potent+peptide+inhibitors+of+human+hepatitis+C+virus+NS3+protease+are+obtained+by+optimizing+the+cleavage+products"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fbi980314n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi980314n%26sid%3Dliteratum%253Aachs%26aulast%3DIngallinella%26aufirst%3DP.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DBianchi%26aufirst%3DE.%26aulast%3DTaliani%26aufirst%3DM.%26aulast%3DIngenito%26aufirst%3DR.%26aulast%3DCortese%26aufirst%3DR.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DSteinkuhler%26aufirst%3DC.%26aulast%3DPessi%26aufirst%3DA.%26atitle%3DPotent%2520peptide%2520inhibitors%2520of%2520human%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520are%2520obtained%2520by%2520optimizing%2520the%2520cleavage%2520products%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D8906%26epage%3D8914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Imperiali, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeles, R. H.</span><span> </span><span class="NLM_article-title">Extended binding inhibitors of chymotrypsin that interact with leaving group subsites S1′–S3′</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">4474</span><span class="NLM_x">–</span> <span class="NLM_lpage">4477</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00388a044" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1987&pages=4474-4477&author=B.+Imperialiauthor=R.+H.+Abeles&title=Extended+binding+inhibitors+of+chymotrypsin+that+interact+with+leaving+group+subsites+S1%E2%80%B2%E2%80%93S3%E2%80%B2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fbi00388a044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00388a044%26sid%3Dliteratum%253Aachs%26aulast%3DImperiali%26aufirst%3DB.%26aulast%3DAbeles%26aufirst%3DR.%2BH.%26atitle%3DExtended%2520binding%2520inhibitors%2520of%2520chymotrypsin%2520that%2520interact%2520with%2520leaving%2520group%2520subsites%2520S1%25E2%2580%25B2%25E2%2580%2593S3%25E2%2580%25B2%26jtitle%3DBiochemistry%26date%3D1987%26volume%3D26%26spage%3D4474%26epage%3D4477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Llinas-Brunet, M.; Bailey, M. D.; Cameron, D.; Faucher, A.-M; Ghiro, E.; Goudreau, N.; Halmos, T.; Poupart, M.-A.; Rancourt, J.; Tsantrizos, Y. S.; Wernic, D. M.; Simoneau, B.</span><span> </span><span class="NLM_article-title">Preparation of hepatitis C inhibitory tripeptides</span>. World Patent Application WO 2000/0009543, February 24,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=M.+Llinas-Brunet&author=M.+D.+Bailey&author=D.+Cameron&author=A.-M+Faucher&author=E.+Ghiro&author=N.+Goudreau&author=T.+Halmos&author=M.-A.+Poupart&author=J.+Rancourt&author=Y.+S.+Tsantrizos&author=D.+M.+Wernic&author=B.+Simoneau&title=Preparation+of+hepatitis+C+inhibitory+tripeptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520hepatitis%2520C%2520inhibitory%2520tripeptides%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Campbell, J. A.; Good, A.</span> World Patent Application WO-2002/060926 A2, August 8,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Campbell%2C+J.+A.%3B+Good%2C+A.+World+Patent+Application+WO-2002%2F060926+A2%2C+August+8%2C+2002."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DJ.%2BA.%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="note"><p class="first last">The measured p<i>K</i><sub>a</sub> value for compound <b>7</b> is 5. See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for a general proceedure.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Schaaf, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, H.-J.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of carboxyl-terminus modified prostaglandin analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1340</span><span class="NLM_x">–</span> <span class="NLM_lpage">1346</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00197a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1979&pages=1340-1346&author=T.+K.+Schaafauthor=H.-J.+Hess&title=Synthesis+and+biological+activity+of+carboxyl-terminus+modified+prostaglandin+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm00197a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00197a012%26sid%3Dliteratum%253Aachs%26aulast%3DSchaaf%26aufirst%3DT.%2BK.%26aulast%3DHess%26aufirst%3DH.-J.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520carboxyl-terminus%2520modified%2520prostaglandin%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1979%26volume%3D22%26spage%3D1340%26epage%3D1346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of some recent tactical applications of bioisosteres in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+applications+of+bioisosteres+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520applications%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, B.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.-L.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6827</span><span class="NLM_x">–</span> <span class="NLM_lpage">6832</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=6827-6832&author=X.+Luauthor=H.+Zhangauthor=X.+Liauthor=G.+Chenauthor=Q.-S.+Liauthor=Y.+Luoauthor=B.-F.+Ruanauthor=X.-W.+Chenauthor=H.-L.+Zhu&title=Design%2C+synthesis+and+biological+evaluation+of+pyridine+acyl+sulfonamide+derivatives+as+novel+COX-2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DQ.-S.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DRuan%26aufirst%3DB.-F.%26aulast%3DChen%26aufirst%3DX.-W.%26aulast%3DZhu%26aufirst%3DH.-L.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520pyridine%2520acyl%2520sulfonamide%2520derivatives%2520as%2520novel%2520COX-2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D6827%26epage%3D6832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Anilkumar, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selyutin, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenblum, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. X</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesburg, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duca, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavalas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sannigrahi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velazquez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vibulbhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, N.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, G. F</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlowski, J. A.,  II.</span><span> </span><span class="NLM_article-title">Novel HCV NS5B polymerase inhibitors: discovery of indole C2 acyl sulfonamides</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">713</span><span class="NLM_x">–</span> <span class="NLM_lpage">717</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=713-717&author=G.+N.+Anilkumarauthor=O.+Selyutinauthor=S.+B.+Rosenblumauthor=Q.+Zengauthor=Y.+Jiangauthor=T.-Y.+Chanauthor=H.+Puauthor=L.+Wangauthor=F.+Bennettauthor=K.+X+Chenauthor=C.+A.+Lesburgauthor=J.+Ducaauthor=S.+Gavalasauthor=Y.+Huangauthor=P.+Pintoauthor=M.+Sannigrahiauthor=F.+Velazquezauthor=S.+Venkatramanauthor=B.+Vibulbhanauthor=S.+Agrawalauthor=E.+Ferrariauthor=C.-K.+Jiangauthor=H.-C.+Huangauthor=N.-Y.+Shihauthor=G.+F+Njorogeauthor=J.+A.+Kozlowski&title=Novel+HCV+NS5B+polymerase+inhibitors%3A+discovery+of+indole+C2+acyl+sulfonamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnilkumar%26aufirst%3DG.%2BN.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DChan%26aufirst%3DT.-Y.%26aulast%3DPu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%2BX%26aulast%3DLesburg%26aufirst%3DC.%2BA.%26aulast%3DDuca%26aufirst%3DJ.%26aulast%3DGavalas%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DSannigrahi%26aufirst%3DM.%26aulast%3DVelazquez%26aufirst%3DF.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DFerrari%26aufirst%3DE.%26aulast%3DJiang%26aufirst%3DC.-K.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DShih%26aufirst%3DN.-Y.%26aulast%3DNjoroge%26aufirst%3DG.%2BF%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DNovel%2520HCV%2520NS5B%2520polymerase%2520inhibitors%253A%2520discovery%2520of%2520indole%2520C2%2520acyl%2520sulfonamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D713%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Glunz, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delucca, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nirschl, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigelt, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheney, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anumula, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luettgen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendina, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harpel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knabb, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priestley, E. S.</span><span> </span><span class="NLM_article-title">Nonbenzamidine acylsulfonamide tissue factor-factor VIIa inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">5244</span><span class="NLM_x">–</span> <span class="NLM_lpage">5248</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5244-5248&author=P.+W.+Glunzauthor=X.+Zhangauthor=Y.+Zouauthor=I.+Deluccaauthor=A.+H.+Nirschlauthor=X.+Chengauthor=C.+A.+Weigeltauthor=D.+L.+Cheneyauthor=A.+Weiauthor=R.+Anumulaauthor=J.+M.+Luettgenauthor=A.+R.+Rendinaauthor=M.+Harpelauthor=G.+Luoauthor=R.+Knabbauthor=P.+C.+Wongauthor=R.+R.+Wexlerauthor=E.+S.+Priestley&title=Nonbenzamidine+acylsulfonamide+tissue+factor-factor+VIIa+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlunz%26aufirst%3DP.%2BW.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DDelucca%26aufirst%3DI.%26aulast%3DNirschl%26aufirst%3DA.%2BH.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DWeigelt%26aufirst%3DC.%2BA.%26aulast%3DCheney%26aufirst%3DD.%2BL.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DAnumula%26aufirst%3DR.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DHarpel%26aufirst%3DM.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DKnabb%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DPriestley%26aufirst%3DE.%2BS.%26atitle%3DNonbenzamidine%2520acylsulfonamide%2520tissue%2520factor-factor%2520VIIa%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5244%26epage%3D5248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Pietschmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">The hepatitis C virus replicon system and its application to molecular studies</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">664</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=657-664&author=T.+Pietschmannauthor=R.+Bartenschlager&title=The+hepatitis+C+virus+replicon+system+and+its+application+to+molecular+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPietschmann%26aufirst%3DT.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DThe%2520hepatitis%2520C%2520virus%2520replicon%2520system%2520and%2520its%2520application%2520to%2520molecular%2520studies%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2001%26volume%3D4%26spage%3D657%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1356</span><span class="NLM_x">–</span> <span class="NLM_lpage">1360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.1002%2Fanie.200390347" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlygsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=1356-1360&author=Y.+S.+Tsantrizosauthor=G.+Bolgerauthor=P.+Bonneauauthor=D.+R.+Cameronauthor=N.+Goudreauauthor=G.+Kukoljauthor=S.+R.+LaPlanteauthor=M.+Llinas-Brunetauthor=H.+Narauthor=D.+Lamarre&title=Macrocyclic+inhibitors+of+the+NS3+protease+as+potential+therapeutic+agents+of+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection</span></div><div class="casAuthors">Tsantrizos, Youla S.; Bolger, Gordon; Bonneau, Pierre; Cameron, Dale R.; Goudreau, Nathalie; Kukolj, George; LaPlante, Steven R.; Llinas-Brunet, Montse; Nar, Herbert; Lamarre, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1356-1360</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A novel class of selective inhibitors of the hepatitis C virus NS3 protease, an enzyme which is essential for viral replication in vivo, was developed.  The inhibitors are based on the structure-activity relationship between a substrate-based peptidomimetic ligand and the HCV NS3 serine protease.  The designed HCV inhibitor and its satd. analogs are the first inhibitors of the NS3 protease which inhibit HCV RNA replication in the cell-based replicon assay.  In addn., they are orally absorbed and stable to metabolic breakdown.  Thus, these compds. show many of the desirable properties of a druglike archetype and could lead t a clin. useful antiviral agent for the treatment of hepatitis C viral infections in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCij3shP5tmLVg90H21EOLACvtfcHk0liRS7z9pW1Gtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlygsrc%253D&md5=e0a3c98ee0096bfc3d058bf0b92b81c3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fanie.200390347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200390347%26sid%3Dliteratum%253Aachs%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DNar%26aufirst%3DH.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DMacrocyclic%2520inhibitors%2520of%2520the%2520NS3%2520protease%2520as%2520potential%2520therapeutic%2520agents%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D1356%26epage%3D1360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitlik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britt, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Court, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farmer, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Drie, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span> </span><span class="NLM_article-title">Inhibitors of hepatitis C virus NS3/4A protease 2. Warhead SAR and optimization</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1441</span><span class="NLM_x">–</span> <span class="NLM_lpage">1446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1441-1446&author=R.+B.+Perniauthor=J.+Pitlikauthor=S.+D.+Brittauthor=J.+J.+Courtauthor=L.+F.+Courtneyauthor=D.+D.+Deiningerauthor=L.+J.+Farmerauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=R.+B.+Levinauthor=C.+Linauthor=K.+Linauthor=Y.-C.+Moonauthor=Y.-P.+Luongauthor=E.+T.+O%E2%80%99Malleyauthor=B.+G.+Raoauthor=J.+A.+Thomsonauthor=R.+D.+Tungauthor=J.+H.+Van+Drieauthor=Y.+Wei&title=Inhibitors+of+hepatitis+C+virus+NS3%2F4A+protease+2.+Warhead+SAR+and+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DPitlik%26aufirst%3DJ.%26aulast%3DBritt%26aufirst%3DS.%2BD.%26aulast%3DCourt%26aufirst%3DJ.%2BJ.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDeininger%26aufirst%3DD.%2BD.%26aulast%3DFarmer%26aufirst%3DL.%2BJ.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DLevin%26aufirst%3DR.%2BB.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DMoon%26aufirst%3DY.-C.%26aulast%3DLuong%26aufirst%3DY.-P.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DE.%2BT.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DVan%2BDrie%26aufirst%3DJ.%2BH.%26aulast%3DWei%26aufirst%3DY.%26atitle%3DInhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%25202.%2520Warhead%2520SAR%2520and%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D1441%26epage%3D1446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="note"><p class="first last">The cyclopropylacylsulfonamide motif has been widely adopted in HCV NS3 inhibitor design:</p></div><div class="NLM_citation" id="rightTab-cit31a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Johansson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poliakov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerblom, E. A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiklund, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winiwarter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, A.</span><span> </span><span class="NLM_article-title">Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-length NS3 (protease-helicase/NTPase): a comparative study of different C-terminals</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2551</span><span class="NLM_x">–</span> <span class="NLM_lpage">2568</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=2551-2568&author=A.+Johanssonauthor=A.+Poliakovauthor=E.+A+Kerblomauthor=K.+Wiklundauthor=G.+Lindebergauthor=S.+Winiwarterauthor=U.+H.+Danielsonauthor=B.+Samuelssonauthor=A.+Hallberg&title=Acyl+sulfonamides+as+potent+protease+inhibitors+of+the+hepatitis+C+virus+full-length+NS3+%28protease-helicase%2FNTPase%29%3A+a+comparative+study+of+different+C-terminals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DA.%26aulast%3DPoliakov%26aufirst%3DA.%26aulast%3DKerblom%26aufirst%3DE.%2BA%26aulast%3DWiklund%26aufirst%3DK.%26aulast%3DLindeberg%26aufirst%3DG.%26aulast%3DWiniwarter%26aufirst%3DS.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DHallberg%26aufirst%3DA.%26atitle%3DAcyl%2520sulfonamides%2520as%2520potent%2520protease%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520full-length%2520NS3%2520%2528protease-helicase%252FNTPase%2529%253A%2520a%2520comparative%2520study%2520of%2520different%2520C-terminals%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D2551%26epage%3D2568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Oertqvist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aakerblom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gossas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabnis, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fransson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandstroem, A.</span><span> </span><span class="NLM_article-title">Phenylglycine as a novel P2 scaffold in hepatitis C virus NS3 protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1448</span><span class="NLM_x">–</span> <span class="NLM_lpage">1474</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=1448-1474&author=P.+Oertqvistauthor=S.+D.+Petersonauthor=E.+Aakerblomauthor=T.+Gossasauthor=Y.+A.+Sabnisauthor=R.+Franssonauthor=G.+Lindebergauthor=U.+H.+Danielsonauthor=A.+Karlenauthor=A.+Sandstroem&title=Phenylglycine+as+a+novel+P2+scaffold+in+hepatitis+C+virus+NS3+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOertqvist%26aufirst%3DP.%26aulast%3DPeterson%26aufirst%3DS.%2BD.%26aulast%3DAakerblom%26aufirst%3DE.%26aulast%3DGossas%26aufirst%3DT.%26aulast%3DSabnis%26aufirst%3DY.%2BA.%26aulast%3DFransson%26aufirst%3DR.%26aulast%3DLindeberg%26aufirst%3DG.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DKarlen%26aufirst%3DA.%26aulast%3DSandstroem%26aufirst%3DA.%26atitle%3DPhenylglycine%2520as%2520a%2520novel%2520P2%2520scaffold%2520in%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D1448%26epage%3D1474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Roenn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gossas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabnis, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daoud, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aakerblom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandstroem, A.</span><span> </span><span class="NLM_article-title">Evaluation of a diverse set of potential P1 carboxylic acid bioisosteres in hepatitis C virus NS3 protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4057</span><span class="NLM_x">–</span> <span class="NLM_lpage">4068</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=4057-4068&author=R.+Roennauthor=T.+Gossasauthor=Y.+A.+Sabnisauthor=H.+Daoudauthor=E.+Aakerblomauthor=U.+H.+Danielsonauthor=A.+Sandstroem&title=Evaluation+of+a+diverse+set+of+potential+P1+carboxylic+acid+bioisosteres+in+hepatitis+C+virus+NS3+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoenn%26aufirst%3DR.%26aulast%3DGossas%26aufirst%3DT.%26aulast%3DSabnis%26aufirst%3DY.%2BA.%26aulast%3DDaoud%26aufirst%3DH.%26aulast%3DAakerblom%26aufirst%3DE.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DSandstroem%26aufirst%3DA.%26atitle%3DEvaluation%2520of%2520a%2520diverse%2520set%2520of%2520potential%2520P1%2520carboxylic%2520acid%2520bioisosteres%2520in%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D4057%26epage%3D4068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Baeck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, P.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waangsell, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorstensson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kvarnstroem, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayesa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waehling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelcman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstroem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Classon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rydergård, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span> </span><span class="NLM_article-title">Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: use of cyclopentane and cyclopentene P2-motifs</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">7184</span><span class="NLM_x">–</span> <span class="NLM_lpage">7202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=7184-7202&author=M.+Baeckauthor=P.-O.+Johanssonauthor=F.+Waangsellauthor=F.+Thorstenssonauthor=I.+Kvarnstroemauthor=S.+Ayesaauthor=H.+Waehlingauthor=M.+Pelcmanauthor=K.+Janssonauthor=S.+Lindstroemauthor=H.+Wallbergauthor=B.+Classonauthor=C.+Ryderg%C3%A5rdauthor=L.+Vrangauthor=E.+Hamelinkauthor=A.+Hallbergauthor=A.+Rosenquistauthor=B.+Samuelsson&title=Novel+potent+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3+protease%3A+use+of+cyclopentane+and+cyclopentene+P2-motifs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaeck%26aufirst%3DM.%26aulast%3DJohansson%26aufirst%3DP.-O.%26aulast%3DWaangsell%26aufirst%3DF.%26aulast%3DThorstensson%26aufirst%3DF.%26aulast%3DKvarnstroem%26aufirst%3DI.%26aulast%3DAyesa%26aufirst%3DS.%26aulast%3DWaehling%26aufirst%3DH.%26aulast%3DPelcman%26aufirst%3DM.%26aulast%3DJansson%26aufirst%3DK.%26aulast%3DLindstroem%26aufirst%3DS.%26aulast%3DWallberg%26aufirst%3DH.%26aulast%3DClasson%26aufirst%3DB.%26aulast%3DRyderg%25C3%25A5rd%26aufirst%3DC.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DHallberg%26aufirst%3DA.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26atitle%3DNovel%2520potent%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%253A%2520use%2520of%2520cyclopentane%2520and%2520cyclopentene%2520P2-motifs%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D7184%26epage%3D7202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Naud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forgione, P.</span><span> </span><span class="NLM_article-title">Potent triazolyl-proline-based inhibitors of HCV NS3 protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3400</span><span class="NLM_x">–</span> <span class="NLM_lpage">3404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3400-3404&author=J.+Naudauthor=C.+Lemkeauthor=N.+Goudreauauthor=E.+Beaulieuauthor=P.+D.+Whiteauthor=M.+Llinas-Brunetauthor=P.+Forgione&title=Potent+triazolyl-proline-based+inhibitors+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNaud%26aufirst%3DJ.%26aulast%3DLemke%26aufirst%3DC.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DBeaulieu%26aufirst%3DE.%26aulast%3DWhite%26aufirst%3DP.%2BD.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DForgione%26aufirst%3DP.%26atitle%3DPotent%2520triazolyl-proline-based%2520inhibitors%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3400%26epage%3D3404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvador-Oden, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickstrom, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Vreken, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pille, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">Structure–activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4853</span><span class="NLM_x">–</span> <span class="NLM_lpage">4858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4853-4858&author=P.+Raboissonauthor=H.+de+Kockauthor=A.+Rosenquistauthor=M.+Nilssonauthor=L.+Salvador-Odenauthor=T.-I.+Linauthor=N.+Roueauthor=V.+Ivanovauthor=H.+Wahlingauthor=K.+Wickstromauthor=E.+Hamelinkauthor=M.+Edlundauthor=L.+Vrangauthor=S.+Vendevilleauthor=W.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=C.+Bouttonauthor=O.+Lenzauthor=F.+Delouvroyauthor=G.+Pilleauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=B.+Samuelssonauthor=K.+Simmen&title=Structure%E2%80%93activity+relationship+study+on+a+novel+series+of+cyclopentane-containing+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3%2F4A+protease+leading+to+the+discovery+of+TMC435350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DSalvador-Oden%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3DRoue%26aufirst%3DN.%26aulast%3DIvanov%26aufirst%3DV.%26aulast%3DWahling%26aufirst%3DH.%26aulast%3DWickstrom%26aufirst%3DK.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DBoutton%26aufirst%3DC.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DPille%26aufirst%3DG.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520study%2520on%2520a%2520novel%2520series%2520of%2520cyclopentane-containing%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520leading%2520to%2520the%2520discovery%2520of%2520TMC435350%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4853%26epage%3D4858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Cummings, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fellander, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraznenok, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nystrom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">Induced-fit binding of the macrocyclic noncovalent inhibitor TMC435 to its HCV NS3/NS4A protease target</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1652</span><span class="NLM_x">–</span> <span class="NLM_lpage">1655</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31g&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.1002%2Fanie.200906696" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31g&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVaktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=1652-1655&author=M.+D.+Cummingsauthor=J.+Lindbergauthor=T.-I.+Linauthor=H.+de+Kockauthor=O.+Lenzauthor=E.+Liljaauthor=S.+Fellanderauthor=V.+Baraznenokauthor=S.+Nystromauthor=M.+Nilssonauthor=L.+Vrangauthor=M.+Edlundauthor=A.+Rosenquistauthor=B.+Samuelssonauthor=P.+Raboissonauthor=K.+Simmen&title=Induced-fit+binding+of+the+macrocyclic+noncovalent+inhibitor+TMC435+to+its+HCV+NS3%2FNS4A+protease+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31gR"><div class="casContent"><span class="casTitleNuber">31g</span><div class="casTitle"><span class="NLM_cas:atitle">Induced-Fit Binding of the Macrocyclic Noncovalent Inhibitor TMC435 to its HCV NS3/NS4A Protease Target</span></div><div class="casAuthors">Cummings, Maxwell D.; Lindberg, Jimmy; Lin, Tse-I.; de Kock, Herman; Lenz, Oliver; Lilja, Elisabet; Fellander, Sara; Baraznenok, Vera; Nystrom, Susanne; Nilsson, Magnus; Vrang, Lotta; Edlund, Michael; Rosenquist, Asa; Samuelsson, Bertil; Raboisson, Pierre; Simmen, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1652-1655, S1652/1-S1652/11</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We have detd. the crystal structure of the macrocyclic inhibitor TMC435 bound to its HCV NS3/4A protease target at a resoln. of 2.4 Å, providing at. detail of induced fit to an extended S2 subsite.  The complex structure helps to rationalize the impact of key modifications in the optimization path that led to 1, and is guiding our understanding of resistance patterns.  Future modeling and structure-based design efforts aimed at NS3/NS4A protease should benefit from the new structure, which represents the first example of a noncovalent NS3/NS4A protease-inhibitor complex deposited in the PDB and details the induced fit involved in accommodating a large P2 substituent.  Inhibitors with large P2 groups that occupy the extended S2 subsite probe the crystallog. obsd. helicase-protease interface, and it is hoped that future studies will clarify the relevance of interfacial contacts to protease activity and protease inhibitor binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAEYqCPA57hLVg90H21EOLACvtfcHk0lhXOb0JbbmBkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVaktbs%253D&md5=535b340784d1af62df32e8cf3bd3fe87</span></div><a href="/servlet/linkout?suffix=cit31g&amp;dbid=16384&amp;doi=10.1002%2Fanie.200906696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200906696%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DLindberg%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DLilja%26aufirst%3DE.%26aulast%3DFellander%26aufirst%3DS.%26aulast%3DBaraznenok%26aufirst%3DV.%26aulast%3DNystrom%26aufirst%3DS.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DInduced-fit%2520binding%2520of%2520the%2520macrocyclic%2520noncovalent%2520inhibitor%2520TMC435%2520to%2520its%2520HCV%2520NS3%252FNS4A%2520protease%2520target%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D1652%26epage%3D1655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Vreken, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">Discovery of novel potent and selective dipeptide hepatitis C virus NS3/4A serine protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5095</span><span class="NLM_x">–</span> <span class="NLM_lpage">5100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5095-5100&author=P.+Raboissonauthor=T.-I.+Linauthor=H.+de+Kockauthor=S.+Vendevilleauthor=W.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=O.+Lenzauthor=F.+Delouvroyauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=M.+Nilssonauthor=A.+Rosenquistauthor=B.+Samuelssonauthor=K.+Simmen&title=Discovery+of+novel+potent+and+selective+dipeptide+hepatitis+C+virus+NS3%2F4A+serine+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520novel%2520potent%2520and%2520selective%2520dipeptide%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520serine%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5095%26epage%3D5100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonov, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Classon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayesa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, P.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahnberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eneroth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikstrom, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Vreken, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Dooren, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kindermans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span> </span><span class="NLM_article-title">Discovery of novel, potent and bioavailable proline-urea based macrocyclic HCV NS3/4A protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6189</span><span class="NLM_x">–</span> <span class="NLM_lpage">6193</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6189-6193&author=S.+Vendevilleauthor=M.+Nilssonauthor=H.+de+Kockauthor=T.-I.+Linauthor=D.+Antonovauthor=B.+Classonauthor=S.+Ayesaauthor=V.+Ivanovauthor=P.-O.+Johanssonauthor=P.+Kahnbergauthor=A.+Enerothauthor=K.+Wikstromauthor=L.+Vrangauthor=M.+Edlundauthor=S.+Lindstr%C3%B6mauthor=W.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=O.+Lenzauthor=F.+Delouvroyauthor=M.+Van+Doorenauthor=N.+Kindermansauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=A.+Rosenquistauthor=B.+Samuelssonauthor=K.+Simmenauthor=P.+Raboisson&title=Discovery+of+novel%2C+potent+and+bioavailable+proline-urea+based+macrocyclic+HCV+NS3%2F4A+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3DAntonov%26aufirst%3DD.%26aulast%3DClasson%26aufirst%3DB.%26aulast%3DAyesa%26aufirst%3DS.%26aulast%3DIvanov%26aufirst%3DV.%26aulast%3DJohansson%26aufirst%3DP.-O.%26aulast%3DKahnberg%26aufirst%3DP.%26aulast%3DEneroth%26aufirst%3DA.%26aulast%3DWikstrom%26aufirst%3DK.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DVan%2BDooren%26aufirst%3DM.%26aulast%3DKindermans%26aufirst%3DN.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26aulast%3DRaboisson%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520novel%252C%2520potent%2520and%2520bioavailable%2520proline-urea%2520based%2520macrocyclic%2520HCV%2520NS3%252F4A%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6189%26epage%3D6193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belfrage, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstroem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waehling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayesa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahnberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelcman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benkestock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agback, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terelius, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikström, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rydergård, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eneroth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of potent inhibitors of the hepatitis C virus NS3/4A protease: exploration of P2 quinazoline substituents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4004</span><span class="NLM_x">–</span> <span class="NLM_lpage">4011</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4004-4011&author=M.+Nilssonauthor=A.+K.+Belfrageauthor=S.+Lindstroemauthor=H.+Waehlingauthor=C.+Lindquistauthor=S.+Ayesaauthor=P.+Kahnbergauthor=M.+Pelcmanauthor=K.+Benkestockauthor=T.+Agbackauthor=L.+Vrangauthor=Y.+Tereliusauthor=K.+Wikstr%C3%B6mauthor=E.+Hamelinkauthor=C.+Ryderg%C3%A5rdauthor=M.+Edlundauthor=A.+Enerothauthor=P.+Raboissonauthor=T.-I.+Linauthor=H.+de+Kockauthor=P.+Wigerinckauthor=K.+Simmenauthor=B.+Samuelssonauthor=A.+Rosenquist&title=Synthesis+and+SAR+of+potent+inhibitors+of+the+hepatitis+C+virus+NS3%2F4A+protease%3A+exploration+of+P2+quinazoline+substituents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DBelfrage%26aufirst%3DA.%2BK.%26aulast%3DLindstroem%26aufirst%3DS.%26aulast%3DWaehling%26aufirst%3DH.%26aulast%3DLindquist%26aufirst%3DC.%26aulast%3DAyesa%26aufirst%3DS.%26aulast%3DKahnberg%26aufirst%3DP.%26aulast%3DPelcman%26aufirst%3DM.%26aulast%3DBenkestock%26aufirst%3DK.%26aulast%3DAgback%26aufirst%3DT.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DTerelius%26aufirst%3DY.%26aulast%3DWikstr%25C3%25B6m%26aufirst%3DK.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DRyderg%25C3%25A5rd%26aufirst%3DC.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DEneroth%26aufirst%3DA.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DSimmen%26aufirst%3DK.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DRosenquist%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520potent%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%253A%2520exploration%2520of%2520P2%2520quinazoline%2520substituents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4004%26epage%3D4011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Lampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrenberg, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafsson, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aakerblom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandstroem, A.</span><span> </span><span class="NLM_article-title">Improved P2 phenylglycine-based hepatitis C virus NS3 protease inhibitors with alkenylic prime-side substituents</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5413</span><span class="NLM_x">–</span> <span class="NLM_lpage">5424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31k&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.1016%2Fj.bmc.2010.05.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31k&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=20541424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31k&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BC3cXoslans78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5413-5424&author=A.+Lampaauthor=A.+E.+Ehrenbergauthor=S.+S.+Gustafssonauthor=A.+Vemaauthor=E.+Aakerblomauthor=G.+Lindebergauthor=A.+Karlenauthor=U.+H.+Danielsonauthor=A.+Sandstroem&title=Improved+P2+phenylglycine-based+hepatitis+C+virus+NS3+protease+inhibitors+with+alkenylic+prime-side+substituents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31kR"><div class="casContent"><span class="casTitleNuber">31k</span><div class="casTitle"><span class="NLM_cas:atitle">Improved P2 phenylglycine-based hepatitis C virus NS3 protease inhibitors with alkenylic prime-side substituents</span></div><div class="casAuthors">Lampa, Anna; Ehrenberg, Angelica E.; Gustafsson, Sofia S.; Vema, Aparna; Aakerblom, Eva; Lindeberg, Gunnar; Karlen, Anders; Danielson, U. Helena; Sandstroem, Anja</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5413-5424</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Phenylglycine has proven to be a useful P2 residue in HCV NS3 protease inhibitors.  A novel π-π-interaction between the phenylglycine and the catalytic H57 residue of the protease was postulated, and it was hypothesized that the introduction of a vinyl on the phenylglycine might strengthen this π-π-interaction.  Thus, a series of acyclic vinylated phenylglycine-based HCV NS3 protease inhibitors, e.g., I, was synthesized and their inhibitory potency evaluated.  Surprisingly, inhibitors based on both D- and L-phenylglycine were found to be effective inhibitors, with a slight preference for the D-epimers.  Furthermore, prime-side alkenylic extension of the C-terminal acylsulfonamide group gave significantly improved inhibitors with potencies in the nanomolar range (∼35 nM), potencies which were retained on mutant variants of the protease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1S6r1UZnWFrVg90H21EOLACvtfcHk0liIuZ0W_c6dvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXoslans78%253D&md5=53f795b5eba3e0b2d27e74fd504229a0</span></div><a href="/servlet/linkout?suffix=cit31k&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.05.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.05.027%26sid%3Dliteratum%253Aachs%26aulast%3DLampa%26aufirst%3DA.%26aulast%3DEhrenberg%26aufirst%3DA.%2BE.%26aulast%3DGustafsson%26aufirst%3DS.%2BS.%26aulast%3DVema%26aufirst%3DA.%26aulast%3DAakerblom%26aufirst%3DE.%26aulast%3DLindeberg%26aufirst%3DG.%26aulast%3DKarlen%26aufirst%3DA.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DSandstroem%26aufirst%3DA.%26atitle%3DImproved%2520P2%2520phenylglycine-based%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitors%2520with%2520alkenylic%2520prime-side%2520substituents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5413%26epage%3D5424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Oertqvist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gising, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrenberg, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larhed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandstroem, A.</span><span> </span><span class="NLM_article-title">Discovery of achiral inhibitors of the hepatitis C virus NS3 protease based on 2(1<i>H</i>)-pyrazinones</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6512</span><span class="NLM_x">–</span> <span class="NLM_lpage">6525</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=6512-6525&author=P.+Oertqvistauthor=J.+Gisingauthor=A.+E.+Ehrenbergauthor=A.+Vemaauthor=A.+Borgauthor=A.+Karlenauthor=M.+Larhedauthor=U.+H+Danielsonauthor=A.+Sandstroem&title=Discovery+of+achiral+inhibitors+of+the+hepatitis+C+virus+NS3+protease+based+on+2%281H%29-pyrazinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOertqvist%26aufirst%3DP.%26aulast%3DGising%26aufirst%3DJ.%26aulast%3DEhrenberg%26aufirst%3DA.%2BE.%26aulast%3DVema%26aufirst%3DA.%26aulast%3DBorg%26aufirst%3DA.%26aulast%3DKarlen%26aufirst%3DA.%26aulast%3DLarhed%26aufirst%3DM.%26aulast%3DDanielson%26aufirst%3DU.%2BH%26aulast%3DSandstroem%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520achiral%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520based%2520on%25202%25281H%2529-pyrazinones%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D6512%26epage%3D6525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Oertqvist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrenberg, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roenn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aekerblom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandstroem, A.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of HCV NS3 protease inhibitors evaluated on the drug-resistant variants A156T and D168V</span> <span class="citation_source-journal">Antiviral Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">852</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=841-852&author=P.+Oertqvistauthor=A.+Vemaauthor=A.+E.+Ehrenbergauthor=G.+Dahlauthor=R.+Roennauthor=E.+Aekerblomauthor=A.+Karlenauthor=U.+H.+Danielsonauthor=A.+Sandstroem&title=Structure%E2%80%93activity+relationships+of+HCV+NS3+protease+inhibitors+evaluated+on+the+drug-resistant+variants+A156T+and+D168V"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOertqvist%26aufirst%3DP.%26aulast%3DVema%26aufirst%3DA.%26aulast%3DEhrenberg%26aufirst%3DA.%2BE.%26aulast%3DDahl%26aufirst%3DG.%26aulast%3DRoenn%26aufirst%3DR.%26aulast%3DAekerblom%26aufirst%3DE.%26aulast%3DKarlen%26aufirst%3DA.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DSandstroem%26aufirst%3DA.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520HCV%2520NS3%2520protease%2520inhibitors%2520evaluated%2520on%2520the%2520drug-resistant%2520variants%2520A156T%2520and%2520D168V%26jtitle%3DAntiviral%2520Ther.%26date%3D2010%26volume%3D15%26spage%3D841%26epage%3D852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Ding, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvest, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazmierski, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, Z.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoue, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7317</span><span class="NLM_x">–</span> <span class="NLM_lpage">7322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7317-7322&author=C.+Z.+Dingauthor=Y.-K.+Zhangauthor=X.+Liauthor=Y.+Liuauthor=S.+Zhangauthor=Y.+Zhouauthor=J.+J.+Plattnerauthor=S.+J.+Bakerauthor=L.+Liuauthor=M.+Duanauthor=R.+L.+Jarvestauthor=J.+Jiauthor=W.+M.+Kazmierskiauthor=M.+D.+Tallantauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=R.+M.+Crosbyauthor=A.+A.+Wangauthor=Z.-J.+Niauthor=W.+Zoueauthor=J.+Wright&title=Synthesis+and+biological+evaluations+of+P4-benzoxaborole-substituted+macrocyclic+inhibitors+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31n&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DJarvest%26aufirst%3DR.%2BL.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DTallant%26aufirst%3DM.%2BD.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DWang%26aufirst%3DA.%2BA.%26aulast%3DNi%26aufirst%3DZ.-J.%26aulast%3DZoue%26aufirst%3DW.%26aulast%3DWright%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluations%2520of%2520P4-benzoxaborole-substituted%2520macrocyclic%2520inhibitors%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7317%26epage%3D7322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Duan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazmierski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gartland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamatake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span> </span><span class="NLM_article-title">Discovery of novel P3-oxo inhibitor of hepatitis C virus NS3/4A serine protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2993</span><span class="NLM_x">–</span> <span class="NLM_lpage">2996</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2993-2996&author=M.+Duanauthor=W.+Kazmierskiauthor=R.+Crosbyauthor=M.+Gartlandauthor=J.+Jiauthor=M.+Tallantauthor=A.+Wangauthor=R.+Hamatakeauthor=L.+Wrightauthor=M.+Wuauthor=Y.-K.+Zhangauthor=C.+Z.+Dingauthor=X.+Liauthor=Y.+Liuauthor=S.+Zhangauthor=Y.+Zhouauthor=J.+J.+Plattnerauthor=S.+J.+Baker&title=Discovery+of+novel+P3-oxo+inhibitor+of+hepatitis+C+virus+NS3%2F4A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31o&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DKazmierski%26aufirst%3DW.%26aulast%3DCrosby%26aufirst%3DR.%26aulast%3DGartland%26aufirst%3DM.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DTallant%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DHamatake%26aufirst%3DR.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26atitle%3DDiscovery%2520of%2520novel%2520P3-oxo%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520serine%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2993%26epage%3D2996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Kazmierski, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamatake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvest, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creech, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span> </span><span class="NLM_article-title">Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutants</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3021</span><span class="NLM_x">–</span> <span class="NLM_lpage">3026</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201278q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31p&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVWltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3021-3026&author=W.+M.+Kazmierskiauthor=R.+Hamatakeauthor=M.+Duanauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=R.+L.+Jarvestauthor=J.-J.+Jiauthor=J.+P.+Cooperauthor=M.+D.+Tallantauthor=R.+M.+Crosbyauthor=K.+Creechauthor=A.+Wangauthor=X.+Liauthor=S.+Zhangauthor=Y.-Y.+Zhangauthor=Y.+Liuauthor=C.+Z.+Dingauthor=Y.+Zhouauthor=J.+J.+Plattnerauthor=S.+J.+Bakerauthor=W.+Buauthor=L.+Liu&title=Discovery+of+novel+urea-based+hepatitis+C+protease+inhibitors+with+high+potency+against+protease-inhibitor-resistant+mutants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31pR"><div class="casContent"><span class="casTitleNuber">31p</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutants</span></div><div class="casAuthors">Kazmierski, Wieslaw M.; Hamatake, Robert; Duan, Maosheng; Wright, Lois L.; Smith, Gary K.; Jarvest, Richard L.; Ji, Jing-Jing; Cooper, Joel P.; Tallant, Matthew D.; Crosby, Renae M.; Creech, Katrina; Wang, Amy; Li, Xianfeng; Zhang, Suoming; Zhang, Yong-Kang; Liu, Yang; Ding, Charles Z.; Zhou, Yasheen; Plattner, Jacob J.; Baker, Stephen J.; Bu, Wei; Liu, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3021-3026</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Urea-based inhibitors were prepd. and characterized in replicase HCV protease-resistant mutants assay.  Several compds., exemplified by I, were found to be more potent in HCV replicon assays than leading second generation inhibitors such as danoprevir and TMC-435350.  Addnl., following oral administration, inhibitor I was found in rat liver in significantly higher concns. than those reported for both danoprevir and TMC-435350, suggesting that inhibitor I has the combination of anti-HCV and pharmacokinetic properties that warrants further development of this series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZf8snkMwqSrVg90H21EOLACvtfcHk0lhWhyG106rUMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVWltb0%253D&md5=43f9016626357a5fea8d6d1e9784e2d8</span></div><a href="/servlet/linkout?suffix=cit31p&amp;dbid=16384&amp;doi=10.1021%2Fjm201278q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201278q%26sid%3Dliteratum%253Aachs%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DHamatake%26aufirst%3DR.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DJarvest%26aufirst%3DR.%2BL.%26aulast%3DJi%26aufirst%3DJ.-J.%26aulast%3DCooper%26aufirst%3DJ.%2BP.%26aulast%3DTallant%26aufirst%3DM.%2BD.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DCreech%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.-Y.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520novel%2520urea-based%2520hepatitis%2520C%2520protease%2520inhibitors%2520with%2520high%2520potency%2520against%2520protease-inhibitor-resistant%2520mutants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3021%26epage%3D3026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31q"><span><span class="NLM_label">(q) </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swestock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span> </span><span class="NLM_article-title">Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2443</span><span class="NLM_x">–</span> <span class="NLM_lpage">2463</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9015526" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31q&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitV2gsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2443-2463&author=J.+A.+McCauleyauthor=C.+J.+McIntyreauthor=M.+T.+Ruddauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=J.+W.+Butcherauthor=K.+F.+Gilbertauthor=K.+J.+Bushauthor=M.+K.+Hollowayauthor=J.+Swestockauthor=B.-L.+Wanauthor=S.+S.+Carrollauthor=J.+M.+DiMuzioauthor=D.+J.+Grahamauthor=S.+W.+Ludmererauthor=S.-S.+Maoauthor=M.+W.+Stahlhutauthor=C.+M.+Fandozziauthor=N.+Trainorauthor=D.+B.+Olsenauthor=J.+P.+Vaccaauthor=N.+J.+Liverton&title=Discovery+of+vaniprevir+%28MK-7009%29%2C+a+macrocyclic+hepatitis+C+virus+NS3%2F4a+protease+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31qR"><div class="casContent"><span class="casTitleNuber">31q</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor</span></div><div class="casAuthors">McCauley, John A.; McIntyre, Charles J.; Rudd, Michael T.; Nguyen, Kevin T.; Romano, Joseph J.; Butcher, John W.; Gilbert, Kevin F.; Bush, Kimberly J.; Holloway, M. Katharine; Swestock, John; Wan, Bang-Lin; Carroll, Steven S.; DiMuzio, Jillian M.; Graham, Donald J.; Ludmerer, Steven W.; Mao, Shi-Shan; Stahlhut, Mark W.; Fandozzi, Christine M.; Trainor, Nicole; Olsen, David B.; Vacca, Joseph P.; Liverton, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2443-2463</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of HCV NS3/4a protease inhibitors which contain a P2 to P4 macrocyclic constraint was designed using a mol.-modeling derived strategy.  Exploration of the P2 heterocyclic region, the P2 to P4 linker, and the P1 side chain of this class of compds. via a modular synthetic strategy allowed for the optimization of enzyme potency, cellular activity, and rat liver exposure following oral dosing.  These studies led to the identification of clin. candidate vaniprevir, MK-7009, which is active against both the genotype 1 and genotype 2 NS3/4a protease enzymes and has good plasma exposure and excellent liver exposure in multiple species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_2CVs9I1H_7Vg90H21EOLACvtfcHk0lhWhyG106rUMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitV2gsr8%253D&md5=dc820c588d5482f6913091a87eaf9af1</span></div><a href="/servlet/linkout?suffix=cit31q&amp;dbid=16384&amp;doi=10.1021%2Fjm9015526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9015526%26sid%3Dliteratum%253Aachs%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DSwestock%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDiscovery%2520of%2520vaniprevir%2520%2528MK-7009%2529%252C%2520a%2520macrocyclic%2520hepatitis%2520C%2520virus%2520NS3%252F4a%2520protease%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2443%26epage%3D2463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31r"><span><span class="NLM_label">(r) </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A protease</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">4607</span><span class="NLM_x">–</span> <span class="NLM_lpage">4609</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja711120r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=4607-4609&author=N.+J.+Livertonauthor=M.+K.+Hollowayauthor=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=J.+W.+Butcherauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=C.+Fandozziauthor=K.+F.+Gilbertauthor=S.-S.+Maoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=M.+Stahlhutauthor=B.-L.+Wanauthor=D.+B.+Olsenauthor=J.+P.+Vacca&title=Molecular+modeling+based+approach+to+potent+P2-P4+macrocyclic+inhibitors+of+hepatitis+C+NS3%2F4A+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31r&amp;dbid=16384&amp;doi=10.1021%2Fja711120r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja711120r%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMolecular%2520modeling%2520based%2520approach%2520to%2520potent%2520P2-P4%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4A%2520protease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D4607%26epage%3D4609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31s"><span><span class="NLM_label">(s) </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, C. W.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span> </span><span class="NLM_article-title">Bismacrocyclic inhibitors of hepatitis C NS3/4a protease</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">9104</span><span class="NLM_x">–</span> <span class="NLM_lpage">9107</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=9104-9107&author=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=K.+T.+Nguyenauthor=C.+J.+McIntyreauthor=J.+J.+Romanoauthor=K.+J.+Bushauthor=S.+L.+Vargaauthor=C.+W.+Rossauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=M.+W.+Stahlhutauthor=D.+B.+Olsenauthor=T.+A.+Lyleauthor=J.+P.+Vaccaauthor=N.+J.+Liverton&title=Bismacrocyclic+inhibitors+of+hepatitis+C+NS3%2F4a+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31s&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DVarga%26aufirst%3DS.%2BL.%26aulast%3DRoss%26aufirst%3DC.%2BW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DBismacrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4a%2520protease%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2008%26volume%3D47%26spage%3D9104%26epage%3D9107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31t"><span><span class="NLM_label">(t) </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescenzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palumbi, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Muzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donghi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span> </span><span class="NLM_article-title">Inhibitors of the hepatitis C virus NS3 protease with basic amine functionality at the P3-amino acid N-terminus: discovery and optimization of a new series of P2-P4 macrocycles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4820</span><span class="NLM_x">–</span> <span class="NLM_lpage">4837</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900372w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4820-4837&author=S.+Harperauthor=M.+Ferraraauthor=B.+Crescenziauthor=M.+Pompeiauthor=M.+C.+Palumbiauthor=J.+M.+Di+Muzioauthor=M.+Donghiauthor=F.+Fioreauthor=U.+Kochauthor=N.+J.+Livertonauthor=S.+Pesciauthor=A.+Petrocchiauthor=M.+Rowleyauthor=V.+Summaauthor=C.+Gardelli&title=Inhibitors+of+the+hepatitis+C+virus+NS3+protease+with+basic+amine+functionality+at+the+P3-amino+acid+N-terminus%3A+discovery+and+optimization+of+a+new+series+of+P2-P4+macrocycles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31t&amp;dbid=16384&amp;doi=10.1021%2Fjm900372w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900372w%26sid%3Dliteratum%253Aachs%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DPompei%26aufirst%3DM.%26aulast%3DPalumbi%26aufirst%3DM.%2BC.%26aulast%3DDi%2BMuzio%26aufirst%3DJ.%2BM.%26aulast%3DDonghi%26aufirst%3DM.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DPesci%26aufirst%3DS.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DGardelli%26aufirst%3DC.%26atitle%3DInhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520with%2520basic%2520amine%2520functionality%2520at%2520the%2520P3-amino%2520acid%2520N-terminus%253A%2520discovery%2520and%2520optimization%2520of%2520a%2520new%2520series%2520of%2520P2-P4%2520macrocycles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4820%26epage%3D4837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31u"><span><span class="NLM_label">(u) </span><span class="NLM_contrib-group">Di Francesco, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dessole, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Muzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span> </span><span class="NLM_article-title">Novel macrocyclic inhibitors of hepatitis C NS3/4A protease featuring a 2-amino-1,3-thiazole as a P4 carbamate replacement</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7014</span><span class="NLM_x">–</span> <span class="NLM_lpage">7028</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900524b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31u&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWgt7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7014-7028&author=M.+E.+Di+Francescoauthor=G.+Dessoleauthor=E.+Niziauthor=P.+Paceauthor=U.+Kochauthor=F.+Fioreauthor=S.+Pesciauthor=J.+Di+Muzioauthor=E.+Monteagudoauthor=M.+Rowleyauthor=V.+Summa&title=Novel+macrocyclic+inhibitors+of+hepatitis+C+NS3%2F4A+protease+featuring+a+2-amino-1%2C3-thiazole+as+a+P4+carbamate+replacement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31uR"><div class="casContent"><span class="casTitleNuber">31u</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease Featuring a 2-Amino-1,3-thiazole as a P4 Carbamate Replacement</span></div><div class="casAuthors">Di Francesco, M. Emilia; Dessole, Gabriella; Nizi, Emanuela; Pace, Paola; Koch, Uwe; Fiore, Fabrizio; Pesci, Silvia; Di Muzio, Jillian; Monteagudo, Edith; Rowley, Michael; Summa, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7014-7028</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of P2-P4 macrocyclic inhibitors of HCV NS3/4A protease characterized by high levels of potency and liver exposure was recently reported.  Within this novel class of inhibitors, a structurally diverse series of compds. I [X = isoquinoline-1,7-diyl, 2-phenylquinoline-4,6-diyl, 2-carbonyl-1,3-dihydroisoindolyl; Y = (CH2)2, (CH2)3, CH2CMe2; Z = thiazol-2,4-diyl, 1,3,4-oxadiazol-2,5-diyl; R1 = i-Pr, t-Bu, cyclohexyl, (S)-EtCHMe, cyclopentyl; R2 = H2C:CH, Et] featuring a 2-amino-1,3-thiazole as replacement of the carbamate in P4 was identified.  Optimization studies focused on structural modifications in the P3, P2, and P1 regions of the macrocycle as well as on the linker chain and resulted in the discovery of several analogs characterized by excellent levels of enzyme and cellular activity.  Among these, I [double bond; X = 2-carbonyl-1,3-dihydroisoindolyl; Y = (CH2)3; Z = thiazol-2,4-diyl; R1 = (S)-EtCHMe; R2 = H2C:CH] displayed an attractive pharmacokinetic profile in preclin. species and showed sustained liver levels following oral administration in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIFtigQW8FUrVg90H21EOLACvtfcHk0lhlI9e-TQ_iFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWgt7fN&md5=76e409fa1d0e9812ee78c4eeabca21ce</span></div><a href="/servlet/linkout?suffix=cit31u&amp;dbid=16384&amp;doi=10.1021%2Fjm900524b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900524b%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BFrancesco%26aufirst%3DM.%2BE.%26aulast%3DDessole%26aufirst%3DG.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DPace%26aufirst%3DP.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DPesci%26aufirst%3DS.%26aulast%3DDi%2BMuzio%26aufirst%3DJ.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DNovel%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4A%2520protease%2520featuring%2520a%25202-amino-1%252C3-thiazole%2520as%2520a%2520P4%2520carbamate%2520replacement%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7014%26epage%3D7028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31v"><span><span class="NLM_label">(v) </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swestock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span> </span><span class="NLM_article-title">Discovery of MK-1220: a macrocyclic inhibitor of hepatitis C virus NS3/4A protease with improved preclinical plasma exposure</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml1002426" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=207-212&author=M.+T.+Ruddauthor=J.+A.+McCauleyauthor=J.+W.+Butcherauthor=J.+J.+Romanoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=K.+F.+Gilbertauthor=K.+J.+Bushauthor=M.+K.+Hollowayauthor=J.+Swestockauthor=B.-L.+Wanauthor=S.+S.+Carrollauthor=J.+M.+DiMuzioauthor=D.+J.+Grahamauthor=S.+W.+Ludmererauthor=M.+W.+Stahlhutauthor=C.+M.+Fandozziauthor=N.+Trainorauthor=D.+B.+Olsenauthor=J.+P.+Vaccaauthor=N.+J.+Liverton&title=Discovery+of+MK-1220%3A+a+macrocyclic+inhibitor+of+hepatitis+C+virus+NS3%2F4A+protease+with+improved+preclinical+plasma+exposure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31v&amp;dbid=16384&amp;doi=10.1021%2Fml1002426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1002426%26sid%3Dliteratum%253Aachs%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DSwestock%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDiscovery%2520of%2520MK-1220%253A%2520a%2520macrocyclic%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520with%2520improved%2520preclinical%2520plasma%2520exposure%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D207%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31w"><span><span class="NLM_label">(w) </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiFilippo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescenzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burlein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHale, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianetti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span> </span><span class="NLM_article-title">Discovery of MK-5172, a macrocyclic hepatitis C virus NS3/4a protease inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300017p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31w&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFyjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=332-336&author=S.+Harperauthor=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=M.+Ferraraauthor=M.+DiFilippoauthor=B.+Crescenziauthor=U.+Kochauthor=A.+Petrocchiauthor=M.+K.+Hollowayauthor=J.+W.+Butcherauthor=J.+J.+Romanoauthor=K.+J.+Bushauthor=K.+F.+Gilbertauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=E.+Niziauthor=S.+S.+Carrollauthor=S.+W.+Ludmererauthor=C.+Burleinauthor=J.+M.+DiMuzioauthor=D.+J.+Grahamauthor=C.+M.+McHaleauthor=M.+W.+Stahlhutauthor=D.+B.+Olsenauthor=E.+Monteagudoauthor=S.+Cianettiauthor=C.+Giulianoauthor=V.+Pucciauthor=N.+Trainorauthor=C.+M.+Fandozziauthor=M.+Rowleyauthor=P.+J.+Colemanauthor=J.+P.+Vaccaauthor=V.+Summaauthor=N.+J.+Liverton&title=Discovery+of+MK-5172%2C+a+macrocyclic+hepatitis+C+virus+NS3%2F4a+protease+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31wR"><div class="casContent"><span class="casTitleNuber">31w</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor</span></div><div class="casAuthors">Harper, Steven; McCauley, John A.; Rudd, Michael T.; Ferrara, Marco; DiFilippo, Marcello; Crescenzi, Benedetta; Koch, Uwe; Petrocchi, Alessia; Holloway, M. Katharine; Butcher, John W.; Romano, Joseph J.; Bush, Kimberly J.; Gilbert, Kevin F.; McIntyre, Charles J.; Nguyen, Kevin T.; Nizi, Emanuela; Carroll, Steven S.; Ludmerer, Steven W.; Burlein, Christine; DiMuzio, Jillian M.; Graham, Donald J.; McHale, Carolyn M.; Stahlhut, Mark W.; Olsen, David B.; Monteagudo, Edith; Cianetti, Simona; Giuliano, Claudio; Pucci, Vincenzo; Trainor, Nicole; Fandozzi, Christine M.; Rowley, Michael; Coleman, Paul J.; Vacca, Joseph P.; Summa, Vincenzo; Liverton, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">332-336</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of HCV NS3/4a protease inhibitors contg. a P2 to P4 macrocyclic constraint was designed using a mol. modeling-derived strategy.  Building on the profile of previous clin. compds. and exploring the P2 and linker regions of the series allowed for optimization of broad genotype and mutant enzyme potency, cellular activity, and rat liver exposure following oral dosing.  These studies led to the identification of clin. candidate 15 (MK-5172), which is active against genotype 1-3 NS3/4a and clin. relevant mutant enzymes and has good plasma exposure and excellent liver exposure in multiple species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAzCaAN9VqJrVg90H21EOLACvtfcHk0lhbJnOyJDug7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFyjurg%253D&md5=efc04ad0ad47aef13b367fc38d6bbf63</span></div><a href="/servlet/linkout?suffix=cit31w&amp;dbid=16384&amp;doi=10.1021%2Fml300017p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300017p%26sid%3Dliteratum%253Aachs%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DDiFilippo%26aufirst%3DM.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DBurlein%26aufirst%3DC.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DMcHale%26aufirst%3DC.%2BM.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DCianetti%26aufirst%3DS.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DPucci%26aufirst%3DV.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDiscovery%2520of%2520MK-5172%252C%2520a%2520macrocyclic%2520hepatitis%2520C%2520virus%2520NS3%252F4a%2520protease%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D332%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31x"><span><span class="NLM_label">(x) </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burlein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span> </span><span class="NLM_article-title">Development of potent macrocyclic inhibitors of genotype 3a HCV NS3/4A protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7201</span><span class="NLM_x">–</span> <span class="NLM_lpage">7206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7201-7206&author=M.+T.+Ruddauthor=J.+A.+McCauleyauthor=J.+J.+Romanoauthor=J.+W.+Butcherauthor=K.+Bushauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=K.+F.+Gilbertauthor=T.+A.+Lyleauthor=M.+K+Hollowayauthor=B.-L.+Wanauthor=J.+P.+Vaccaauthor=V.+Summaauthor=S.+Harperauthor=M.+Rowleyauthor=S.+S.+Carrollauthor=C.+Burleinauthor=J.+M.+DiMuzioauthor=A.+Gatesauthor=D.+J.+Grahamauthor=Q.+Huangauthor=S.+W.+Ludmererauthor=S.+McClainauthor=C.+McHaleauthor=M.+Stahlhutauthor=C.+Fandozziauthor=A.+Taylorauthor=N.+Trainorauthor=D.+B.+Olsenauthor=N.+J.+Liverton&title=Development+of+potent+macrocyclic+inhibitors+of+genotype+3a+HCV+NS3%2F4A+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31x&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DBush%26aufirst%3DK.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DHolloway%26aufirst%3DM.%2BK%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DBurlein%26aufirst%3DC.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGates%26aufirst%3DA.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMcClain%26aufirst%3DS.%26aulast%3DMcHale%26aufirst%3DC.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DTaylor%26aufirst%3DA.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDevelopment%2520of%2520potent%2520macrocyclic%2520inhibitors%2520of%2520genotype%25203a%2520HCV%2520NS3%252F4A%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7201%26epage%3D7206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31y"><span><span class="NLM_label">(y) </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burlein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span> </span><span class="NLM_article-title">Development of macrocyclic inhibitors of HCV NS3/4A protease with cyclic constrained P2-P4 linkers</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7207</span><span class="NLM_x">–</span> <span class="NLM_lpage">7213</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7207-7213&author=M.+T.+Ruddauthor=C.+J.+McIntyreauthor=J.+J.+Romanoauthor=J.+W.+Butcherauthor=M.+K.+Hollowayauthor=K.+Bushauthor=K.+T.+Nguyenauthor=K.+F.+Gilbertauthor=T.+A.+Lyleauthor=N.+J.+Livertonauthor=B.-L+Wanauthor=V.+Summaauthor=S.+Harperauthor=M.+Rowleyauthor=J.+P.+Vaccaauthor=S.+S.+Carrollauthor=C.+Burleinauthor=J.+M.+DiMuzioauthor=A.+Gatesauthor=D.+J.+Grahamauthor=Q.+Huangauthor=S.+W.+Ludmererauthor=S.+McClainauthor=C.+McHaleauthor=M.+Stahlhutauthor=C.+Fandozziauthor=A.+Taylorauthor=N.+Trainorauthor=D.+B.+Olsenauthor=J.+A.+McCauley&title=Development+of+macrocyclic+inhibitors+of+HCV+NS3%2F4A+protease+with+cyclic+constrained+P2-P4+linkers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31y&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DBush%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DWan%26aufirst%3DB.-L%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DBurlein%26aufirst%3DC.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGates%26aufirst%3DA.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMcClain%26aufirst%3DS.%26aulast%3DMcHale%26aufirst%3DC.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DTaylor%26aufirst%3DA.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26atitle%3DDevelopment%2520of%2520macrocyclic%2520inhibitors%2520of%2520HCV%2520NS3%252F4A%2520protease%2520with%2520cyclic%2520constrained%2520P2-P4%2520linkers%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7207%26epage%3D7213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31z"><span><span class="NLM_label">(z) </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazmierski, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamatake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvest, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creech, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span> </span><span class="NLM_article-title">Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groups</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7351</span><span class="NLM_x">–</span> <span class="NLM_lpage">7356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7351-7356&author=X.+Liauthor=Y.+Liuauthor=Y.-K.+Zhangauthor=J.+J.+Plattnerauthor=S.+J.+Bakerauthor=W.+Buauthor=L.+Liuauthor=Y.+Zhouauthor=C.+Z.+Dingauthor=S.+Zhangauthor=W.+M.+Kazmierskiauthor=R.+Hamatakeauthor=M.+Duanauthor=L.+L.+Wrightauthor=G.+K.+Smithauthor=R.+L.+Jarvestauthor=J.-J.+Jiauthor=J.+P.+Cooperauthor=M.+D.+Tallantauthor=R.+M.+Crosbyauthor=K.+Creechauthor=A.+Wang&title=Synthesis+and+antiviral+activity+of+novel+HCV+NS3+protease+inhibitors+with+P4+capping+groups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31z&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DKazmierski%26aufirst%3DW.%2BM.%26aulast%3DHamatake%26aufirst%3DR.%26aulast%3DDuan%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26aulast%3DJarvest%26aufirst%3DR.%2BL.%26aulast%3DJi%26aufirst%3DJ.-J.%26aulast%3DCooper%26aufirst%3DJ.%2BP.%26aulast%3DTallant%26aufirst%3DM.%2BD.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DCreech%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520antiviral%2520activity%2520of%2520novel%2520HCV%2520NS3%2520protease%2520inhibitors%2520with%2520P4%2520capping%2520groups%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7351%26epage%3D7356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31aa"><span><span class="NLM_label">(aa) </span><span class="NLM_contrib-group">Bilodeau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhardwaj, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordeleau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forgione, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolicoeur, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemke, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Meara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span> </span><span class="NLM_article-title">Synthesis and optimization of a novel series of HCV NS3 protease inhibitors: 4-arylproline analogs</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4267</span><span class="NLM_x">–</span> <span class="NLM_lpage">4271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4267-4271&author=F.+Bilodeauauthor=M.+D.+Baileyauthor=P.+K.+Bhardwajauthor=J.+Bordeleauauthor=P.+Forgioneauthor=M.+Garneauauthor=E.+Ghiroauthor=V.+Gorysauthor=T.+Halmosauthor=E.+S.+Jolicoeurauthor=M.+Leblancauthor=C.+T.+Lemkeauthor=J.+Naudauthor=J.+O%E2%80%99Mearaauthor=P.+W.+Whiteauthor=M.+Llin%C3%A0s-Brunet&title=Synthesis+and+optimization+of+a+novel+series+of+HCV+NS3+protease+inhibitors%3A+4-arylproline+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31aa&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBilodeau%26aufirst%3DF.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBhardwaj%26aufirst%3DP.%2BK.%26aulast%3DBordeleau%26aufirst%3DJ.%26aulast%3DForgione%26aufirst%3DP.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DJolicoeur%26aufirst%3DE.%2BS.%26aulast%3DLeblanc%26aufirst%3DM.%26aulast%3DLemke%26aufirst%3DC.%2BT.%26aulast%3DNaud%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DJ.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520optimization%2520of%2520a%2520novel%2520series%2520of%2520HCV%2520NS3%2520protease%2520inhibitors%253A%25204-arylproline%2520analogs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4267%26epage%3D4271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31ab"><span><span class="NLM_label">(ab) </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemke, C. T.</span><span> </span><span class="NLM_article-title">Discovery of novel P2 substituted 4-biaryl proline inhibitors of hepatitis C virus NS3 serine protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4436</span><span class="NLM_x">–</span> <span class="NLM_lpage">4440</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4436-4440&author=M.+D.+Baileyauthor=T.+Halmosauthor=C.+T.+Lemke&title=Discovery+of+novel+P2+substituted+4-biaryl+proline+inhibitors+of+hepatitis+C+virus+NS3+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31ab&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DLemke%26aufirst%3DC.%2BT.%26atitle%3DDiscovery%2520of%2520novel%2520P2%2520substituted%25204-biaryl%2520proline%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520serine%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4436%26epage%3D4440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31ac"><span><span class="NLM_label">(ac) </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordeleau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemke, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Meara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span> </span><span class="NLM_article-title">Peptide backbone replacement of hepatitis C virus NS3 serine protease C-terminal cleavage product analogs: discovery of potent succinamide inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4447</span><span class="NLM_x">–</span> <span class="NLM_lpage">4452</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4447-4452&author=M.+D.+Baileyauthor=J.+Bordeleauauthor=M.+Garneauauthor=M.+Leblancauthor=C.+T.+Lemkeauthor=J.+O%E2%80%99Mearaauthor=P.+W.+Whiteauthor=M.+Llinas-Brunet&title=Peptide+backbone+replacement+of+hepatitis+C+virus+NS3+serine+protease+C-terminal+cleavage+product+analogs%3A+discovery+of+potent+succinamide+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31ac&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBordeleau%26aufirst%3DJ.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DLeblanc%26aufirst%3DM.%26aulast%3DLemke%26aufirst%3DC.%2BT.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DJ.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26atitle%3DPeptide%2520backbone%2520replacement%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520serine%2520protease%2520C-terminal%2520cleavage%2520product%2520analogs%253A%2520discovery%2520of%2520potent%2520succinamide%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4447%26epage%3D4452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31ad"><span><span class="NLM_label">(ad) </span><span class="NLM_contrib-group">Moreau, B.; O’Meara, J. A.; Bordeleau, J.; Garneau, M.; Godbout, C.; Gorys, V.; Leblanc, M.; Villemure, E.; White, P. W.; Llinas-Brunet, M.</span><span> </span><span class="NLM_article-title">Discovery of hepatitis C Virus NS3-4A protease inhibitors with improved barrier to resistance and favorable liver distribution</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/jm400121t</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm400121t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=B.+Moreau&author=J.+A.+O%E2%80%99Meara&author=J.+Bordeleau&author=M.+Garneau&author=C.+Godbout&author=V.+Gorys&author=M.+Leblanc&author=E.+Villemure&author=P.+W.+White&author=M.+Llinas-Brunet&title=Discovery+of+hepatitis+C+Virus+NS3-4A+protease+inhibitors+with+improved+barrier+to+resistance+and+favorable+liver+distribution&doi=10.1021%2Fjm400121t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31ad&amp;dbid=16384&amp;doi=10.1021%2Fjm400121t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400121t%26sid%3Dliteratum%253Aachs%26aulast%3DMoreau%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520hepatitis%2520C%2520Virus%2520NS3-4A%2520protease%2520inhibitors%2520with%2520improved%2520barrier%2520to%2520resistance%2520and%2520favorable%2520liver%2520distribution%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26doi%3D10.1021%2Fjm400121t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31ae"><span><span class="NLM_label">(ae) </span><span class="NLM_contrib-group">Seiwert, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebryany, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kossen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, P. T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misialek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoycheva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condroski, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hingorani, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beigelman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, L. M.</span><span> </span><span class="NLM_article-title">Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227)</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4432</span><span class="NLM_x">–</span> <span class="NLM_lpage">4441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=4432-4441&author=S.+D.+Seiwertauthor=S.+W.+Andrewsauthor=Y.+Jiangauthor=V.+Serebryanyauthor=H.+Tanauthor=K.+Kossenauthor=P.+T.+R.+Rajagopalanauthor=S.+Misialekauthor=S.+K.+Stevensauthor=A.+Stoychevaauthor=J.+Hongauthor=S.+R.+Limauthor=X.+Qinauthor=R.+Riegerauthor=K.+R.+Condroskiauthor=H.+Zhangauthor=M.+G.+Doauthor=C.+Lemieuxauthor=G.+P.+Hingoraniauthor=D.+P.+Hartleyauthor=J.+A.+Joseyauthor=L.+Panauthor=L.+Beigelmanauthor=L.+M.+Blatt&title=Preclinical+characteristics+of+the+hepatitis+C+virus+NS3%2F4A+protease+inhibitor+ITMN-191+%28R7227%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31ae&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeiwert%26aufirst%3DS.%2BD.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DKossen%26aufirst%3DK.%26aulast%3DRajagopalan%26aufirst%3DP.%2BT.%2BR.%26aulast%3DMisialek%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DStoycheva%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DS.%2BR.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DRieger%26aufirst%3DR.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DDo%26aufirst%3DM.%2BG.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DHingorani%26aufirst%3DG.%2BP.%26aulast%3DHartley%26aufirst%3DD.%2BP.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26atitle%3DPreclinical%2520characteristics%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520inhibitor%2520ITMN-191%2520%2528R7227%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D4432%26epage%3D4441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31af"><span><span class="NLM_label">(af) </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condroski, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebryany, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenglowsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madduru, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodard, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geck Do, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandhuber, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stengel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beigelman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiwert, S. D.</span><span> </span><span class="NLM_article-title">Discovery of danoprevir (ITMN-191/R7227), a highly selective and potent Inhibitor of hepatitis C virus (HCV) NS3/4A protease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1021/jm400164c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400164c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Y.+Jiangauthor=S.+W.+Andrewsauthor=K.+R.+Condroskiauthor=B.+Buckmanauthor=V.+Serebryanyauthor=S.+Wenglowskyauthor=A.+L.+Kennedyauthor=M.+R.+Madduruauthor=B.+Wangauthor=M.+Lyonauthor=G.+A.+Dohertyauthor=B.+T.+Woodardauthor=C.+Lemieuxauthor=M.+Geck+Doauthor=H.+Zhangauthor=J.+Ballardauthor=G.+Vigersauthor=B.+J.+Brandhuberauthor=P.+Stengelauthor=J.+A.+Joseyauthor=L.+Beigelmanauthor=L.+Blattauthor=S.+D.+Seiwert&title=Discovery+of+danoprevir+%28ITMN-191%2FR7227%29%2C+a+highly+selective+and+potent+Inhibitor+of+hepatitis+C+virus+%28HCV%29+NS3%2F4A+protease&doi=10.1021%2Fjm400164c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31af&amp;dbid=16384&amp;doi=10.1021%2Fjm400164c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400164c%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DBuckman%26aufirst%3DB.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DWenglowsky%26aufirst%3DS.%26aulast%3DKennedy%26aufirst%3DA.%2BL.%26aulast%3DMadduru%26aufirst%3DM.%2BR.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DLyon%26aufirst%3DM.%26aulast%3DDoherty%26aufirst%3DG.%2BA.%26aulast%3DWoodard%26aufirst%3DB.%2BT.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DGeck%2BDo%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBallard%26aufirst%3DJ.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DBrandhuber%26aufirst%3DB.%2BJ.%26aulast%3DStengel%26aufirst%3DP.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DL.%26aulast%3DSeiwert%26aufirst%3DS.%2BD.%26atitle%3DDiscovery%2520of%2520danoprevir%2520%2528ITMN-191%252FR7227%2529%252C%2520a%2520highly%2520selective%2520and%2520potent%2520Inhibitor%2520of%2520hepatitis%2520C%2520virus%2520%2528HCV%2529%2520NS3%252F4A%2520protease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26doi%3D10.1021%2Fjm400164c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Vispo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, V.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of new oral hepatitis C antiviral drugs</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.1517%2F17425255.2013.729577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=23094639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVGmsL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=5-16&author=E.+Vispoauthor=P.+Barreiroauthor=V.+Soriano&title=Pharmacokinetics+of+new+oral+hepatitis+C+antiviral+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of new oral hepatitis C antiviral drugs</span></div><div class="casAuthors">Vispo, Eugenia; Barreiro, Pablo; Soriano, Vicente</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-16</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Approx. 175 million people worldwide are chronically infected with the hepatitis C virus (HCV), representing 3% of the total world population.  Until recently, the only available therapeutic option for these patients was the combination of pegylated IFN-α plus ribavirin that overall resulted in HCV eradication in less than a half of cases.  The development of new therapies with greater efficacy has been eagerly awaited but new challenges have emerged, with drug interactions being among the most challenging.Areas covered: This review updates the main pharmacokinetic and pharmacodynamic characteristics of the most promising new oral direct-acting antivirals (DAA) for hepatitis C. Given that a large proportion of chronic hepatitis C patients receive other medications, drug interactions are further discussed.Expert opinion: The recent approval of the first HCV genotype 1 protease inhibitors is a landmark step in the fight against the HCV pandemic.  The benefit of higher rates of response along with shorter duration of treatment is counterbalanced by significant drug interactions and unprecedented complexities in the use of these drugs and management of their side effects.  The knowledge of key pharmacol. parameters of distinct DAA is important for care providers in charge of chronic hepatitis C patients as it will avoid the danger of unexpected drug interactions.  This concern must be particularly emphasized in special group populations, such as in HIV-HCV coinfected individuals and transplant patients, in whom interactions between DAA and antiretrovirals or immunosuppressants, resp., are frequent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQKHyYbjQVarVg90H21EOLACvtfcHk0liHvXiedmJQ_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVGmsL3I&md5=a9e2a8f9c9c5556d8ca8dea1054195cc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1517%2F17425255.2013.729577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2013.729577%26sid%3Dliteratum%253Aachs%26aulast%3DVispo%26aufirst%3DE.%26aulast%3DBarreiro%26aufirst%3DP.%26aulast%3DSoriano%26aufirst%3DV.%26atitle%3DPharmacokinetics%2520of%2520new%2520oral%2520hepatitis%2520C%2520antiviral%2520drugs%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2013%26volume%3D9%26spage%3D5%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Reddy, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morcos, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lave, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P.</span><span> </span><span class="NLM_article-title">Pharmacokinetic/pharmacodynamic predictors of clinical potency for hepatitis C virus nonnucleoside polymerase and protease inhibitors</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3144</span><span class="NLM_x">–</span> <span class="NLM_lpage">3156</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=3144-3156&author=M.+B.+Reddyauthor=P.+N.+Morcosauthor=S.+Le+Pogamauthor=Y.+Ouauthor=K.+Frankauthor=T.+Laveauthor=P.+Smith&title=Pharmacokinetic%2Fpharmacodynamic+predictors+of+clinical+potency+for+hepatitis+C+virus+nonnucleoside+polymerase+and+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DM.%2BB.%26aulast%3DMorcos%26aufirst%3DP.%2BN.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DOu%26aufirst%3DY.%26aulast%3DFrank%26aufirst%3DK.%26aulast%3DLave%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DP.%26atitle%3DPharmacokinetic%252Fpharmacodynamic%2520predictors%2520of%2520clinical%2520potency%2520for%2520hepatitis%2520C%2520virus%2520nonnucleoside%2520polymerase%2520and%2520protease%2520inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D3144%26epage%3D3156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Lindenbach, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Unravelling hepatitis C virus replication from genome to function</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">938</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.1038%2Fnature04077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=16107832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXotFent7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=933-938&author=B.+D.+Lindenbachauthor=C.+M.+Rice&title=Unravelling+hepatitis+C+virus+replication+from+genome+to+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Unravelling hepatitis C virus replication from genome to function</span></div><div class="casAuthors">Lindenbach, Brett D.; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">436</span>
        (<span class="NLM_cas:issue">7053</span>),
    <span class="NLM_cas:pages">933-938</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the discovery of the hepatitis C virus over 15 years ago, scientists have raced to develop diagnostics, study the virus and find new therapies.  Yet virtually every attempt to dissect this pathogen has met with roadblocks that impeded progress.  Its replication was restricted to humans or exptl. infected chimpanzees, and efficient growth of the virus in cell culture failed until very recently.  Nevertheless hard-fought progress has been made and the first wave of antiviral drugs is entering clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI6vc6EOs8vLVg90H21EOLACvtfcHk0li5e1G3cx02Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXotFent7o%253D&md5=553517cac32b797ef7a2d07f496a7b5c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnature04077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04077%26sid%3Dliteratum%253Aachs%26aulast%3DLindenbach%26aufirst%3DB.%2BD.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DUnravelling%2520hepatitis%2520C%2520virus%2520replication%2520from%2520genome%2520to%2520function%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D933%26epage%3D938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1420</span><span class="NLM_x">–</span> <span class="NLM_lpage">1456</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx200211v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptlCitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1420-1456&author=N.+A.+Meanwell&title=Improving+drug+candidates+by+design%3A+a+focus+on+physicochemical+properties+as+a+means+of+improving+compound+disposition+and+safety"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1420-1456</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of small mol. drug candidates from the discovery phase to a marketed product continues to be a challenging enterprise with very low success rates that have fostered the perception of poor productivity by the pharmaceutical industry.  Although there have been significant advances in preclin. profiling that have improved compd. triaging and altered the underlying reasons for compd. attrition, the failure rates have not appreciably changed.  As part of an effort to more deeply understand the reasons for candidate failure, there has been considerable interest in analyzing the physicochem. properties of marketed drugs for the purpose of comparing with drugs in discovery and development as a means capturing recent trends in drug design.  The scenario that has emerged is one in which contemporary drug discovery is thought to be focused too heavily on advancing candidates with profiles that are most easily satisfied by mols. with increased mol. wt. and higher overall lipophilicity.  The preponderance of mols. expressing these properties is frequently a function of increased arom. ring count when compared with that of the drugs launched in the latter half of the 20th century and may reflect a preoccupation with maximizing target affinity rather than taking a more holistic approach to drug design.  These attributes not only present challenges for formulation and absorption but also may influence the manifestation of toxicity during development.  By providing some definition around the optimal physicochem. properties assocd. with marketed drugs, guidelines for drug design have been developed that are based largely on calcd. parameters and which may readily be applied by medicinal chemists as an aid to understanding candidate quality.  The physicochem. properties of a mol. that are consistent with the potential for good oral absorption were initially defined by Lipinski, with addnl. insights allowing further refinement, while deeper analyses have explored the correlation with metabolic stability and toxicity.  These insights have been augmented by careful analyses of physicochem. aspects of drug-target interactions, with thermodn. profiling indicating that the signature of best-in-class drugs is a dependence on enthalpy to drive binding energetics rather than entropy, which is dependent on lipophilicity.  Optimization of the entropic contribution to the binding energy of a ligand to its target is generally much easier than refining the enthalpic element.  Consequently, in the absence of a fundamental understanding of the thermodn. complexion of an interaction, the design of mols. with increased lipophilicity becomes almost inevitable.  The application of ligand efficiency, a measure of affinity per heavy atom, group efficiency, which assesses affinity in the context of structural changes, and lipophilic ligand efficiency, which relates potency to lipophilicity, offer less sophisticated but practically useful anal. algorithms to assess the quality of drug-target interactions.  These parameters are readily calcd. and can be applied to lead optimization programs in a fashion that helps to maximize potency while minimizing the kind of lipophilic burden that has been dubbed "mol. obesity".  Several recently described lead optimization campaigns provide illustrative, informative, and productive examples of the effect of paying close attention to carefully controlling physicochem. properties by monitoring ligand efficiency and lipophilic ligand efficiency.  However, to be successful during the lead optimization phase, drug candidate identification programs will need to adopt a holistic approach that integrates multiple parameters, many of which will have unique dependencies on both the drug target and the specific chemotype under prosecution.  Nevertheless, there are many important drug targets that necessitate working in space beyond that which has been defined by the retrospective analyses of marketed drugs and which will require adaptation of some of the guideposts that are useful in directing lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQrUfIwZiIR7Vg90H21EOLACvtfcHk0li5e1G3cx02Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptlCitLs%253D&md5=9ddcf6dc81bf8ab0441df5037979ff4e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Ftx200211v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200211v%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DImproving%2520drug%2520candidates%2520by%2520design%253A%2520a%2520focus%2520on%2520physicochemical%2520properties%2520as%2520a%2520means%2520of%2520improving%2520compound%2520disposition%2520and%2520safety%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1420%26epage%3D1456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span> </span><span class="NLM_article-title">A systematic approach to the optimization of substrate-based inhibitors of the hepatitis C virus NS3 protease: discovery of potent and specific tripeptide inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">6584</span><span class="NLM_x">–</span> <span class="NLM_lpage">6594</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0494523" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6584-6594&issue=26&author=M.+Llin%C3%A0s-Brunetauthor=M.+D.+Baileyauthor=E.+Ghiroauthor=V.+Gorysauthor=T.+Halmosauthor=M.+Poirierauthor=J.+Rancourtauthor=N.+Goudreau&title=A+systematic+approach+to+the+optimization+of+substrate-based+inhibitors+of+the+hepatitis+C+virus+NS3+protease%3A+discovery+of+potent+and+specific+tripeptide+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm0494523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0494523%26sid%3Dliteratum%253Aachs%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DGoudreau%26aufirst%3DN.%26atitle%3DA%2520systematic%2520approach%2520to%2520the%2520optimization%2520of%2520substrate-based%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%253A%2520discovery%2520of%2520potent%2520and%2520specific%2520tripeptide%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D26%26spage%3D6584%26epage%3D6594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Johnson, F.</span><span> </span><span class="NLM_article-title">Allylic strain in six-membered rings</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr60254a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1968&pages=375-413&author=F.+Johnson&title=Allylic+strain+in+six-membered+rings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fcr60254a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr60254a001%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DF.%26atitle%3DAllylic%2520strain%2520in%2520six-membered%2520rings%26jtitle%3DChem.%2520Rev.%26date%3D1968%26volume%3D68%26spage%3D375%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Anderson, G. M.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domelsmith, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houk, K. N.</span><span> </span><span class="NLM_article-title">Methoxy group nonplanarity in <i>o</i>-dimethoxybenzenes. Simple predictive models for conformations and rotational barriers in alkoxyaromatics</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">2344</span><span class="NLM_x">–</span> <span class="NLM_lpage">2352</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00503a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1979&pages=2344-2352&author=G.+M.+Andersonauthor=P.+A.+Kollmanauthor=L.+N.+Domelsmithauthor=K.+N.+Houk&title=Methoxy+group+nonplanarity+in+o-dimethoxybenzenes.+Simple+predictive+models+for+conformations+and+rotational+barriers+in+alkoxyaromatics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fja00503a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00503a018%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DG.%2BM.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26aulast%3DDomelsmith%26aufirst%3DL.%2BN.%26aulast%3DHouk%26aufirst%3DK.%2BN.%26atitle%3DMethoxy%2520group%2520nonplanarity%2520in%2520o-dimethoxybenzenes.%2520Simple%2520predictive%2520models%2520for%2520conformations%2520and%2520rotational%2520barriers%2520in%2520alkoxyaromatics%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1979%26volume%3D101%26spage%3D2344%26epage%3D2352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Mecozzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doughtery, D. A.</span><span> </span><span class="NLM_article-title">Cation–pi interactions in aromatics of biological and medicinal interest: electrostatic potential surfaces as a useful qualitative guide</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">10566</span><span class="NLM_x">–</span> <span class="NLM_lpage">10571</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=10566-10571&author=S.+Mecozziauthor=A.+P.+Westauthor=D.+A.+Doughtery&title=Cation%E2%80%93pi+interactions+in+aromatics+of+biological+and+medicinal+interest%3A+electrostatic+potential+surfaces+as+a+useful+qualitative+guide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMecozzi%26aufirst%3DS.%26aulast%3DWest%26aufirst%3DA.%2BP.%26aulast%3DDoughtery%26aufirst%3DD.%2BA.%26atitle%3DCation%25E2%2580%2593pi%2520interactions%2520in%2520aromatics%2520of%2520biological%2520and%2520medicinal%2520interest%253A%2520electrostatic%2520potential%2520surfaces%2520as%2520a%2520useful%2520qualitative%2520guide%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1996%26volume%3D93%26spage%3D10566%26epage%3D10571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Hansch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikaitani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lien, E. J.</span><span> </span><span class="NLM_article-title">Aromatic substituent constants for structure–activity correlations</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1207</span><span class="NLM_x">–</span> <span class="NLM_lpage">1216</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00269a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1973&pages=1207-1216&author=C.+Hanschauthor=A.+Leoauthor=S.+H.+Ungerauthor=K.+H.+Kimauthor=D.+Nikaitaniauthor=E.+J.+Lien&title=Aromatic+substituent+constants+for+structure%E2%80%93activity+correlations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm00269a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00269a003%26sid%3Dliteratum%253Aachs%26aulast%3DHansch%26aufirst%3DC.%26aulast%3DLeo%26aufirst%3DA.%26aulast%3DUnger%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DNikaitani%26aufirst%3DD.%26aulast%3DLien%26aufirst%3DE.%2BJ.%26atitle%3DAromatic%2520substituent%2520constants%2520for%2520structure%25E2%2580%2593activity%2520correlations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1973%26volume%3D16%26spage%3D1207%26epage%3D1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Dougherty, D. A.</span><span> </span><span class="NLM_article-title">The cation−π interaction</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">885</span><span class="NLM_x">–</span> <span class="NLM_lpage">893</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar300265y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2013&pages=885-893&author=D.+A.+Dougherty&title=The+cation%E2%88%92%CF%80+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Far300265y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far300265y%26sid%3Dliteratum%253Aachs%26aulast%3DDougherty%26aufirst%3DD.%2BA.%26atitle%3DThe%2520cation%25E2%2588%2592%25CF%2580%2520interaction%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2013%26volume%3D46%26spage%3D885%26epage%3D893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fleming, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravikumar, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shook, B. C.</span><span> </span><span class="NLM_article-title">Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">7902</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100762r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7902-17&issue=22&author=F.+F.+Flemingauthor=L.+Yaoauthor=P.+C.+Ravikumarauthor=L.+Funkauthor=B.+C.+Shook&title=Nitrile-containing+pharmaceuticals%3A+efficacious+roles+of+the+nitrile+pharmacophore"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=10.1021%2Fjm100762r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100762r%26sid%3Dliteratum%253Aachs%26aulast%3DFleming%26aufirst%3DF.%2BF.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DRavikumar%26aufirst%3DP.%2BC.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DShook%26aufirst%3DB.%2BC.%26atitle%3DNitrile-containing%2520pharmaceuticals%253A%2520efficacious%2520roles%2520of%2520the%2520nitrile%2520pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D22%26spage%3D7902%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit42b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wheeler, S. E.</span><span> </span><span class="NLM_article-title">Understanding substituent effects in noncovalent interactions involving aromatic rings</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1038</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar300109n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFWgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2013&pages=1029-1038&author=S.+E.+Wheeler&title=Understanding+substituent+effects+in+noncovalent+interactions+involving+aromatic+rings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42bR"><div class="casContent"><span class="casTitleNuber">42b</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding Substituent Effects in Noncovalent Interactions Involving Aromatic Rings</span></div><div class="casAuthors">Wheeler, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1029-1038</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Noncovalent interactions involving arom. rings such as π-stacking, cation/π, and anion/π interactions are central to many areas of modern chem.  Decades of exptl. studies have provided key insights into the impact of substituents on these interactions, leading to the development of simple intuitive models.  However, gas-phase computational studies have raised some doubts about the phys. underpinnings of these widespread models.  In this Account we review our recent efforts to unravel the origin of substituent effects in π-stacking and ion/π interactions through computational studies of model noncovalent dimers.  First, however, we dispel the notion that so-called arom. interactions depend on the aromaticity of the interacting rings by studying model π-stacked dimers in which the aromaticity of one of the monomers can be "switched off".  Somewhat surprisingly, the results show that not only is aromaticity unnecessary for π-stacking interactions, but it actually hinders these interactions to some extent.  Consequently, when thinking about π-stacking interactions, researchers should consider broader classes of planar mols., not just arom. systems.  Conventional models maintain that substituent effects in π-stacking interactions result from changes in the aryl π-system.  This view suggests that π-stacking interactions are maximized when one ring is substituted with electron-withdrawing groups and the other with electron donors.  In contrast to these prevailing models, we have shown that substituent effects in π-stacking interactions can be described in terms of direct, local interactions between the substituents and the nearby vertex of the other arene.  As a result, in polysubstituted π-stacked dimers the substituents operate independently unless they are in each other's local environment.  This means that in π-stacked dimers in which one arene is substituted with electron donors and the other with electron acceptors the interactions will be enhanced only to the extent provided by each substituent on its own, unless the substituents on opposing rings are in close proximity.  Overall, this local, direct interaction model predicts that substituent effects in π-stacking interactions will be additive and transferable and will also depend on the relative position of substituents on opposing rings.  For cation/π and anion/π interactions, similar π-resonance-based models pervade the literature.  Again, computational results indicate that substituent effects in model ion/π complexes can be described primarily in terms of direct interactions between the ion and the substituent.  Changes in the aryl π-system do not significantly affect these interactions.  We also present a simple electrostatic model that further demonstrates this effect and suggests that the dominant interaction for simple substituents is the interaction of the charged ion with the local dipole assocd. with the substituents.  Finally, we discuss substituent effects in electrostatic potentials (ESPs), which are widely used in discussions of noncovalent interactions.  In the past, widespread misconceptions have confused the relationship between changes in ESPs and local changes in the electron d.  We have shown that computed ESP plots of diverse substituted arenes can be reproduced without altering the aryl π-d.  This is because substituent-induced changes in the ESP above the center of aryl rings result primarily from through-space effects of substituents rather than through changes in the distribution of the π-electron d.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCxWKVlXTL2LVg90H21EOLACvtfcHk0ljIJpRHpVIGsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFWgu7k%253D&md5=045fc22890c76cf01d324cfcc2e44760</span></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=10.1021%2Far300109n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far300109n%26sid%3Dliteratum%253Aachs%26aulast%3DWheeler%26aufirst%3DS.%2BE.%26atitle%3DUnderstanding%2520substituent%2520effects%2520in%2520noncovalent%2520interactions%2520involving%2520aromatic%2520rings%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2013%26volume%3D46%26spage%3D1029%26epage%3D1038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Yedidi, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fyvie, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garimella, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wingfield, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuya, H.</span><span> </span><span class="NLM_article-title">P2′ benzene carboxylic acid moiety is associated with decrease in cellular uptake: evaluation of novel nonpeptidic HIV-1 protease inhibitors containing P2 bis-tetrahydrofuran moiety</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">4920</span><span class="NLM_x">–</span> <span class="NLM_lpage">4927</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=4920-4927&issue=10&author=R.+S.+Yedidiauthor=K.+Maedaauthor=W.+S.+Fyvieauthor=M.+Steffeyauthor=D.+A.+Davisauthor=I.+Palmerauthor=M.+Aokiauthor=J.+D.+Kaufmanauthor=S.+J.+Stahlauthor=H.+Garimellaauthor=D.+Dasauthor=P.+T.+Wingfieldauthor=A.+K.+Ghoshauthor=H.+Mitsuya&title=P2%E2%80%B2+benzene+carboxylic+acid+moiety+is+associated+with+decrease+in+cellular+uptake%3A+evaluation+of+novel+nonpeptidic+HIV-1+protease+inhibitors+containing+P2+bis-tetrahydrofuran+moiety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYedidi%26aufirst%3DR.%2BS.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DFyvie%26aufirst%3DW.%2BS.%26aulast%3DSteffey%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DD.%2BA.%26aulast%3DPalmer%26aufirst%3DI.%26aulast%3DAoki%26aufirst%3DM.%26aulast%3DKaufman%26aufirst%3DJ.%2BD.%26aulast%3DStahl%26aufirst%3DS.%2BJ.%26aulast%3DGarimella%26aufirst%3DH.%26aulast%3DDas%26aufirst%3DD.%26aulast%3DWingfield%26aufirst%3DP.%2BT.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DMitsuya%26aufirst%3DH.%26atitle%3DP2%25E2%2580%25B2%2520benzene%2520carboxylic%2520acid%2520moiety%2520is%2520associated%2520with%2520decrease%2520in%2520cellular%2520uptake%253A%2520evaluation%2520of%2520novel%2520nonpeptidic%2520HIV-1%2520protease%2520inhibitors%2520containing%2520P2%2520bis-tetrahydrofuran%2520moiety%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26issue%3D10%26spage%3D4920%26epage%3D4927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Han, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cliff Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, D. A.</span><span> </span><span class="NLM_article-title">Transporter studies with the 3-<i>O</i>-sulfate conjugate of 17α-ethinylestradiol: human liver drug transporters</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1072</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1072-82&issue=7&author=Y.+Hanauthor=D.+Buslerauthor=Y.+Hongauthor=Y.+Tianauthor=C.+Cliff+Chenauthor=D.+A.+Rodrigues&title=Transporter+studies+with+the+3-O-sulfate+conjugate+of+17%CE%B1-ethinylestradiol%3A+human+liver+drug+transporters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DY.%26aulast%3DBusler%26aufirst%3DD.%26aulast%3DHong%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DCliff%2BChen%26aufirst%3DC.%26aulast%3DRodrigues%26aufirst%3DD.%2BA.%26atitle%3DTransporter%2520studies%2520with%2520the%25203-O-sulfate%2520conjugate%2520of%252017%25CE%25B1-ethinylestradiol%253A%2520human%2520liver%2520drug%2520transporters%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26issue%3D7%26spage%3D1072%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit44b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">Hepatocyte uptake experiments were performed according to the silicone oil layer method (ref <a onclick="showRef(event, 'cit44a'); return false;" href="javascript:void(0);" class="ref cit44a">44a</a>). Fresh rat hepatocytes were isolated from SD rats. Fresh dog and cryopreserved human hepatocytes were purchased from Cellzdirect (Durham, NC) and In Vitro Technologies (Baltimore, MD), respectively. In brief, hepatocyte uptake was initiated by adding a solution of [3H]BMS-605339 to cell suspensions (1 mL, 2 ×10<sup>6</sup> cells/mL) that had been preincubated at 37 °C for 3 min in Krebs–Henseleit buffer. At 20 s and 1 min, 200 μL aliquots of each cell suspension were placed in centrifuge tubes containing 50 μL of 3 M KOH and were covered by 100 μL of a mixture of silicone/mineral oil (density, 1.015). The samples were then centrifuged to sediment the hepatocytes into the 3 M KOH layer, and both cell and medium radioactivity was determined in a liquid scintillation spectrophotometer. To evaluate if BMS-605339 uptake is energy-dependent, ice-cold cells were preincubated at 4 °C for 3 min and uptake determinations performed as described for the 37 °C experiments. To obtain <i>K</i><sub>m</sub> values for hepatocytic uptake of [<sup>3</sup>H]BMS-605339, the uptake was measured at different concentrations of [<sup>3</sup>H]BMS-605339 (0.5–250 μM).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hepatocyte+uptake+experiments+were+performed+according+to+the+silicone+oil+layer+method+%28ref+44a%29.+Fresh+rat+hepatocytes+were+isolated+from+SD+rats.+Fresh+dog+and+cryopreserved+human+hepatocytes+were+purchased+from+Cellzdirect+%28Durham%2C+NC%29+and+In+Vitro+Technologies+%28Baltimore%2C+MD%29%2C+respectively.+In+brief%2C+hepatocyte+uptake+was+initiated+by+adding+a+solution+of+%5B3H%5DBMS-605339+to+cell+suspensions+%281+mL%2C+2+%C3%97106+cells%2FmL%29+that+had+been+preincubated+at+37+%C2%B0C+for+3+min+in+Krebs%E2%80%93Henseleit+buffer.+At+20+s+and+1+min%2C+200+%CE%BCL+aliquots+of+each+cell+suspension+were+placed+in+centrifuge+tubes+containing+50+%CE%BCL+of+3+M+KOH+and+were+covered+by+100+%CE%BCL+of+a+mixture+of+silicone%2Fmineral+oil+%28density%2C+1.015%29.+The+samples+were+then+centrifuged+to+sediment+the+hepatocytes+into+the+3+M+KOH+layer%2C+and+both+cell+and+medium+radioactivity+was+determined+in+a+liquid+scintillation+spectrophotometer.+To+evaluate+if+BMS-605339+uptake+is+energy-dependent%2C+ice-cold+cells+were+preincubated+at+4+%C2%B0C+for+3+min+and+uptake+determinations+performed+as+described+for+the+37+%C2%B0C+experiments.+To+obtain+Km+values+for+hepatocytic+uptake+of+%5B3H%5DBMS-605339%2C+the+uptake+was+measured+at+different+concentrations+of+%5B3H%5DBMS-605339+%280.5%E2%80%93250+%CE%BCM%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Wang, Z. A.; Sun, L.-Q.; Sit, S.-Y.; Sin, N.; Scola, P. M.; Hewawasam, P.; Good, A. C.; Chen, Y.; Campbell, J. A.</span><span> </span><span class="NLM_article-title">Preparation of peptides as hepatitis C virus inhibitors</span>. World Patent Application WO-2003/099274 A1, December 4,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=Z.+A.+Wang&author=L.-Q.+Sun&author=S.-Y.+Sit&author=N.+Sin&author=P.+M.+Scola&author=P.+Hewawasam&author=A.+C.+Good&author=Y.+Chen&author=J.+A.+Campbell&title=Preparation+of+peptides+as+hepatitis+C+virus+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%2BA.%26atitle%3DPreparation%2520of%2520peptides%2520as%2520hepatitis%2520C%2520virus%2520inhibitors%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Briet, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookes, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davenport, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, F. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabin, V.</span><span> </span><span class="NLM_article-title">Synthesis of novel substituted isoquinolones</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5761</span><span class="NLM_x">–</span> <span class="NLM_lpage">5766</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=5761-5766&author=N.+Brietauthor=M.+H.+Brookesauthor=R.+J.+Davenportauthor=F.+C.+A.+Galvinauthor=P.+J.+Gilbertauthor=S.+R.+Mackauthor=V.+Sabin&title=Synthesis+of+novel+substituted+isoquinolones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBriet%26aufirst%3DN.%26aulast%3DBrookes%26aufirst%3DM.%2BH.%26aulast%3DDavenport%26aufirst%3DR.%2BJ.%26aulast%3DGalvin%26aufirst%3DF.%2BC.%2BA.%26aulast%3DGilbert%26aufirst%3DP.%2BJ.%26aulast%3DMack%26aufirst%3DS.%2BR.%26aulast%3DSabin%26aufirst%3DV.%26atitle%3DSynthesis%2520of%2520novel%2520substituted%2520isoquinolones%26jtitle%3DTetrahedron%26date%3D2002%26volume%3D58%26spage%3D5761%26epage%3D5766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2267</span><span class="NLM_x">–</span> <span class="NLM_lpage">2270</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=2267-2270&author=M.+Llinas-Brunetauthor=M.+Baileyauthor=G.+Fazalauthor=E.+Ghiroauthor=V.+Gorysauthor=S.+Gouletauthor=T.+Halmosauthor=R.+Mauriceauthor=M.+Poirierauthor=M.-A.+Poupartauthor=J.+Rancourtauthor=D.+Thibeaultauthor=D.+Wernicauthor=D.+Lamarre&title=Highly+potent+and+selective+peptide-based+inhibitors+of+the+hepatitis+C+virus+serine+protease%3A+towards+smaller+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DFazal%26aufirst%3DG.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DMaurice%26aufirst%3DR.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DWernic%26aufirst%3DD.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DHighly%2520potent%2520and%2520selective%2520peptide-based%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520serine%2520protease%253A%2520towards%2520smaller%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D2267%26epage%3D2270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scola, P. M.</span><span> </span><span class="NLM_article-title">A facile synthesis of 1-substituted cyclopropylsulfonamides</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">728</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=725-728&author=J.+Liauthor=D.+Smithauthor=H.+S.+Wongauthor=J.+A.+Campbellauthor=N.+A.+Meanwellauthor=P.+M.+Scola&title=A+facile+synthesis+of+1-substituted+cyclopropylsulfonamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DWong%26aufirst%3DH.%2BS.%26aulast%3DCampbell%26aufirst%3DJ.%2BA.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DScola%26aufirst%3DP.%2BM.%26atitle%3DA%2520facile%2520synthesis%2520of%25201-substituted%2520cyclopropylsulfonamides%26jtitle%3DSynlett%26date%3D2006%26spage%3D725%26epage%3D728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="note"><p class="first last">Crystal structure data (CCDC 984481) has been deposited to Cambridge Structure Database.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">McPhee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheaffer, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friborg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaniewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosure, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scola, P.</span><span> </span><span class="NLM_article-title">Preclinical profile and characterization of the hepatitis C virus NS3 protease inhibitor asunaprevir (BMS-650032)</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5387</span><span class="NLM_x">–</span> <span class="NLM_lpage">5396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=5387-5396&author=F.+McPheeauthor=A.+K.+Sheafferauthor=J.+Friborgauthor=D.+Hernandezauthor=P.+Falkauthor=G.+Zhaiauthor=S.+Levineauthor=S.+Chaniewskiauthor=F.+Yuauthor=D.+Barryauthor=C.+Chenauthor=M.+S.+Leeauthor=K.+Mosureauthor=L.-Q.+Sunauthor=M.+Sinzauthor=N.+A.+Meanwellauthor=R.+J.+Colonnoauthor=J.+Knipeauthor=P.+Scola&title=Preclinical+profile+and+characterization+of+the+hepatitis+C+virus+NS3+protease+inhibitor+asunaprevir+%28BMS-650032%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DSheaffer%26aufirst%3DA.%2BK.%26aulast%3DFriborg%26aufirst%3DJ.%26aulast%3DHernandez%26aufirst%3DD.%26aulast%3DFalk%26aufirst%3DP.%26aulast%3DZhai%26aufirst%3DG.%26aulast%3DLevine%26aufirst%3DS.%26aulast%3DChaniewski%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DBarry%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DSun%26aufirst%3DL.-Q.%26aulast%3DSinz%26aufirst%3DM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DKnipe%26aufirst%3DJ.%26aulast%3DScola%26aufirst%3DP.%26atitle%3DPreclinical%2520profile%2520and%2520characterization%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitor%2520asunaprevir%2520%2528BMS-650032%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D5387%26epage%3D5396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Lok, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martorell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everson, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghalib, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reindollar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustgi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wind-Rotolo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrova, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquinelli, C.</span><span> </span><span class="NLM_article-title">Preliminary study of two antiviral agents for hepatitis C genotype 1</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">366</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm401840s&amp;key=10.1056%2FNEJMoa1104430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm401840s&amp;key=22256805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm401840s&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1yltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2012&pages=216-224&author=A.+S.+Lokauthor=D.+F.+Gardinerauthor=E.+Lawitzauthor=C.+Martorellauthor=G.+T.+Eversonauthor=R.+Ghalibauthor=R.+Reindollarauthor=V.+Rustgiauthor=F.+McPheeauthor=M.+Wind-Rotoloauthor=A.+Perssonauthor=K.+Zhuauthor=D.+I.+Dimitrovaauthor=T.+Eleyauthor=T.+Guoauthor=D.+M.+Graselaauthor=C.+Pasquinelli&title=Preliminary+study+of+two+antiviral+agents+for+hepatitis+C+genotype+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Preliminary study of two antiviral agents for hepatitis C genotype 1</span></div><div class="casAuthors">Lok, Anna S.; Gardiner, David F.; Lawitz, Eric; Martorell, Claudia; Everson, Gregory T.; Ghalib, Reem; Reindollar, Robert; Rustgi, Vinod; McPhee, Fiona; Wind-Rotolo, Megan; Persson, Anna; Zhu, Kurt; Dimitrova, Dessislava I.; Eley, Timothy; Guo, Tong; Grasela, Dennis M.; Pasquinelli, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">216-224</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Patients with chronic hepatitis C virus (HCV) infection who have not had a response to therapy with peginterferon and ribavirin may benefit from the addn. of multiple direct-acting antiviral agents to their treatment regimen.  METHODS: This open-label, phase 2a study included an exploratory cohort of 21 patients with chronic HCV genotype 1 infection who had not had a response to previous therapy (i.e., had not had ≥2 log10 decline in HCV RNA after ≥12 wk of treatment with peginterferon and ribavirin).  We randomly assigned patients to receive the NS5A replication complex inhibitor daclatasvir (60 mg once daily) and the NS3 protease inhibitor asunaprevir (600 mg twice daily) alone (group A, 11 patients) or in combination with peginterferon alfa-2a and ribavirin (group B, 10 patients) for 24 wk.  The primary end point was the percentage of patients with a sustained virol. response 12 wk after the end of the treatment period.  RESULTS: A total of 4 patients in group A (36%; 2 of 9 with HCV genotype la and 2 of 2 with genotype lb) had a sustained virol. response at 12 wk after treatment and also at 24 wk after treatment.  Six patients (all with HCV genotype la) had viral breakthrough while receiving therapy, and resistance mutations to both antiviral agents were found in all cases; 1 patient had a viral response at the end of treatment but had a relapse after the treatment period.  All 10 patients in group B had a sustained virol. response at 12 wk after treatment, and 9 had a sustained virol. response at 24 wk after treatment Diarrhea was the most common adverse event in both groups.  Six patients had transient elevations of alanine aminotransferase levels to more than 3 times the upper limit of the normal range.  CONCLUSIONS: This preliminary study involving patients with HCV genotype 1 infection who had not had a response to prior therapy showed that a sustained virol. response can be achieved with two direct-acting antiviral agents only.  In addn., a high rate of sustained virol. response was achieved when the two direct-acting antiviral agents were combined with peginterferon alfa-2a and ribavirin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiY7QiDziiRbVg90H21EOLACvtfcHk0liSIb-x6AMlTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1yltrw%253D&md5=5b986bac6ea53144898c91e8e2eaf5bc</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1104430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1104430%26sid%3Dliteratum%253Aachs%26aulast%3DLok%26aufirst%3DA.%2BS.%26aulast%3DGardiner%26aufirst%3DD.%2BF.%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DMartorell%26aufirst%3DC.%26aulast%3DEverson%26aufirst%3DG.%2BT.%26aulast%3DGhalib%26aufirst%3DR.%26aulast%3DReindollar%26aufirst%3DR.%26aulast%3DRustgi%26aufirst%3DV.%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DWind-Rotolo%26aufirst%3DM.%26aulast%3DPersson%26aufirst%3DA.%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DDimitrova%26aufirst%3DD.%2BI.%26aulast%3DEley%26aufirst%3DT.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DPasquinelli%26aufirst%3DC.%26atitle%3DPreliminary%2520study%2520of%2520two%2520antiviral%2520agents%2520for%2520hepatitis%2520C%2520genotype%25201%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D366%26spage%3D216%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NWK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NWK','PDB','4NWK'); return false;">PDB: 4NWK</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i74"><a href="/doi/suppl/10.1021/jm401840s">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_14051"></div></div></div></div></div><hr /></hr><p class="last">Experimental details of biological assays, synthetic intermediates, and p<i>K</i><sub>a</sub> determinations. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401840s/suppl_file/jm401840s_si_001.pdf">jm401840s_si_001.pdf (155.64 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401840s&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-5%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm401840s%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401840s" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a8148aff724bb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
